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Abstract
Isolation o f  the testis-specific human gene TSGA10 was reported in 2001 (Modarressi et 
al.). In this project, I have carried on the work by further characterising the gene and its 
product by cloning and sequencing the mouse homologue (TsgalO) (GenBank 
Accession no. AF5300501). TsgalO was localised ( ^ 7  r -XSH)  ‘ to mouse 
chromosome 1 band B, and RNA in situ hybridization and RT-PCR experiments 
showed that TsgalO  transcripts were developmental^ regulated and expressed in 
pachytene cells o f  the testis. It was also expressed in some other actively dividing cells 
such as foetal tissues, primary tumors and astrocytes. Interestingly, the program Pfam 
(which predicts protein structural motifs) suggests that the TsgalO protein contains a 
‘myosin like’ coiled-coil domain. A Green fluorescent protein (GFP)-TsgalO fusion 
gene was constructed and cell transfection resulted in the formation o f short thick 
protein filaments. Antibodies raised individually against the N-terminus and C-terminus 
parts o f  the TsgalO protein were used to localise TsgalO protein expression by 
immunohistochemistry. In collaboration with Hossein Modarressi and Frans Van der 
Hoorn, using immuno-blotting and staining techniques, I discovered that TsgalO 
encodes a 82 kD precursor protein in spermatids which is incorporated into sperm tails. 
Upon passage o f sperm into the epididymis this is processed to a 27 kD protein which is 
associated with the fibrous sheath, a major tail structure. Using TsgalO  as bait in a yeast 
two-hybrid experiment,utestis cDNA library was screened for proteins that interacted 
with TsgalO. Three candidate interacting proteins were found; Odf2, a previously 
described protein o f  the fibrous sheath, the rat homologue o f  F U 32880 , (a hypothetical 
human protein whose gene is expressed predominantly in spermatocytes, spermatids
2
and mature sperm cells), and the mitochondrial protein cytochrome c l .  Using 
immunocytochemistry I then localised FLJ32880 (newly named as TSGA10 interacting 
protein, TSGA10IP) in the sperm tail as another fibrous sheath protein. These results 
support the theory that TsgalO has a role to play in the fibrous sheath o f the sperm tail, 
and also suggest a possible functional involvement with a mitochondrial protein. 
Antibody was raised against the mouse homologue o f  TSGA10IP for further study. I 
suggest that TsgalO  plays multiple roles, one in sperm tail formation and possibly a 
second role in cell cycle regulation.
1 All of the nucleotide numbers given in this thesis are based on TsgalO sequence (AF530050) which I 
submitted into the GenBank database.
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Chapter 1: Introduction
1.1 Testis and Seminiferous tubules
The testis lies within a serous sac named tunica vaginalis and is covered by a 
smooth white capsule, the tunica albuginea, from which septa extend into the organ 
to divide it into 200-300 pyramidal lobules (in human). Each pyramid contains one 
to three tightly packed and highly convoluted seminiferous tubules, which contain 
gametes in various stages o f  development and supportive Sertoli cells. The tubules in 
each lobule join to form a short, straight tube called the straight rectus tubule. From 
all lobules, these tubules connect to form a collecting network towards the posterior 
portion o f  the testis called retes testis, which empties into the highly convoluted 
efferent ductule. The tunica vasculosa contains a plexus o f blood vessels and delicate 
loose connective tissue, extending over the internal aspect o f the tunica albuginea 
and covering the septa and all testicular lobules. The testis can be considered as a 
gland with two closely related functions; the first, carried out by somatic cells, is its 
function in exocrine and endocrine secretion producing semen and male sex 
hormones (androgens) in mature testis. The second role is the production o f germ 
cells and their maturation to fertile spermatozoa. Before puberty, the number o f  the 
most immature germ cells (spermatogonia) is relatively small and is present in no 
later stages o f  maturation. After puberty meiosis commences leading to the 
production o f  spermatids which look nothing like the sperm they will develop into 
over the next 70-odd days. They move towards the Sertoli cells rapidly and bury 
their heads within them, like ostrich heads in the sand.
85-90% o f  the testis is composed o f  seminiferous tubules. Each seminiferous 
tubule is surrounded by a well-defined cellular basement membrane (figure 1. 1).
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This contains myoid cells and has a loose coat of interstitial fibrocytes separating the 
interstitial and basal components. No blood and lymphatic vessels or nerves 
penetrate into the seminiferous tubules.
S d
Figure 1.1- Mouse Seminiferous Tubules, Hematoxyline and Eosin (H&E) staining, x40 (I = 
interstitial space, Sg = spermatogonia Sc = primary spermatocytes, Sd = spermatids, St =
Sertoli cell nuclei)
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1.2 Differentiation of the Mammalian testis
The first signs o f  testicular organisation can be recognised at approximately 
42 days after fertilization in human when cells in the medial portion o f the 
mesonephros gather into cords o f  primordial Sertoli cells which come to cover 
inflowing germ cells to form primordial tubules. A Y chromosomal gene, SRY  (sex 
determining region on the Y chromosome), acts as a switch signal for testis 
differentiation which involves several steps controlled by other non-Y-linked genes, 
such as WT1, EMX2, LIM1, SF1, SOX9 (figure 1.2). Since other genes, such as Wnt4 
in mouse, and DAX1, are necessary for the initiation o f the female pathway in sex 
determination, female development cannot be considered a default process (Sinici et 
al., 2003). Expression o f the SRY gene is restricted to gonadal somatic cells at 10.5-
12.5 days post coitum (dpc) in the mouse (Sinclair et a l., 1990). However, even if  
normal SRY  exists, the haploinsufficienty o f SOX9 or KTS+ splicing form o f  WT1 
can cause male-to-female sex reversal. Furthermore, duplication o f  the partial region 
on the X chromosome including the DAX1 gene can also cause male-to-female sex 
reversal. The sex-determining system seems to be sensitive both for gene dosage and 
level o f gene expression. In males, SF1 has a role during sexual development in 
regulating expression o f  Mullerian inhibiting substance (MIS) or anti-Mullerian 
hormone (AMH) (Behringer et a l,  1994; Lahbib et a l, 1997). WT1 is a zinc-fmger 
transcription factor, which associates and synergizes with SF1 (Nachtigal et a l,  
1998). DAX1 is an X-linked gene, thought only to be activated in the absence o f  SRY 
expression and is important for female sex development (review, Swain and Lovell- 
Badge, 1997; Swain et a l., 1998). However, although D axl (an orphan nuclear
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receptor) was originally proposed to act as an 'anti-testis' factor, NrObl (also called 
D axl and Ahch, which encodes D axl) has in fact been known to be required for 
testis differentiation (Meeks et al., 2003). Most o f these genes involved in sex 
determination are transcription factors and are able to switch on or off other genes. 
DAX1 and WT1 oppose each other to modulate SF1 mediated transactivation o f  
male-specific genes. In addition, there are other genes both X-linked (SOX3) and 
autosomal (SOX9) which are involved in sex determination (Jimenez and Burgos, 
1998). The detail o f  these genes interactions is still unknown. In the absence o f SRY 
gene expression, the bi-potential gonad differentiates into an ovary over 100 days 
(weeks 6-20), however, when it is expressed; it develops into a testis (in 70 days). By  
the end o f the sixth week the human testis shows evidence o f  differentiation. 
Primordial germ cells migrate from the posterior wall o f  the yolk salk into primitive 
sex cords in the genital ridge. During their migration they proliferate in response to 
some mitogenic factors such as LIF (leukemia inhibitory factor) and MGF 
(mastocyte growth factor) (De Felici et a l, 1992). The precursors o f  the Sertoli cells 
are derived from cells o f  the primitive sex cords. The outer part o f  the testicular sex 
cords form the seminiferous tubules and the inner portion is the origin o f  the efferent 
ductules. MIS controls the subsequent steps o f male sexual differentiation by causing 
the Mullerian ducts to be degenerated resulting in development o f the Wolffian ducts 
into the seminal vesicles, epididymis and vas deferens. Differentiation o f the male 
external genitalia at this stage depends on androgenic hormone secreted from the 
foetal testis (Huhtaniemi, 1994). Hormonal activity o f the Leydig cells is finished by 
about the 18th week and these cells then remain undeveloped and are not reactivated
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until puberty when they stimulate spermatogenesis.
All of these genes that play a role in mammalian testis differentiation affect the 
DMRT1 gene (mapped in 9p24.3) and its encoded protein as the final target (Boyer et 
al., 2002). DMRT1 is demonstrated to be implicated in human testis differentiation, 
and has a gonad-specific and sexually dimorphic expression profile during 
embryogenesis in mammals, birds, and a reptile (Alligator mississippiensis) (Smith 
et al., 1999). High DMRT1 expression is necessary for testicular differentiation, 
whereas lower expression is compatible with ovarian differentiation. Since DMRT1 
represents an ancient, conserved component of the vertebrate sex-determining 
pathway, it seems that it is conserved during evolution. It has been shown that 
haploinsufficiency of this dosage-sensitive gene is responsible for the failure of 
testicular development and feminization in XY patients with monosomy for 9p 
(Smith et al., 1999).
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Figure 1.2- Genes and the pathway involved in gonadal development and differentiation.
Chromosomal location o f  candidate genes in the testicular development cascade are: SRY: Y p ll.3 ,  
DAX1: Xp21-p22, SF1: 9q33, WT1: l lp l3 ,  SOX9: 17q24-q25 and AMH: 19pl3.3, DMRT1: 9p24.3 
(DMRT1 has synergistic effects to SRY and SOX9 secondary to androgenic hormonal stimulation).
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1.3 The regulation of germ cell differentiation 
(spermatogenesis and spermiogenesis), and sperm 
structure
The pathway o f  sperm development is an excellent system for studying 
cellular division and differentiation because it is possible to isolate cells at various 
stages o f  differentiation all the way from the stem cells (spermatogonia) to mature 
sperm cells. The process o f  spermatogenesis is like a mini-system o f development in 
terms o f  differentiation that goes on in the life o f  the cell. It is one o f  the few systems 
that allow us to examine human differentiation. Cell differentiation begins with 
totipotent stem cells, in a cycle o f continual self-renewal, that eventually become 
committed to a very specific pathway, finally leading to mature spermatozoa.
The mitotic division o f germ cells is similar to many mitotically active 
undifferentiated tissues such as those in tumours or the foetus. While some 
‘housekeeping’ genes that contribute to basic structural or metabolic cellular 
functions are expressed throughout the body, other tissue-specific genes that 
contribute to specific function in differentiated cell types are expressed in a regulated 
fashion. It is likely that, due to the structural and functional changes that take place 
in male germ cells during spermatogenesis, many germ cell-specific gene products 
are involved in this differentiation process. This process is seen to occur in parallel 
with changes in the expression o f total RNA and stage specific proteins (Hoog, 1995, 
Monesi, 1965, Boitani et al., 1980).
The spermatogenic cells are actively replicating cells at various stages o f a complex 
differentiating process (from the division o f  a spermatogonia to the production o f a
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completed spermatozoa) called spermatogenesis. The premature germ cells become 
spermatogonia o f  the germinal epithelium. There are three sequential major phases in 
spermatogenesis: growth o f the spermatogenic tissue by mitosis, the meiotic 
divisions and finally morphological changes into a sperm. Spermiogenesis is the 
process, which morphologically changes a spermatid into a spermatozoon. This 
transformation includes nuclear condensation, acrosome formation, loss o f most o f  
the cytoplasm, elongation, development o f the tail and arranging mitochondria into 
the upper part o f  the tail to power it. The processes o f spermatogenesis and 
spermiogenesis also require a contribution from the somatic cells (Hecht, 1995). 
Androgens produced by somatic cells are necessary for the production and successful 
delivery (via development o f  normal sexual behaviour and secondary sexual 
characteristic) o f spermatozoa. In an average man, three quarters o f  sperm cells 
developed do not reach ejaculation, and only half o f  those that do are functional. 
Throughout spermatogenesis, a somatic cell group, the Sertoli cells, nurtures the 
developing germ cells. The Sertoli cells are responsible for sustaining the germ cells, 
and providing them with nutrients, as well as secreting hormonal factors and proteins 
that regulate their development. Sertoli cells also have biochemical interaction and a 
metabolic influence in relation to germinal cells (review, Griswold, 1998). These 
cells are also phagocytic (Carr, et a l., 1968). Sertoli cells also secret retes testis fluid 
and androgen binding protein under the control o f testosterone and/or FSH. They 
also contain a high concentration o f a carbohydrate storage compound, glycogen, 
which supplies energy to the developing sperm. Tight junctions connect their 
membranes. These are leak proof junctions that form a barrier between the
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circulatory system and the lumen of the seminiferous tubules. This barrier prevents 
germ cells provoking the immune system and is important because spermatozoa are 
produced during puberty, long after the period of self-recognition by the immune 
system. The spermatogenic developmental pathway occurs from the germinal 
epithelium of the seminiferous tubules. Up to their meiotic stage, the developing 
germ cells are found on the external side of the Sertoli tight junction barrier 
(Holstein et al. 2003).
Basal lamina
Spermatogonia
Secondary ^  
spermatocytes 
and spermatids
Sertoli cel
Lumen o f
seminiferous"
tubule
Sperm ceHr
Figure 13.1- Schematic diagram o f a cross-section o f a
seminiferous tubule, showing developing sperm cells (by 
Sarah Manistre)
A t puberty, spermatogonia proliferate. Type A Smgie, (A s )  spermatogonia may 
divide to produce separate daughter cells of their own kind, or A primary ( A pr) , and then 
A ai spermatogonia. Cytoplasmic cleavage is not complete in the formation of A pr this 
is the only difference between Asecondary ( A s) and A pr. Similarly, when A pr divide, a 
chain of cells linked by cytoplasmic bridges is formed, A ai. A s ,  A pr and A ai are 
undifferentiated spermatogonia. Under a light microscope, these cells appear darker
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than other spermatogonial cells when stained with Hematoxyline and Eosin (H&E). 
The type As, Apr and Aai spermatogonia are moved to specific sites along the 
seminiferous tubules probably as a result o f  signalling from other cells o f the 
interstitium. In mice they have been seen to space themselves so that they are well 
spaced out as they develop in a cyclic manner (Chiarini-Garcia et. al. 2001).
Type Aai spermatogonia divide to produce type Ai spermaotognia. These cells may 
be distinguished from type Aai, as they have larger, more spherical nuclei. The RNA 
binding protein DAZ  is thought to be involved in the signalling pathway underlying 
differentiation o f  type A^ into type Ai (Bianca et. al. 2001). Type Ai divides to 
produce type A2 in which nuclear vacuoles (detectable in A! spermatogonia) are not 
seen. A small amount o f  heterochromatin (condensed chromatin) is adjacent to the 
internal nuclear membrane. Type A 2  divides to produce type A 3 . In these cells, the 
nuclei are more spherical still, and a larger amount o f  heterochromatin can be seen 
around the inside o f  the nuclear membrane. Type A 3 divides to produce type A 4 . 
These cells are similar to type A 3 , but have a further increased amount o f  
heterochromatin around the inside o f the nuclear envelope, and the most spherical 
nuclei o f the A type spermatogonia. As they develop, type A spermatogonia spread 
laterally along the base o f  the seminiferous tubule and remaining on the blood-side 
o f  the barrier formed by the tight junctions o f the Sertoli cell membranes (Chiarini- 
Garcia et. a l,  2001 b) (figure 1.3.2).
Up until this point, the cells are thought to be stem cells, not committed to a 
particular fate. The dosage o f  a protein produced by the Sertoli cells, Glial cell line- 
derived neurotrophic factor (GDNF) determines whether or not the stem cells
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differentiate (Meng et al., 2002). In mice, low levels o f GDNF promote 
differentiation causing the mice to be fertile but to have a decreased rate o f  
spermatogonial cell proliferation later in life. At high levels, GDNF causes mice to 
be infertile and large cell clusters form in the seminiferous tubules. The clustered 
cells do not express the c-kit marker for differentiating spermatogonia, which 
suggests that high levels o f  GDNF prevent differentiation o f spermatogonial stem 
cells and promote self-renewal. This explains why there is a build up o f  
undifferentiated cells even though the proliferation rate is not especially high. The 
clusters remain until they are broken down during puberty and taken up by Sertoli 
cells.
At high concentrations, self-renewal or A type accumulation occurs, at low  
concentrations, the type A4 spermatogonia divide to form intermediate 
spermatogonia, a cell type committed to become sperm cells (Meng et. al. 2000). 
Intermediate spermatogonia are similar in appearance to type A4, again with a darker 
nucleus due to the heterochromatin, now covering virtually the whole interior o f  the 
nuclear membrane (figure 1.3.2). Intermediate spermatogonia divide to produce type 
B spermatogonia which have more oval shaped nuclei and which stain more darkly 
than any o f  their precursors.
The heterochromatin on the inner membrane o f the nuclear envelope is seen under 
the light microscope to form into clumps attached to the membrane, with less o f  the 
surface being covered than in intermediate spermatogonia (Chiarini-Garcia et. al. 
2001). The type B spermatogonia in turn divide to form the primary spermatocytes, 
the cells in which meiosis I (the first meiotic division) occurs. Primary spermatocytes
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Figure 1.3.2- Cellular 
divisions o f spermatogenesis
Sperm Cells
are the largest of the germinal epithelial cells. They are also the first cells to move 
within the Sertoli cell barrier, passing down within recesses in the Sertoli cells 
(Holstein et. al. 2003) (figure 1.3.2).
The primary spermatocytes go through the first division of meiosis, forming the 
secondary spermatocytes. It is during this division that chiasmata form, leading to 
genetic recombination. The secondary spermatocytes then complete meiosis. The 
products of the second meiotic division are the spermatids, which go through the 
process of spermiogenesis (figure 1.3.3).
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Type A Spermatogonia (2N ))—{ Spontaneous cell Death ) (apoptosis) 
—{recycle type A spermatogonia}
Type B Spermatogonia
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Primary Spermatocyte (2N )
Prophase ______
1 st Meiotic 
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Figure 1 3 3 -  Schematic showing the stages o f  mitotic and meiotic division during the differentiation o f  germ 
cells. The ploidy o f  each cell type is indicated. The whole process o f sperm maturation from spermatogonia 
to presence o f  sperm in an ejaculate will take at least 80 days and depends on hormonal signals combined 
with a mechanical process (Jequier, 2000).
At the end of meiosis, the spermatids, while having haploid nuclei, do not have the 
structural characteristics of mature sperm cells. The cells, still linked together by 
cytoplasmic bridges, appear rounded, with no defined head and tail. Head and tail 
differentiation occur simultaneously during the second stage of sperm production,
35
Chapter 1; Introduction
spermiogenesis. Throughout this stage, intricate and highly specific modifications in 
the composition o f  several cellular organelles occur.
The major hormones that regulate mammalian spermatogenesis are:
Androgens (e.g., testosterone),which are secreted by the Leydig (interstitial) cells, 
and are located in the connective tissue between the seminiferous tubules.
Luteinizing hormone (LH) and follicle stimulating hormone (FSH), which are 
released from the pituitary under the control o f gonadotropin-releasing hormone 
(GnRH) from the hypothalamus. Androgens in the circulation cause a reduction in 
the production o f  LH under a classical feedback-inhibition mechanism. Germ cells 
lack FSH receptors, but Sertoli cells have them. One effect o f  FSH on Sertoli cells is 
to cause them to secrete androgen-binding protein, which binds to androgens and 
may facilitate their direct effects on germ cell differentiation.
Growth Factors are proteins that bind to receptors in the surface o f  target cells and 
either stimulate cell division or alter cell fate. Sertoli cells produce a number o f  
growth factors o f  significance. One is seminiferous growth factor (SGF), which 
stimulates somatic cell proliferation and blood vessel production in the testis during 
fetal and postnatal development. In the adult, Sertoli cells respond to their own 
production o f  SGF by producing sulfated glycoprotein-2 (SGP-2; also called 
Clusterin or Apolipoprotein J). This is an autocrine interaction. SGP-2 is the major 
secretory product o f adult Sertoli cells. It, in turn, binds to the membranes o f  
spermatozoa. This is a paracrine interaction. SGP-2 is thought to be involved in 
protecting cells from apoptotic cell death (Clark et al, 1997; Clark and Griswold, 
1997; Viard et al, 1999).
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The first step towards the development of the sperm head is the formation of the 
acrosomal vesicle. This is a membrane-bound sac containing specialised enzymes 
involved in digesting a pathway to, and fusion with the egg membrane. It has both an 
inner and an outer membrane and forms a cap over the anterior of the nucleus in the 
mature spermatid.
Golgi Cap Acrosomal Maturation
Phase Phase Phase
Golgi
i
i
r
Acrosomal vesicle Acrosome
Figure 1.3.4- Formation o f  sperm acrosome
The acrosomal vesicle or acrosome is derived from the flattened stacks of membrane 
sacs that make up the golgi apparatus. This has been seen to take place in four stages 
(Abou-Haila et al. 2000), (Figure 1.3.4). The first stage is the golgi stage, during 
which small membrane bound granules form the stacks of the golgi. These then fuse 
together to form a large membrane bound sac, in close contact with the nuclear 
envelope. Next is the cap phase, in which the newly formed acrosomal vesicle 
becomes enlarged, and as it does so, flattens out over the nucleus. Third is the 
acrosomal phase, in which the acrosome adopts a concave structure. The final stage 
is maturation, when the characteristic cap-like structure, covering a large portion of 
the surface of the nucleus is established. The nucleus and the acrosomal cap rotate, 
then they are facing the anterior (head end), end of the future sperm cell. This leaves
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the posterior (future tail end), facing into the lumen o f the seminiferous tubule 
(Gilbert et. al. 2003). A transient structure named ‘manchette ’ is seen in sperm head 
consisting o f  microtubules that encircle the condensing nucleus. The manchette 
consists o f  the microtubule mantle, a perinuclear ring, and dense plaques at the distal 
ends o f the mantle (Tres and Kierszenbaum, 1996).
Meanwhile, tail development is initiated on the opposite side o f the nucleus. The 
flagellum first projects from the surface o f a round spermatid during early 
spermiogenesis by forming an axoneme, which originates from the distal centriole 
(Fawcett and Phillips, 1969). The axoneme is composed o f microtubules, arranged 
such that there are two at the centre, surrounded by nine doublets. It is this structure 
that facilitates the whipping motion o f the tail, and thus provides propulsion for the 
sperm cell. The developing flagellum extends down into the lumen o f the 
seminiferous tubule.
During the next stage, changes occur in the nucleus, so that it becomes smaller and 
flatter. The chromatin, usually organised in a solenoid structure, maintained by 
histones, becomes further condensed. The histones are replaced by protamines. The 
protamines interact with the minor groove o f the DNA molecule, effectively cross- 
linking and neutralising the phosphodiester backbone o f  the molecule. Residues on 
the protamine complexes form hydrogen bonds, hydrophobic associations and 
disulphide bonds with each other (Balhom 1982). This results in condensation, 
aiding the formation o f a more compact, crystalline chromatin structure. Under these 
conditions, transcription is prevented from taking place, thus any subsequent protein
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synthesis is reliant on mRNA, transcribed prior to this stage and stored as messenger 
ribonucleic protein, mRNP (Schmidt et. al. 1997).
Also at this stage, the mitochondria are localised towards the posterior of the 
developing cell’s cytoplasm. These mitochondria are distinct from somatic cell 
mitochondria, as they contain large vacuoles (Hecht 1998). They accumulate around 
the flagellum near the centriole. Here they become more crescent shaped, and 
organise themselves end to end in such a way that they coil around the axoneme, 
forming a sheath (Metz et. al. 1985). This becomes the midpiece of the sperm. From 
this position they can supply the ATP required for the protein dynein in the axoneme
to produce mechanical movement of the microtubules. In other words, the
mitochondria in the midpiece provide the energy for the sperm cell to swim (Figure 
1.3.5).
Finally, the residual
cytoplasm is discarded,
releasing the fully formed 
sperm into the lumen of the 
seminiferous tubules
(Gilbert et. al. 2003). The 
sperm then pass along the 
seminiferous tubules to the
Figure 1.3.5- Schematic diagram representing 
different stages o f  sperm maturation during 
spermiogenesis
4 P*
V *.
epididymis mediated by peristaltic contraction of the seminiferous tubules.
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In the proximal region of the epididymis, the sperm cells mature further. 
Modifications of cell surface proteins occur, enabling the sperm cell to bind to the 
zona pellucida, and subsequently penetrate the oocyte. Also, it is in the epididymis 
that the sperm cells acquire self-propulsion. The fully functional sperm cells are then 
stored in the terminal region of the epididymis until they are needed. 
Spermatogenesis is generally considered to be about 8 stages but the number differs 
with species and investigator. The number of divisions (and their rate) undergone by 
spermatogonia determines the rate of sperm production. Briefly, spermatogenesis is 
controlled (synchronized) by Sertoli cells and Leydig cells (Interestitial cells) via 
androgen secretion under LH control (Yoshida and Oshima, 1994). Spermatogenic 
cells require testosterone especially at the primary spermatocyte stage. Some believe 
FSH has a role in later stages of spermiogenesis (Moura and Erickson, 2001), too. 
Inhibin (produced by Sertoli cells and which inhibits pituitary release of FSH) may 
be involved as a negative feedback (Chada et al., 2003).
Temporal Appearance of Spermatogenic Cells in the Prepuberal 
Mouse Testis According to Bellve et al., 1977
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Mature sperm structure and motility
Each spermatogonium lining the tubules divides rapidly so enables each testicle to 
produce between 300 and 600 sperm per gram o f  testis per second. On average, 
sperm production rate is 1,500 per second per testicle. It takes 74 days to form sperm 
and 26 day for them to mature as they pass through the epididymis and vas deferens. 
After maturation a sperm swims at a rate o f  3 mm (1/10 in) per hour and lashes its 
tail 800 times to swim one cm (1/3 in). Then it must travel through 30-40 cm o f  male 
and female 'plumbing' to reach the Fallopian tube (more than 100,000 times its 
length). After ejaculation it reaches the Fallopian tubes within 30-60 minutes (which 
is helped along by eddy currents). The average survival for a sperm in the female 
reproductive tract is 3-4 days.
Sperm cells (figure 1.3.7) are made up o f  a head and a tail. The head contains the 
nucleus and has an acrosome situated at the tip. A number o f digestive enzymes are 
housed in the acrosome. These break down the surface o f  the egg allowing 
penetration o f  the sperm during fertilisation. The tail o f a sperm enables it to travel 
by acting as a propeller. Although sperm motility in reproduction is important, little 
is known about the signalling pathways and molecular mechanisms responsible for 
assembly and function o f the sperm flagellum. The sperm flagellum has four main 
compartments: the connecting piece, the midpiece, the principal piece and the end 
piece (Fawcett, 1975). The axoneme extends throughout the length o f flagellum 
starting from the centriole in the connecting piece. The axoneme is a cytoskeletal 
structure and is a flagellar motor composed o f  a 9-microtubule doublet ring 
surrounding a central pair o f  microtubules. Mammalian sperm ultrastructure is highly
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conserved. Axonemes are found not only in sperm cells but in all flagellated and 
ciliated cells from Chlamydomonas flagella to the inner-ear hair cells o f mammals 
(Turner, 2003). Sperm motility is driven by the protein dynein, which hydrolyses 
ATP to provide the energy required for the sliding o f  adjacent outer doublet 
microtubules. Sperm mitochondria are present only in the mitochondrial sheath (MS) 
o f the midpiece (figure 1.3.8). This MS is not present in the principal piece, 
therefore, to supply the energy needs o f  the axonemal dyneins in the distal flagellum 
segment, either other regions o f  the sperm flagellum must be able to produce ATP or 
the ATP produced by sperm mitochondria would need to travel some distance.
Dynein arms project from each o f the outer 9 doublets (Figure 1.3.8). One spoke 
originates from each o f the 9 outer microtubular doublet pairs going toward the 
central pair in a helical fashion. In the midpiece, 9 outer dense fibres (ODFs) lay 
outside each o f the outer axonemal microtubule doublets and a sheath o f  
mitochondria encloses the ODFs and the axoneme. The ODFs develop during 
midspermiogenesis. It has been suggested that the ODFs’ functions in sperm motility 
are structural, providing passive elasticity to the motile flagellum (Fawcett, 1975). In 
the principal piece an MS is not present and the ODFs associated with outer 
axonemal doublets 3 and 8 are replaced by 2 longitudinal columns o f the fibrous 
sheath (FS). The FS is a cytoskeletal structure with two roles in sperm motility: a 
mechanical role by providing a rigid support for the flagellum and a second role by 
creating an “I-beam”-like structure, along which the microtubules can slide, by 
supporting outer doublets 3, 8 and the central pair o f microtubules (figure 1.3.8). In 
activated axonemal sliding with ATP, the FS slides proximally toward the
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connecting piece while doublets 1, 2, 4-7 and 9 (but not 3 and 8) are extruded 
distally. Fibrous sheath sliding is cAMP-dependent, which suggests protein kinase A 
(PK-A) involvement (Si and Okuno, 1993, 1995). The morphogenesis of ODFs and 
FS along the axoneme is well defined: ODFs are assembled in a proximal-to-distal 
direction in step 8 to 19 spermatids while the FS is assembled distally to proximally 
along the flagellum length in step 2 to 17 spermatids (Irons and Clermont, 1982; Oko 
and Clermont, 1989; Clermont et al, 1990).
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Figure 1.3.7 (http://wvyw.ucalgarv.ca/~fVdhoom/picture.1999.htmO
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Many ODF and FS proteins are likely to be encoded by testis-specific genes 
expressed in the flagellum o f the spermatid (Oko and Clermont, 1989). It is very 
likely that the functions o f  these components rely on the networks, which are formed 
by interactions between individual ODF and FS proteins (Shao et al., 1999).
Another role for FS has also been proposed in protecting sperm from oxidative stress 
that interferes with sperm motility (Fulcher et al, 1995).
In the distal end o f  the flagellum, the FS and ODFs are tapered and terminated, until 
the axoneme is surrounded only by the plasma membrane to form the end piece. 
Both FS and ODF structures are formed slowly during spermiogenesis and they 
continue to be made after transcription ceases in midstage spermatids (Irons et al., 
1982). Significant delays have been reported between the initiation o f transcription 
and translation for several fibrous sheath proteins, including GAPDS (Bunch et al., 
1998), AKAP4 (Carrera et al., 1994, El-Alfy et al., 1999), FS39 (Catalano et al., 
2001), and outer dense fibre proteins Odfl (Morales et al., 1994), Odf2 (Schalles et 
al., 1998), and Spag4 (Shao et al., 1999). Synthesis o f these proteins does not 
commence until after their mRNA transcription has ceased necessitating 
posttranscriptional regulation o f their mRNAs. A testis and brain RNA-binding 
protein, Translin (TB-RBP/translin) has been shown to be involved in this regulation 
(Yang et al., 2003).
The sperm swim in a fluid produced by the seminal vesicles and prostate gland. This 
fluid provides them with nutrients and enables them to swim from the testis, along 
the epididymis and vas deferens, and to the ejaculatory duct.
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Figure 1.3.8 Schematic feature o f  a mammalian sperm and the ultrastructure o f  the flagellum.
(A) Mammalian sperm flagellum consisting o f  connecting piece, midpiece, principal piece and end 
piece.
(B) Cross section o f  a midpiece segment showing the plasma membrane (PM) and mitochondrial 
sheath (MS) surrounding the 9 outer dense fibres (ODFs). The 9 outer microtubule doublets o f  the 
axoneme (OMDA) with dynein arms (DA), radial spokes (RS) and the central pair o f  microtubule 
doublets (CP) are within the ODFs.
(C) Cross section o f  a principal piece segment showing ODFs 3 and 8 are replaced by fibrous sheath 
(LC). Two longitudinal columns (LCs) are connected by transverse ribs (TR). (D) Cross section
o f  an end piece segment. (By Regina Turner, J Androl. 2003 Nov-Dec;24(6):790-803)
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1.4 Genes involved in spermatogenesis
It has been estimated that 15,000 to 20,000 genes are expressed in germ cells 
(Zhang et al., 1997). They can be classified in many ways. Below is one possible 
way:
• genes expressed in testis and spermatogenic cells which are 
housekeeping and are therefore also expressed in most other cells
• genes expressed (predominantly) in testis and produce a testis specific 
form of a protein
• genes expressed in testis with alternative form of protein in other 
tissues
• Y chromosome linked genes
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1.4.1 Testis specific genes expressed predominantly in testis
There are about twenty thousand different transcripts in germ cells, relatively 
few o f them have been characterized in detail but some which include:
PRM: Protamine is a main nuclear protein in sperm and is encoded by the P R M gene 
located in 16 p l3.3. PRM is associated with sperm nuclear shape and initiates 
condensation o f  the chromatin and packaging into the sperm head (Lee et al., 1995). 
ACR: (Pro)acrosin is the zymogen form o f the serine protease acrosin and is 
expressed throughout early stages o f  spermatogenesis (in pachytene spermatocytes) 
(Nayemia et al., 1994), then starts to accumulate into the Golgi system (Ventela et 
al., 2000 ).
SPRM1 is a member o f  the POU-domain gene family that is exclusively expressed 
in spermatogenesis, predominantly in the haploid spermatid. It is a transcription 
factor. Both human and mouse genes are testis specific in their expression.
SPAM1: sperm adhesion molecule 1 (SPAM1) gene is located in the same region as 
the cystic fibrosis gene (7q31.3) and is involved in sperm-egg adhesion by aiding the 
penetration o f  the egg's cumulus cell layer (Jones et a l., 1995). The gene expression 
is mainly limited to testis although it has been recently shown in vas deferens and 
efferent ducts as well (Zhang et al., 2004).
PGK-2: PGK-2 is expressed specifically during spermatogenesis. Its expression is 
initiated with the onset o f  male germ cell meiosis, and continues into the later stages 
o f spermatocytes and in round spermatids.
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1.4.2 Genes expressed in testis with alternative form of protein in 
other tissues (somatic cells) or altered expression
The reason for the presence o f  testis-specific isoforms o f proteins in testis 
may be due to the specific physiology o f the testis because o f  having non­
differentiated and dividing cells. Surprisingly, expression has been found in male 
germ cells genes unexpected to be active during spermatogenesis such as the smooth 
muscle gamma actin gene (Gu et al., 1996). Also, many proto-oncogenes have 
altered expression during germ cell division; e.g. the mouse genes c-abl and c-mos (a 
protein tyrosine kinase and a protein serine/threonine kinase), are both expressed in 
many tissues. However, they are present in the testis with a different transcript size 
compared to those seen in somatic tissues. In addition, a protein apparently binds to a 
negative regulatory element (NRE) o f the c-mos promoter to repress expression in 
somatic tissues, but not in germ cells (Xu and Cooper, 1995). Sequences nearly 
identical to the NRE o f c-mos are present in the promoter regions o f other genes 
exclusively expressed in germ cells, e.g. PRM2, PK2, cytochrome Cj and Hst70, 
suggesting this may be a common mechanism for suppressing their expression in 
somatic cells (review, Eddy, 1998).
Testis specific promoters have been described for a number o f genes expressed 
during spermatogenesis. It has been proposed that the choice o f promoter is governed 
by DNA methylation (review, Herman and Baylin 2000).
HSP70: encodes Hsp70-2 protein in humans and Hsc70t protein in mice, which are 
molecular chaperones and possibly are linked to mechanisms that inhibit apoptosis o f  
spermatocytes (Dix et al., 1996; Eddy, 1999).
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LDHC: encodes lactate dehydrogenase-C (LDHc) isozyme which has been found in 
mature testes o f  many species including men (Zinkham et al., 1965).
H it- The mammalian testis-specific histone H it gene is transcribed in primary 
spermatocytes during spermatogenesis (Doenecke et al., 1994). It is likely that H it is 
essential for dramatic changes in chromatin structure and the changing patterns o f  
gene transcription seen during spermatogenesis.
G3PD- Glyceraldehyde 3 phosphate dehydrogenase also has a post meiotic isozyme 
(GAPD-S) which is expressed only in male germ cells and is associated with the 
fibrous sheath o f  the flagellum (Welch et al., 1995).
ACE: Angiotensin Converting Enzyme gene encodes a testis-specific isozyme found 
only in differentiating spermatids and mature sperm (Sibony et al., 1994). It has a 
haploid expression and post-meiotic translation.
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1.4.3 Y chromosome linked genes
There are several families o f  Y linked genes. In 1996 it was shown that a 
deletion in the distal part o f the long arm o f the Y chromosome (Yql 1) can result in 
azoospermia. This area o f the Y chromosome is referred to as the azoospermia factor 
(AZF) region. At least two gene families encode RBP (RNA Binding Protein) in the 
AZF region. The first o f them is RBMY (RNA Binding Motif) (Chai, 1997&1998) 
consisting o f  approximately 30 genes and psuedogenes spread over both arms o f  the 
Y chromosome. RBM is a nuclear protein that is expressed exclusively in human 
male germ cells o f  foetal, prepubertal and adult testis (Cooke and Elliot, 1997). 
AZFb deletion results in reduced levels o f the RBMY protein and spermatogenic 
impairment at the meiotic and post meiotic transition resulting in type II Sertoli Cell 
Only Syndrome and limited spermatogenesis (review Krausz and McElreavy, 1999). 
The RBMY family has an X-linked homologue in both human and mouse. A 
deletion in the AZFc region located within this region is the gene family ‘Deleted in 
azoosperm ia’ (DAZ) associates with observed severe hypospermatogenesis more 
often than with Sertoli cell-only syndrome (Roijen et al., 1995; Vereb et al., 1997). 
Deletion o f  this gene family on its own is not sufficient to cause complete loss o f the 
spermatogenic line (Ferlin et a l., 1999).
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1.5 The regulation of Testis-specific gene expression 
through common promoter elements
Studies on the mechanisms that regulate testis-specific gene expression have 
been focused mainly at the transcriptional level because it is so frequently 
responsible for dynamic regulation o f the gene product. Many studies have drawn 
analogy to the mechanisms that have been shown to regulate transcription in testis. 
Some genes such as CREMT have a similar temporal expression pattern during germ 
cell differentiation tend to contain the same transcriptional regulatory motifs. The 
binding site for the cAMP response modulator element (CREMT) is present in the 
promoters o f  many testis-specific transcripts (review, Goldberg, 1996; Sassone- 
Corsi, 1997). This transcription factor plays an important role in the nuclear response 
to cAMP signal transduction pathway in neuroendocrine cells. In mouse and human, 
lack o f the CREM gene has a severe effect on spermatogenesis (post-meiotic arrest) 
and germ cell apoptosis (Nantel and Sassone-Corsi P. et al., 1996) and may lead to 
oligozoosperma (Peri et al., 1998).
Signalling mechanisms often require a signal source (hormones), a signal reception 
system (e.g., G protein-coupled receptors) and an intracellular signal response 
system. Paracrine signals originate from nearby cells and there are varying paracrine 
interactions between the germ cells and Sertoli cells due to their intimate location. It 
has been reported that Sertoli cell-mediated phagocytosis (to eliminate apoptotic 
spermatic cells in testis) is regulated by a complex set o f positive and negative 
signals emitted by the germ cells at distinct maturation stages (Grandijean, 1997). In 
the classic pathway o f  activation, steroid hormones pass through the cell membrane
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and bind to intracellular receptors. These receptors are hormone-regulated 
transcription factors that activate migrating components into the nucleus and regulate 
gene expression. Also steroids are able to act in another way as a 'non genomic 
action' (review, Wehling, 1997). In addition, when estradiol makes a complex with 
an intracellular receptor it activates the tyrosine kinase and MAP-kinase (Mitogen- 
activated protein) pathway in human mammary cancer MCF-7 cells and acts in a 
similar fashion to a peptide mitogen (Migliaccio et al., 1996). The first part o f  
spermatogenesis is mitosis and the best-known pathway o f stimulation o f mitosis 
(RAS -> RAF MAPK cascade) is strongly stimulated by mitogens, growth 
hormones and proto-oncogene products (Cobb et al., 1995). MAP kinases 
phosphorylate and activate nuclear transcription factors that in turn activate genes 
controlling the cell cycle. Testis specific promoters have been described for a 
number o f  genes expressed during spermatogenesis (see above).
The transformation in the sperm body during the process o f  meiotic division and the 
post-meiotic period is accompanied by changes in the expression pattern o f genes 
which are necessary for post-meiotic functions in spermatid or sperm. Some genes 
have been identified that are not transcribed until after the meiotic reduction (review, 
Hecht, 1990). There remain many unanswered questions: Does any translation occur 
in sperm right up until fertilization and what is the exact process o f  translation in the 
very small volume o f  cytoplasm, which remains in sperm during spermatogenesis? 
Where are the origins o f  transcripts for protein production? Are these transcripts 
made post-meiotically or are they stored mRNAs transcribed at the pre-meiotic 
stage? The expression o f proteins in the acrosome and sperm Golgi apparatus
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together with the importance o f the ER-chaperone protein calreticulin are likely signs 
o f translation in sperm (review, Okabe et al., 1998). Repression and activation o f  
translation require proteins or antisense RNAs that bind to regulatory elements in the 
RNA and regulate the translatability o f messages. mRNA binding proteins (RBPs) 
bind to specific sequence sites o f a transcript and prevent translation thus creating 
stored 'paternal' mRNAs. After transcription o f  protamine 1 gene in round spermatids 
the mRNA is stored in an untranslatable form as messenger ribonucleoprotein 
(mRNP) particles for as long as a week before it is translated. Protamine 1 contains a 
"Y box”-binding site for RBP attachment. At least two separate regions o f the 
protamin 1 gene 3 ’ UTR are capable o f  repressing the translation o f  reporter mRNA 
in transgenic mice (review, Braun, 1998). Synthesis o f a translational activator such 
as a protein kinase or phosphatase that modifies the mRNP might be necessary. 
Evidence that mRNPs and polysomes can associate with cytoskeletal elements 
supports the presence o f  a mechanism for organised protein synthesis (Braun, 2000). 
Y box proteins are sequence-specific RNA binding proteins. M ysl (a mouse Y box 
protein) may be associated with untranslated RNAs (Tafuri et al., 1993). The mouse 
p48 and p52 box proteins are highly expressed in the testis and have been shown to 
bind non-specifically to various RNAs in vitro, including Prm l, Prm2, Tnpl, hGH  
and pGem-2  RNAs (Kwon et al., 1993). Shortening o f the poly A tail o f mRNAs 
from about 100-200 nucleotides to about 30 occurs in spermatogenesis and it may 
not be required for translational initiation. In testis, migration, proliferation and 
differentiation o f the most immature germ cells (spermatogonia) can be regulated by 
the c-kit ligand (Bhasin et al., 1994; Griswold 1993). The c-Kit proto-oncogene
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encodes a transmembrane tyrosine-kinase receptor with homology to the receptors 
for platelet-derived growth factor (PDGF) and CSF-1 (Chabot, 1998). The CSF-1 
growth factor stimulates the growth and survival o f myelomonocytic lineage cells 
such as macrophages. Steel factor (SLF) is a hematopoieitic and tissue growth factor 
produced by Sertoli cells that binds to the receptor encoded by c-Kit proto-oncogen 
(Witte, 1990; Rossi et al., 1993). The c-kit receptor is present in type A 
spermatogonial population (Sorrentino et al., 1991). The Sertoli cell hormone binds 
to the c-kit tyrosine kinase receptor on spermatogonia and results in activation o f  
mitosis. The above-mentioned growth factors belong to the PDGF family which are 
the major protein growth factor in human serum.
Gonadotropin receptors belong to a subgroup o f the super G protein-coupled 
receptors. A large N-terminal extracellular domain (responsible for binding o f the 
hormone) containing leucine-rich repeats characterizes these receptors. An important 
secretion o f  Sertoli cells are transforming growth factors B (TGF-B), a superfamily 
o f  growth factors, whose receptors are also expressed in mammalian testis. They 
regulate a variety o f developmental processes including spermatogenesis (review, 
Massague, 1998). Inhibin and bone morphogenesis protein (BMP) are two members 
o f  this family that play roles in spermatogenesis.
54
Chapter 1: Introduction
1.6 TSGA10: mRNA, cDNA, amino acid sequences 
and predicted protein preliminary analysis
TSGA10 was originally identified by differential display RT-PCR (DDRT-PCR) in 
the Galton laboratory in 2001 (Modarressi et al., 2001). The DDRT-PCR experiment 
was carried out on a range o f adult human tissues, and TSGA10 was one o f a limited 
number o f  cDNA fragments that appeared to be specifically expressed in testis. 
TSGA10 is composed o f  19 exons and the whole gene extends over more than 120kb 
(figure 1.6.1). It is shown that the gene is expressed in adult normal testis but not in 
other adult tissues, including those, which are functionally related to testis. 
Interestingly, it is not expressed in the testes o f some infertile patients. Northern 
analysis confirmed the specific expression o f  TSGA10 in testis and showed that the 
mRNA length is about 3.2 kb (Modarressi et al., 2001).
Searching NCBI GenBank database with the human TSGA10 sequence revealed just 
one homologous rat sequence for the gene in April 2001. In addition, TSGA10 
sequence were found in cDNA libraries made from some neoplastic cells, this 
suggested that the protein may play a role in cell cycle. The TSGA10 gene has a long 
5’ untranslated region (UTR) whereas many 5’UTR sequences are only 20 -100- 
nucleotides long among eukaryotic mRNAs (Kozak, 1987). The efficiency o f  
translation from the first AUG initiation codon can be increased by the presence o f a 
long 5’UTR via loading an added 43S-pre-initiation complex termed pre-loading 
(Kozak, 1991). Conversely, it is impaired by shortened 5’UTR o f reporter mRNAs 
to less than 12 nucleotides (Sedman et al., 1990). However, many cellular mRNAs 
with long 5’UTRs are poorly translated as a result o f upstream AUGs, uORFs and/or
55
Chapter 1: Introduction
l-c»ggt>tct»« cct«tctttgt»tttttggMittt»t*t*qttccta»cmt»»tc«ttg -R12
61-ttcaatgggtct&a.TTTTTTTTTcctttaaAffgcatttggata.cctttgtgatagaaAag 
1-gcccttttcttcatccattgatqqtttqatagtqgqctqqqaaqqaaaqctqtqttcctc -GSP12 
1-cacattagqcaqcaaatacttgattqatttqatatttaqcttaqtcaaattgaagatoto -GSP11 
l-aaacagacaaatcatggcttggaagaatgtqttaqqaaactcttqqatagtaaqgagqtg -Rll 
01-geaagcagtcaagtagaegatttaaecagecaeaafcgageateteegeaaagaattgatt 
l-aAaattgaccaactagcagagcaactcgaaaaagagaaaaattttgtggtggattccgcc 
l-aacaaggaacttgaagaagccaagattgatctcatttgccagcaaaataatattatagta 
1-ttggaagatacaataaaaaggcttaaatataettgattcctfctgtcaagactttggaago 
1-aqacaaagatcactataaqagtqaaqctcaacattqaqaaaqATCatqcqaaqtaggtct -CSP10 -MET 
1-aaaagtccaaqacqcccatcaccaactqcccqqqqtqcaaactqtgatqtaqaactttto -RIO 
l~aagacaacaacaag*gatcgtgaagaacttaaatgcatgctggaaaaatatgagcgccat 
1-etggcagaaattcagggeaatgtcaaggttcttaaatctgagagagacaagatcttectt 
1-ettt.atgaacaggcacaggaagaaattacocgacttcgacgagaaatgaCgaaaagctgt; 
l-aagagtcctaaatcaacaacggcacatqctattctccqqcqaqtqqagactgaaagagat -GSP9 
01-gtageatttactgaettacgaagaatgaccacagaacgagatagtctaagggagaggcta 
1-aagattgctcaagagacagcatttaatgagaaggctcacctggaacaaaggatagaggag 
21-ctggagtgtacaqfctcataatcttgatgatgaacgtatggagcaaatgtcaaatatgact 
1-ttgatgaaggaaaccataagcactgtggaaaaagaaatgaaatcactagcaagaaaqgca 
1-atqgataccqaaaqtqaacttqgcagacaaaaaqcaqaqaataatectttqagacttttg -R8 
1-tatgaaaacacaqaaaaaqatct.t:t:ct.gatactcagcgacaccttgctaagaa»aaatat 
1-gagctacagcttactcaggagaaaattatgtqcttqqatgaaaaaattgataacettaca 
1-agqcaaaatattqcacagcgagaagaaatcaqcattcttqqtqqaaccctcaatgatctg -OSP6 
1-OCtaaagaaaaqqaatqcctgcaaqcatgtttqqataaaaaatctqaqaatattqcatcc 
1-cttgqagagagtttqqcaatqaaaqaaaaqaccatttcaqqcatqaagaataCcattgct -R6 
l-gagatggaacagqcatcaagacagtgt.aotoagqecctaAttqtqt:qtgaacaaoacBt.t 
1-tccagaatqcgtcggcaattggatgagacaaatgatgagctggcccagatcgccagggaa 
l-agagatatcttggetcatgacaatgacaatctccaggaacagtfctgecaaagctaaacaa 
1-gaaaaccaggcactgtccaaaaaattgaatgacactcataatgaacttaatgacataaaa 
l-cagaagBttcaagatactaatttggaggttaacaagctgaagaatatattaaagtctgaa 
01-gaatctgaqaaccqgcaaatqatqgaacaacttcgaaaaqccaatgaagatqctqaaaac -R5 
l-tgggaaaataaaqcccgtcaatcagaggcagataacaataccctcaaactggaacttatc 
1-actgctgaggcagagggtaacagateaaaagaaaaagtagattccctcaacagagaggtt 
l-gagcaacacttaaatgcagaaaggtcttacaagtcccagatttctaccttacataaatct 
1-gttgtaaaaatggaagaggagcttcagaaggttcagtttgaaaaagtgtccgctcttgca 
1-qatttqtcttctaotagggaactctgtattaaacttgactoaaqcaaaqaacttcttaat -QSP5 
l-cgacagctggttgctaaagaecaagaaatagaaatgagggagaatgag^eagattctgct. 
1-cattctgaaattgaactcctgaggagecagatggcaaatgagagaatctccatgcagaat 
1-ctagaaqctttBCtqqtqqccaatcqaqacaaagaatatcaqtctcaqataqcacttcaa -R4
1-gaaaaagaatctgaaattcagcttcttaaagaacacctttgtttggcagaaaataaaatg 
1-gccatccaqagt.agagatgtggcccagt.tcagaaatgttgtcacacaattgqaagctgat 
1-ttaqacattaccaaaagacaactaqqaacagagcgctttgaaaqgqaqaqqqccqtacaa -0SP4 
21-gaacttcgccgccaaaattattcaagtaatgcttatcatatqagttctacaatgaagcca 
1-aatacaaaatgtcattcaccagaacgtgcCcaccatcgatctcctqaccqagqcctagaC 
l-cgatcattagaagagaatctttgccacagagatttcTOAcacctgaaatgattcttcaca -STOP 
01-tccctqaqaaagqtcaaaqttacaaactqaTTTTTTTTTTTTTTgctacatqagtqcatt -OSP3 
1-tatcttttaaatgcttqqcaatqteaaaeqtatttattaaetttgtgtotctqaatctct -Ri 
1-qttctaatqtqccatqttgcaqtqactqaqatgacttataaaacaaaatgtat.atqctct -08P2 
l-totatccatqeaatqataqtqaqtqtaaaatctgcttactteaotattgaaeactattct -QSP1 
l-qttcactatctBgagtaaataaaqaaqcttattaaaacagggaaaaaaaaaaaa
1 2 3 4 5 6 7 8 9 1011 12 13 14 15 16 17 18 19
Figure 1.6.1- The sequence o f  the TSGA10 gene including complete coding sequence (the initiating 
methionine at position 583 and the stop codon at position 2677 are indicated on the right). Some o f  
primers used are underlined and mentioned at the right, as is the polyadenylation signal. Polymorphic 
regions in the 5' and 3' UTRs are also indicated in upper case letters. There is an alternative splice 
acceptor site at the beginning o f  exon 4 leading to the incorporation o f  an additional 44 nucleotides 
(5'-ataattttagatactgaaaaagcacaaaataaatctccttctag-3'). The TSGA10 gene contains 19 exons (solid black 
boxes are coding regions and solid grey boxes are untranslated regions, the alternatively spliced 
region in exon 4 is shown as a white box). Exons two to nineteen start at positions 229, 445, 511, 634, 
793, 964, 1042, 1192, 1309, 1465, 1521, 1690, 1801, 1987, 2197, 2400, 2505 and 2655, respectively. 
The length o f  introns are 791, >8744, 1337 or 1293, 397, >2971, 90, 1240, >12234, >2532, >5493, 
>1163, 2707, 3763, >18793, >1192, >1625, >427 and 19976 base pairs, respectively.
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secondary structure. Long 5’UTRs are present in mRNAs encoding proto-oncogenes, 
transcription factors, growth factors and their receptors (Kozak 1987, 1991) 
suggesting a role in tightly controlled translation.
In 2001, human TSGA10 protein sequence composed o f  698 amino acids (see 
appendix) showed to have a domain homologous to myosin tail.
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1.7 The investigation of protein interaction
The interaction o f one protein with another protein forms the molecular basis 
for many cellular processes. Thus an important part o f a protein’s functional profile 
has to be which, if  any, other proteins it interacts with. An important part o f this 
study was to investigate which other proteins react with TSGA10. The yeast two- 
hybrid system provides an in-vivo system for the detection o f  protein interaction. It 
enables detection o f weaker interactions that other methods, such as co- 
immunoprecipitation, may not be sensitive enough to pick up. It has the further 
advantage o f identifying not just the interacting proteins, but also the genes that 
encode them (Chien et. al. 1991). Since this approach has been used in the work 
described in this thesis, it is explained here.
This is usually carried out in yeast as they are able to express most 
mammalian genes and performing the test in vivo increases the accuracy o f  the 
results. The system utilises properties o f a yeast Saccharomyces cerevisiae protein 
called GAL4. GAL4 is a transcriptional activator, which switches on transcription o f  
genes whose protein products are involved in galactose metabolism. The GAL4 
protein itself consists o f two functional domains: The N-terminal domain that binds 
to upstream activating sequences (UASs) o f  the genes that it regulates, GAL4 DNA- 
BD; and the C-terminal domain, that activates transcription o f the downstream genes, 
GAL4 AD. The two domains are functionally distinct from one and other, and both 
are required to activate transcription o f the galactose metabolising enzyme genes. 
This is exploited in the yeast two-hybrid system devised by Stanley Fields and Ok- 
kyu Song in 1989.
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The yeast two-hybrid system works by separating the two functional domains of the 
GAL4 protein. The separate functional domains are each then used to create a hybrid 
protein. One hybrid protein is comprised of GAL4 DNA-BD and protein A, and the 
other is comprised of GAL4 AD and protein B. Interaction between proteins A and B 
can then be tested. If A and B form an interaction complex, the UAS-binding domain 
and the activating domain of GAL4 are brought into close proximity. The UAS 
binding domain binds to the UAS, and the proximate activating domain activates 
transcription of downstream genes. Thus the interaction can be screened for by 
selecting for expression of genes whose transcription is activated by GAL4, e.g. 
galactose selection (Fields and Song 1989). The system can be used to screen cDNA 
libraries, enabling isolation of clones encoding proteins that interact with a protein of 
interest.
The hybrid proteins are 
encoded on two yeast 
plasmids. On one plasmid, 
GAL4 DNA-BD is encoded, 
upstream and in-frame of the 
cDNA encoding the protein 
of interest. This is the bait 
plasmid construct. On the 
other plasmid, GAL4 AD is 
encoded, upstream and in- 
frame with a cloning site
Figure 1.7- Yeast two-hybrid interaction activates 
transcription o f  downstream selectable marker genes
No interaction between Bait 
and protein 1 ,thus no 
downstream gene 
transcription activation
G al4 UAS Promoter Reporter
nano
Protein 2 interacts with the Bait, 
thus downstream gene 
transcription activated
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into which library cDNA is cloned. This is the library plasmid. The two plasmids are 
introduced into the same yeast, Saccharomyces cerevisiae, cell. The plasmids have 
yeast promoters upstream o f the hybrid protein gene construct, and thus once in the 
yeast cell, both hybrid proteins are produced.
The principle drawback o f the yeast two-hybrid system is that it can throw up a large 
number o f false positives. It is therefore important to consider yeast strains, and 
vectors carefully to try to minimise the number o f false positives.
In the case o f  TSGA10, this information could reveal how the protein affects sperm 
motility and how mutations and abnormalities may cause infertility. Interactions 
between proteins are studied using the two-hybrid system to discover whether any 
other proteins found in the testis interact with the product o f  the TsgalO gene.
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1.8 Aims
The main aim o f this project was to investigate the role o f the testis-specific TSGA10 
gene and the function o f its encoded protein in order to draw some conclusions about 
how the gene may be involved in male fertility. Briefly the following strategy was 
followed in this work. Each step was designed to obtain information that would 
relate to the function o f  the gene.
1- Clone the mouse homologue o f the TSGA10 gene (TsgalO) to work on mouse as 
an animal model because the gene is highly conserved in mammals. Examine the 
DNA sequence in terms o f gene structure, transcription factor binding sites and 
signalling to other genes.
2- Confirm the expression pattern in testis and other organs using RT-PCR and In 
Situ Hybridisation.
3- Raise an antibody against a portion o f the TsgalO protein and examine the tissue- 
specific expression pattern o f the protein by western blotting and 
immunohistochemistry.
4- Use the antibody to study the protein localization within the cell (e.g. sperm, 
astrocytes) by immunofluorescence and immunocytochemistry.
5- Transfect a TsgalO  coding sequence linked to a reporter gene (e.g. GFP) into a 
wide spectrum o f cells to study its subcellular localization.
6- Examine the interaction o f TsgalO with other proteins using the yeast two-hybrid 
system.
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Chapter II: 
Materials and methods
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2.1 RNA extraction
All experiments including RNA extraction were done in a RNase free environment. 
DEPC treated double distilled water was used for making all solutions. The slides for 
RNA in situ hybridization were dried in a fume hood and stored in a dust free 
container at room temperature. All plastics used were siliconised and all glassware 
was baked at 180°C overnight
2.1.1 Solid tissues (testis, embryos)
The protocol used was described by Chomczynski and Sacchi (1987). RNA was 
extracted from mature mouse testis, developmental stages o f rat testis (after birth) and 
whole mouse embryos (E7, E10.5, E12.5, E13.5, E14.5, E15.5, E16.5, E17.5, E18.5 
and El 1.5, E l5.5 head embryo) with Trizol (Gibco BRL).
2.1.2 Cell cultures
This protocol is a modification o f the solid tissue preparation above. The amount o f  
guanidine was increased to keep the molarity (1.5-2 M) correct for a liquid system. 
RNA extraction was performed on mouse neuro2A (a neural crest specific cell line) 
and NB4 cells (an acute promyelogenic leukemia cell line) from a starting sample of 
250 pi o f culture medium. The biological samples were first lysed and homogenised in 
the presence o f a highly denaturing guanidine isothiocyanate (GITC)-containing 
solution that immediately inactivates RNase to ensure isolation o f intact RNA. In
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order to do this, after thawing out both the cells and the solution containing GITC, 400 
pL o f  this solution was added to the sample and mixed on a roller for 15 minutes. 
Then 65 pL (1/10 o f  the volume o f the sample and GITC-containing solution) o f 2 M 
sodium acetate was added to the solution and thoroughly vortex mixed. Sodium 
acetate helps precipitate RNA and DNA. A 650 pi aliquot (equivalent to the volume o f  
the sample plus GITC-containing solution) o f  water-saturated phenol was added and 
the whole was thoroughly vortex mixed. The resulting solution was passed back and 
forth several times through a 19-gauge hypodermic needle using a 1-ml syringe to 
shear the DNA. Then 130 pi (2 x the volume o f sodium acetate) o f chloroform was 
added, vortex mixed and put on ice for 15 minutes. The solution was then centrifuged 
at 13000-rpm (lOOOg) for 20 minutes. The upper aqueous layer was taken o ff into a 
fresh 1.5-mL tube and mixed with an equal volume o f isopropanol (propan-2-ol). This 
precipitated the RNA. The solution was incubated at -70°C for at least two hours 
(overnight was satisfactory). The frozen sample was centrifuged at 13000-rpm (lOOOg) 
for 15 minutes and a pellet was formed. The supernatant was pipetted off. Finally, 
any lasting impurities were removed by washing the RNA pellet in 100 pL 70% (v/v 
in water) ethanol. After a further five minutes centrifugation at 13000-rpm (lOOOg), 
the ethanol was removed and the RNA pellet dried for 10 minutes in a vacuum 
desiccator. The tube was spun down briefly to ensure the pellet was at the bottom of  
the tube. The RNA pellet was dissolved in 10-20 pi DEPC-treated water, depending 
on the pellet’s size. The RNA was stored at -70°C and used as the substrate for the 
ribozyme and DNase in the cell free system cleavages, or for making cDNA. Total 
RNA extraction was also performed in the same way on K562 cells to provide a
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control substrate in the cleavage reactions. For the cells o f neural crest origin, the 
RNA has been extracted from primary cell cultures o f neural crest cells obtained from 
mouse embryos (8.5 dpc) and cultured for 6 days.
2.2 Reverse Transcription (RT) reaction
The nucleic acid pellet obtained using the method above was depleted o f  any 
contaminating DNA by treatment with DNase I (Gibco BRL). The concentration o f  
the remaining RNA was determined by spectrophotometry (absorbance at OD 260) 
and 1 pg o f this total RNA was reverse transcribed using MMLV Reverse 
transcriptase (Invitrogen, Burlington) and oligohexamer primers with RT buffer at 
55°C for 50 min. The amount o f single stranded cDNA was determined by checking 
on agarose gel.
2.3 Cloning protocols
2.3.1 Vectors
In all cloning experiments the vector was digested by the appropriate 
restriction enzyme, in the presence o f BSA if  necessary. The linear vector was 
electrophoresed through a 1% agarose gel buffered with TAE, and was extracted from 
a gel slice using the QIAquick gel extraction kit (QIAgen). The purified DNA was 
then dephosphorylated using calf intestine alkaline phosphatase (Amersham 
Pharmacia Biotech), and the concentration o f DNA was measured by
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spectrophotometry. Vectors used were pTAG, EGFP-c2, pGBKT7, pGADT7 and 
pGAD424 (Clontech) (See Appendix for vector information).
2.3.2 Inserts
DNA fragments for cloning were produced in several ways; they were either 
amplified by PCR from BAC R-138D5 containing both ends of the human TSGA10 
gene or were produced by restriction digestion of the same PAC, or of the TsgalO 
mouse homologue cDNA (clone P2), or by PCR amplification of the mouse testis 
reverse transcription product. All the DNA fragments to be cloned were extracted 
from 1% agarose gels (usually buffered with TAE, Appendix 4.2) using the QIAquick 
gel extraction kit (Qiagen) and glass wool purification method. After extraction of 
inserts from the gel, the DNA concentration was determined by spectrophotometry 
(CIBA-CORNING 2800 Spectrascan). Table 2.3.2 shows the details of the constructs, 
which were made and used in this project.
Table 2.3.2- TsgalO constructs and relevant vectors
Vector Name_________ Total Length_____ Insert Length start End Promoter
pBluescript II/TsgalO (P2) 5.7 Kb 2.732 Kb -533 2732 Lac
EGFP-c2/T9galO 6.8 Kb 2.117 Kb 1 2117 CMV
pGBKT7/Tsga!0 10.4 Kb 2.117 Kb 1 2117 GaL4
PGBKT7/TsgalO-N 935 Kb 1.042 Kb 1 1041 GaL4
pGBKT7/Tsga!0-C 9.42 Kb 1.123 Kb 994 2117 GaL4
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2.3.3 Ligation of digested vectors and the DNA fragments to be inserted
Typically 100-250 ng o f digested vector DNA and a 3 to 5-fold molar excess o f the 
fragment were used with 2-4 Weiss units o f T4 DNA ligase (New England BioLabs or
recommendation o f  enzyme manufacturer) for 16 hours. Alternatively, the ligation 
reactions were carried out using the Rapid Ligation Kit (Promega) for a 12pi reaction 
and incubated at 24°C for 1.5hours:
Samples o f the ligations were then electrophoresed on a gel described previously.
For blunt-ended ligations, the digested fragment was first phosphorylated using 
T4 polynucleotide kinase enzyme (New England Biolabs) by incubation at 37°C for 
30 minutes. To fill in overhangs, the fragment was incubated at 12-16°C for 20 
minutes with 20 units o f T4 DNA polymerase (New England Biolabs) and a low (1 
mM) concentration o f dNTPs. The reaction was stopped by incubation at 75°C for 10 
minutes.
2.3.4 Bacterial transformation and PCR of colonies
5-10 pi o f  the ligation reactions were mixed with 50 pi o f competent E.coli DH5a, 
JM109 or XL-Blue cells (Gibco BRL), incubated on ice for 30 minutes, heat shocked
Roche) in a total volume o f lOpl at 16°C or 4°C (respectively according to the
2x Rapid ligation buffer 
Digested vector DNA  
Digested insert DNA  
T4 DNA ligase
5 pi
3 pl (Ipg)
3 pi (600ng) 
3p
67
Chapter 2: Materials and Methods
at 42°C for 60-90 seconds and then returned to ice. After a couple o f minutes Lauria- 
Bertani (LB) (see appendix) medium (950 pl) was added to each transformation and 
the tubes were placed in a shaking incubator at 37°C for 1 hour, at 250 RPM. 
Aliquots o f  100 and 500 pl o f  the culture were spread onto LB plates containing the 
appropriate antibiotic marker (ampicillin for pTAG and kanamycin for EGFP-c2 and 
pGBKT7) (and, where appropriate, IPTG and Xgal), and incubated at 37°C overnight. 
Once colonies o f E. coli had grown on the agar plates, 6 colonies were taken from 
each plate. PCR reactions were then set up with each colony to test for the presence o f  
the inserted DNA. The reactions were set up using the same method as before but the 
PCR program was modified so that the first denaturing cycle ran for 5min instead o f  
3min. This was to ensure the bacterial cell walls would be broken to release the DNA  
inside. Following the PCR reaction, the samples were electrophoresed on an agarose 
gel and photographed.
2.3.5 Small-scale plasmid DNA preparation
4.5ml o f  LB containing appropriate antibiotics was inoculated with a picked colony 
and the suspension was grown at 37°C overnight. DNA was prepared from a 4 ml o f 
culture using the QIAprep Spin Miniprep Kit (Qiagen). The plasmids were analysed 
by restriction analysis or by PCR, and positive samples were sequenced to confirm the 
positive clones. In some experiments, before growing the colonies, PCR was used to 
screen the colonies on the plate and find a positive clone that was then grown 
overnight. In some cases plasmids were prepared and purified manually as:
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2ml o f overnight bacterial culture grown from the colonies was transferred to fresh 
tubes. Then bacteria were pelleted by centrifugation for lmin at 10,000 rpm, 
supernatants were discarded and 200 jli1 o f Solution 1 (resuspension buffer: 50mM 
glucose, 25mM tris pH8, lOmM EDTA pH8) was added to the DNA pellet and mixed 
well by vortexing. Then 200pl o f Solution 2 (0.2M NaOH, 1% SDS) and 200pl o f  
Solution 3 (precipitation buffer: 60ml 5M potassium acetate, 11.5pl 37% acetic acid, 
28.5pl water) was added and mixed gently after each addition. The mixture was 
centrifuged for 3min at 10,000 rpm and the supernatant was transferred to fresh tubes. 
The pellet was discarded. 500 pl o f isopropanol was added to the supernatant, mixed 
and the tube was centrifuged for 5min at 10,000 rpm and the supernatant was 
discarded. Then the DNA pellet was resuspended in 500pl o f 70% ethanol and the 
tube was centrifuged for lmin at 10,000 rpm. The remaining supernatant was 
discarded, and this centrifugation step was repeated. Finally the DNA resuspended in 
50pl o f distilled water. DNA samples were then electrophoresed on an agarose gel.
2.4 Bacterial cultures
The Escherichia coli (E.coli) strains DH5a, XL-Blue and JM109 were used in 
the experiments. Cultures were grown in LB medium. Agar plates were poured from 
LB containing 1.5% (w/v) agar and antibiotic (25-35 pg/ml). Where blue/white 
screening was used, Xgal (40 pg/ml) and IPTG (0.1 mM) were also added to the agar 
by spreading the solutions on top o f  the agar after it had set and been dried in a fume 
cupboard.
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2.5 Large-scale preparation of plasmid and PAC DNA
DNA was prepared from 500 ml overnight cultures o f PAC D2/ containing the 
mouse TsgalO gene using a Qiagen-tip 500 and following the manufacturer’s protocol 
for preparation o f  large-construct DNA without removal o f genomic DNA. The same 
Qiagen-tip 500 kit was used for plasmid preparation from similar overnight cultures o f  
vectors to be used in subcloning experiments, sequencing and/or yeast transformation.
2.6 Digestion with restriction enzymes
All restriction digest experiments were carried out at 37°C for a minimum o f 2 hours 
and sometimes as long as 10 hours. Restriction digests were set up using the following 
method for a 25pl reaction:
1 Ox buffer 2.5pl
Restriction enzyme 1 30U
Restriction enzyme 2 30U
Purified PCR product 6pl (1-10 ug) 
ddH20  14pl
The digested DNA was run on a 1% TAE agarose gel and the required DNA was 
purified by using the QIAquick gel extraction kit (Qiagen). Sometimes DNA was 
purified on a PCR purification column (Qiagen).
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2.7 Ethanol Precipitation
i) 20pl PCR product for each sample was mixed with 2.5 pl 5M NaCl and 
lOOpl o f 100% ethanol in 1.5 ml tubes.
ii) The tubes o f  solution were then placed in the -70° C freezer for 30 min.
iii) The tubes were then centrifuged at 14000 rpm for 10 minutes, and the 
supernatant discarded
iv) The pellets were resuspended in 150pl o f 70 %  ethanol, centrifuged again 
at 14000 for 10 minutes, and once again the supernatant was discarded.
v) The remaining purified DNA pellets were then resuspended in approx. 20-
30 pl o f distilled water.
2.8 Polymerase chain reaction (PCR)
When the purpose o f PCR was to generate template for sequencing part o f a 
gene to be used to search the htgs database, or to screen bacterial colonies, Taq DNA  
polymerase was used. When PCR was used to amplify different fragments to be 
inserted into a construct, Pwo DNA polymerase which is a high fidelity DNA  
polymerase due to it’s 3 ’ to 5’ exonuclease (proofreading) activity, was used (Roche). 
In both cases PCR was performed using a 25pl reaction and a hot start protocol. 
Whenever Taq was used as the polymerase the protocol was as below:
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Reaction mixture: Taq buffer (10 x) 2.5 jul
dNTPs (2mM) 2.5 pl
Taq DNA polymerase (5 U/pl) 0.1 pl
DMSO 1.25 pl
Downstream primer (10 pmol/pl) 1.25 pl
Upstream primer (10 pmol/pl) 1.25 pl
Template DNA (200ng/pl or a bacterial colony) 1.0 pl
ddH20  15.15 pl
Total 25 pl
Hot start with: 94°C 3 min
Then 30 cycles of: 94°C 30 seconds
50-69°C 30 seconds (Ta o f  primers)
72°C 1-3 min (dependent on fragment length)
Then one cycle of: 68°C 7 min
When Pwo DNA polymerase was used, 2pl o f each primer (10 pmol/pl) was used to 
give a 500 nM concentration o f each primer. Otherwise, the protocol was as for Taq 
DNA polymerase.
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2.9 Oligonucleotides
Oligonucleotides for the PCR reactions were designed using the programme 
Primer3 at http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi. All 
oligonucleotides were ordered from Invitrogen (Table 2.9). All o f the nucleotide 
locations given in the table and in this thesis are based on the sequence o f mouse 
TsgalO which I submitted to the GenBank database (AF530050). The sequence is 
numbered from the first o f the two-methionine residues at the 5’ end.
2.10 Electrophoresis protocols
Sufficient electrophoresis-grade agarose (Gibco BRL), to produce a 1% gel 
was heated in an appropriate volume o f TAE or TBE. Once cast and set, the gel was 
immersed in the same buffer in a gel tank and run at approximately 4-4.5 V/cm 
voltage gradient. Four sets o f markers were used on agarose gels depending on the 
relative sizes o f the experimental DNA to be determined. These were X DNA/Hind III 
fragments and lkb ladder (Gibco BRL) (range 23130-564 bp), 500 bp ladder (Gibco 
BRL) (range 8000-500 bp), and 100 bp ladder (Gibco BRL) (range 2075-100 bp). In 
each case 0.5 to 1.5 pg was used depending on the size o f the well in the gel.
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T a b le  2.9: O lig o n u c leo tid e  seq u en ces
Oligonucleotide Sequence (5’ 3 ’) # Nucleotide AF530050)
1.MHF4’ CTG GAT TCC TTT GTC AAG ACT (459-479)
2. MR4 ATG GGC GTC TCG GAC TCT TAG A (570-549)
3.MF5’ GCT GCA AAC TGT GCT GTA GA (585-604)
4. MR5’ AAG GAG GAA GGT CTT GTC T (734-716)
5.MF6 GCT CGA CTT CGA CGA GAA AT (759-778)
6.MF19 TGC ACA GGA CCT GGA GTG TA (2606-2625)
7.MR19 TGA AAA CCC TTT ATT TTT GGT G (2717-2696)
8. MR6’ GCA TGT GCT GTG GTT GAC TT (819-800)
9. RpGEX AGA GCC TCG AGA TTC TGC ATG (Xhoi) (2242-2222)
10. FpGEX ATT TAG AAT TCA TGA TGA GAA ATA GAT CTA AG 
(EcoRl) (535-566)
11. MF4-TC10clone ATT CAA GCT TAA TGA TGA GAA ATA GAT CTA AG
(Hind III) (534-554)
12. MR19-TC10clone TCG AAT TCT CAA ATC TCA CTG TGA ACA TG
(EcoRI) (2650-2629)
13. MIF4 GCC AGC TCT GGC TTC ATA GT
14. MG4 GTT GCC TTT TGG TAA TGT C (2433-2415)
15.MR12 GGT TAA CAC CAA AGA ACA TCA G (1-22)
16. MR5 GCA TAC ACT TTA GCT CTT CAC G (650-629)
17. MR6 GCT TTT CAT CAT TTC TCG TCG (788-768)
18. MF5 GTC AAG GTT CTC ACA TCT GAG A (693-714)
19. MF4 ATC TAA GAG TCC GAG ACG CCC ATC (548-571)
20. M32880F CGG CTA CAC AGG CAG TTA CA
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Table 2.9: C ont’d
O ligonucleotide Sequences 5 ’ -> 3 ’ # Nucleotide (AF530050)
21. M32880R AGT GAG TCT GGC GTT GGT CT
22. GAL4AD TAC CAC TAC AAT GGA TG
23. pGBKT7-5’ TCA TCG GAA GAG AGT AGT
24. pGBKT7-3’ GTC ACT TTA AAA TTT GTA T
25. pGAD424-5’ CTA TTC GAT GAT GAA GAT ACC CCA CCA AAC CC
26. pGAD424-3’ AGT GAA CTT GCG GGG TTT TTC AGT ATC TAC GA
27. T30df2 ATC GAA ATT AAC CCT CAC TAA AGG CAG GCA ATG
AGG TGG ATT CT (T3 Promoter)
28. T70df2 ATC GAT AAT ACG ACT CAC TAT AGG ACC ATG TCT
GCC TCA TCC TC (7 7  Promoter)
29. T7MtclO ATC GAT AAT ACG ACT CAC TAT AGG ACT CAG CGA
CAT CTT GCT (7 7  Promoter) (1182-1199)
30. T3Mtcl0 ATC GAA ATT AAC CCT CAC TAA AGG AGA CTT TTT
ATC CAG ACA (T3 Promoter) (1358-1341)
31. YTHM CAC TCT CCC ATG GGA AGC TTA ATG ATG AGA AAT
(Ncol) (527-546)
32. MFE17 GAG ACG TGG CAC AGT TCA GA (2365-2384)
33.MRE18 GCT CTG GTG AAT GGC ATT TT (2550-2531)
34. R6H TCA TTG CTG AGA TGG AAC AG (1444-1463)
35. F-HIFla-rat CTG TGG GGT TTC GTT TCT GT
36. R-HIFla-rat TGT TTT CTT TTG AGC CGG TAA
37. FLJ32880F CGG CTA CAC AGG CAG TTA CA
38. FLJ32880R AGT GAG TCT GGC GTT GGT CT
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2.11 RNA In Situ Hybridization
2.11.1 Pretreatment of slides
Slides were incubated for 30 seconds in coplin jars containing 2%  APES (3- 
aminopropyltriethoxy-silane) in methanol and 9% methanolone in dH20.
2.11.2 Preparation of tissue slides
To prepare mouse tissue, a male from an outbred transgenic strain (CBAxC51Bl/6) 
was selected for dissection. The mouse was the result o f back crossing (strain carrying 
the smalleye mutation) for several generations. Organs were dissected and fixed in 4% 
paraformaldehyde for 6-18 hours and then in 20% sucrose in PBS overnight.
2.11.3 Preparing Cryostat Sections
A 7-ml bijou was used to mould aluminium foil into an embedding chamber 
wrapped (3-4 times) round the bottom, trimmed and then filled with OCT (BDH) at 
room temperature. A fixed mouse testis was placed onto a plastic petri dish to allow 
most o f the sucrose solution to drain off and then it was dropped onto the surface o f 
the OCT and allowed to sink. The chamber was put onto a bed o f dry ice to be frozen. 
The content o f the block was then placed onto a drop or two o f OCT on the chuck o f  
the microtome and was frozen in place using the bed o f dry ice. Cutting was started at 
30 micrometres per section until the tissue was reached then was continued at 10-12 
micrometres per section. TESPA (Triethoxysilylpropylamine)-coated slides were 
pressed onto the leading edge o f a section which was lifted onto the slide. When all 
sections were cut, the slides were dried for 1-2 hours in a fume hood. Slides were then 
placed in a light-tight plastic box which was sealed with tape and stored at -70°C.
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2.11.4 Preparation of labeled RNA probe
A program via www.genebee.msu.su/services/ma2-reached.html was used to predict 
the secondary structure of the mouse TsgalO mRNA (figure 1.16). A 195-nucleotide 
DNA sequence was identified which was unlikely to form any stable secondary 
structure and oligonucleotides were designed to amplify this region from cDNA 
(figure 2.11.4). A T7 and T3 promoter sequence was added to the 5’ end of the 
forward (T7MtclO 5’ATC GAT AAT ACG ACT CAC TAT AGG ACT CAG CGA CAT CTT 
GCT3’) and reverse (T3MtclO 5’ATC GAA ATT AAC CCT CAC TAA AGG AGA CTT TTT 
ATC CAG ACA3’) primers respectively. 1 pg DNA of PCR product was used after 
purification (with Qiagen PCR purification kit) as the template for RNA synthesis 
using either T7 or T3 RNA polymerase. The RNA probe (riboprobe) was prepared by 
incubating at 37°C for 3 hours with Digoxigenin conjugated UTP (Amersham) using 
the T7 labeling kit (Ambion) according to the manufacturer’s instruction. The 
Digoxigenin labeled riboprobe was purified by ethanol precipitation according to the 
manufacture instruction. The riboprobe in DEPC treated water, was collected in a 0.5 
ml tube and treated with Dnase to remove the template clone DNA. 2pl was then taken 
for running in an agarose gel while the rest (16pl) was stored at -20°C until required.
MF4-TC10clone 195-bp Riboprobes (nucleotide 976-1170) MR19-TC10clone
- g g ^ j m a a B m m m m m m m m  2067 bp m m m m m m m m m M
Figure 2.11.4- Murine TsgalO cDNA (ORF) and location of different primers used to amplify cDNA 
fragments to be used as probe in ISH, northern blotting or for screening of bacterial colonies and plasmids.
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2.11.5 (In Situ) Hybridization
The compositions o f solutions are described in the Appendix. Tissue sections, 
sections were thawed while the probe was diluted (-200-1000 fold dilution) in 
hybridisation buffer and denatured at 70°C for 5 minutes. 100 jil o f hybridization mix 
(recipe in appendix) was added to each slide, which was covered with a coverslip. The 
slides were hybridised overnight at 65°C in a sealed box (with Kimwipes on the base 
moistened with lx  salts/50% formamide, two wooden sticks were placed inside the 
box to support the slides).
The slides were then transferred to a coplin jar and placed in washing solution 
(recipe in appendix) preheated to 65°C for one hour, and the coverslips were allowed 
to fall off. The slides were washed two further times in washing solution preheated to 
65°C for 30 minutes each. Then they were washed in MABT (100 mM Maleic acid, 
150 mM NaCl, 0.1% Tween-20) for 2 * 30 min at room temperature and blocked in 
M-Block (MABT + 2% Blocking Reagent + 20% heat-inactivated serum) for at least 
one hour at room temperature (40pl o f M-Block per section) without a coverslip. After 
dilution o f  anti-DIG antibody in M-Block (1:1500) 75 pi was placed on the section 
and a coverslip was placed over it. The slide was then incubated in the humidified 
chamber overnight at 4°C.
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2.11.6 Signal Detection
The complex o f DIG-labelled riboprobe and anti-DIG antibody was detected by 
using the alkaline phosphatase method. Positive signals were developed by using 
nitro-blue tetrazolium chloride (NBT) / 5-bromo-4-chloro-3’-indolyphosphate p- 
toluidine salt (BCIP) as alkaline reaction detector. Next day, coverslips were removed 
and the sections were washed 4-5 times at room temperature in MABT, for 20 min 
total and then washed in staining buffer (recipe in the appendix) for 2 x 10 min.
The slides then transferred into a coplin jar wrapped in foil full (80 mis) o f staining 
buffer plus NBT/BCIP. (40ml staining buffer, 40ml 20% PVA, 360^1 NBT, 280pl 
BCIP). The staining reaction was stopped with 2 washes in PBT (PBS + 0.1% Tween 
20), dehydrated in 100% ethanol (x2), then histocleared (x2) in histoclear solution and 
mounted in DPX.
2.12 Sequencing
Templates for DNA sequencing were given to the DNA sequencing department, 
Wolfson Institute, University College London (UCL), who carried out all sequencing 
reactions using an ABI PRISM® 3100 Genetic Analyzer sequencing machine.
2.13 Quantification of DNA
To determine the concentration o f DNA, 5 or 10 pi o f sample was added with 
dlUO to a final volume o f 1 ml and the absorbance at 260 nm was measured. The 
purity o f the sample was determined by measuring the absorbance at 260 nm/280 nm.
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2.14 Calcium Phosphate-mediated DNA Transfection of cells
2.14.1 DNA preparation
The desired amount o f DNA was ethanol precipitated, washed in 70% ethanol, 
dried and resuspended in sterile water or TE at a concentration o f 1-3.5 mg/ml.
2.14.2 Cells
The following cell lines were used into study: HeLa, NIH 3T3 mouse fibroblast 
and hamster fibroblast (64063al2) hybrids containing chromosome 9 (a gift from 
Carol Jones) were used.
2.14.3 Preparing the calcium phosphate precipitate
The calcium phosphate co-precipitation method (Promega) was used for the 
transfection o f adherent cells. Cells were seeded on 10 cm dishes 1 day prior to the 
transfection. For stable transfection 1 x 106 cells were plated on each 10 cm dish. For 
transient transfection anywhere from 1 to 5 x 105 cells are plated. The confluence o f  
the cells was 50-90% on the day o f transfection. 0.5-3 hours prior to transfection the 
medium was renewed and the transfection was carried out in the following order:
- In one tube (tube A) 5-10pg o f plasmid was mixed with sterile distilled water 
to a total volume o f 240 pi, and 31 pi o f 2M calcium phosphate solution was 
added.
- 240pl (i.e., the same volume as tube A) o f 2 X HBS (1.5 mM NaHPC>4, 280
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mM NaCl, 50 mM HEPES with a pH o f 7.05-7.12) was prepared in another tube 
(tube B).
- Solution A was added dropwise into tube B while tube B was slowly vortexed. 
The precipitated particles appeared while the solutions were mixed. The quick 
addition o f solution A can result in poor precipitation.
- The transfection solution was left at room temperature for twenty minutes, 
gently mixed, and then added dropwise into the cell culture plate.
- The plate was moved gently back and forth to distribute the transfection 
solution.
- The plate was incubated at 37°C with 5% CO2 for 2-12 hours.
- Calcium phosphate containing medium was removed from the plate and the 
cells were washed with fresh medium.
- 48-72 hours after transfection the selection drug was added to the cultures and 
the cells were incubated for selection by the drug.
2.14.4 Versin/trypsin treatment of the cells
This step enhances nuclear uptake o f the introduced DNA (Chu and Sharp, 
1981). The medium was aspirated and each dish was washed 2 times with 5 ml o f PBS 
to remove most o f the precipitates. Typically, cells were maintained in nonselective 
medium for 1-2 days post-transfection, and then trypsinized by removing the final 
wash and adding enough trypsin/versin solution to cover the cell monolayer. Dishes 
were swirled whilst being washed, and were then checked under the microscope to see 
whether the cells had become detached from the dish.
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2.14.5 Transient assay and stable transfection
Cells were harvested, stained or analyzed 48 to 60 hours after the precipitate 
was placed on the cells. For stable transfection selective medium (G418) was placed 
on the cells one day after the transfection and cells were fed with fresh selective 
medium every 3 days.
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2.15 Northern Blot
2.15.1 Radiolabelling DNA probes by random priming
DNA to be used as probes was labelled by random priming (Feinberg and 
Vogelstein; 1984) using the rediprime DNA labelling system (Amersham Pharmacia 
Biotech). This system contains a dried, stable labelling mix o f dATP, dGTP, dTTP, 
Klenow enzyme and random primers (9mers). Approximately 25ng o f DNA was 
diluted to a volume o f 45pl in sterile distilled water, denatured by boiling for 5 
minutes and added to the labelling mix, together with 2-4pl o f [a-32P]dCTP 
(lOmCi/mL, 3000 Ci.mm of1). After incubation at 37°C for 20-60 minutes, 
unincorporated [a-32P]dCTP and primers were removed by passing the labelling 
reaction through a Sephadex G-50 column.
2.15.2 Northern Blotting
Blots were prepared as described in Maniatis containing lOpg RNA per lane. 
Probes were prepared as described above.
Pre-hybridization and hybridization were carried out for 2 hours at 60° C, and 20 
hours at 65°C respectively in solutions made according to the manufacturer's 
recommended protocol. The blot was washed twice in 2><SSC and 0.05% SDS for 30’ 
at room temperature and once in O.lxSSC and 0.1% SDS for 40’ at 55°C. The blot 
was exposed to X-ray film (Kodak-Biomax-MR) for 36 hours.
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2.16 Raising Antibodies against TsgalO and FLJ32880 proteins
2.16.1 Peptide design strategy
The amino acid sequences o f mouse TsgalO protein and the mouse homologue o f  
human hypothetical FLJ32880 protein were analyzed. After considering important 
factors for selecting peptides (described in section 3.4.1), the antibodies were raised 
against them (see following section).
In addition, I hoped to raise antibodies which would recognize both the rodent and 
human homologues o f  this protein. This meant that the immunising peptides had to be 
conserved, which was not necessarily the best strategy for raising an antibody in 
another mammal (rabbit). In the TsgalO protein sequence, the antigen prediction file 
generated by the program “Peptide Structure (GCG)” shows that it is not the easiest 
protein to work with due to the lack o f proline residues apart from the N-terminus 
region. However, the N terminus looked as though it is completely exposed and was 
worth considering. (Provided there is no reason to think it is chopped off post 
translationally.) Regions containing Proline and Arginine, and some hydrophobic 
amino acids are likely to be antigenic.
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2.16.2 Immunisation program
Eurogentec (Belgium) generated peptide polyclonal antibodies to the selected peptide 
sequences using multiple antigenic peptides (MAP method) in the following 
immunization procedures. The peptides were synthesized and conjugated to a carrier 
protein through the amino- or carboxy terminus depending on the position o f  the 
peptide within the native protein and the antigenicity profile. Two rabbits were used 
for each immunization. A proprietary immunization protocol (table 2.16.2), which 
allowed the production o f 70-80 ml serum per rabbit within 80 days followed. One- 
month extension was requested based on the ELISA result for TsgalO antisera. Both 
animals came from the same high antibody responding breed and were subjected to 
strict veterinarian controls. Finally both animals were bled.
Im munization schedule
Day 0 14 28 38 56 66 80
Injection 1st 2nd 3rd 4th
Bleed pre-
immune
2
ml
2+20
ml
50-60 ml
Table 2.16.2 - Immunization Protocol: two rabbits - 80 days
2.16.3 Antibody titre by enzyme-linked immunosorbent assay (ELISA)
The company, which made the antisera, also carried out ELISA results to assay the 
titre o f the antibody using the following procedures:
1. Making conjugate with horseradish peroxidase: first, 2 mg Horseradish peroxidase 
(HRP) was dissolved in 1 ml water (solution A) and 21.4 mg NalO in 1 ml water 
solution (B). 100 pi o f solution B was added to solution A (color changed to dark
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green), and left for 10 min at room temperature. The reaction was then put into the 
dialysis tube (such as Molecular cut o ff 20,000). At this stage the tube was put into 5 
mM NaAcetate buffer, pH 4.0 in a 2 to 3 / flask and dialysed overnight (color changed 
to gold). To raise the pH o f  the HRP solution to pH9.0, 0.2 M NaCarbonate buffer, pH
9.5 was added and the pH was monitored using a universal pH paper.
2. Antibody purification by protein G: the antibody solution was mixed (8 mg o f IgG 
in 1 ml), which had been pre-dialyzed to 0.01 M NaCarbonate buffer, pH 9.0 
overnight, and the mixture was incubated for 2 hr at room temperature. At this stage, 
100 pi o f freshly prepared, 0.1 M NaHBr4 in water was added to the solution, and this 
was incubated at 4°C for 2 hr. The mixture was then put into a dialysis tube and 
dialyzed against PBS overnight.
3. 96-well plate: The solid phase reaction was was carried out in a 96-well plate 
(Coming' Nunc').
4. Buffers and other reagents consist of:
a) Plate buffer: 0.1 M Sodium carbonate buffer, pH 9.5,
b) Reaction buffer: 0.01 M Sodium phosphate buffer, pH 7.2, 0.15 M NaCl 
(PBS), 0.5% BSA,
c) Washing buffer: 0.05% Tween-20, 0.01 M Sodium,
d) phosphate buffer, pH 7.2 or 0.05% Tween-20, 0.15 M NaCl,
e) Developing buffer: 0.05 M Sodium acetate buffer, pH 5.5,
f) TMB stock solution: Tetramethylbenzidine 1 mg/ml in DMSO.
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2.17 Immunohistochemistry (IHC) and Immunocytochemistry
2.17.1 Preparing slides
8-12 microns (p) thick were cut from paraffin embedded tissues and placed on the 
positive charged SuperFrost glass slides (BDH). Then they were baked for half an 
hour at 55°C to fix them to the slides to prevent the tissue from detaching during 
immunohistochemistry. The slides were then stored in a cold room at 4°C until 
immunohistochemistry was performed.
2.17.2 Tissue fixation and processing
Sections o f mouse, rat, boar and pig testes, mouse brain, various developmental stages 
o f mouse embryos and human germ cell tumor were selected for 
immunohistochemical analysis. All human cells and tumour sections were obtained 
from patients who had given informed consent for their use in research.
Sections were prepared from mouse embryos from 10.5-dpc (days post coital) (E10) to 
newborn (19.5-dpc). The mothers o f the embryos were killed and then the embryos 
were dissected out and kept in 1% Phosphate Buffered Saline (PBS) for less than 1 
hour. Embryos were processed for sectioning and paraffin embedding by being placed 
in 4%  Paraformaldehyde, made with 1% PBS, and were left overnight in the cold 
room. The larger embryos o f 17.5 and 18.5dpc were injected as well as being 
immersed so that all the tissue was exposed to the preservative.
Alternatively for the fixation, Camoy’s or Bourne’s solutions were used. The recipe 
for Camoy’s fixative is:
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Ethyl alcohol (100%) 70ml
Chloroform 30ml
Acetic acid 10ml
Again the larger embryos were injected with Comoy’s and left overnight. The 
following morning they were washed and stored in 70% ethanol.
Individual embryos were embedded in paraffin using the standard NIH method 
(http://cgap-mf.nih.gov).
2.17.3 IHC procedure and DAB staining
The first stage o f the immunohistochemistry protocol involved deparaffmation and 
hydration o f  the slides, so that the tissue on the slides would be effectively treated in 
the later stages o f the protocol. The slides were bathed in xylene for twenty minutes, 
changing the xylene after the first ten minutes. The xylene dissolves the paraffin. The 
slides were then bathed in ethanol at 100%, 90% and 70% concentrations respectively, 
each for ten minutes. Antigen retrieval is then performed to combat post translational 
modifications o f TSGA10, in particular glycosylation so that the antibodies can 
recognise the antigen. Antigen retrieval involves ‘baking’ the slides in 0.01 M sodium 
citrate buffer (pH=6). The slides were ‘baked’ in the microwave for five minutes on 
each o f high (900 W), medium (600 W) and low (300 W) settings consecutively. It 
was necessary to ensure that the citrate buffer did not dry out during the ‘baking’ so 
extra was added as needed so that the tissues were always covered. When the slides 
came out o f the microwave they were immediately bathed in ice cold 1% Phosphate
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Buffer Solution. The slides were then treated with 6% Hydrogen Peroxide in PBS for 
twenty to thirty minutes to remove endogenous peroxidase activity. Hydrogen 
Peroxide is light sensitive so the slides were kept in the dark while the reaction was 
occurring. The reaction was stopped by rinsing with PBS three times each for ten 
minutes, and then the slides were put in PBS on a moving tray for 3 minutes to ensure 
they were rinsed properly, this stops the Hydrogen Peroxide reaction. At this point in 
the protocol the slides were incubated in 3% Normal Goat Serum (NGS) overnight. 
NGS blocks all sites to which the primary and secondary antibodies might bind non- 
specifically later in the procedure. After blocking with NGS the slides were separated 
into three groups and specific peptides were added to block certain parts o f the protein. 
In one group the N terminus is blocked, in the other the C terminus and the third group 
the whole protein is blocked, this is the negative control. The peptides were added to 
the NGS solution for one hour and the primary antibody was added at a concentration 
o f 0.2% at 37°C for one and a half hours. The slides were then rinsed three times, 
each for ten minutes, in PBS with 0.1% ‘Tween 20’. The tissue slides were then 
incubated in the secondary antibody, Goat Anti- Rabbit IgG conjugated to peroxidase 
(CHEMICON International, CA, USA). The secondary antibody recognises the 
primary antibody and the peroxidase is recognised by the staining kit. The secondary 
antibody was added at a dilution factor o f 1:660 (1.5pg/ml) for thirty minutes. The 
slides were again rinsed in PBS three times each for ten minutes. Once the antigen 
(TSGA10) had been recognised specifically by the primary antibodies and the primary 
antibodies had been recognised by the secondary antibodies, it was necessary to stain 
the tissues in order to detect the labelled protein under the microscope. To do this I
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used the Di-amino Benzidine (DAB) kit and so care had to be taken when using this. 
Using distilled water the DAB solution was prepared based on the kit (2 drops o f  
buffer stock solution to 5ml o f distilled water, then mixing, adding 4 drops o f DAB 
stock solution, and then adding 2 drops o f hydrogen peroxide solution and mixing 
well. The slides were lined up on a tray and the DAB was added to the slides for 
between 2-10 minutes until the tissue on the slides darkened. The slides were then 
rinsed by shaking off excess DAB and then rinsing in tap water to remove the 
remaining DAB. They were then incubated in 0.05M sodium bicarbonate for ten 
minutes. An enhancer was then used to amplify the DAB signal. The DAB enhancing 
solution was pipetted over the slides as they were lined up in a tray and then excess 
was shaken off after ten to twenty seconds and the slides were re-immersed in tap 
water to stop the reaction. The DAB kit and DAB enhancing solution were supplied by 
Vector Laboratories. The slides were again placed on a tray and Hematoxylin and 
Eosin (H&E) counterstain was added. This was left on the slides for thirty seconds 
then the excess was shaken o ff and the slides were submersed in tap water. The slides 
were then dehydrated by submersing them in ethanol at concentrations o f 70%, 90% 
and 100% respectively each for thirty seconds. The slides were left to dry, and then 
DPX was used to fix the cover slips. The slides were then stored at room temperature 
until being analysed under the microscope. Using Di-amino Benzidine and 
Hematoxylin & Eosin (H&E) to stain and counterstain the slides, the immune signal 
will show as brown (stained by DAB) and the background will be blue (stained by 
H&E). Phalloidin conjugated to TRITC (Sigma) was also used (according to the 
manufacturer’s instruction) to stain actin filaments.
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2.17.4 Indirect Immunofluorescence Analysis
For immunostaining o f mouse, bovine and boar sperm, immunocytochemistry 
was performed. Mature bovine and boar spermatozoa were collected from their 
epididymis and washed in PBS. Spermatozoa were pelleted and resuspended in 
demembranization buffer (5 mM 1,4-dithiothreitol [DTT], 50 mM Tris-HCl [pH 9.0], 
and 2% v/v Triton) followed by fixation in 4%  formaldehyde. The cells were spread 
on cover slips treated with poly-L-lysine (Sigma) and incubated with primary 
antibody diluted 1:25 (v/v) in blocking solution for 1 h at 37°C and washed in PBS. 
Sperm were incubated for 1 h at 37°C with secondary antibody (FITC-conjugated goat 
anti-rabbit IgG; Jackson Immunoresearch Laboratory, Inc., West Grove, PA) diluted 
1:100 (v/v) in blocking solution and washed in PBS before staining with DAPI (as 
described above). Cover slips were mounted on glass slides with Permount SP15-100 
(Fisher Scientific, Edmonton, AB, Canada). Slides were viewed with a Zeiss confocal 
fluorescent microscope.
2.17.5 Taking photos
A Zeiss 100M light microscope was used to detect the signals. The photographs were 
taken with a Kodak MDS camera attached to the microscope, and coupled to a monitor 
was used to take pictures o f the slides under the microscope. Normal Panasonic and 
Gold KODAK films were used and developing tools in Boots/Jessop photo shops were 
used for the photos developing.
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2.18 Western Blot (SDS-PAGE method)
2.18.1. Setting up the gel.
1 large (19 x 20cm) and 1 small glass plates were used. The best side o f each plate was 
chosen (ie. with no cracks or chips), cleaned with detergent, rinsed well with ddH2 0 ,
dried and then wiped over with ethanol.
Both sides o f  the spacer gaskets (use the thicker ones for protein gels) were smeared 
with Vasoline and placed onto the large plate as shown below with the black rubber 
facing upwards.
10cm
The small plate was placed on top and secured at the bottom with bulldog clips.
The plates were placed into a tray, water was added to check for leaks, if  OK this was 
emptied and the apparatus was dried with a paper towel.
20cm
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2.18.2 Pouring the Gradient
The gradient maker was cleaned and checked for blockages and a magnetic stirrer was 
placed into the middle compartment.
Acrylamide solutions were prepared as below.
5% 15%
50% glycerol 0 3.6ml
dH20 10.55ml 1.2ml
Acrylamide/Bis, 37.5:1, 30%T 2.79ml 8.36ml
1.5M Tris-HCl pH8.8 3.34ml 3.34ml
TEMED 15|nl 15pl
10% SDS 200p,l 200 j l l 1
10% w/v (APS) 50|xl 25pl
The ammonium persulphate was added last (just before use), and mixed briefly. 
Making sure the lever on the gradient maker was in the closed position, the 5% mix 
was poured into the outer ring o f the gradient maker and the 15% mix into the inner 
ring.
15% mix + stirrer
5% mix
The glass plates were placed inside a plastic tray, to contain any spills. The solution 
was pumped into the apparatus and covered with layers o f water. Gels could be stored 
at 4°C.
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2.18.3 Pouring the stacking gel
The apparatus was allowed to come to room temperature. The water was removed. 
The solution was prepared as below:
3%
dH20  15.5ml
0.5M Tris-HCl pH6.8 2.5ml
Acrylamide/Bis, 37.5:1, 30%T 2.0ml
TEMED 20pl
10% SDS 200jLtl
10% w/v (ammonium persulphate) 200pl
The ammonium persulphate was added last as before, mixed gently then poured on top 
of the set gradient gel using a plastic pasteur pipette. When the gel reached the top o f  
the small glass plate the spacer comb was added at an angle to avoid trapping air 
bubbles. The gel was left to set for about an hour.
2.18.4 Sample Preparation.
30pl o f sample was mixed with 30pl o f dissolving buffer. For markers I used 7pl o f  
Rainbow marker (Amersham) mixed with 7pl o f sample buffer.
Samples were boiled for 2 minutes and markers for 30 seconds before loading on the 
gel. 100-500pl culture (according to the condition o f growth) was taken and 
centrifuged for 5min, its supernatant discarded and 50-100 pi 2 x treatment buffer 
added. In this step, the cells were ruptured by freezing and thawing three times using
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liquid nitrogen and then sonication with high frequency for 1 minute at ice cold 
temperature. Just before SDS-PAGE and western blotting it was boiled for 5 min and 
centrifuged briefly.
2.18.5 Tank set up
Freshly boiled protein samples were electrophoresed through an SDS gel in a BioRad 
apparatus. The gels were electrophoresed at 180V 45mA until the blue dye reached the 
bottom o f the gel (~ 8 hrs) and then continued to run for a further hour.
2.18.6 Western Blotting
Proteins were transferred from the SDS gel to the blots in transfer buffer at an initial 
current o f  0.1-0.18A, 45-90V for 17 hours onto an Amersham polyvinylidene fluoride 
(PVDF) filter.
2.18.7 Antibody staining
The sandwich was removed from the Western blotting apparatus and the gel and the 
PVDF were placed together on the glass plate. The position o f the gel was marked on 
the PVDF including any orientation marks.
The gel was discarded and the PVDF was placed into a glass tray containing blocking 
buffer (5% non-fat milk) and incubated at 4°C with shaking for a minimum o f 6 hours.
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The membrane was transferred to a plastic bag and antibody was added at an 
appropriate dilution (for TsgalO antisera: 1:1000 in blocking solution). The bag was 
sealed and incubated overnight (or weekend) at 4°C with shaking.
The antibody solution was removed from the bag and the membrane was washed in a 
glass tray in PBS for 5x 5min at 4°C with shaking.
Then GOAT anti Rabbit IgG conjugated to peroxidase (diluted 1:4000 in PBS) was 
added to the membrane in the bag and incubated for 2 hours at 4°C with shaking. The 
membrane was removed from the bag and washed again in a glass tray in PBS for 5 x 
5 minutes at 4°C with shaking.
For chemiluminescence signal detection, the ECL Plus Amersham kit was used by 
applying 2ml/10cm detection solution and was left for a maximum o f 5-6 minutes. 
Longer exposure led to high background.
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2.19 Yeast two hybrid assay
2.19.1 Yeast strains, MATCHMAKER yeast two hybrid assay
The Saccharomyces cerevisiae yeast strain, AH 109, was used for transformation or 
co-transformation with plasmid containing bait plasmids (TsgalO , either o f the two 
halves o f TsgalO) and Saccharomyces cerevisiae yeast strain, Y187, was used for the 
mating protocol.
Table 2.19.1- Bait strain - AH109 - characteristics
Genotype Phenotype
MATa Mating type a
trpl-901 Deletion mutation, cells cannot synthesise 
tryptophan, and are thus unable to grow on 
minimal media lacking it.
leu2-3,l 12 Double mutation, cells cannot synthesise leucine, 
and are thus unable to grow on minimal media 
lacking it.
ura3-52 Deletion mutation, preventing cells from 
synthesising uracil. The lacZ construct, 
containing the functional gene, is integrated into 
the yeast genome at this location, enabling 
selection of recombinants through growth on - 
ura media.
his3-200 Deletion mutation, cells cannot synthesise 
histidine, unless in the presence of GAL4. (see 
below)
gal4A Deletion mutation
gal80A Deletion mutation
LYS2::GAL1uas- Reporter gene construct. HIS3 reporter gene is
GAL1 7ata_HIS3 activated when GAL4 binds to the corresponding 
upstream activating sequence, GAL1UAs
GAL2uas-GAL2tata- Reporter gene construct. ADE2 reporter gene is
ADE2 activated when GAL4 binds to the corresponding 
upstream activating sequence, GAL2uas.
URA3;; MEL 1 uas- Reporter gene construct. lacZ reporter gene is
MEL 1 TATA" 13CZ activated when GAL4 binds to the corresponding 
upstream activating sequence, MEL1UAs
MEL1 Gene encoding a-galactosidase, naturally 
activated by GAL4
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Table 2.19.2- Library strain - Y187 characteristics
Genotype Phenotype
MATct Mating type a
ura3-52 (see Table 2.19.1)
his3-200 (see Table 2.19.1)
ade2 - 1 0 1 Deletion mutation, cells cannot synthesise 
adenine, and are thus unable to grow on 
minimal media
trp 1-901 (see Table 2.19.1)
leu2-3,112 (see Table 2.19.1)
gal4A (see Table 2.19.1)
gal80A (see Table 2.19.1)
met- Met- phenotype in this strain is unstable and 
was not used in these experiments.
URA3::GAL1UAs- Reporter gene construct. lacZ reporter gene
GAL1 tata "lflcZ is activated when GAL4 binds to the 
corresponding upstream activating 
sequence, GAL1uas
MEL1 (see Table 2.19.1)
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2.19.2 B ait and prey dom ains
Bait plasmid - pGBKT7-TsgalO: Mouse TsgalO cDNA was cloned into the multiple 
cloning site of pGBKT7, between the N col and EcoRl restriction sites.
This plasmid encodes the GAL4 DNA binding domain (GAL4 DNA-BD) upstream 
and in frame with the multiple cloning site. Thus when TsgalO was inserted into the 
multiple cloning site, a fusion protein of TsgalO-GAL4 DNA-BD, i.e. the bait protein 
is encoded by the plasmid. pGBKT7 contains both S. cerevisiae and E. coli origins of 
replication, and thus can be transformed into both. It also contains selectable markers 
for both the kanamycin resistance gene for selection in E. coli and the metabolic 
marker gene TRP1 for selection in S. cerevisiae.
Also the 5' and 3' halves of TsgalO were amplified and separately cloned into plasmid 
vectors. Figure 2.19.2 shows the schematic of the primers that were designed for the 
PCR reaction to make TsgalO-N and TsgalO-C constructs as bait plasmids to see their 
possible interactions:
sOS.
^  p mtigalO  \_£_^ p G B K T 7
& s^ StoR. EcoRl D
Figure 2.19.2A- A Primer design to make TsgalO-N,C halves bait construct (not to scale)
The two halves of the mouse TsgalO gene were amplified by PCR using primers A 
and B, and C and D (figure 2.19.2, A+B). Once suitable primers had been picked, 
using Primer3, restriction sites were added to the beginnings of primers B and C. An 
EcoRl site was added to primer B and an N col site was added to primer C. Two 
random nucleotides were also added to the beginning of the EcoRl restriction site and
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T c t a c t g a t t t t t c c t c g a g a a g a c c t t g a c a t g a t t t t g a a a a t g g a t t c t t t a c a g g a t a t a a a a g c
a t t g t t a a c a g g a t t a t t t g t a c a a g a t a a t g t g a a t a a a g a t g c c g t c a c a g a t a g a t t g g c t t c a g t
g g a g a c t g a t a t g c c t c t a a c a t t g a g a c a g c a t a g a a t a a g t g c g a c a t c a t c a t c g g a a g a g a g t a g
t a a c a a a g g t c a a a g a c a g t t g a c t g t a t c g c c g g a a t t t g t a a t a c g a c t c a c t a t a g g g c g a g c c g c
c a t c a t g g a g g a g c a g a a g c t g a t c t c a g a g g a g g a c c t g c a t a t g g c a c t c t
c a c t c t c c a tg g (g a a g c t t )a tg a tg a g a a a t
a t g a t g a g a a a t a g a t c t a a g a
g t c c g a g a c g c c c a t c g c c a a c t t c c c g g g c t g c a a a c t g t g c t g t a g a g c t t t t g a a g t c a a c t g c a a
g a g a c c g t g a a g a g c t a a a g t g t a t g c t g g a a a a a t a t g a a c g t c a t t t g g c a g a a a t c c a g g g c a a c g
t c a a g g t t c t c a c a t c t g a g a g a g a c a a g a c c t t c c t c c t t t a t g a g c a g g c a c a g g a a g a a a t t g c t c
g a c t t c g a c g a g a a a t g a t g a a a a g c t g t a a g t c t c c t a a g t c a a c c a c a g c a c a t g c t a t t c t t c g t c
g g g t a g a g a c g g a g a g a g a t g t a g c c t t c a c t g a c c t a c g a a g a a t g a c c a c a g a g c g a g a c a g t c t g a
g a g a a a g g c t c a a g a t t g c t c a a g a g a c a g c g t t c a a c g a g a a g g c t c a c t t g g a a c a g c g g a t a g a g g
a g c t g g a g t g c a c a g t t c a c a a c c t t g a t g a t g a g c g c a t g g a a c a g a t g g c a a a c a t g a c t t t g a t g a
a g g a a a c c a t a a c c a c t g t g g a a a a a g a a a t g a a a t c a t t a g c a a g a a a g g c a a t g g a c a c c g a g a g t g
a g c t t g g c a g a c a a a a a g c a g a g a a t a a t t c t t t g a g a c t t t t a t a t g a a a a c a c a g a a a a a g a t c t t t
c t g a t a c t c a g c g a c a t c t t g c t a a g a a a a a a t a t g a g c t a c a g c t t a c t c a g g a g a a a a t t a t g t g c t
t g g a t g a a a a a a t t g a t a a t t t c a c g a g g c a a a a t a t t g c a c a g c g a g a a g a a a t c a g c a t t c t t g g t g
c a a c c c t c a a t g a c c t g g c t a a a g a a a a g g a a t g c c t g c a a g c g t g t c t g g a t a a a a a g t c t g a g a a c a
t t g c a t c c c t t g g c g a g a g c t t g g c a a t g a a a g a a a a a a c c a t t t c a g g c a t g a a g a a t a t c a t t g c t g
a g a t g g a a c a g g c a t c a a g a c a g t c t a c t g a a g c c c t c a t t a t g t g c g a a c a a g a t a t t t c c a g g a t g c
g c g a tg c g c c g g c a g t t g g a c g a g a c a a a t g a t g a g c t g g g t c a g a t t g c c a g g g a g a g a g a t a t
g a t tcca tg g g ca g t tg g a cg a g a ca a
a t  q t c a q a t tq c c a q g g a g a q a g a ( a t t c ca)
t a t c t t g g c t c a t c a g a a t a c c a a t c t t c a a g a a c a g t t t g c c a a a g t c a a a c a a g a a a a c c a g g c a c t  
g t c c a a a a a a c t g a a t g a t a c t c a t a c t g a a c t c a g t g a c a t a a a g c a g a a g g t c c a g g a c a c g a a t c t  
g g a g g t t a a c a a g t t g a a g a a c a t a t t a a a g t t t g a g g a a t c t g a g a a c c g g c a a a t a a t g g a a c a a c t  
c c g a a a a g c c a a t g a a g a t g c t g a a a a c tg g g a a a a t a a g g c c c g c c a g a c a g a g g c a g a a a a c a a c a c  
c c t c a a a c t g g a a c t t a t c a c t g c t g a a g c a g a g g g c a a c a g a t t a a a g g a a a a a g t t g a t g c c c t t a a  
c a g a g a g g t t g a g c a a c a c c t a a a c g c a g a g c g c t c t t a c a a a t c c c a g a t t g c a a c t t t a c a c a a g t c  
t c t t g t g a a g a t g g a g g a g g a g c t t c a g a a g g t t c a g t t t g a g a a g g t g t c t g c t c t c g c a g a t t t g t c  
t t c c a c a a g g g a a c t c t g c a t a a a a c t c g a c t c a a g c a a a g a a c t t c t t a a t c g a c a g c t g g t t g c c a a  
a g a t c a g g a a a t a g a a a t g a t g g a g a a t g a g c t g g a c t c a g c g c g c t c t g a a a t t g a a c t g c t c c g g a g  
t c a g a t g a c a a a c g a g a g g a t c t c c a t g c a g a a t c t c g a g g c t c t g c t g g t g g c c a a c c g g g a c a a a g a  
g t a c c a g t c t c a g a t a g c a c t g c a g g a a a a g g a g t c t g a g a t c c a g t t g c t g a a g g a g c a c c t c t g c c t  
g g c t g a g a a c a a a a t g g c c a t c c a g a g c a g a g a c g t g g c a c a g t t c a g a a a t g t t g t a a c g c a g t t a g a  
a g c a g a t t t g g a c a t t a c c a a a a g g c a a c t c g g g a a g a a c g t t t t g a a a g g g a a a g g g c t g t c c a a c t t  
c g c c g c c a g a a t t a t t c a a g c a a t g c t t a t a a t t t c g g t c c a a t g g a g c c a a a t a c a a a a t g c c a t t c a  
c c a g a g c g t g t t c a c c a t c g g t t t c c t g a c c g a g g c t t c g a c c g a t c a t t g g a a g a g t a a g t g t g c a c a  
g g a c c t g g a g t g t a g c c a t g t t e a c a g tg a g a t f c t g a g g a a g c g a g g a a a c t g a t a c t a a a c c t g g t t a  
a t a a g a c a t g a t g a c a c c g a a t t c c c g g g g a t c c g t c g a c c t g c a g c g g c c g c a t a a c t a g c a t a a c c c  
c t t g g g g c c t c t a a a c g g g t c t t g a g g g g t t t t t t g c g c g c t t g c a g c c a a g c t a a t t c c g g g c g a a t t  
t c t t a t g a t t t a t g a t t t t t a t t a t t a a a t a a g t t a t a a a a a a a a t a a g t g t a t a c a a a t t t t a a a g t g  
a c t c t t a g g t t t t a a a a c g a a a a t t c t t a t t c t t g a g t a a c t c t t t c c t g t a g g t c a g g t t g c t t t c t c  
a g g t a t a g c a t g a g g t c g c t c t t a t t g a c c a c a c c t c t a c c g g c a t g c a a g c t t g g c g t a a t c a t g g t c  
a t a g c t g t t t c c t g t g t g a a a t t g t t a t c c g c t c a c a a t t c c a c a c a a c a t a c g a g c c g g a a g c a t a a a  
g t g t a a a g c c t g g g g t g c c t a a t g a g t g a g g t a a c t c a c a t t a a t t
Figure 2.19.2B- Partial sequence o f  pGBKT7 plasmid with TsgalO insert (1st and 2nd portions). 
Key: Plasmid sequence, TsgalO sequence, Primers A and B, Primers C and D Restriction sites for
Ncol and EcoRl
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four random nucleotides were added before the N col site. These extra nucleotides 
enabled the enzymes to bind to the sequences and cleave them. This cleavage was 
necessary to create complementary ends and enable the fragments to be ligated into 
fresh plasmid. The positions o f the N col site in primer C was adjusted such that the 
junction would be in the correct reading frame for translation o f the second half o f the 
sequence to produce a functional protein.
The sequences o f  the primers are shown below:
A (YTHM) CACTCTCCCATGGGAAGCTTAATGATGAGAAAT
{Ncol)
B TGGAATTCTCTCTCCCTGGCAATCTGAC
(EcoRl)
C GATTCCATGGGCAGTTGGACGAGACAAAT
(Ncol)
D (MR 19TC1 Oclone) TCGAATTCTCAAATCTCACTGTGAACATG
(EcoR I)
Prey plasmid - pGAD424: This plasmid encodes the GAL4 activating domain (GAL- 
AD) upstream and in frame with the multiple cloning site. When rat testis cDNA  
library was inserted into the multiple cloning site, one third o f the clones coded for a 
fusion protein o f  testis protein-GAL4-AD. pGAD242 contains both S. cerevisiae and 
E. coli origins o f replication, and thus can be transformed into both. It also contains 
selectable markers for both the bla ampicillin resistance gene for selection in E. coli 
and the metabolic marker gene LEU2 for selection in S. cerevisiae.
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2.19.3 The rat cDNA Library
Since the protein was known to be testis specific, proteins that interact with it 
must be expressed in the testes. Thus a testis cDNA library was screened using the 
yeast two-hybrid system. So TsgalO protein interaction was studied by rat testis 
library screening pretransformed in pGAD424 vector (Clontech). Approximately 
200,000 rat testis cDNA independent clones were cloned into the multiple cloning 
sites o f pGAD242, between the EcoRl and Sail restriction sites. The library was a gift 
of Professor Frans Van der Hoorn, University o f  Calgary, Alberta, Canada.
2.19.4 Yeast transformation
The protocol outlined below, based on the Clontech MATCHMAKER Two-Hybrid 
System, was used for the yeast co-transformations. The protocol was scaled up four 
times so that enough yeast cells could be plated onto the 32 plates required for the 
experiment. For yeast transformation, 2-3 yeast colonies (2-3mm in diameter) were 
added to 4ml YPD medium, vortexed to mix and incubated at 30°C overnight with 
shaking at 250rpm. Then the culture was transferred into 30ml YPD medium, 
incubated at 30°C for 3hours with shaking at 250rpm and centrifuged for 5min at 2000 
x g. After discarding the supernatant, the DNA pellet was resuspended in 20ml o f  
water and vortexed to mix. After centrifuging for 5min at 2000 x g and discarding the 
supernatant again, the DNA was pelleted in 15ml o f lxTE/LiAc, centrifuged for 5min 
at 2000 x g, and the supernatant discarded. Then the DNA pellet was resuspended in 
lml o f lxTE/LiAc and the following were added to each tube: lOOng DNA-binding 
domain plasmid, lOOng activation domain plasmid (or library plasmid), 5pg Herring
102
Chapter 2: Materials and Methods
testes carrier DNA, 0.1ml yeast competent cells. Then after vortexing, 0.6ml o f  
PEG/LiAc solution (0.5ml lOxTE, 0.5ml lOxLiAc, 4ml PEG4000) was added, 
vortexed to mix, and incubated at 30°C for 45min with shaking at 200rpm. One tenth 
o f the volume o f the transformation o f dimethylsulphoxide (DMSO) was added to 
each tube and gently inverted to mix before heat shock for 15min in a 42°C water bath. 
Then it was chilled on ice for l-2min, centrifuged for 15sec at 14000rpm and the 
supernatant was discarded. Finally, the cell pellet was resuspended in 0.5ml TE or 
water just before plating out onto SD medium (yeast nitrogen base without amino 
acids, agar, water, 40% glucose, and with the appropriate dropout supplement) 
containing amino acids lacking either ‘Leu, Trp’ or ‘Leu, Trp, His, Ade’.
250pl o f each transformation was plated out and incubated at 30°C for two days.
To estimate transformation efficiency, yeast colonies were counted in the control plate 
by using the formula:
Transformation efficiency = __________ no. colonies x total suspension volumef pi)
Volume plated(jil) x dilution factor x amount DNA(pg)
2.19.5 PCR of colonies
Following the transformation, samples were taken from four yeast colonies on each 
SD/-Trp plate. The samples were tested in a PCR reaction to see if  the plasmids 
contained the inserted DNA and would therefore be suitable for the yeast mating. The 
first denaturing stage o f  the PCR reaction was increased from 3min to 5min to allow 
the DNA to be released from the yeast cells. The PCR products were electrophoresed 
on an agarose gel.
103
Chapter 2: Materials and Methods
2.19.6 Yeast Mating
Yeast mating is a convenient method o f introducing two different plasmids into the 
same host cells, and, in some applications, can be used as a convenient alternative to 
yeast co-transformations (Bendixen et al., 1994; Harper et al., 1993; Finley & Brent, 
1994).
The yeast mating was carried out to create cells that contained both bait and library 
plasmids. Both bait and library strains are grown up in an overnight culture in SD 
medium. The two strains are then combined, YPDA/Kan is added, and the suspension 
is incubated overnight at 30°C, with gentle swirling. As the two strains are o f different 
mating types (see above), they mate, producing diploid cells in which both plasmids 
are found. The cells are then plated out on double drop out media, so that only cells 
containing both plasmids can grow.
The following small-scale protocol worked well for creating diploids by yeast mating.
a. One colony o f each type was picked to use in the mating. Only large (2 -3 -mm), 
fresh (<2 -months old) colonies from the working stock plates were used.
b. Both colonies were placed in one 1.5-ml microcentrifuge tube containing 0.5 ml of 
YPD medium and tubes were vortexed to resuspend the cells completely.
c. Tubes were incubated at 30°C overnight (20-24 hr) with shaking at 200 rpm.
d. 100 pi aliquots o f the mating culture were spread on the appropriate SD minimal 
media. Double dropout (-Leu/-Trp) was used to select for both plasmids (mating 
efficiency) and triple dropout (-Leu/-Trp/-Ade) to select for diploids in which a 
positive two-hybrid interaction is occurring.
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2.19.7 Plasmid Isolation from Yeast
The yeast mini-prep was carried out manually according to the technique on page 35 
o f the Clontech protocol in yeast protocols handbook. The yeast cells must first be 
stripped o f their cell walls. This was done with the digestive enzyme lyticase. The 
resulting spheroplasts (no cell walls) were then burst open using SDS. The DNA  
released was purified either by ethanol precipitation (see below) or by the chromaspin 
columns provided by Clontech. The DNA isolated was then used as a template for 
PCR.
DNA was isolated from yeast colonies in the first incidence to establish that the 
plasmids were present in the cells growing on the selective media. In the second 
incidence, it was necessary to isolate DNA in order to screen for clones that encoded 
interacting proteins.
For plasmid isolation from yeasts, it was done both manually and using kit (BD 
Clontech). Necessary materials are:
• Appropriate SD liquid or agar medium to keep selection on the plasmids (Appendix 
4.2).
• Sterile, 1.5-ml microcentrifuge tubes.
• 20% SDS
• Lyticase Solution (5 units/pl in TE buffer; store at 4 C for up to 2 months or at -2 0  C 
for up to 6 months. If colloidal material precipitated, the solution mixed by inversion 
before using).
• Using kit: CHROMA SPIN-1000 DEPC-H20 Columns (BD Clontech, #K1334-1) 
and 2-ml centrifuge tubes for use with the columns
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• In cases o f  not using the kit, phenol xhloroform extraction and ethanol precipitation 
was performed using: phenol:chloroform:isoamyl alcohol (25:24:1), 10 M ammonium 
acetate, 95-100% ethanol.
To prepare yeast cultures for lysis from a liquid culture, a large (2-4-mm), fresh (2-4- 
day-old) yeast colony was inoculated into 0.5 ml o f the appropriate SD liquid medium 
and vortexed vigorously to completely break up the colony and resuspend the cells. 
Then it was incubated at 30°C overnight with shaking at 230-250 rpm. The following 
day, the cells were pelleted by centrifugation at 14,000 rpm for 5 min the supernatant 
was discarded and the pellets were resuspended in the residual liquid (total volume 
-5 0  pi).
Then 10 pi o f lyticase solution was added to each tube. The tube contents were mixed 
by vortexing or repeatedly pipetting up and down and the tubes were incubated at 
37°C for 30-60 min with rotary shaking at 200-250 rpm. Optionally a drop o f  the cell 
suspension was checked under a phase contrast microscope (400x) for the progress o f 
cell lysis by adding a drop o f 20% SDS to the side o f the coverslip. As they come into 
contact with the SDS, most cells should lose their refractile appearance and appear as 
"ghost-like” spheroplasts. If there were still many intact cells present, the samples 
were incubated for another 30 min. Then 10 pi o f 20% SDS was added to each tube 
and vortexed vigorously for 1 min to mix. The samples were put through one 
freeze/thaw cycle (at -20°C ) and vortexed again to ensure complete lysis o f the cells. 
The entire contents o f the tube were poured onto a prespun CHROMA SPIN-1000 
Column and the plasmid DNA was purified according to the CHROMA SPIN User 
Manual. Finally purified plasmid DNA was eluted from the column. Alternatively, if
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cleaning the prep manually (not using CHROMA SPIN Columns), the volume o f the 
sample was brought up to 200 pi in TE buffer (pH 7.0) and 200 pi o f  the 
phenol:chloroform:isoamyl alcohol (25:24:1) mixture was added. The tubes were 
vortexed at highest speed for 5 min, centrifuged at 14,000 rpm for 10 min, and the 
aqueous (upper) phase was transferred to a fresh tube and 8 pi o f 10M ammonium 
acetate / 500 pi o f 95-100% Ethanol were added and placed at -70°C  or in a dry- 
ice/ethanol bath for 1 hr. Finally the tubes were centrifuged at 14,000 rpm for 10 min, 
supernatants were discarded, the pellets were dried and resuspended in 20  pi o f H2O. 
Since the amount o f plasmid DNA recovered was small relative to the contaminating 
genomic DNA, it could not be measured by A260 nm or seen on an agarose gel. 
However, it could be used to transform competent bacterial cells.
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2.19.8 Control plasmids
The protein products o fp53  and the T-antigen gene are known to interact strongly.
Bait control plasmid - pGBKT7-53 (provided by Clontech): it encodes a fusion protein 
o f Murine-p53 and the GAL4 DNA-BD and is a shuttle vector suitable for use in both
S. cerevisiae and E. coli, as it contains both S. cerevisiae and E. coli origins o f  
replication, and the kanamycin resistance and TRP1 metabolic markers.
Library control plasmid - pGADT7-T: The library control plasmid was also provided 
by Clontech. It encodes a fusion protein o f the SV40 large T antigen and the GAL4 
AD. Again it is a shuttle vector, suitable for use in both S. cerevisiae and E. coli, as it 
contains both S. cerevisiae and E. coli origins o f replication, and the ampicillin 
resistance and TRP1 metabolic markers. The library and bait control plasmids provide 
a positive control for protein interaction as p53 and SV40 large T antigen interact, 
bringing the GAL4 activation domain (AD) and DNA-binding domain (BD) into close 
enough proximity to activate the reporter genes downstream o f the ‘upstream 
activation sequence’ (UAS) GAL4 binds to. Thus cells containing both the library 
control and the bait control plasmid should be able to grow under -Trp/-Leu/-His/-Ade 
selection if  the experiment is carried out appropriately.
2.19.9 Culture media
All culture media were made up and autoclaved at 121 °C for 15 minutes. Based on the 
type o f experiment and the plasmids transformed in the yeast strains, the appropriate 
selective media was used. After yeast transformation or mating, the product was plated 
onto either SD/-Leu, SD/-Trp, SD/-Leu/-Trp or SD/-Leu/-trp/-Ade/-His medium.
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2.20 Fluorescence In Situ Hybridization (FISH)
2.20.1 Probe synthesis: Labeling and purification of the PAC clone
10(j,l o f standard stock solution o f purified PAC 618H14 clone containing the mouse 
TsgalO gene was taken and denatured by boiling for 5 minutes, then snap cooled in 
ice-water mix. 50 pi o f  labelling mixture was prepared using Random Prime Kit 
(Gibco BRL, Gaithersburg, MD) with Avidin-conjugated fluorescein isothiocyanate 
based on the kit instruction and incubated at 37°C for 3 hours before stopping the 
reaction by heating to 65°C for 10 minutes. 2pl salmon sperm DNA (lOpg/pl stock) 
was added and the DNA were precipitated using ethanol. After centrifugation, the 
supernatant was removed, the pellet dried briefly and then resuspended in 40 pi 
ultrapure formamide (Boehringer Mannheim or Intergene (Cat. No. S4117).
2.20.2 Hybridization and detection
The probe was applied to male mouse metaphase spreads as described (by Gillett et al., 
1993) and the slides were covered with parafilm before incubation in a humid chamber 
at 37°C for 12-16 hours. Then the slides were washed by the proper washing solution 
(0.1% SCC) at 45°C and room temperature. After washing, the slides were immersed 
and blocked in blocking buffer (5% non fat milk powder) for 10 minutes. For 
detection, 50pl o f BI buffer containing 4pg FITC-Avidin (Vector Labs, DCS grade) 
was used for 60 minutes. FITC signals and the DAPI (4,6-diamidine-2-phenylindole 
dihydrochloride) banding pattern were merged for figure preparation. Images o f  
metaphase preparations were captured with a cooled CCD camera using the Cyto 
Vision Ultra image collection and enhancement system (Applied Imaging Int.).
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3.1 Cloning the mouse homologue of the TSGA10 gene (TsgalO) 
and studies of its transcripts
One o f the main aims o f  this project was to find out more about the TSGA10 gene, 
which was known to be expressed in human testis and rat spermatocytes, and, 
therefore, thought to be involved in spermatogenesis or spermiogenesis. As well as the 
interesting biology o f these processes, genes, which affect these two processes, may 
later be investigated with the hope that they may be used to design treatments for male 
infertility and male contraceptives. Recently, a group in Switzerland (Primig et al, 
http://germonline.unibas.ch/gene_page.php?species_id=7&orf_id=268998#) used U34 
A and B microarrays (GeneChips) to determine the expression levels o f 11955 
transcripts in highly enriched populations o f rat spermatogonia, spermatocytes, round 
spermatids and total testis samples. By comparing data from germ cells to Sertoli cells 
1268 mRNAs were identified as being strongly differentially expressed. The loci 
organised into four expression clusters whose transcriptional peak induction patterns 
correspond to somatic, mitotic, meiotic and post-meiotic cell types. A subset o f  
meiotically expressed genes was not detected in three somatic control tissues (Sertoli, 
skeletal muscle and brain). This group includes TsgalO, which is a member o f the 
meiotic cluster.
To understand more fully the expression profile o f this gene we have isolated 
and characterised the mouse homologue. A partial cDNA sequence from Rattus 
norvegicus spermatocyte (Accession no. AF092091) was aligned with the human 
TSGA10 sequence (Accession no. AF254756) and an existing pair o f human primers 
(GSP5 and R6H) was identified which showed just one internal nucleotide difference
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to the rat sequence. These were used in an RT-PCR using mouse testis cDNA and a 
primer annealing temperature 10°C lower than usual. The resulting RT-PCR products 
were electrophoresed on an agarose gel, and then, after re-amplification as shown in 
figure 3.1, a product o f the same size as the human control was observed. This band 
was cut from the gel and sequenced from both ends. Comparison with TSGA10 
sequence revealed 89% similarity between the mouse and human sequences.
Approximately 2 x l0 5 p.f.u. o f a mouse testis cDNA library, made from purified 
spermatocytes (Mahadevaiah et al., 1998) were plated out on two 22x22 cm plates and 
duplicate filter lifts were taken. Replica filters were screened with a radioactively 
labelled PCR product derived from the mouse RT-PCR product described above using 
one round o f synthesis with Klenow DNA polymerase and the PCR primers. The 
plaques giving the strongest signals were isolated by replating and rescreening and one 
(clone P2) was sequenced from the ends using vector (pBluescript SK) primers. The 
complete TsgalO coding region was sequenced using templates either o f  mouse RT- 
PCR products or the mouse spermatocyte cDNA clone P2. The mouse sequence which 
had 89% homology to the human TSGA10 sequence over most o f  its length, was 
submitted into GenBank (accession no. AF530050).
A mouse genomic library consisting of seven gridded filters (128 x 10 PAC 
clones, 1.5 x 105 bp insert size (Osoegawa et al. 2000) provided by the UK HGMP 
Sanger Centre) was screened (by Hossein Modarressi) with a human cDNA probe. 
The probe corresponds to nucleotides 1493 to 2125 o f the human gene. Eight positive 
signals were obtained and the corresponding bacterial colonies were checked by PCR
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using primers designed from the mouse testis cDNA clone sequence and located in the 
5' end of the gene.
Figure 3.1- RT-PCR using mouse oligo dT primed cDNA and human primers GSP5 and R6 at an 
annealing temperature o f  44 °C. In gel A a band from human cDNA is seen (in lane 2). A very faint 
band was visible in lane 1 the same size as the human PCR product. Lane 3 is the PCR negative control 
(water). Gel B shows re-amplification o f PCR A products with 26 PCR cycles at an annealing 
temperature o f  54 °C. The template for lane 1 was obtained by pricking the band in gel A lane 1 with a 
needle. Template in lane 2 was 0.2 pi o f  the mouse RT-PCR product. The template in lane 3 was from 
cDNA as in gel A lane 2. The bands in gel B lanes 1 and 2 were excised for sequencing. Lane 4 is a 
negative (water) control. Lane L is lOObp ladder in both panels.
The PCR results confirmed that colonies 635E6, 552E13, 652L5, 41302 and 
618H14 contained the 5' end of the mouse gene. The library used in this experiment 
was equivalent to approximately six fold genome coverage and the hybridisation 
results (8 colonies) is consistent with the gene being present in a single copy (like the 
human gene, Modarressi et al. 2001).
R e - a m p l i f i c a t i o n
L 1 2 3 L 1 2 3 4
600bp
B
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In November 2004, apart from the sequence, which was submitted by me, there are 4 
other sequences for mouse homologues of TSGA10 (TsgalO). They are listed in table
3.1. The sequences are shown aligned in appendix 8.1.
Table 3.1- Mouse TsgalO transcripts and polypeptides identified in sequence databases using mouse 
genome informatics (http://www.informatics.jax.org)
Sequence Type Length Strain/Species Description From 
Sequence Provider
NM_207228 RNA 3499 Not Specified Mus musculus testis specific 10 {TsgalO), 
mRNA.
BC066782 RNA 3499 Not Specified Mus musculus testis specific 10, mRNA 
(cDNA clone MGC:74389 
IMAGE:6705127), complete cds.
AF530050 RNA 2732 C57BL/6J Mus musculus TsgalO mRNA, complete 
cds.
A Y 618264 RNA 2522 Not Specified Mus musculus TsgalO isoform mRNA, 
complete cds, alternatively spliced.
AK030254 RNA 2701 C57BL/6J Mus musculus adult male testis cDNA, 
RIKEN full-length enriched library, 
clone:4933432N21 product:CP431 
(FRAGMENT) homolog [Rattus 
norvegicus], full insert sequence.
Sequences NM 207228, BC066782, A Y 618264 and AK030254 were searched for matches [to
complete cDNA sequence AF530050)
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3.1.1 Genomic localisation of TsgalO
The human TSGA10 gene was mapped by fluorescence in situ hybridisation to human 
chromosome 2ql 1.2, and mouse TsgalO was mapped to the syntenic region on mouse 
chromosome 1 (figure 3.1.1). Two mouse PAC clones (RP34-178E16 and RP23- 
21P10) from the HGP Sanger centre cover the whole of the mouse TsgalO gene. 
Subsequent genome analysis using genome browser and BLAST mapviewer (BLAST 
http://www.ncbi.nlm.nih.gov/mapview) revealed that the Rattus norvegicus 
homologue is located in chromosome 9q21, which is again in the human synteny 
region.
Figure 3.1.1- Localization of mouse TSGA10 on mouse chromosome 1 (red dots) to the band B by
in situ hybridisation with a probe amplified by PCR from intron exon 4 to mouse metaphase 
chromosomes. The positions o f  hybridization signals (red dots) are marked by arrows. Original 
magnification xlOO (figure from Modarressi et al., 2004).
%
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3.2 Studying the expression pattern o f the TsgalO gene using in situ
Hybridization and Northern blotting
As described previously, male germ cell development proceeds as the cells 
move in a peripheral-to-central fashion in the seminiferous tubules of the testis. RNA 
extracted from different mouse tissues was first analyzed by Northern blotting using a 
mouse 7sgtf/0-ORF DNA probe.
The result, shown in figure 3.2A, indicates that TsgalO expression is restricted to testis, 
in which a single major transcript was observed. Rehybridization of filters with an actin 
probe confirmed the presence of intact RNA in all instances. The observed size of 
TsgalO mRNA is 3.2 kb, similar to the human TsgalO transcript. A faint band above 
the major mRNA was visible, possibly resulting from splice intermediates or 
alternative splicing.
B O  H Li K T S m  U Lu Si
B e t a - A c t i n
1 2  3 4 5 6 7 8  9  1 0
Figure 3.2A- TsgalO mRNA is expressed in testis. RNA was isolated from adult mouse tissues and 
analyzed by Northern blotting using TsgalO cDNA as a probe (top) and B-actin (bottom) as a control. 
Lanes I-10: brain (B), ovary (O), heart (H), liver (Li), kidney (K), testis (T), skeletal muscle (Sm), 
uterus (U), lung (Lu), and small intestine (Si) RNA. Indicated are 28S and 18S ribosomal marker RNAs 
and 4S tRNAs.
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In parallel the in situ hybridization technique was used to identify and localize TsgalO 
RNA in testis.
To prepare a labeled RNA probe (riboprobe), a 195-nucleotide DNA sequence was 
identified which was unlikely to form a stable secondary structure, and 
oligonucleotides T7MtclO and T3MtclO (figure 3.2B1) were designed and used to 
amplify this region from cDNA. lp g  DNA o f PCR product was used after purification 
(with Qiagen PCR purification kit) as the template for RNA synthesis using either T7 
or T3 RNA polymerase. 2pl o f each riboprobe before and after treatment with DNase I 
was taken for running in an agarose gel (figure 3.2B2). The remaining (16pl) was 
stored at -20°C until required.
The probes were labelled with digoxigenin (using the alkaline phosphatase method) 
and hybridised to mouse tissue sections. TsgalO gene products (mRNA) were not 
detectable in sections including liver, kidney, heart, and lung. In contrast, some 
expression was detected in brain sections in clusters o f cells, and TsgalO gene products 
were found in significantly stained testis sections (figure 3.2.C). Labelling signal 
indicating the presence o f TSGA10 RNA was detected in most cells except in the basal 
(peripheral) layers o f seminiferous tubules. The highest relative levels o f TsgalO were 
detected in the third layer o f germ cells. These might be the secondary spermatocytes, 
the product o f the first meiotic division.
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880
T7 TsgalO
5’
T3
685
3’
2 0 6 7
Sense T A A T A C G A C T C A C T A T A G  G A C T C
A G C G A  C A  T C T T G C  IT A A G A A A A A  
T A T G A G C T A C A G C T T A C T C A G  
A G A A A A T T A T G T G C T T G G A T G  
A A A A A T T G A T A A T T T C A C G A G  
C A A A A T A T T G C A C A G C G A G A  
G A A A T C A G C A T T C T T G G T G C A  
C C C T C A A T G A C C T G G C T A A A G  
A A A G G A A T G C C T G C A A G C G
G T C T G G A T A A A A A G T C T G G A A A
T C A C T C C C A A T T A A
< ~ T 3 Anti-Sense
Figure 3.2B1- Schematic feature and sequence o f Riboprobe Synthesis.
Oligonucleotides with the T3 and T7 RNA polymerase promoters were designed to amplify a 195-bp 
section o f  the T sg a lO  cDNA (nucleotides 685-880), and below the sequence o f  this region. The primer 
sequences are underlined, and the T3 and T7 recognition sequences added to these are shown in blue.
Before DNase Treatm ent A fter DNase T reatm ent
M arker T3 riboprobe T7 riboprobe T3 riboprobe T7 riboprobe
Figure 3.2B2- TsgalO sense and antisense riboprobes. 2pi each was run before and after DNase 
treatment on a DEPC treated gel to check presence and integrity o f the RNA. After DNase I treatment 
any template DNA is removed, and the RNA is still present and full length.
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Figure 3.2C- In situ hybridisation, 100 x. T3 and T7 -prim ed riboprobes to TsgalO were 
hybridised to thin sections o f mouse testis fixed with 4% formaldehyde-embedded in OCT.
Panel A and D show the antisense T3 probe hybridisation. D is counterstained with hematoxyline and 
Eosine (H&E), B shows the sense probe and C and E are controls without probe. Hybridisation is seen 
in panels A and D. Some artificial spots are seen in common between A, B and C, which are caused by 
the microscope and camera.
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3.3 Studying the expression of the TsgalO gene in testis at various 
stages of development using RT-PCR and Northern blotting
RNA was extracted from rat testis at different developmental stages. The RNA 
was then converted to cDNA, which was checked for the presence o f cDNA by PCR 
amplification using primers spanning an intron o f the rat actin gene (figure 3.3A). The 
cDNA was then amplified using primers GSP5 and R6H from the TsgalO gene (figure 
3.3B); note that mouse and rat TsgalO [accession no. AF530050, XM_237066] are over 
95% identical. Rat germ cells were used in this experiment. The results show that the 
TsgalO transcript is first detected in rat testis between Days 15 and 21 after birth. The 
developmental stages o f  rat spermatogenesis are well characterised (figure 3.3D) and 
expression at days 15-21 corresponds to the presence o f the transcript in pachytene 
cells during meiosis. This is in agreement with our cloning o f TsgalO cDNA from 
spermatocytes.
In Northern blot analysis, a filter o f RNA from testis at various stages o f development 
was hybridised with a PCR product spanning the TsgalO cDNA. Hybridisation is seen 
from 21 days after birth onwards (figure 3.3C).
The result o f Northern blot hybridisation is in agreement with the results o f the RT- 
PCR.
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1- Marker
2- Foetal testis
3- Testis (5 days)
4- Testis (10 days)
5- Testis (15 days)
6- Testis (21 days)
7- Testis (25 days)
8- Testis (31 days)
9- Testis (adult)
10-Negative control (water)
11- Positive control
C-
D-
Figure 3.3- TsgalO expression in different developmental stages of rat testis.
A- A control RT-PCR amplification using rat p-actin primers spanning an intron (intron II), indicated 
that all the cDNAs that were tested, gave a product o f  the correct size (375bp) as shown.
B-RT-PCR using rat oligo dT primed cDNA and human TSGA10 primers GSP5 and R6H at an 
annealing temperature o f  53 °C. The expected PCR product size (indicated by an arrow) was 632bp.
C- Northern blot o f  RNA derived from rat testis at various numbers o f  days after birth ranging from (5 
days to adult). The blot was hybridised with the whole mouse cDNA, reamplificated by PCR at 60°C. 
Hybridisation is seen faintly at 21 days after birth, and strongly thereafter.
D-Developmental schedule o f  cell types present in rat testis at different stages o f  development (Maikov 
et al. 1998).
5-d 10-d 15-d 21-d 25-d 31-d Adult
2.7 kb
Stage No Description of developmental stage Age of rat (days)
I Spermatogonia and somatic cells only 6-7
II Initiation of meiosis I-leptotene cells 13-14
III Appearance of zygotene cells 17-18
IV Appearance of early pachytene cells 19-20
V Appearance of late pachytene cells 22-23
VI Appearance of round spermatids 24-25
VII Appearance of elongated spermatids 30-31
VIII Appearance of elongated spermatozoa 36-37
A-
1 2 3  4 5  6 7 8 9  10 11
pactin
1 2 3 4 5 6 7 8 9  10
B- TsgalO
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3.4 The expression o f TsgalO  in m ouse embryos at various stages 
of developm ent, and in em bryonic brain
RNA from various developmental stages of mouse embryos was converted to cDNA 
and used for PCR using primers from the TsgalO and 6 actin genes; Primer pairs of 
MG4 (reverse primer mouse) and R6H (forward primer human, mouse, rat) were used. 
Either testis-derived cDNA or a cloned TsgalO plasmid construct was used as positive 
controls with Taq DNA polymerase. The RT-PCR results show that TsgalO is not 
expressed in embryonic stem cells (figure 3.4), which suggests that it may be turned on 
sometime between 4.5 and 7.5 dpc. This is confirmed by the RT-PCR of embryos at 
later developmental stages (figure 3.4B). The expression commenced by 7.5 dpc and 
contained until newborn (figure 3.4C). Also it was expressed in brain of 11 dpc 
embryos (figure 3.4B and D). Alternative splicing (isoform) products were observed in 
whole embryos (figure 3.4D) as well as mature testis (figure 3.4A) but not in the 
embryo brain RNA (figure 3.4D).
1 2 3  4 5 6 7 8 9  10 11
A
Figure 3.4A- RT-PCR in mice 3 dpc embryos (embryonic stem cells) shows no TsgalO expression in 
embryonic stem -ES- cells but in mature testis with an alternative splicing.
I -Marker
2- ES cells (1) (first division)
3- ES cells (2) (first division) Embryonic stem cells (embryo after about 3 days) from ES cell culture
4- ES cells (1) (fourth division)
5- ES cells (2) (fourth division) ES cells treated with Retinoic acid (makes cells neural differentiation)
6- ES cells (3) (first division)
7- cDNA from mouse testis
8- cDNA from mouse heart
9-cDNA from NIH3T3 cell
10- Positive control from p2 clone, mouse TsgalO
II - Negative control
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M E11.1 E11.5 E11.5 E15.5 E7.5 E13.5 +
Head
1 2  3 4 5 6 7
1.5 Kb
1.2 Kb 
1 Kb
Figure 3.4B- RT-PCR o f RNA extracted from mouse embryos using mouse TsgalO primers MG4 and 
R6H at 52°C. Lanes 1-4 RNA is from head o f mouse embryos at various days p.c. Each lane contains 
RNA from two heads. In lanes 5 and 6 RNA is from whole embiyos at 7.5 and 13.5 days p.c. The 
positive control is testis RNA. Negative is water. Expression can be seen in lanes 5 and 6. The two bands 
represent the alternative splicing products.
M E12 E13 E l 4 E15 E16 E17 E18 Testis -
1 Kb 
500 bp
Figure 3.4C- RT-PCR o f RNA extracted from mouse embryos at stages from day 12 to 
newborn. The primers are the same as in B. Positive control is testis. Negative control is water. 
Expression is seen at all stages. The splice variant can only be seen at stages E 12 and E13.
M El l  head E13
800 bp 
500 bp 
300 bp
Figure 3.4D- Reamplification and semi-nested PCR of 1 ul from the PCR product obtained in B, from RNA 
extracted from head at 11 days p.c. and whole embryos at 13 days p.c. Semi-nested primers were R68 and 
ER18. The primers span the region of alternative splicing. Alternate splice products can be seen in the whole 
embryo, but not in the head. However, expression of the full-length transcript is seen in the head after 
reamplification (compare with B), and most likelyrepresents expression in the brain.
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3.5 Analysis o f the expression of TsgalO in Neural Crest cells
Since neural crest cells are another example of dividing and differentiating cells, it was 
possible that TSGA10 would also be expressed in these cells and their derivatives. I 
therefore carried out RT-PCR using cDNA which the RNA was extracted from 
primary cell cultures of neural crest cells obtained from mouse embryo neural tubes 
(8.5 dpc) cultured for 6 days (a gift from Dr Aldamaria Puliti). A pair of primers 
(MFE17 and MRE18) in different exons (17 and 18) was used. TsgalO expression also 
was assessed in 13-dpc embryonic guts as a neural crest derivative. RNA extracted 
from adult mouse brain was used as a control. The mouse neuro2A (derived from 
neuroblastoma) cell line was also tested. A 169-bp band was obtained from neural crest 
cells, embryonic gut and brain but it was not amplified from neuro2A cells (figure 3.5). 
A band of about 500 bp was present in all the samples tested. This band is likely to
1 2 3 4 5 6
500 bp 
200 bp
Figure 3 .5 -  RT-PCR showing TsgalO expression in neural crest cells and the brain. 1) 100 bp
ladder 2) E8 Neural crest cells 3) E l3 Gut 4) Brain 5)N euro2A  6) N egative control
represent amplification of genomic DNA contamination, since intron 18 is 304-bp 
long. However, I did not have time for further experiments. The 186-bp band from the 
brain was sequenced and shown to correspond exactly to the expected TsgalO cDNA
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specific fragment. TsgalO is expressed in the neural crest cells, as it is in the brain. 
However, no expression is seen in neuro2A (a neuroblastoma cell line). Expression of 
TsgalO is seen in several in malignant tissues (see section 3.6, Tanaka et al., 2004) but 
not all tumour types.
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3.6 TsgalO is expressed in the Acute Promyelocytic Leukemia (APL) 
specific NB4 cell line
There are some ESTs from both the 5’ and 3 ’ ends o f the TsgalO gene in GenBank 
(Accession nos. AW057728, AI696619, AW591313, BE047007, and BF243403), 
which were isolated from poorly differentiated adenocarcinoma o f the stomach, acute 
myelogenous leukaemia and germ cell tumors. To test the expression pattern o f TsgalO 
gene in an Acute Myeloid Leukemia (AML), acute premyelocytic leukemia (APL) cell 
line (NB4) was selected and RNA was extracted from it and converted to cDNA. 
TsgalO 5’-end primer pairs o f MHF4’ (forward primer), MR5’ (reverse primer) and 
TsgalO 3’-end primers o f MFE17 (forward primer) and MRE18 (reverse primer) were 
used. Amplification was carried out using DNA Taq polymerase (AB) for 32 cycles, 
each cycle consisting o f 94°C for 30 s, 50°C for 30 seconds and 72°C for 75 seconds. 
Both experiments showed TsgalO expression (figure 3.6) in the acute premyelocytic 
leukemia (APL) cell line (NB4). A larger band (lkb) is also seen, which is probably 
due to genomic DNA contamination and indeed, the size o f the PCR product is what 
would be expected with these primers if the amplification included intron 17.
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NB4(1) NB4(2) NB4(3) NB4(4) NB4(5) M
RT-PCR 
+ve band
800 bp
500 bp
400 bp
300 bp
100 bp
Figure 3.6 A- RT-PCR experiment o f  RNA extracted from 5 
different N B 4 cell culture plates. Each RNA sample was amplified 
separately using 5 ’ terminus primers M HF4’ and M R 5 \ The 
primers span an intron o f  475 bp. The RT-PCR product o f  200 bp 
can be seen in all samples.
Tsga10-5’ experiment
M NB4(1) NB4(2) NB4(3) NB4(4) Testis
1000 bp
 z
Genomic
band
RT-PCR 
+ve band
Tsga10-3’ experiment
Figure 3.6B- RT-PCR experiment o f  RNA extracted from 4 different 
N B 4 cell culture plates. Each RNA sample was amplified separately 
using 3 ’ terminus primers MG4 and MFE17. The primers span an 
intron o f  860 bp, and two products can be seen. The smaller is the 
result o f  RNA amplification, and the longer is probably the result o f  
genom ic D N A  contamination.
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3.7 Studying in more detail the alternative splicing of 
TSGA10 exon 16
Results shown in sections 3.2 and 3.4 illustrate that isoforms o f the TsgalO gene 
transcript (cDNA) exist (e.g. see figures 3.2A, 3.4A). I investigated whether 
alternative splicing caused these. The PCR reaction using TsgalO primer pairs 
spanning the relevant region -MG4 (reverse primer in exon 12) and R6H (forward 
primer in exon nineteen) with testis and mouse whole embryo RNA as the template 
produced a smaller size band in addition to the expected 990 bp band. This small 
band was reamplified after purification, using the same primers. Sequence analysis 
confirmed that the whole o f exon sixteen might be spliced out to make a shorter 
isoform o f the transcript. The sequence o f the TsgalO  isoform was submitted and 
deposited in the NCBI GenBank database (BLAST as Accession No. A Y 618264). 
This isoform does not cause a frame shift, but results in a protein, lacks 70 amino 
acids -in  cDNA check it lacks 210 bases- (Appendix 8.1). In Northern Blot with 
RNA extracted from different mouse tissues (figure 3.2), TsgalO is expressed in 
testis showing two transcripts compatible with the RT-PCR results.
Two transcripts were observed in mouse embryo: TsgalO alternative splicing 
(isoform) products were observed in whole embryos as well as mature testis but not 
in the embryo brain (figure 3.4A,B).
Exon 16 is flanked by two long introns o f 17 and 20 kb respectively. Alternative 
splicing is observed in other genes where exons are flanked by long introns (e.g. 
PKC-6  gene which its first intron to the exon is as long as 17 kb in human), 
indicating a complexity involved in gene splicing (Suh et al., 2003).
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3.8 TsgalO gene structure
Previous work from our laboratory and in this thesis has identified TSGA10 as a 
testis-specific human gene. It has been shown to be expressed in normal testis, but 
not in a variety o f other tissues. It is expressed in neither foetal testis nor testis o f  
two infertile patients but it is expressed in several human foetal tissues and some 
primary tumours. TSGA10 sequence data was deposited with the EMBL/GenBank 
Data Libraries (Accession No. AF254756). Later a sequence called “NYD-SP7” 
was submitted by a group in China and was named as a member o f the nucleoporin 
family (without any evidence being shown). TSGA10 has 99% homology to this 
sequence. A number o f rodent TsgalO sequence has been submitted to GenBank. 
Table 3.8A summarises these various sequences.
Table 3.8A- Summary of rodent TsgalO sequences submitted in GenBank database.
_______  Human TSGA10 (H), Mouse TsgalO (M), Rat TsgalO (R )._________________
Accession
number
Name Species Deposited
by
Homology
(%)
Description
AF530050 TsgalO M B.
Behnam 89% to H
18 exons
AY618264 TsgalO M B.
Behnam
90% to H 17 exons (spliced version)
AF092091 TsgalO R S. Hoyer- 
Fender
94% to H Partial cDNA from rat 
spermatocyte cDNA library
XM_343557 Cp431 R IMAGE 94% to H 
and M
16 exons
XM_136734 Cp431 M IMAGE 90% to H
19 exons, produces 
hypothetical protein 
4933432N21 extends 77bp 
upstream of AF530050 first 
exon and extends the open 
reading frame in a 5 ’ 
direction by 202 aa
NM_207228 TsgalO M RIKEN 90% to H 20 exons, replaces sequence 
XM 136734
AK030254 Cp431 M RIKEN 89% to H 19 exons
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The 5’ ends o f my mouse TsgalO Sequence and all o f the cp431 sequences are 
aligned in figure 3.8A. This figure shows that upstream o f the conserved ‘double 
methionine’ start codon (green box), the sequences differ: XM_136734 extends 77 
bp upstream into a possible first exon, which extends the ORF in 5 ’ direction by 606 
nucleotides. Figure 3.8B illustrates how the different 5’ sequences in the different 
TsgalO transcripts may represent alternative first exons.
MOUSE C P 4 3 1  GGCGGTCCACGTCGCTACGTGCTCGCTCG--------------------------------------------------------------------------- 8 0
MOUSE C P 4 3 1  GGCGGTCCACGTCGCTACGTGCTCGCTCGGGTGCGCGCGCACGATCCGTAGTCTCCGCGA 1 7 6
A F 5 3 0 0 5 0  -------------------------------------------------------------------------------------------------------------------------------------------------
MOUSE T s g a l O  GCCGGACGGAAGTGGAGCGTAGGCGCCGGGGAG-------------------------------------------------------- GTGG 3 9
RAT T S G A 10 TGCTGTCTACGTCGCTACGTGCTCGCTCG------------------------------------------------------------------------------ 3 3 2
MOUSE C P 4 3 1  ------------------------------------------GGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTT 1 2 0
MOUSE C P 4 3 1  GAGGGCGTGTCGAGACAGGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTT 2 3 6
A F 5 3 0 0 5 0  ------------------------------------------GGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTT 4 3
MOUSE T s g a l O  AAGAAGAGCCCCGCTCAGGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTT 9 9
RAT T S G A 10 ------------------------------------------GGTTACCACCAAAGAACATCAGTTTGGTCTCGGGGCTCCAGTT 3 7 2
★ ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ ★ * ★ ★ ★ ★
MOUSE C P 4 3 1  TCTGAAGCTGGAAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGAT 1 8 0
MOUSE C P 4 3 1  TCTGAAGCTGGAAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGAT 2 9 6
A F 5 3 0 0 5 0  TCTGAAGCTGGAAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGAT 1 0 3
MOUSE T s g a l O  TCTGAAGCTGGAAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGAT 1 5 9
RAT T S G A 10 TCTGAAGCTGGAAGAAACCAGAATACTTTCCAACTAGAACAAGAAGGGAGAACCCAAGAT 4 3 2
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  ★ ★ ★ ★ ★ ★ * ★ ★ ★ ★ ★ ★
MOUSE C P 4 3 1  AGATTCATCTCTACACTGAAATT-ACAGATTGAAGATCTCAAACAGACAAATCATGACTT 2 3 9
MOUSE C P 4 3 1  AGATTCATCTCTACACTGAAATT-ACAGATTGAAGATCTCAAACAGA-AAATCATGACTT 3 5 4
A F 5 3 0 0 5 0  AGATTCATCTCTACACTGAAATTTACAGATTGAAGATCTCAAACAGACAAATCATGACTT 1 6 3
MOUSE T s g a l O  AGATTCATCTCTACACTGAAATT-ACAGATTGAAGATCTCAAACAGACAAATCATGACTT 2 1 8
RAT T S G A 10 AGAGTCATCTCTACACTGAAATT-ACAGATTGAAGATCTCAAACAGACAAATCATGACCT 4 9 1★★★ ★★★★★★★★★★★★★★★★★★★ ★★★★★★★★★★★★★★★★★★★★★★★ ★★★★★★★★★★ ★
MOUSE C P 4 3 1  GGAAGAATATGTTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGA 2 9 9
MOUSE C P 4 3 1  GGAAGAATATGTTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGA 4 1 4
A F 5 3 0 0 5 0  GGAAGAATATGTTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGA 2 2 3
MOUSE T s g a l O  GGAAGAATATGTTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGA 2 7 8
RAT T S G A 10 GGAAGAATGTGTTAGGAAACTCTTGGATAGTAAAGAGGTGGTAAGCACTCAAGTAGATGA 5 5 1
★★★★★★★★ ★★★★★★★★★★★★★★★★★★★★★★★★★★★★★ ★★★★★★★★★★★★★★★★★★★★★
MOUSE C P 4 3 1  CTTAGCCAACCACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACTAGCAGA 3 5 9
MOUSE C P 4 3 1  CTTAGCCAACCACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACTAGCAGA 4 7 4
A F 5 3 0 0 5 0 CTTAGCCAACCACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACATGCAGA 2 8 3
MOUSE T s g a lO  CTTAGCCAACCACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACTAGCAGA 3 3 8
RAT T S G A 10 TCTAACCAACCACAATGAGCATCTTTGTAAAGAGTTGCTTAAACTTGACCAACTAGCAGA 6 1 1★ ★ ★★★★★★★★★★★★★★★★ ★★★★★★★★★★★★★★★ ★★*★★★★*★★★★★★★ ★★★★★
MOUSE C P 4 3 1  GAAATTACAAAAAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGC 4 1 9
MOUSE C P 4 3 1  GAAATTACAAAAAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGC 5 3 4
A F 5 3 0 0 5 0  GAAATTACAAAAAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGC 3 4 3
MOUSE T s g a l O  GAAATTACAAAAAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGC 3 9 8
RAT T S G A 10 GCAATTGCAAAAAGAAAAGAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGC 6 7 1★ ★★★★ ★★★★★★★★★★★ ★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★
MOUSE C P 4 3 1  AAAGATTGAACTCATTTGCCAGCAAAATAATATAACAGTATTAGAAGATACAATCCAAAG 4 7  9
MOUSE C P 4 3 1  AAAGATTGAACTCATTTGCCAGCAAAATAATATAACAGTATTAGAAGATACAATCCAAAG 5 9 4
A F 5 3 0 0 5 0  AAAGATTGAACTCATTTGCCAGOAAAATAATATAACAGTATTAGAAGATACAATCCAAAG 4 0 3
MOUSE T s g a l O  AAAGATT GAACT CATTT GC CAGOAAAATAATATAACAGTATTAGAAGATACAAT C CAAAG 4 5 8
RAT T S G A 10 AAAGATTGAACTCATTTGCCAGCAAAATAACATAACAGTATTAGAAGATACAATTAAAAA 7 3 1★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★ ★★★★★★★★★★★★★★★★★★★★★★★
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MOUSE C P 4 3 1  
MOUSE C P 4 3 1  
A F 5 3 0 0 5 0  
MOUSE T s g a lO  
RAT TSG A 10
MOUSE C P 4 3 1  
MOUSE C P 4 3 1  
A F 5 3 0 0 5 0  
MOUSE T s g a lO  
RAT TSG A 10
MOUSE C P 4 3 1  
MOUSE C P 4 3 1  
A F 5 3 0 0 5 0  
MOUSE T s g a lO  
RAT TSG A 10
GCTTAAGTCCATAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGA 5 3 9  
GCTTAAGTCCATAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGA 6 5 4  
GCTTAAGTCTATAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGA 4 6 3  
GCTTAAGTCCATAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGA 5 1 8  
GCTTAAGTCAATAATTTTAGAGACTGAAAAAGTACAAAATACATCTCCTTCTAGACTTGA 7 9 1  ★ ★★★★★★★★ ★★
TTCCTTTGTCAAGACTTTAGAAGCAGACAGAGATTA-TTATAAGA-CTGAAGCTCAGAAT 5 9 7  
TTCCTTTGTCAAGACTTTAGAAGCAGACAGAGATTA-TTATAAGA-CTGAAGCTCAGAAT 7 1 2  
TTCCTTTGTCAAGACTTTAGAAGCAGACAGAGATTAGTTATAAGAACTGAAGCTCAGAAT 5 2 3  
TTCCTTTGTCAAGACTTTAGAAGCAGACAGAGATTA-TTATAAGA-CTGAAGCTCAGAAT 5 7 6  
TTCCTTTGTCAAGACTTTAGAAGCAGACAGAGATTA-TTATAAGG-CTGAAGCTCAGAAT 8 4  9 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  * * * * * * *  * * * * * * * * * * * * * *
GAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCG 6 5 6  
GAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCG 7 7 1  
GAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCG 5 8 3  
GAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCG 6 3 5  
GAAATAGATCTAAGAGTCCAAGACGCCCATCACCAACTTCTCG 9 0 8
TTAAG-
TTAAG-
TTAAG
TTAAG-
TTGAG-
Figure 3.8A- Alignment of mouse and rat TsgalO 5’ end sequences. The first four sequences 
(including AF530050) are mouse transcripts. Accession numbers o f  the first and second mouse 
cp431 in alignment: XM_136734, and AK030254 respectively. The first sequences. Green box is 
double methionine starting ORF o f TsgalO. Red nucleotides are sequencing errors o f  my sequence 
(AF530050).
The presence of different sites for an ORF in a gene may result in a different 
promoter region, which in turn might have a role in regulating the transcriptional 
activity of that gene. To investigate the possible functional effects of any variation 
in the 5’ flanking region of TsgalO or different splicing sites that start its ORF at 
different sites, it would be an idea for future studies to examine TsgalO 
transcriptional activity, perhaps using the luciferase reporter gene assay (see 
discussion section 7.2).
Regarding conservation, besides human and mouse, for TsgalO and its longer 
variant with 202 more amino acids in the 5’ upstream sequence, there are ESTs or 
cDNA sequences for human, mouse, rat, bovine, hamster, zebra fish, chicken, pig 
and Chimpanzee. At the protein level for TsgalO, there are known amino acid 
sequences, which are submitted in GenBank for human, mouse and rat. However, 
for cp431 protein, amino acid sequences are submitted just for mouse (XP_136734), 
cow (XP_416892), and rat (AAC72234) species.
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Figure 3.8B- Exons/introns boundaries and schematic structure o f TsgalO gene and in its isoforms in mouse and rat.
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3.8.1 First exon splicing and its variations in rodent TsgalO
The existence o f alternative TsgalO transcripts described in mouse (accession no. 
AK030254, XM_136734, NM_207228 and AF530050) (figure 3.8A,B) may 
represent polymorphism in the 5’ end o f the gene, but also raise the possibility o f an 
extra exon. Additionally, this extra first exon may vary due to alternative splicing in 
mouse testis transcripts. Perhaps there is more than one first exon in the 5’ end o f  
the TsgalO transcripts and these different first exons may result in expression o f the 
gene at various times and in various tissues. To look at this possibility, I first carried 
out a BLAST and BLAT search o f the ‘High-Throughput Genomic Sequences’ -  
HTGS- (http://www.ncbi.nlm.nih.gov/HTGS/) database using human and mouse 
(AF530050) TSGA10 cDNA sequences. The boundaries o f all exons/introns were 
found o f in the BLAT search. AF530050 had 89% homology to the human TSGA10 
sequence over most o f its length. Also a partial cDNA sequence from Rattus 
norvegicus spermatocyte (Accession no. AF092091) was aligned with the human 
TSGA10 sequence (Accession no. AF254756). Matching exon one in human, 
mouse, rat (figure 3.8B) and pig suggest the presence o f  either a different promoter 
and exon 1 in human and pig TSGA10 compared to mouse and rat genes or 
alternative use o f different exon ones in different tissues (unlikely because both 
human and mouse gene were sequenced directly from adult testis). The rat and pig 
cDNA sequences are partial but both contain most o f exon one. Interestingly, on 
alignment o f the mouse sequence to the human genomic clone sequence ACO19097, 
a match was found between mouse exon one and a region located 8260bp upstream 
o f human exon one. The region was appropriately orientated in the human genome
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clone and showed 89% identity to mouse exon one (base 1 to 130). With the 
exceptions o f exons 1 and 19, the positions o f the mouse exon / intron junctions 
were conserved compared to the human gene.
On searching the Ensambl database I found one additional sequence to those found 
in the BLAST database (ENST000035053). This sequence was most similar to long 
cp431 and had 21 exons.
The 5’ flanking region o f the most highly conserved mouse exon one was sequenced 
from PAC 618H14. It was aligned with the corresponding 5’ upstream region o f the 
match site o f mouse exon one in the human genomic clone ACO 19097 and the 5 ’ 
flanking region o f the genuine human TSGA10 exon one also from AC 1019097. 
65% identity was seen between the mouse 5’ flanking region and its homologue 
from the human clone. Putative TATA boxes are present in both sequences. There is 
no significant match to the human exon one 5’ region. Now, mouse TsgalO four 
transcripts were aligned with human TSGA10 sequence using BLAT genome 
browser. Interestingly, only one o f mouse transcripts (NM_207228) was found 
downstream (99072542) to the first possible human exon one. The upper part o f  
figure 3.8.1 A shows human transcripts mapped back onto the human genome and 
the lower part o f it shows mouse and rat transcripts mapped back onto the human 
genome. Figure 3.8.IB shows mouse transcripts mapped back onto the mouse and 
human/rat genome respectively. Each transcript is shown in a particular colour.
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Figure 3.8.1 A - -Schematic location of human T SG 4105 ' end exons and posabte splicing by using Ensem bt- The fourth exon in this 
schematic is conserved in human TSGA10 transcripts but the third one by using mouse and rat TsgalO sequences. However, the first exon of hu 
TSGA10 seems to be Altered in mouse. Lower scheme shows the location ofmouse and rat homologues of the 5’ exons in human genome.
AF530050
Mouse Genome 5’—
(Muse sequence) NM 207228
Mouse Genome 5 4
(Huran and rat sequence)
Figure 3.8.1 .B i- Schematic location of mouse TigalO  S' end first exons and possible splicing by usng Eitsem bl- The third econ in this 
scnemauc is conserved in mouse TsgalO transcripts but the forth one by using huran and the first one in rat TsgalO sequences. However, the first e> 
of human TSGA10 seems to be altered in mouse Lower scheme shows the location of rat and Inman homologues o f the 5’ end exons in mouse genor
It seems that there is a lot of alternative splicing for the first exon of the 
TSGAlO/TsgalO gene, which may be tissue specific. Therefore, there may be 
alternative promoters that may be tissue specific. Although there are several 
possible exon one for the gene transcripts in different species, the rodent and human 
first exons of TSGAlO/TsgalO gene are different and neither is found in the genome 
of the other species.
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3.8.2 Altered last exon of TsgalO
Alignment o f the various TsgalO sequences shows that there is also variation in the 
last (two) exon(s) o f TsgalO. The alternative sequences appear after the stop codon 
in exon nineteen. Using mouse genome browser (http://genome.ucsc.edu), TsgalO 
reveals three different last exons due to differing in polyadenylation (poly A) signals 
in mouse and rat transcripts (see figure 3.8B). Alternative splicing in exons 19 and 
20 may result in three different transcripts. This variation in the last exon o f TsgalO 
is detected not only in different species, but also in different strains. For example, 
mouse clone BC066782 shows this variation compared to our sequenced clone 
(AF530050). No match was found by BLAST in any database to the mouse exon 19 
with the exception o f one mouse testis EST (accession no. AV283000). Interestingly 
the result o f RT-PCR using the primers o f 3 ’ end o f mouse TsgalO, which show 
three different bands (two o f them very close in size) is consistent with the presence 
o f possible variation in the last exon o f TsgalO and might illustrate this variation 
(see figure 3.4D).
3.8.3 Alternative splicing of TsgalO exon 16
A s was described previously, exon 16, which is flanked by two long introns 
o f  17 and 20 kb respectively, can be omitted from the mRNA. Alternative splicing 
is observed in other genes where exons are flanked by long introns, e.g. the human 
PKC-6 has an intron o f 17Kb preceeding the first exon (Suh et al., 2003). The first 
exon o f this gene may be spliced out completely without any mutational frame shift.
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Considering the sizes o f the TsgalO protein components detected by Western 
Blotting, exon 16 may not only be spliced out completely resulting in no frame shift, 
but also may be the end o f a transcript, resulting in the 65 KDa protein component 
detected by the anti-TN antibody (figure 4.2A).
138
Chapter 4: Studying the expression of the protein encoded by TsgalO
Chapter IV:
Studying the expression of the protein 
encoded by TsgalO
139
Chapter 4: Studying the expression of the protein encoded by TsgalO
Looking at the expression patterns o f the TsgalO gene gave an indication where to 
study expression o f the protein. Data o f protein expression can give a good indication 
of the function o f a gene, based on its localisation in a tissue, its association with other 
proteins and its association with particular cellular structures.
I have studied the expression pattern o f the TSGA10 protein using Western blotting, 
immunohistochemistry o f  tissue sections, and these different methods o f subcellular 
localisation.
4.1 R aising antibody against TsgalO
Initially the TsgalO amino acid sequence was analyzed in order to choose a region 
suitable to raise antibodies against. The TsgalO ORF starting from double methionine 
(at aminoacid # 1) is conserved in all transcripts encoding the protein. This conserved 
region o f the TsgalO protein was considered for raising an antibody. Several other 
factors were considered and came into play when selecting peptides for antibody 
production. First and foremost were the hydrophilicity, then antigenicity, and finally 
accessibility. All o f these parameters are not independent and take other parameters 
into account as well. For example, in order for a peptide to be antigenic, it should be 
fairly hydrophilic (chances o f being on the surface are higher). If it is likely to be on 
the surface then it will be fairly accessible. Since it is always advisable to select more 
than one region to ensure production o f useful antibodies, 3 peptides were selected 
from the TsgalO protein sequence. Antibodies to various regions may serve different 
purposes. A given antibody may be more suitable for blotting, immunoprecipitation, 
histochemistry, etc. In addition, if  both antibodies react with the same band, then we
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can be pretty sure that they recognize the right protein. O f course cross-reactivity o f  
these sequences with other closely related members and other desirable features 
specific to this protein could be considered. Also it was a good idea to study some 
possible post-translational modification o f the protein.
In the TsgalO protein sequence, the antigen prediction file generated by Peptide
Structure (GCG) shows that it is not the best protein to work with due to the lack o f
proline residues apart from the N-terminus region. However, the N terminus looks as 
though it is completely exposed and could be worth considering. (Provided there is no 
reason to think it is chopped off post translationally.) Prolines, R/K and some 
hydrophobics are good to be included.
The peptides selected for raising polyclonal antibodies against TsgalO as follows:
1) N-terminal- aa 2-15 + cysteine C-terminally for coupling: H2N -
MRNRSKSPRRPSPT- COOH2, very nice prediction, no alpha helix prediction, so the 
antibodies against them may recognize the native protein. This might be possibly the 
best peptide. A BLAST search shows the specificity o f  the selected amino acid 
sequence to TSGA10 protein.
2) Middle- aa 207-220 + cysteine N-terminally for coupling: H2N -
CYENTEKDLSDTQRH- COOH2, good surface probability and antigenic index, 
predicted rather alpha helical like most o f the TsgalO sequence, so the antibodies 
against this sequence probably work only in Western Blots. The result o f a BLAST 
search shows the specificity o f selected amino acid sequence to TSGA10 protein.
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3) C-terminal- aa 676-689 + cysteine N-terminally for coupling: H2N - 
CHRFPDRGFDRSLEE - COOH (C-terminal). BLAST searches show the specificity 
o f the selected amino acid sequence to TSGA10 protein.
TsgalO peptides’ sequences and their names are shown in table 4.1. There is evidence 
that the TsgalO protein may be cleaved into two parts o f  27 and 57 KDa (Modarressi et 
al., 2004, see section 4.2). As far as the antibodies are concerned, both the ‘N- 
terminus’ and ‘middle’ antibodies recognise the 27 KDa N-terminal portion. The 
sequences o f  the above peptides are conserved in all three (human, mouse and rat) 
species.
Table 4.1- TsgalO peptides’ sequences which antibodies raised against them
Name (number) Peptide name and sequence Position of amino 
acids in protein
TN (EP021582) N-terminus peptide: MRNRSKSPRRPSPT 2 - 1 5
TM (EP021583) Middle peptide: YENTEKDLSDTQRH 207 - 220
TC (EP0311142) C-terminus peptide: HRFPDRGFDRSLEE 676 - 689
After synthesis o f  the selected peptides, they were injected into rabbits, then the 
antisera were obtained by bleedings and affinity purified based on the protocol 
described (materials and methods). Titration o f antibodies against TsgalO peptides was 
determined by ELISA assay with the peptide as antigen. O f the four immunized 
rabbits, two generated antibodies that recognized TsgalO N-terminus peptides TN and 
TM, and two generated antibodies against the TsgalO C-terminus peptide TC. As 
shown in the following titration curves (figure 4.1), the immunization programs were 
successful, in that antibodies were raised against each o f  the peptides injected.
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Figure 4.1- ELISA result for TsgalO rabbit antisera against the N, C-termini peptides: TN (upper), TM 
(middle) and TC (bottom); Peptide (straight line) and Carrier (discontinuous) PPI= Pre-immune serum, 
SAB C1/C2 = Serum antibody in Rabbits 1 and 2 (2 rabbits are immunized), PEAK= affinity purified
antibody
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4.2 Studying the expression pattern o f TSG A10 protein by W estern 
blotting
The antibodies raised against the TsgalO protein were hybridised to a Western blot of 
protein extracted from adult mouse testis (figure 4.2A).
Figure 4.2A- Immunoblotting indicates TsgalO protein expression in testis with different sizes. Panels o f  
western blots containing protein extracts from testis were probed to illustrate the components recognised 
by either the N-terminus or C-terminus (N, C) peptides. A different subset o f proteins were recognised by 
the TN, TM and TC antibodies than were recognised by both antibodies (N, C). Lanes 3 (N) and 7 (C ) 
were taken from the blot in figure 4.2B, where a control hybridisation with pre-immune serum is shown.
In this experiment the panels were probed in such a way as to identify the proteins 
recognised by either the N or C terminus antibodies. Since the antibodies are produced 
as a mixture, it is necessary to block the blot with the peptide that is not required to
144
Chapter 4: Studying the expression of the protein encoded by TsgalO
hybridise. In the membranes which were probed with TN antisera (i.e. blocked by TC 
peptide), there are bands o f about 27, 46, 57, 65 and 84 KDs size for the testis protein 
while in the blot stained by TC antisera (i.e. blocked by TN and middle peptides), 84- 
KD and 57-KD protein components were prominent. No bands were seen in the blot, 
which was hybridised with pre-immune serum, this control non-stained blot is shown in 
figure 4.2B.
Ensembl predicts the size o f TsgalO protein to be 81261.60 Da (81 KDa). In the 
immuno-study by western blotting in testis, the presence o f several protein components 
for TsgalO (figure 4.2A) may be due to protein degradation during protein extraction, 
may be an indication o f post-translational modification, or may represent cross reaction 
of the antibodies to other proteins. However, we already know from the RT-PCR 
experiments that TsgalO mRNA undergoes alternative splicing, so this accounts for the 
sizes o f 2 protein components: the complete protein has a molecular weight o f about 
84 KDa, the splicing out o f exon 16 results in the removal o f  70 amino acids which will 
weigh about 8.5 KDa, resulting in a protein o f 46 KDa. Other explanations for the 
additional protein sizes are explored in the following experiments (see also figure 4.2D).
4.2.1 Studying the expression pattern of TsgalO proteins in developmental 
stages of embryogenesis by Western blotting
Using the same hybridisation protocol as the previous experiment, the expression pattern 
of the TsgalO protein was studied during embryogenesis as well as in adult testis (figure 
4.2B). In the case o f the 10.5-dpc mice embryo protein extracts stained by the TN
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antibody there are just 57 and 103-KDa prominent protein bands. In the 13.5 dpc mouse 
embryo there are some bands including 84 and 27 KDa. In the 17.5-dpc-mouse embryo 
84 and 57 KDa bands seem to be the prominent protein extracts components. The non­
specific bands might be due to further processing of TsgalO during developmental stages 
of embryogenesis. In the blot stained by TC antibody just a bright band of 84 KDa 
protein component is observed in 10.5-dpc embryos. Apart from this 84-KDa protein, a 
~30 KDa protein band in 13.5 dpc and the 57 KDa protein band in 17.5 dpc mouse 
embryo were detected.
A B C
T igalO -N A b TigalO -C Ab
103 KD
84  K D
6 5 KD  
57 KD  
45.5 KD
27 K D
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Figure 4.2B- Western blot o f protein extracts from embryos and adult testis.
In each panel lane 1 is protein extract from mature testis, lane 2 is extract from 10.5 dpc mouse embryo 
(E10), lane 3 is from 13.5 dpc mouse embryo (E13) and lane 4, 18.5 dpc mouse embryo (E18). In A, the 
blot was hybridised to the N-terminus antibody (TN). In B, it was hybridised with the C-terminus (TC) 
and in C it was hybridised with the pre-immune sera as a control. Different sized proteins are recognised 
by two ends o f  the protein, and also at different stages o f  embryogenesis.
In the blot which was stained by TN antibody: there are 6 bands o f  about 27, 30, 45.5, 57, 76 and ~103 
size for the testis protein while just 57 and 84-KD bands are prominent in 10.5 dpc mouse embryo. In 13.5 
dpc mouse embryo prominent protein components o f  76, 57, 30 and 27 KDa are detected. In 17.5 dpc 
mouse embryo 76 and 57 bands seem to be detected as main protein components.
In the blot which stained by TC antibody: -103 , 84 and 57-KD protein components are stained in testis 
(although 76 and 65 KDa faint bands were seen as well) while just a bright band o f  84-KD (and a faint 
103-KDa) protein component is observed in 10.5 dpc. Apart from this 84-KD protein, another 30-KD 
protein bands in 13.5 dpc mouse embryo and 57-KD protein component in 17.5 dpc mouse embryo are 
observed.
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4.2.2 Examining TsgalO protein expression in sperm fractions by Western 
blotting
To further characterize the TsgalO protein and analyze its temporal expression pattern 
during spermatogenesis, germ cells were elutriated and analyzed. Three fractions were 
obtained containing pachytene spermatocytes, round spermatids, and elongating 
spermatids. TN antisera recognized a 65-KDa band in germ cells. This analysis also 
showed that TsgalO protein is most abundant in elongating spermatids (figure 4.2C(A)). 
A small amount o f TsgalO protein is visible in the extract from round spermatids, which 
may be due to o f the presence o f elongating spermatids in that cell fraction. Because 
TsgalO RNA but not protein is detectable in spermatocytes, as evidenced by the present 
developmental study and the cloning o f TsgalO cDNA from a spermatocyte cDNA  
library, these results suggest the possibility o f translational control.
To define the location o f TsgalO in cells, nuclear extracts and cytoplasmic extracts were 
prepared from germ cells. Protein loading was analysed using Coomassie Blue staining 
o f gel-separated proteins (not shown). The same amount o f protein was transferred to 
blots and probed with all three anti-TsgalO antiserum. The result o f immunoblotting 
revealed that the protein is present in the cytoplasm, but not in the nucleus (figure 
4.2C(B), lanes 2 and 3). A control demonstrates that, as expected, the CREMr 
transcription factor is predominantly present in the nuclear extract (figure 4.2C(B), lanes 
4 and 5). Figure 4.2C (C) shows the results o f an experiment designed to examine the 
association o f the TsgalO protein with different regions o f the sperm tail. In the first lane 
of protein extract from whole sperm tails a small amount o f the 65 KDa TsgalO protein 
is detectable, but there are an additional 2 proteins o f 32 and 27 KDa. Purification o f  the 
two sperm tail components outer dense fibers (ODF) and fibrous sheath (FS) shows that
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the protein represents the N-terminal portion of the protein since it hybridises to the TN 
and TM antibodies (figure 4.2C(D)). The TC antibody hybridises to the whole 65 KDa 
protein but not to the 27 KDa component. It seems that the protein is cleaved post- 
translationally into two portions, one of which is associated with the fibrous sheath. This 
will be examined further in section 4.4.3.
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Figure 4.2C- Immunoblot analysis o f TsgalO protein. A) Indicated germ cell tractions (lanes 1-3) 
were obtained from adult rat testes using centrifugal elutriation. Cells were lysed and used for Western 
blot analysis using TN, TM and TC antiserum. Lanes 1-3: spermatocytes, round spermatids, and 
elongating spermatids, respectively. Note that 65-kDa TsgalO is predominantly expressed in elongating 
spermatids. B) Western blot analysis o f  total testis (T), cytoplasmic (C), and nuclear (N) fractions o f  
testicular germ cells using anti-TsgalO antiserum raised against all three peptides (lanes 1-3, respectively). 
Loading o f equal amounts o f  cytoplasmic and nuclear samples was analyzed by Coomassie Blue staining 
before immunoblotting (not shown). As a control, cytoplasmic and nuclear proteins were also analyzed 
using anti-CREMr antibody, which detects the testicular CREMr transcription factor (lanes 4 and 5, 
respectively). Note the presence o f  TsgalO in cytoplasmic fractions. C) Analysis o f  TsgalO in sperm tail. 
Extracts from rat sperm tails (lane 1) and two major components o f rat sperm tails, ODF and FS (lane 2 
and 3, respectively), were gel separated and used for the immunoblot analysis using anti-TsgalO antiserum 
raised against all three peptides. Note that FS, but not in ODF, contain a prominent 27-kDa 
immunoreactive TsgalO protein. D) Immunoblot analysis o f  65-kDa TsgalO and mature 27-kDa FS 
TsgalO was carried out using affinity-purified antibodies against peptides located in three different regions 
o f TsgalO protein. Lanes 1 and 3: cytoplasm fraction from testicular germ cells. Lanes 2 and 4: FS 
proteins isolated from sperm tails. Lanes 1 and 2: filters were probed with affinity-purified antibody 
against a peptide located at the N-terminus (amino acids 2-15: N-term). Lanes 3 and 4: filters were probed 
with affinity-purified antibody against a peptide located at amino acids 206-219 (middle).
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4.2.3 Discussion: TsgalO protein processing and modification
These experiments studying the localisation o f the two halves o f the TsgalO protein 
strongly indicate that the two halves are independently located in the sperm, and 
therefore may have different functions. This requires that the protein is modified post­
translation by cleavage. The N-terminus is associated with the fibrous sheath in the 
principal piece o f the sperm, whereas the C-terminus seems to be associated with the 
midpiece (containing outer dense fibres, axoneme and mitochondria). On the Western 
blot, there are 103-KD, 84-KD, 65-KD, 45-KD and 27-KD bands using anti-N antibody, 
and three bands o f 103, 84-KD and 57-KD size when using TsgalO-C-terminus antisera. 
Considering this, if  the cp431-encoded protein (with about 892 aa) is a form o f TsgalO 
(with 689 aa), the most probable forms o f the TsgalO protein might be such as those 
shown in the schematic below (figure 4.2D). It seems that the main cleavage site o f the 
protein (creating the 27-KD fibrous sheath protein) is most probably close to the N- 
terminus part o f TsgalO. This fibrous sheath compartment might include either an 18.5- 
KD cp431 N-terminus upstream component (202 aa) or just the N terminal regions o f 
TsgalO. The 65-KD protein component, which was detected by the anti-TN antibody, 
may be the result o f translation o f a possible alternative splice variant o f TsgalO 
containing just 15 exons.
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Cleavage site 1
or cp431 iso orm?
14-terminus
Peptide
19 KD 27 KD 
N-terminus
<-----------
Main cleavage site
C-terminus peptide 
A
57 KD
C-terminus
-  84 KD TSGA10 (689 aa)
103 KD Cp431 (892 aa)-
65-KDTsgalO N component
84KD TsgalO component
Figure 4.2D- Schematic feature of possible TsgalO cleavage sites resulting in its post-translational 
modification. Cleavage may be less likely occurs very close to TsgalO N-terminus resulting in 19-KD  
cp431 N-terminus component to be part o f  27-KD N-terminus FS protein. More likely, the cleavage 
occurs in a place o f  TsgalO protein where all o f  27-K D FS component is the first TsgalO N-terminus. 65- 
KD component could be the product o f  a TsgalO transcript containing 15-exon.
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4.3.1 Studying expression of the TsgalO protein in testis using 
immunohistochemistry (1HC)
The expression o f the TsgalO protein was investigated in the testis o f different 
species (mouse, rat, goat and boar), and in different stages o f testis development. The 
TsgalO antisera obtained from the injected rabbits contain antibodies to three TsgalO 
peptides: two in the N-terminal region (N and M) and one at the C terminus (C). In order 
to detect expression o f the N-terminal portion o f the protein in the IHC experiments, the 
antisera were blocked with some o f the C peptide (hereto called TN antisera). To detect 
the C terminus the antisera were blocked with N  and M peptides (TC antisera). As a 
control the preimmune sera was used. In immunohistochemistry studies o f 21-day 
(immature) mouse testis using TN antisera, we found a limited number o f primary 
spermatocytes expressing the TsgalO protein N-terminus (figure 4.3.1 A). Staining was 
stronger in mature mouse testis (figure 4 .3 .IB). The N-terminus o f the TsgalO protein 
was seen weakly staining a filamentous/fibrous shape in primary spermatocytes, but 
stronger staining was associated with elongated spermatids at stage V, and mature sperm. 
Germ cells and spermatogonia were not stained using this antibody. 
Immunohistochemistry on mature rat testis using the TN antiserum showed staining 
specifically o f elongated sperms. However, when the C terminus was used staining was 
seen in the cytoplasm o f almost all spermatogonial cells within the seminiferous tubules 
(figure 4.3.1C (A)(B)). These patterns o f  changes in localisation o f the TsgalO protein 
during the different stages suggest TsgalO is physiologically significant in 
spermatogenesis.
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In addition the different locations of the staining o f the two halves of the protein may 
correlate with the N-terminus being associated with the fibrous sheath o f more mature 
sperm. However, the difference in staining pattern observed between anti TN and anti TC 
may be due to posttranslational modification of the protein (as shown in Western 
Blotting). Alternatively, it might be due to differential accessibility o f the antigens; in 
other words the N-terminal might be buried in one place and the C-terminal in another.
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Figure 4.3.1A- Immunostaining of immature mouse testis with the TsgalO N-terminal peptide. Adjacent sections 
o f a 21 day after birth (immature) mouse testis were hybridised to (A) TsgalO antisera blocked with C terminal 
peptides, leaving the N terminal peptides available for hybridisation and (B) TsgalO preimmune serum as a control. 
Positive staining (brown colouration) is seen in a small number of secondary spermatocytes (indicated by green 
arrows) in (A). No staining is seen in the control experiment (B), just the blue H&E background stain.
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Figure 43.1B- Immunostaining of mature mouse testis using the TsgalO N-terminal peptide. Adjacent sections 
were stained with (A) the TN antiserum and (B) the preimmune serum as a control. Strong brown staining can be seen
in (A), and is associated with elongated spermatids.
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Figure 4.3.1C- Immunostaining of mature rat testis (x400). Adjacent sections of mature rat testis 
were hybridised to (A) the TN antisera, (B) the TC antisera and (C) pre-immune sera. The N-terminus 
of the TsgalO protein is detected predominantly in elongated sperms, whereas the C-terminus is detected 
in the cytoplasm of almost all spermatogonial cells (B). Only blue background staining is seen in the 
control experiment (C).
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Immunohistochemistry was also carried out on mature pig and goat testes using the TN 
antisera. Staining was seen in both species. In the pig it seemed that the staining was 
localised in the seminiferous tubules and epithelium, but it is difficult to say exactly due 
to structural difference from the slides being prepared from retes testis (figure 4.3. ID). 
The staining in the goat appeared to be associated with elongated spermatids.
B
Figure 4.3.1D- Mature pig (boar) testis stained with the TsgalO antisera. In (A) the section is stained 
with the TN antisera and in (B) the section is stained with pre immune serum as a control. Brown staining 
can be seen in (A) but, due to the morphology o f the retes testis, it is difficult to say which cell types it is 
associated with.
Figure 4.3.1E- Immunostaining of mature goat testis with TsgalO antisera. In (A) the section is 
stained with the TN antisera and in (B) the section is stained with pre immune serum as a control. Brown 
staining is seen in (A), and may be associated with elongated spermatids, but it is not possible to be certain 
o f this localisation from these sections.
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4.3.2 Examining TsgalO protein expression in brain and glia cells by 
immunohistochemistry
Having examined the expression pattern o f the TsgalO protein in testis, and seeing that it 
appears to be spatially and temporally regulated, I continued to look at its expression in 
other tissues. From the RT-PCR results, it was clear that the RNA is expressed in neural 
crest cells and in brain (sections 3.4 and 3.5). In addition, on genome database searching, 
a large number o f ESTs homologous to TsgalO were found in medulla and cerebellum 
cDNA libraries.
In these series o f experiments, using adult mouse brain, whole brains were dissected and 
serial sections o f 10-12 microns including all parts o f the brain were obtained. From 
approximately 100 sections 4 or 5 sections representative o f  each different brain region 
were selected and transferred to a single slide ready for hybridisation. Figure 4.3.2A 
shows transverse sections o f the cerebellum and the hippocampus and surrounding areas 
(cortex and thalamic nuclei) in adult mouse brain. The stained parts o f the brain seem to 
be every cell o f glia origin, including the granular layer o f the cerebellum, hippocampus, 
thalamus and subventricular zone. Interestingly, the signals o f TsgalO 
immunoreactivities were observed using both o f TN and TC antisera suggesting that the 
whole protein is expressed in these dividing neural cells. In the hippocampus there were 
certain distinct areas that did not express TsgalO, which correlated with the areas where 
pyramidal neurons are found. Pyramidal neurons are also found in the areas in the 
cerebellum where TsgalO was not being expressed. There is staining in the cortex, which 
is apparent throughout the white matter and is most likely again to represent glial cell 
origin. Glial cells divide throughout adulthood and are first present in the foetal cortex
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towards the end o f development. The presence o f staining in the foetal brain embryos 
from day 10.5 dpc onwards indicates TsgalO protein expression in prenatal brain when 
active axonal transport is happening. Also TsgalO protein expression was evident in 
astrocytes (neuroglia cells) (figure 4.3.2B).
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Figure 4.3.2A- Left panel consists o f  sections o f dissected cerebellum, fixed in Bouin’s were stained with 
DAB and counterstained with H&E (xlOO). The right panel shows the sections o f  dissected cerebellum at 
a lower magnification (xlO). The sections A were hybridised with the TN antiserum, in (B), TC antiserum 
and in (C) the control was blocked with N, M, C peptides. Brown staining (DAB) is seen with both N  and 
C peptides in the granular layer, but not in the control experiment (C).
157
Chapter 4: Studying the expression of the protein encoded by TsgalO
Figure 4.3.2B- Im m unostaining o f the adult mouse brain subventricular zone. (A) xlO control experiment 
blocked with all three TsgalO antibodies prior to hybridisation and staining with DAB and H&E. No brown staining is 
seen in either the control experiment or when the section is hybridised with the TN antibody (B). When hybridised 
with the TC antibody brown staining can be seen at lOx magnification (C), and more clearly at high magnification in 
(D), x400. The staining seems to be localised in the granular layer, which includes astrocytes.
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4.3.3 Looking for expression of TsgalO by Immunostaining whole 
embryos at various developmental stages
From the RT-PCR experiments, which showed that the TsgalO gene is expressed 
in testis and brain, a high level o f  expression was also seen in RNA extracted from 
embryos at different stages o f development (section 3.4). Also, the alternative splice 
variant seemed to appear only at the later stages o f  embryonic development. It is most 
likely that TsgalO is expressed in actively dividing tissues. To verify this hypothesis I 
examined the expression o f the TsgalO protein in whole embryo sections by 
immunostaining with the TN and TC antisera.
The following series o f figures show mouse embryos at various stages o f  
embryogenesis from day 10 to day 19 (newborn). Paraffin-embedded sections o f 10-12 
microns hybridised to either the TsgalO N-terminal (TN) or C-terminal (TC) antibody. 
For control experiments the antibody mix was blocked with all 3 o f  the TsgalO peptides. 
The slides were stained with DAB, and counterstained with H&E. Brown signal 
represents hybridisation. The figures are shown in sequence o f increasing age and show 
amplifications o f the regions where hybridisation to the probes was seen. A summary o f  
the results is presented following the figures.
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Figures 4.3.3A-K: Immunostaining of whole embryo sections at various stages of development. In
each case adjacent sections were stained with either the TN, or TC antibody, or, as in controls the antibody 
mix was blocked with all three TsgalO peptides. The brown signal represents staining. In each o f  the 
following figures is shown the age o f  the embryo (days post coitus), the magnification, the antibody used, 
and a brief description o f  the tissue in which hybridisation is seen.
Staining in sub-epithelial region
Ventricle
Figure 4 .3 .3 A -10.5 dpc, Brain, (xlOO), (A) TN-no staining is seen, (B) Control- no staining is seen, 
(C) TC-staining is seen in the subepithelial region.
Figure 4 .3 .3B -11.5 dpc, Brain, (x400). (A) TC- staining is seen in some non-differentiated cells in the 
sub-epithelial region o f  the brain. (B) Control-no staining
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Figure 4 .3 .3C -14.5 dpc, Spine, x200. (A) TN- a small amount o f staining is seen. (B) TC- staining is 
localised in the striation o f  muscle, plus within the vertebrae. (C) Control-no staining.
Vertebrae
c
Figure 4 .3 .3D -15.5 dpc, Spine, (x 100). (A) TN, (B) TC-with both the TN and TC antibodies intense 
staining is seen in the vertebrae. (C) Control-no staining
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Epithelium
Vibrissae
follicle
A
Figure 4.3.3E- 15.5 dpc, Whiskers (Vibrissae follicles), (A-B, x200), (C-E, x630).
(A, C) TN-staining can be seen in the vibrissae follicles and the ectodermal epithelium. (B, D) TC- some 
faint staining in the follicles can be seen at higher magnification. (E) Control- no staining is seen.
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H  b m u c o s a l  
e p i t h e l i u m
Figure 4.3.3F- 15.5 dpc, Intestine, (xlOO). Staining is seen in the submucosal epithelial cells when using 
both the TN and TC antibodies for hybridisation. In the control experiment (C) no staining is seen.
Figure 4 .3 .3G -16.5 dpc, tail, (x200). The TN antibody was used in this experiment where staining can be 
seen in the central portion o f  the tail - perhaps this is proliferative bone or cartilage. Some staining may
also be seen in the lower visceral organs.
ubepithe
B
Figure 4.3.3H- 17.5 dpc, Pancreas, (xlOO). In this experiment (A) the TC antibody hybridizes to the 
subepithelial layers o f the intestinal mucose. These cells are derived from neural crest cells. (B) Control
no staining is seen.
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Figure 4.3.31- 17.5 dpc, Head, (xlOO). Left panel: Top- Using the TN antibody staining can be seen in 
the tongue. Bottom- Control, no staining is seen. Right panel: Top- The TN antibody also detects TsgalO 
expression the muscles o f  the eyeball. Middle-These muscles are also stained in the experiment using the 
TC antibody. Bottom- Control, no staining is seen. ESTs have been identified in cDNA libraries made 
from RNA extracted from eyeballs.
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m m m
Cortex Radiating neurons Vibrissae follicles
Figure 4.3.3J- New born, Brain, (xlOO). Staining is seen when using the TC antibody (A), particularly in 
the brain cortex -  seen as a bundle o f radiating neurons, in the cortex, and in the vibrissae follicles. In (B) 
the TN antibody was used, and no staining was seen.
m s& m
Amygdal
Hippocampus
Figure 4.3.3K- New born, Brain, xlOO. Using the TC antibody (A) produces staining in several regions 
o f the brain including the amygdal region, the hippocampus, the retina and the vibrissae follicles. With the 
TN antibody (B) the only definite staining is in the vibrissae follicles. In the control experiment (C) no 
staining is seen.
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Table 4.3.3 summarises the observations presented in the previous series o f figures 
(figures 4.3.3 A-K), along with some additional results not shown as figures.
In most cases, once protein expression was detected in an organ or tissue-type by one or 
other o f the TsgalO antibodies it was seen at all subsequent developmental stages.
Table 4.3.3- Summary of the pattern of TsgalO protein expression in mouse Embryogenesis
Mouse Embryos TsgalO-N TsgalO-C
E10.5 - (brain) sub-epithelial region
E11.5 - Non-differentiated cells 
Brain sub-epithelial cells
E13.5 - Paravertebral Epithelium
E14.5 - Vertebrae and Paravertebral regions
E15.5 Primordia o f vibrissae- 
follicle Brain Trunk 
Vertebrae Epithelium
Vertebrae and Paravertebral regions 
Intestinal mucosa 
Eye muscle
E16.5 Tail -
E17.5 Tongue 
Eye Muscles
Intestinal mucosa Pancreas 
Eye Muscles 
Liver
E18.5 Tail Epithelium Vertebrate 
Eye (Retina) 
Telencephalon (Radial glia cells?)
New Born Intestinal mucosa 
Primordia o f  vibrissae 
follicle
Brain (cortex and radial glia cells, 
subventricular zone) Eye muscle 
Primordia o f vibrissae follicle 
Intestinal mucosa
TSGA10 appeared to be expressed weakly during the early stages o f  embryogenesis 
however its expression increased over time. This was evident when comparing E l0.5 
and El 1.5 embryos, where the C-terminus is expressed in both, but is stronger by stage 
El 1.5 (figures 4.3.3 A-B). In E13.5 embryos, both the N  and C-terminus are expressed,
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however the signals from the C-terminus are far stronger. The C-terminus seems to be 
expressed in epithelium and in the paraventricular areas. The N-terminus is not only 
expressed more weakly but also it is not present in as many areas. The N-terminus may 
have a structural role in cells (see section 4.4.2).
The C-terminus is expressed in the paraventricular zone; this is significant as the 
paraventricular zone is a key area for cell proliferation in the developing nervous system. 
The expression o f TSGA10 increases in E l4.5 embryos, the C-terminus is now evident 
in the vertebrae as well as the paraventricular zone and the epithelium. The N-terminus 
is also weakly expressed in certain areas, but increases significantly by E l5.5, when it is 
expressed strongly in the brain (which reflects the expression in adult mice), the trunk, 
lower visceral organs, epithelium and primordia o f vibrissae follicles. This may mark a 
transition in the developing embryo from proliferation to differentiation in these areas. 
The C-terminus is still expressed in the vertebrae although not as strongly as in E l4.5 
which could be due to the degradation o f the protein or a decrease in translation, or a 
combination o f these due to the slowing down o f proliferation. The C-terminus is now 
also expressed in the developing eye. By E l6.5 the expression o f TSGA10 in the 
epithelium and vertebra has diminished. The C-terminus is now being expressed in the 
developing tail bud and the N-terminus is being expressed in the developing digits, this 
coincides with the time at which the digits re-orientate themselves to be parallel. The 
expression patterns change again during E l7.5. The C-terminus is strongly expressed in 
the lower visceral organs including the small intestine and the liver whereas the N- 
terminus is not. Both the N and C termini o f TsgalO protein are expressed in tissue 
surrounding the eye, this is probably in the muscles o f the eyelids, and the time o f
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expression coincides with the time at which they close. At E l 8.5 there is no expression 
of the N-terminus, but the C-terminus is expressed weakly in many areas including the 
vertebra, tail epithelium, lower visceral organs and the cortex. The newborn mouse 
expresses high amounts o f both the C- and N-terminus in the brain, intestine, primordia 
o f vibrissae follicles and head areas.
The timing o f expression o f the TsgalO protein during embryogenesis from E l0.5 was 
similar to that o f its message (mRNA) in the mouse embryo and in embryonic brain 
development as revealed by RT-PCR.
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4.3.4 Using immunohistochemistry to examine expression of the 
TsgalO protein expressions in cancerous cells (1HC)
Some evidence that TSGA10 might be expressed in cancerous cells was provided when 
an EST (BE047007) in GenBank isolated from a germ cell tumor was seen to be 
identical to the TSGA10 transcript in nucleotides 2378-2981.
I decided to investigate thus pattern o f expression further by using the method o f  
immunohistochemistry to identify TsgalO expression in a non-teratomatous germ cell 
tumour. The tumour was diagnosed and provided as a gift by Professor Ming-Qing Du 
(Department o f Pathology, UCL, at the moment in Department o f  Pathology, University 
o f Cambridge).
Using TN antibody a general diffuse staining was observed in the human female germ 
cell tumour (figure 4.3.4). This may represent expression o f the whole TSGA10 protein, 
and confirm the findings o f others (e.g. Tanaka et al., 2004) that TSGA10 is expressed in 
cancers.
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Figure 4.3.4- 10-12-micron sections o f  a human female (ovarian) germ cell tumour were hybridised to the 
TN antibody (right hand panel) and were stained with DAB and counterstained with H&E. Adjacent 
sections were used for the experiment and the controls (left hand panel). For controls the antibody mix was 
blocked with all three o f  the TsgalO peptides. Different parts o f  the tumour are shown in each o f  the 
images. Diffuse staining is seen in the slides o f  the right hand panel and indicates TSGA10 expression.
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4.4 Subcellular localization o f  the TsgalO  protein
Having examined TsgalO expression at the protein level by Western blotting, 
and then in different tissues by immunohistochemistry, I wanted to study its expression 
within the cell with the hope that the localisation o f the protein may give further 
indication o f its function. I studied the subcellualar expression o f protein using two 
methods: first using transfection o f a GFP/TsgalO construct into several cell types 
(section 4.4.1) and by immunocytochemistry in astrocytes (4.4.2) and sperm cells 
(4.4.3).
4.4.1 Studying the intracellular localisation of TsgalO protein by 
Transfection of GFP/TsgalO construct in HeLa, hamster 
fibroblasts and NIH3T3 cells
In order to examine the subcellular localization o f  the TsgalO protein, the open 
reading frame (from double methionine to Stop codon) region o f the mouse TsgalO 
gene was subcloned from cDNA clone P2 into the vector pEGFP-C2 using the Hindlll 
and EcoKl sites. Two oligonucleotides, “MF4TC10clone” and “MR19TC10clone”, 
were designed which would amplify a 2.1 kb fragment containing the open reading 
frame o f the TsgalO gene. They were given 5' extensions containing a Hindlll site and 
an EcoR I  site respectively. After amplification using proofreading DNA polymerase 
Pwo, the 2.1 kb fragment was electrophoresed through an agarose gel (figure 4.4.1 A), 
cut out and purified using a Qiagen column. It was then digested with EcoRl and 
Hindlll and ligated into pEGFP-C2. After transformation o f E. coli, plating and 
selection o f the colonies containing the insert, its miniprep product was sequenced to
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confirm that the cloning o f TsgalO into the vector had not caused a frame-shift 
mutation (figure 4.4.1(A)B) (map in Appendix).
Transfections o f hamster fibroblasts (64063al2), HeLa cells and mouse fibroblasts 
were carried out. The cell lines were transfected with either the pEGFP-TsgalO  DNA, 
which produces a GFP-TsgalO  fusion protein, or as a control with pEGFP vector DNA  
that produces Green Fluorescent Protein (GFP) and were fixed and stained with DAPI 
to visualize nuclei 24 or 48 h after transfection. Transfected mouse fibroblasts 
(NIH3T3) were also treated with Phalloidin to detect actin fibers.
In hamster fibroblasts, the TsgalO protein was located in the cytoplasm (figure 4.4.IB) 
and seemed to be associated with short, thick filaments, and has particularly localized 
in the perinuclear region. This pattern o f localization is also seen when the fusion 
protein is transfected into HeLa cells (figure 4.4.1C).
Although these cells (fibroblasts and the HeLa cells) are not necessarily those cells that 
would be expected to express TsgalO- these would more likely be the testis, brain and 
other actively dividing cells- the fibroblasts and HeLa cells were available and seemed 
a reasonable cell type in which to try out the experiment. It seems that they have 
proved to be a reasonable model, since a similar pattern o f localization was 
consistently seen, and this was markedly different from the control experiment. I then 
continued to carry out a similar experiment in the more relevant cells o f sperm and 
astrocytes.
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| 2 .1  kb  [
Figure 4.4.1 A- Making the EGFP-C2/TsgalO construct. A) Double digestion o f  the vector (EGFP- 
C2) and amplified insert (TsgalO) using Hind III and EcoR I sites. B) DNA sequence o f the EGFP- 
C2/Tsgal0 construct showing the junction confirming that no frame shift mutation has been created.
Figure 4.4.IB- A) NIH3T3 mouse fibroblasts were transfected with the pEGFP vector DNA as a 
control. In this case the GFP can be seen throughout the cell. B) The cells were transfected with the 
TsgalO construct. In this case the GFP-TsgalO fusion protein seems to be localized in specific areas o f  
the cell. C) Atin was stained using TRITC-coupled Phalloidin (red). The GFP-TsgalO fiision protein is 
also seen (green), and this is shown at higher magnification in D.
E) Hamster fibroblasts (64063al2) were transfected with the pEGFP-TsgalO construct (green) and 
nuclei were stained with DAPI (blue). The fusion protein is highly associated with the nucleus. In the 
control (F) the cells were transfected with the pEGFP-C2 vector. The green colorations is more scattered 
in this case. Magnifications were (A-C, x20), (D, xlOO), (E, F, x400).
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Figure 4.4.1 C- Localising the 
TsgalO protein in HeLa cells. H ela 
cells were transfected with either the 
pEGFP-C2 vector as a control (A , B) or 
with the TsgalO-GFP construct (C-F). 
The GFP is seen as a green fluorescent, 
and the nuclei are stained with DAPI 
(blue). In the control experim ents (A and 
B) the protein is seen diffused 
throughout the cell. W hen the fusion 
protein was used (C-F) the green stain is 
seen tightly associated with the outside 
o f  the nucleus.
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4.4.2 Studying the localisation of the TsgalO protein within
astrocytes using the N and C terminus antibodies, visualised 
by fluorescence microscopy
In section 4.3.1 immunostaining o f the adult mouse brain hybridised to the TN and TC 
antibodies indicated expression o f the TsgalO protein in astrocytes. Also, some ESTs 
with TsgalO sequence were identified in medulla, cerebellum and brain cDNA 
libraries. Based on this evidence I studied TsgalO protein expression in astrocytes 
derived from a man involved in astrocytoma grade III, WHO classification.
In this experiment the astrocytes were hybridised to either the TN or TC antibody, and 
were visualised using a mouse anti-rabbit FITC-conjugated IgG secondary antibody. 
When the slides are viewed using a confocal microscope the nuclei are seen as blue 
(DAPI staining), and the antibody reveals the location o f the TsgalO protein as a green 
signal.
Using the TN antibody, the protein appears to be localized within the nucleus, while 
using antibody against TsgalO-C-terminus shows localisation close to the nuclear 
membrane (figure 4.4.2). Furthermore, the C-terminus seems to be localised in a single 
structure close to the nucleus, possibly the centrosome or the Golgi. The N-terminus 
may also be present here, but clearly shows additional signals within the nucleus.
TC specific points around the nucleus may suggest that the protein is associated with a 
single organelle such as the centrosome. TN inside the nucleus suggests interaction 
with DNA and control o f cell division.
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Figure 4.4.2- Immunolocalization o f  the TsgalO protein in the astrocytes. TsgalO-N-terminus is 
localised within the nucleus while TsgalO-C-terminus is localized at nuclear membrane. Each photo 
contains some astrocytes derived and cultured from an anaplastic astrocytoma tumour (Grade 3, WHO). 
The photomicrograph is taken at 630X magnification. Mouse anti-rabbit FITC-conjugated IgG used as 
secondary antibody.
(A) The astrocytes hybridised with the TN antibody;
(B,C) The astrocytes hybridised with TC antibody, in this case the green signal is in a specific 
perinuclear localisation;
(D) Control, treated with no primary antibody.
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4.4.3 Determining the localisation of the TsgalO protein in sperm by 
immunocytochemistry and immunofluorescence
Evidence from Western blotting o f protein extracts from the two major 
components o f rat sperm tail, the outer dense fibres (ODF) and the fibrous sheath (FS), 
indicated that in the fibrous sheath a prominent 27-KDa band is seen (figure 4.2C). 
This 27-KDa fragment seems to represent the N  terminus o f the TsgalO protein, which 
is cleaved from the complete protein. In order to confirm this observation and to refine 
the localisation indirect immunofluorescence microscopy o f epididymal sperm was 
carried out using antibodies TN and TC, which recognise the N  and C terminal 
portions o f the protein respectively.
Using the TN antibody, fluorescence was seen primarily in the principal piece 
region o f the sperm tail, in both mouse and boar (figures 4.4.3A-C). There is some 
fainter fluorescence in the mid-piece, and it is likely that the TsgalO N terminal region 
is expressed here, but it may be difficult to detect due to the mitochondrial sheath and 
the solenoid structure o f this portion o f the sperm tail. In the control experiment, the 
TN antibody did not hybridise to sperm that had been blocked with peptides to both 
parts o f the TsgalO protein (figures 4.4.3B-C).
Direct immunofluorescence microscopy o f epididymal sperm from mouse, cow and 
boar was also carried out using antiserum TC. The result shows that C-terminus 
component o f TsgalO is present in the midpiece o f the tail but not the principal piece 
(figures 4.4.3D-F). Sperm incubated with all o f  the blocked primary antibodies did not 
show any staining and non-specific secondary antibody binding to sperm was also 
undetectable.
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Figure 4.4.3A- Indirect immunofluorescence analyses o f  TsgalO in epididymal mouse sperm. 
Epididymal spermatozoa were fixed on poly-L-lysine coated glass cover slips and hybridised with anti-TN 
antiserum followed by secondary antibody conjugated to Cy3. The principal piece of sperm tails, which is 
distal to the midpiece, strongly fluoresced (red). Sperm heads, showing very weak staining, are indicated with 
arrows. Bar = 20 pm
Principal piece
^-----------------  Mid-piece
Figure 4.4.3B- Indirect immunofluorescence analysis o f TsgalO in epididymal mouse sperm. 
Epididymal spermatozoa were fixed on poly-L-lysine coated glass cover slips and: A) stained with anti- 
TN antiserum followed by secondary antibody conjugated to FITC. The principal piece o f sperm tails, 
which is distal to the mid piece, fluoresced strongly (green). Sperm heads and midpiece, showed weak 
staining;
B) Control (blocked with TN, TM, TC peptides) (* 400) sperm heads appear blue due to DAPI staining 
o f nuclei
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Figure 4.4.3C- Indirect immunofluorescence analyses of TsgalO N-terminus in epididymal boar 
sperm. Epididymal spermatozoa were fixed on poly-L-lysine coated glass cover slips and: A,B) stained with TN 
antiserum followed by secondary antibody conjugated to FITC. The principal of sperm tails, which is distal to the 
mid-piece, as well as sperm head and end piece of sperm tail strongly fluoresced. C) Control, sperm heads
appear blue due to DAPI staining o f  nuclei, A(x630) B,C (*400)
Principal piece. 
Mid-piece
Figure 4.4.3D- Indirect immunofluorescence analysis o f TsgalO in epididymal mouse sperm. 
Epididymal spermatozoa were fixed on poly-L-lysine coated glass cover slips and: A) stained with TC 
antiserum followed by secondary antibody conjugated to FITC. The midpiece o f  sperm tails, which is 
proximal to the principal piece, strongly fluoresced (green). Sperm heads show weak staining;
B) Control, sperm heads appear blue due to DAPI staining o f nuclei (TN, TM, TC blocked) (x 630)
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Figure 4.4.3E- Indirect immunofluorescence analyses o f TsgalO in epididymal bovine sperm. 
Epididymal spermatozoa were fixed on poly-L-lysine coated glass cover slips and: A,B,D) stained with 
TC antiserum followed by secondary antibody conjugated to FITC. The midpiece o f sperm tails, which 
is proximal to the principal piece, strongly fluoresced. Sperm heads show weak staining;
C) Control (blocked with C, M, N  peptides), sperm heads appear blue due to DAPI staining o f  nuclei
mid piece
midpiecc
midpiece
Figure 4.4.3F- Indirect immunofluorescence analyses o f  TsgalO C-terminus in epididymal boar sperm. 
Spermatozoa were fixed on poly-L-lysine coated glass cover slips and: A,B,C) stained with TC antiserum followed 
by secondary antibody conjugated to FITC. The midpiece of sperm tails, which is proximal to the principal piece, 
strongly fluoresced. Sperm heads show weak staining; D) Control, sperm heads appear blue due to DAPI 
staining o f nuclei
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Chapter V:
Examining TSGA10 protein interaction 
using the Yeast Two Hybrid assay
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In the previous experiments overall observations about the behaviour o f the TsgalO 
protein have come to light. The two halves o f the protein seem to behave differently in 
the cell: in sperm the N terminus is associated with the fibrous sheath in the principal 
piece o f the sperm tail, whereas the C terminus is associated with the midpiece (section 
4.3.3), in astrocytes the N  terminal region appears to be located within the nucleus, 
whereas the C terminal portion is distinctly perinuclear. A way to try and understand the 
reasons for the locations o f the protein, and therefore to be able to make predictions 
about function, is to investigate which other proteins TsgalO might interact with. This 
can be achieved using the yeast two-hybrid system (Zhu and Hannon, 2000). The 
experiment involves using a plasmid construct containing the cDNA encoding the 
protein o f interest (the ‘bait’ TsgalO), and introducing (by yeast mating, or co­
transformation) this into yeast cells along with plasmid constructs containing ‘prey’ 
sequences, in this case a rat testis cDNA library. Where the bait protein interacts with a 
prey protein, the yeast genes encoding selectable markers within the constructs can be 
transcribed, and the yeast colony will survive on selection media (see methods section 
2.5).
Making the bait construct- “YTHM” and “MR19TC10clone” oligonucleotides were 
used to amplify a 2.1 kb fragment containing the entire open reading frame o f the TsgalO 
gene using pGFP-C2/TsgalO  as a template. These two oligonucleotides were given 5' 
extensions containing an N col site and an EcoR I  site respectively.
After amplification using proofreading DNA polymerase Pwo, and digestion with Ncol 
and EcoRl the 2.1 kb fragment was electrophoresed through an agarose gel and purified
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using a Qiagen column. It was then ligated into the bait vector pGBKT7 which contains 
the GAL4 binding domain promoter; T7, ADH1, a multiple cloning site and TRP1 in the 
cassette (see Appendix for its map). The vector had been previously digested with the 
same two restriction enzymes. The construct o f the bait plasmid was sequenced to 
confirm its proper junction to make sure that no from shift mutations had been created 
and then the yeast strain AH 109 was transformed by it with a high efficiency (~ x io8 
colonies per pg DNA). Then pretransformed rat testis (in pGAD424 plasmid) was used to 
transform yeast strain AH 109 containing the bait construct.
Yeast Transformation- Since the transformation could be performed so efficiently, it 
was reasonable to transform AH 109 yeast strain already containing the bait plasmid with 
the library plasmid. An aliquot o f the transformed yeast was plated onto SD/-Trp/-Leu 
plates to select for the presence o f both plasmids, and surviving colonies were counted.
Table 5A- Yeast clones with library and bait plasmid counted after co-transformation in yeast strain AH 109
Date o f  counting Approximate number o f  colonies
09.10.03 (1:2000 diluted control) 213
09.10.03 400,000
Transformation efficiency = no. colonies x total suspension volume (pH
Volume plated(pl) x dilution factor x amount DNA(pg)
~ 210x2000
100x0.005x0.1
~ 8 x 106 colonies per pg DNA
This is about ten times less efficient than the single plasmid transformation. This a good 
reason for doing the mating experiment as well, however it is still quite efficient.
The remainder o f the transformation was plated on SD/-Trp/-Leu/-His/-Ade, to select for 
a two hybrid reaction. Seventeen yeast colonies were obtained after a 2-week incubation.
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PCR of plasmid mini-preps using primers pGAD 3' and pGAD 5' confirmed the 
presence of the library plasmid in these colonies (results not shown) and showed the size 
of the inserts. Only four out of the seventeen screened colonies, looked like they may 
have contained an insert. These colonies, M l, B l, S2 and S3 were re-screened by PCR 
again using the primers pGAD 3' and pGAD 5' on a mini-prep product from the colonise 
pGADT7-T was used as a template for the positive control, and no template in the 
negative control. The PCR products were then run on an agarose gel alongside the Gibco 
1 Kb DNA ladder (figure 5A).
Figure 5A- PCR products o f  plasmids extracted from yeast colonies that survived the selection procedure. 
In this research, using primers pG A D 3’ and p G A D 5\ only are plasmid (S3 lane 3) seem s to contain one 
insert, and maybe two. The inserts are 2 Kb and 750 bp in size. Lanes 1 (M l), 2 (S2), 3 (S3), 4  (B l) ,
5 (positive control), 6 (negative control).
The only colony in which there appears to be a plasmid with an insert is S3, which has 
two, one around 750 bp, and one around 2,000 bp. These bands were labelled S3b (big 
band), and S3s (small band).
The S3 colony could contain 2 populations of cells, each containing a different plasmid. 
The plasmids were isolated from the yeast cells and transformed into E. coli DH5a. This
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enabled the two types o f plasmid to be separated as each E. coli cell can only take up 
one plasmid. Several individual E. coli colonies were then picked and grown up in liquid 
culture. A sample o f this was re-plated, while DNA was prepared from the rest o f each 
culture using the mini-prep method. The mini-prep DNA then underwent PCR using the 
same primers as above. Both plasmids were rescued and representative colonies were 
then stored as a glycerol stocks at -70°C and were sequenced. S3b showed 100% identity 
to an anonymous transcript from Rattus norvegicus described as “similar to 
‘hypothetical protein FLJ32880’”. This transcript had been found in testis cDNA 
libraries, maturing and mature sperm, and pancreas. S3s showed a high degree o f  
similarity to Mus musculus ‘phosphorylase kinase alpha2 (Phaka2)’, which is expressed 
in a range o f tissues, including the adult testis (Table 5B).
Yeast mating
In order to obtain more yeast colonies containing plasmids with inserts I carried out the 
two-hybrid experiment again using the yeast mating method, rather than co­
transformation. First it was necessary to transform the yeast strain Y187 with the rat 
testis library in pGAD424. Then Y187 colonies growing on SD/-Leu were counted. To 
be sure that every clone in the testis cDNA library had a reasonable chance o f being 
rescued, at least three times as many colonies were sought, as there were clones in the 
original library. As about 200,000 independent recombinant clones were in the testis 
library, I aimed to rescue at least 600,000 colonies in Y187 (See table 5.1 A).
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Around 4,500,000 colonies containing the library plasmid were obtained. This is 
sufficient to expect that each independent cDNA clone be represented many times. Both
Table 5B- Rat testis library clones counted after transformation in yeast strain Y187
Date of counting Approximate number of colonies on plate
01.10.03 90,000
03.10.03 160,000
03.10.03 600,000
06.10.03 2 ,0 0 0 , 0 0 0
06.10.03 2 ,0 0 0 , 0 0 0
06.10.03 (1:2000 diluted) 2,400
large and small colonies were seen.
To estimate transformation efficiency, yeast colonies were counted on the control plate 
(from the 06.10.03) by using the formula:
Transformation efficiency =  no. colonies x total suspension volume(pl)
Volume plated(pl) x dilution factor x amount DNA(jig)
a  2400 x 2000
100 x 0.005 x 0.1
~ 9.6 x 107 colonies per pg DNA
This transformation was about 10 times as efficient as the co-transformation method. 
Mating between the bait strain, AH 109 and the library strain, Y187 was then carried out 
according to the protocol outlined in the methods section (2.19). As a control, Y187 
containing pGADT7-T (library control plasmid) and AH 109 containing pGBKT7-53 
(bait control plasmid) were also grown up in overnight culture. The Y187 containing the 
library control plasmid was mated to both the AH 109 containing the bait control plasmid 
and to AH 109 containing the bait plasmid itself. The diploid cells produced by the 
mating were then plated out on SD-Trp/-Leu, to select for the presence o f both plasmids
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and to permit an estimate o f mating efficiency, and also on SD-Trp/-Leu/-His/-Ade. The 
results are shown in Table 5C.
Table 5C- Transformation efficiency and bait positive control ty/ yeast mating
Mating Y187 containing library control 
(pGADT7-T) plasmid mated to 
AH109 containing:
Media Approximate number 
of colonies
A Bait control (pGBKT7-p53) SD-Trp/-Leu ~ 5,000
B Bait control (pGBKT7-p53) SD-Trp/-Leu/-His/-Ade ~ 3,000
C Bait (pGBKT7-TsgalO) SD-Trp/-Leu ~ 5,000
D Bait (pGBKT7-Tsgal 0) SD-Trp/-Leu/-His/-Ade 0
The cells from mating A that grew on the double selection media demonstrated that the 
TRP1 and LEU2 marker genes were both active in the cells, in other words, the co­
transformation was successful. A similar number o f colonies were obtained under the 
double selection from mating C, showing that the bait strain-control strain mating was 
also successful, thus the method works with the experimental (TsgalO) bait plasmid.
Only cells from mating B grew on the quadruple selection media. The two hybrid 
proteins encoded by the control plasmids should interact to activate the HIS3 and ADE2 
selectable genes, and thus be capable o f growing on -Trp/-Leu/-His/-Ade drop-out 
media. The large T antigen and the TsgalO protein however should not interact; no 
colony growth is seen from mating D, under the quadruple selection. This shows that the 
selection for the two-hybrid interaction worked.
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Results of the mating experiment between strains AH109 containing the bait plasmid 
(TsgalO) and Y187 containing the library plasmid: The bait strain AH109 containing 
pGBKT7-TsgalO was mated to the library strain Y187 containing the rat cDNA library 
in pGAD424. The resulting diploid cells were plated onto twenty-six plates containing 
more than two hundreds yeast colonies grown. This is because the protein interaction 
has to take place in order to switch on genes that are necessary for growth on PCR 
analysis, three colonies grew on selection media: LI (insert approximately 150 bp), L3 
(insert approximately 2,000 bp) and Y1 (insert approximately 750 bp) (figure 5B). 
Further PCR reactions of yeast colonies from this experiment are shown in the following 
figures (5C and 5D).
Lanes
10
~ 2 ,000b p
750bp
~ 300b p
150bp
50bp
Figure 5B- Electrophoresis 
of PCR products, from DNA 
mini-prep of colonies 
produced by yeast mating- 
DNA was prepared from the 
colonies using the mini-prep 
method. PCR reactions were 
then carried out using the 
primers pGAD 3' and pGAD 
5'. The PCR products were 
then run on the electrophoresis 
gel alongside the Gibco 1 Kb 
DNA ladder. Lanes are: (2) 
LI, (3) L2, (4) L3, (5)Z 1,
(6) Z2, (7) Z3, (8) Y l,
(9) positive control,
(10) negative control.
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Lanes 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Figure 5C- In this PCR experiment from yeast colonies, two appear to contain plasmids with inserts, these 
are A'l (insert approximately 1,100 bp) and A'6 (insert approximately 850 bp). Lanes are (2) A l, (3) A2, 
(4) A3, (5) A4, (6) A5, (7) A ’l ,  (8) A ’2, (9) A ’6, (10) C l, (11) D l, (12) D2, (13) D3, (14) D5, (15) 
positive control.
Lanes
1 2 3 4 5 6 7 8 9 10 11 12 13 14
~ l,1 0 0 b p
~850b p
~600b p
~550b p
~50b p
~500b p
15 16 17 18 19 20 21
Figure 5D- In this PCR reaction, three o f  the yeast colonies seem to contain plasmids with inserts, these 
are F2 (approximately 850 bp and 600 bp), F3 (approximately 1,100 and 550 bp) and F5 (approximately 
500 bp). Lanes are (1) Kb ladder. (2) C2, (3) D4, (4) D7, (5) D9, (6) E l, (7) E2, (8) E3, (9) E4, (10) E5,
(11) FI, (12) F2, (13) F3, (14) f U  . (15) F5, (16) F6, (17) G2, (18) G3, (19) G4, (20) positive 
control, (21) 100-bp ladder.
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In total only 9 yeast colonies remained as candidates containing potentially interesting 
inserts. They are listed in Table 5D.
Table 5D
Colony name Approximate insert size (base pairs)
LI 150
L3 2,000
Yl 750
U14 850
AT 1,100
A '6 850
F2 600 and 850
F3 1,100 and 550
F5 500
Electrophoresis was carried out in which all of the PCR products from colonies obtained 
by mating containing sizeable inserts were run alongside each other (see figure 5E).
[ a n es
~2 ,000b p
~ l,1 0 0 b p
~850b p
~750b p
~600b p
~550b p
~500b p
~150b p
~50b p
Figure 5E- PCR o f each o f  the 9 
clones containing inserts already 
shown in figures 5B-D, 
illustrating the range o f  insert 
sizes. Lanes are: (1) LI, (2) L3, 
(3) Y l, (4) U14, (5) A T , (6) A ’6,
(7) F2, (8) F3, (9) F5, (10) 1Kb 
ladder.
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Three individual colonies were picked from each o f the re-plated colonies screened. 
Plasmid DNA was isolated from them using the mini-prep method. The plasmids were 
transformed into E. coli DH5a. Where there were two plasmid types, i.e. in colonies F2, 
F3 and S2, this enabled the two types o f plasmid to be separated as each E. coli cell can 
only take up one plasmid. Several individual E. coli colonies from each transformation 
were then picked and grown up in liquid culture. A sample o f this was re-plated, while 
DNA was prepared from the rest o f each culture using the mini-prep method. The mini- 
prep DNA then underwent PCR using the same primers as above. Colonies containing 
appropriate bands (seen in the electrophoresis o f the PCR products) were then stored as 
a glycerol stock at -70°C to be sent for sequencing (see below). The plasmid DNA was 
isolated from the E. coli cells using the mini-prep method, and used as a template for 
PCR. The PCR reactions were carried out using the primers pGAD 3* and pGAD 5'. 
pGADT7-T was used as a template for the positive control. No DNA template was 
added to the negative control. The PCR products were then run on the electrophoresis 
gel alongside the Gibco 1 Kb DNA ladder to check the inserts. A sample o f each PCR 
product was sent for sequencing.
All o f the nucleotide sequences reads are shown in Appendix 8.1. NCBI basic alignment 
search tool (BLAST) was used to identify the origin o f the cloned inserts by aligning the 
sequences obtained with those stored in its database. The results o f this search are shown 
in tables 5E.
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Table 5E- Bioinformatic characteristics of yeast colonies containing candidate prey insert interacting to 
________  bait TsgalO protein by transformation (S3b) and mating (the rest of them)___________
Colony
name
Insert
size
(bp)
Length
of
sequence
(bp)
Significant 
alignment found in 
BLAST search
Accession
number
Further 
information 
about gene
LI 150 1 2 1
pGAD242 cloning 
vector
U07647.1
GI:464015
L3 2 , 0 0 0 -850
Rattus norvegicus 
similar to hypothetical 
protein FLJ32880 —
Yl 750 716
Mus musculus Tripartite 
motif protein 37 
(Trim37)
BC059070.1
GI:37589511
Ubiquitously
expressed
U14 850 780
Mus musculus 
Hypothetical protein 
MGC23918
XM_343490.1 
GI:34866381
Ubiquitously
expressed
A'l 1 , 1 0 0 8 6 6
Mus musculus 
Transcription factor-like 
protein MORF-related 
gene 15 protein 
(MRG15)
XM_222925.2
GI:34880963
Expressed in a large 
range of tissues, 
including the adult 
testes.
A’6 850 830
Mus musculus 
Cytochrome c-1 (Cycl) XM 216944.2 
GI:34866852
Ubiquitously 
expressed 
mitochondrial protein
F2 600 468
Mouse peroxisomal 
biogenesis factor 3 
(Pex3)
BC054252.1
GI:32450617
Ubiquitously
expressed
F3
oo■^4I 701
Rattus norvegicus 
Sperm outer dense fibre 
major protein 2  (Odf2 ) 
Cenexin 1
AF162756.2 
GI: 17388905
A molecular 
scaffolding protein 
with a link between 
centriole maturation 
and sperm tail protein
F5
ooI 439
Mus musculus 
1500002M01 gene
BC004785.1 
GI: 13435875
Expressed in a range 
of tissues, including 
the adult testes.
S3b -  2 , 0 0 0 832
Rattus norvegicus 
similar to hypothetical 
protein FLJ32880
XM_341991.1 
GI: 34861446
Found in cDNA 
libraries of testes, 
maturing and mature 
sperm, and pancreas
S3s
750 1,250
Chimeric clone: 
First portion: Mus 
Musculus Phosphorylase 
kinase alpha2 (Phka2) 
Second portion: Mus 
musculus BAC clone 
RP24-233P3
AL928806.14
GI:33569179
AC 122445.3 
GI:25046668
Expressed in a range 
of tissues, including 
the adult testes
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Clone LI showed homology to a part o f the cloning vector and thus was probably a false 
positive. The inserts o f  Y l, U14, A '6 and F2 are clones containing ubiquitously 
expressed sequences, i.e. they are expressed in every cell o f the body. Those that have 
been characterised appear to have housekeeping-related functions. It seems unlikely that 
any o f these, except CytC-1 (A’6) would actually interact with the TsgalO protein in the 
sperm tail, as it is such a specific structure. These interactions may have been false 
positives, or may have been chance interactions between proteins that do not normally 
come into contact with one another. The same was probably true o f  the genes from 
which the inserts cloned in AT, F5 and S3s are derived although these genes are known 
to be expressed in the testis. The three inserts that looked the most promising were those 
found in clones F3, L3 and S3b particularly since clones L3 and S3b contained the same 
sequence found in testis and sperm cDNA libraries, and F3 contains the sequence 
encoding a protein associated with outer dense fibres.
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5.1 C onfirm ing the interaction o f the TsgalO  protein with 3 candidate  
proteins: FLJ32880 hypothetical protein, Cyc-1 and odf2
This confirmation experiment was needed to eliminate the possibility that some mutation 
in the yeast cells in the previous co-transformation and mating experiments had 
permitted colony growth in the absence of a genuine two-hybrid interaction. Cells from 
the bait strain stock (containing the pGBKT7-TsgalO plasmid alone), were co­
transformed with the plasmids isolated from the colonies in which an interaction was 
previously detected. The plasmids were grown up in E. coli prior to the transformation. 
The resulting transformation suspension was then plated out on both double (-Trp/-Leu) 
selective media, and quadruple (-Trp/-Leu/-His/-Ade) selective media. A sample of 
AH 109 that did not contain the pGBKT7-TsgalO plasmid was transformed and also 
plated out, as well as controls on single (-Leu), and triple (-Trp/-Leu/-Ade) selective 
media. See Table 5.1 A.
Table 5.1 A- Repeat transformation and screening o f  plasmids containing candidate proteins interacting 
_________________________________________ with TsgalO_________________________________________
Colony
name
AH109/-Leu AH109/-Leu/
-His/-Ade
AH109 with 
pGBKT7-TsgalO/ 
-Leu/-Trp
AH109 with 
pGBKT7- 
TsgalO/-Leu/ 
-Trp/-His/-Leu
LI Colony growth No growth Colony growth No growth
L3 Colony growth No growth Colony growth Colony growth
Y l Colony growth No growth Colony growth No growth
U14 Colony growth No growth Colony growth No growth
AT Colony growth No growth Colony growth No growth
A '6 Colony growth No growth Colony growth Colony growth
F2 Colony growth No growth Colony growth No growth
F3 Colony growth No growth Colony growth Colony growth
F5 Colony growth No growth Colony growth No growth
S3b Colony growth No growth Colony growth Colony growth
S3s Colony growth No growth Colony growth No growth
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The cells transformed with the library plasmid alone grew on SD/-Leu; this showed that 
the library plasmid conferred on the AH 109 leucine auxotrophs the ability to grow 
without leucine, as it should do. Similarly, when the AH 109 cells were co-transformed, 
the ability to grow on media without tryptophan was conferred. This showed that the 
plasmid selections were working. No cells grew in the absence o f  the bait plasmid when 
under selection for Adenine and Histidine as well as Leucine. This provided evidence 
that the proteins encoded by the library plasmids were not capable o f inducing 
expression from the His and Ade promoters on their own. There were no colonies found 
to be growing on the plates containing cells transformed with the plasmids isolated from 
LI, Y l, U14, and A ’l,  F2, F5 and S3s. This means that the selectable genes downstream 
of the His promoter, were not activated, indicating that no interaction was taking place 
between the protein encoded by the library plasmid, and TsgalO. These must have been 
false positives. However, there was growth on the plates containing cells transformed 
with the plasmids isolated from L3, A'6 , F3 and S3b (see figure 5.1 A).
Using the yeast two-hybrid assay I found three proteins that interact with TsgalO. The 
first is “L3 or S3b”: a hypothetical protein, FLJ32880, which had been found in human 
spermatids, medulla and pancreas. The second is “F3”: an outer dense fibre protein 
encoded by the Odf2 gene, which is expressed in rat and human testis, epididymis and 
foetal brain. The third is “A ’6”: Cytochrome C l, which is a subunit o f an electron- 
transfer chain in the mitochondria.
195
Chapter 5: Examining TsgalO protein interaction using yeast two hybrid assay
Figure 5.1 A- Co-transformation of bait construct with candidate interacting proteins in 
AH109 yeast strain. This experiment confirmed possible interaction o f  the TsgalO protein 
(encoded by the bait construct) with proteins encoded by A ’6 (A), F3 (B), L3 (C) and S3 (D) 
constructs.
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5.2 Determining whether the N or C terminus of the TsgalO interact 
with the proteins identified by the yeast two hybrid assay
In previous sections I have shown the TsgalO protein may be cleaved, and its N- 
terminus localizes in sperm tails as a fibrous sheath protein. The focus o f  this part of 
project was to find out which half o f the TsgalO protein interacts with the proteins 
identified above by performing separate yeast two-hybrid assays with each portion o f the 
gene. The gene was divided into two fragments by amplifying with PCR primers 
designed to amplify either the 5" or 3' half o f the gene sequence. The two fragments 
were then used to construct bait plasmids. The yeast two-hybrid screens were carried out 
by co-transforming the yeast with bait and prey plasmids and by mating yeast cells 
containing the bait plasmid with those carrying the prey plasmid. The yeast cells were 
plated onto medium, which could select those cells in which a protein-protein interaction 
had taken place. As before, the experiment was carried out, once using co­
transformation o f yeast strain AH 109, and once using mating between strains AH 109 
and Y187 in order to introduce the bait and prey plasmid combinations into the same 
yeast cell.
Making the Constructs- Figure 5.2A shows TsgalO 5' N-terminus and 3' C-terminus 
halves o f TsgalO amplified with primers A-D (see methods section 2.19.2). The product 
of this PCR reaction were then purified by ethanol precipitation and digested with 
restriction enzymes EcoRI and Hind III (figure 5.2B).
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A  B
1Kb 3' 5' 1Kb 3 ’ 5’ Plasmid
Figure 5.2- A) Agarose gel (1.3%) electrophoresis o f  purified PCR products o f  TsgalO N/C-portions 
B) Electrophoresis o f  the products from (A) with EcoRl and N col The marker is 1 Kb ladder
The wide bands present on the gel (figure 5.2A) were produced by amplification of the 
two portions of TsgalO. The 5' band can be seen to be approximately lOOObp which 
corresponds to its predicted length o f 1079bp. The band produced by the C-terminal half 
(3’) is about llOObp in size, which corresponds to its predicted length o f 1142bp. By 
comparing the brightness o f the bands to those produced by the ladder, the amount of 
DNA estimated to be in each reaction was 300ng/pl. Figure 5.2B shows the DNA 
purified from the restriction double digests (iscoRI and Ncol). The digested fragments 
were predicted to be 1059bp (5') and 1137bp (3') in length due to their ends having been 
trimmed by the restriction enzymes (iscoRI and Ncol). The band produced by the 
plasmid corresponds to the size o f pGBKT7, which is 7.3kb in length. Once the DNA 
had been cleaved by the same restriction enzymes, two TsgalO fragments were ligated 
into the other plasmid. Figure 5.2C shows the two portions o f the TsgalO gene ligated 
into the pGBKT7 plasmid:
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3' 5' 1Kb
7126bp 
1018bp
Figure 5.2C- Electrophoresis o f  ligated DNA o f  TsgalO 573 ’-portions (2 pi ligation reaction, lpl Loading 
buffer, 2pi 1Kb ladder. Run 2hours at 40v)
The gel shows that the ligation reactions were partially successful. A faint band 
produced by unligated 5' fragments can still be seen at about lOOObp. The larger bands 
of approximately 8000bp represent the plasmid ligated with each of the two portions of 
TsgalO. Then plasmids containing the two portions of TsgalO were transformed into 
competent E. coli cells. A positive control was included with cells transformed with 1 pi 
of the empty plasmid (diluted to give lng/pl). The agar contained kanamycin because 
the pGBKT7 plasmid is kanamycin resistant; therefore, only cells containing the plasmid 
would be able to grow on the plates (figure 5.2D). The transformation efficiency was 
calculated using the following equation and the results are shown in table 5.2A:
No. of colonies x 10  ^ x lOOOpl (total vol. transformation) 
lng pGBKT7 1000 200pl (vol. transformation plated)
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Table 5.2A- Transformed E. Coli colonies containing TsgalO-57 3 ’ portions
Plate No. of colonies Transformation efficiency (cfu/pg plasmid)
5' 80 4 x 105
3' 100 5 x  105
pGBKT7 600 3 x  106
pGBKT7
Figure 5.2D- The E. coli colonies which were transformed with the plasmids (TsgalO-5’/pGBKT7, 
TsgalO-37pGBKT7) to make bait constructs
The colonies numbered in the photographs in figure 5.2D were tested by PCR with 
primers pGAD424-5’ and pGAD424-3’ to see if they contained the expected inserts. A 
negative control was included for each set of primers with water replacing the DNA 
template. The results are shown in figure 5.2E. The gel shows that three of the E. coli 
colonies transformed with pGBKT7 and the 5' fragment took up plasmids containing the 
insert, and one colony took up the 3’ plasmid and insert. The very small fragments at the 
bottom of the gel were produced by unused primers. Two colonies were selected for 
DNA miniprep and yeast transformation, one containing the 5' portion of TsgalO and 
one containing the 3 ' portion (figure 5.2F).
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Figure 5.2E- Electrophoresis of PCR products of TsgalO 5 ’ (lanes 1-6) and 3 ’ (lanes 8-13) ends ligated 
into the pGBKT7 vector and transformed into E. Coli. Primer pairs were (YTHM, B) for 5’ and (C, 
MR19TC10clone) for 3 ’ portions. Lanes 7 and 14 contained water instead o f  DNA. (2pl PCR product, ljil 
Loading buffer, 2pi 1Kb ladder. Run for lhour at 40v).
1Kb 5' 3'
Figure 5.2F- Electrophoresis o f  the plasmid miniprep products o f TsgalO-5’ and TsgalO-3’ (5pl 
miniprep, lpl Loading buffer, 3pl 1Kb. Run for lhour at 40v)
Co-transformation of yeast- The Saccharomyces cerevisiae yeast strain, AH 109, was 
co-transformed with plasmid containing either of the two portions of TsgalO (bait) and 
one of the three different genes (prey) encoding proteins previously shown to interact 
with the intact TsgalO protein. The gene fragments used in the prey plasmid were A '6 
(C ycl\ F3 (Odf2), L3 and S3b (both like FLJ32880). Parallel controls were included; 
cotransformation with pGBKT7-TsgalO (the complete TsgalO gene) and pGBKT7 
(empty plasmid). The co-transformed yeasts were plated onto SD medium with either
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-Leu/-Trp or -Ade/-His/-Leu/-Trp dropout supplements. Only yeast cells containing 
both plasmids will grow on SD/-Leu/-Trp medium. Only yeast colonies in which the 
bait and prey proteins have interacted will grow on SD/-Ade/-His/-Leu/-Trp medium. 
Table 5.2B shows the results o f the yeast co-transformation. The plates marked * also 
contained many small red colonies produced by yeast cells which were able to grow 
without expressing the reporter genes and are not evidence o f  an interaction between two 
proteins. The red colour indicated that the yeast still had a ‘-Ade’ phenotype. In results 
100 colonies or more are counted.
Table 5.2B- Co-transformed yeast colonies containing TsgalO and TsgalO/5’, TsgalO/3’ portions
AH109 SD/-Leu/-Trp SD/-Ade/-His/-Leu/-Trp
A'6 F3 L3 S3 A'6 F3 L3 S3
5' 88 300 200 17 16 14 200 10
3' 51 300 300 2 0 3* 0 10
TsgalO 25 200 200 0 17 100 100 0
pGBKT7 23 300 300 4 0* 19* 0* 2*
The SD/-Leu/-Trp plates were set up to select yeast cells, which had been transformed 
with both plasmids. It was therefore expected that colonies would grow on all these 
plates, provided the co-transformation procedures were successful. Colonies were found 
on all the plates except where the yeast cells had been transformed with TsgalO and S3. 
However, few colonies were found on any o f the S3 plates indicating that the 
transformation efficiency o f  the plasmid containing this gene was poor. The 
transformation efficiency o f the plasmid containing the A '6 gene was also reduced, 
although to a lesser extent. These results were probably caused by a low concentration o f  
plasmid being used for the co-transformations.
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In co-transformation with pGBKT7 vector, no colonies were expected to grow on the 
SD/-Ade/-His/-Leu/-Trp plates. However, small numbers o f colonies were found on two 
o f the plates, those with the F3 and S3 genes. It may be possible that the activation 
domain in the prey plasmid was able to activate transcription without a DNA-binding 
domain. However, as this had not been seen with the same plasmids in previous 
experiments and most o f the colonies were very small and red, they were ignored. 
Interactions were expected to take place between the TsgalO protein and the proteins 
transcribed from all four bait plasmids as these results had already been seen in previous 
yeast two-hybrid screens. The expected results were observed for proteins L3 and F3, 
however, few colonies with the A '6 protein and no colonies with S3 grew. Again this 
was likely to be due to a low concentration o f plasmid being used.
The results show a strong interaction between the N-terminal portion o f  the TsgalO 
protein and L3 and probably with S3 (given the small numbers o f colonies overall with 
S3). Weaker interactions also took place between this part o f TsgalO and A '6 and F3. 
The C-terminal portion o f TsgalO showed only a weak interaction with F3 though the 
reaction with S3 was comparable to that o f the N-terminal portion. As such a small 
number o f colonies containing the 3' portion o f TsgalO and F3 grew, it is possible that 
this result is a false positive. Therefore, it is likely that interactions between TsgalO and 
other proteins take place primarily in the N-terminal portion but to a lesser extent may 
also involve the C-terminal portion o f the protein.
This experiment could not be taken any further because o f  lack o f time. However, it is 
currently being repeated and extended by a third year undergraduate project student.
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Testing the two halves of TsgalO interactions using the yeast-mating method;
Transformation of Yeast strains for yeast mating experiment- Transformations were 
carried out for use in a yeast mating. AH 109 was transformed with the two portions o f 
TsgalO and a second yeast strain, Y187, was transformed with the three genes known to 
interact with TsgalO. The transformed AH109 yeast cells were plated onto SD/-Trp 
medium and the transformed Y187 yeast plated onto SD/-Leu medium. As controls, the 
transformed yeast cells were also plated onto SD/-Leu/-Trp medium. The purpose o f the 
controls was to check that the yeast strains were only transformed with one plasmid. The 
results o f the transformations are shown in table 5.2C.
Table 5.2C- Transformation of candidate proteins and the N and C termini of TsgalO into yeast Y187
SD/-Leu SD/-Trp SD/-Leu/-Trp
Y187 + A'6 100 -
Y187+ F3 100 -
Y187 + L3 100 -
Y187 + S3 100 -
AH109 + 5' 300 -
AH109 + 3' 300 -
As expected, no colonies were able to grow on the SD/-Leu/-Trp plates as no yeast cells 
contained both the bait and prey plasmids. Colonies were found on the other selection 
plates indicating that the yeast strains successfully took up the plasmids they were 
transformed with. More colonies from the AH 109 strain grew than from the Y187 strain. 
This may be due higher plasmid concentrations being used to transform this strain. It is 
also possible that the Y187 yeast cells were not as competent as the AH 109 cells.
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PCR of colonies- Samples of the yeast colonies were tested by PCR to check for the 
presence of the two portions of TsgalO (figures 2.19.2A-B). A negative control was 
included with water replacing the DNA. Figure 5.2G shows the results of the PCR 
reactions:
Figure 5.2G- Electrophoresis of PCR product of TsgalO 5’ (A) and 3’ (B) ends expressed in 
yeast colonies. Primers were (YTHM, B) and (C, MR19TC10clone) (25pl PCR product, 5pl 
Loading buffer, 15pl 1Kb ladder. Run at 40v)
All four samples of DNA amplified from the yeast colonies transformed with the 5' 
portion of TsgalO have produced bands of about lOOObp, which corresponds to the size 
of the 5' fragment. Also the correct size DNA was amplified from the samples 
transformed with the 3 ' portion of TsgalO. Small size bands on the gel were produced.
Yeast mating- The yeast strains AH 109 (containing the two portions of TsgalO) and 
Y187 (containing the three genes known to produce proteins which interact with 
TsgalO) were mated to confirm the protein-protein interactions which took place in the 
yeast co-transformations. Control matings were also included. The control bait plasmid 
used was pGBKT7-53 and the control prey plasmid was pGADT7-T. The bait strains 
were also mated with untransformed Y187 cells and the prey strains were mated with 
untransformed AH 109 cells and with pGBKT7 containing the full TsgalO gene. The
A
lKbladd. 5'1 5'2 5'3 5'4
B
1Kb ladder 3T  3'2 +
1018bp
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results o f the yeast matings plated onto SD/-Leu/-Trp plates are shown in table 5.2D. 
This plating demonstrates whether there are two plasmids present in the yeast cells and 
indicates that the mating had worked.
Table 5.2D- The number of colonies grown by Yeast mating of Y187 strains (containing candidate 
 ________interacting proteins) to AH109 strains (containing bait constructs)_____________
Y187
AH109
SD/-Leu/-Trp
A'6 F3 L3 S3 pGADT7-T Y187
5' 500 500 500 500 500 0
3' 500 500 500 500 500 0
TsgalO 500 500 500 500 500 0
pGBKT7-53 0 0 0 0 14 0
AH109 0 23 0 0 0 0
The untransformed AH 109 and Y187 yeast cells when transformed with any other strain 
should have been unable to grow on the -Leu/-Trp plates, as they should have had only 
one o f the LEU2 or TRP1 genes. However, a small number o f colonies were found on 
the plates containing normal AH 109 cells and Y187 cells with F3 (23 colonies). This 
result was probably caused by contamination o f  the plate with yeast cells containing a 
bait plasmid.
All the yeast cells containing the p53  gene and the prey plasmids should have grown on 
the -Leu/-Trp plates. Only those cells with p53  and the T-antigen gene formed colonies 
due to known interaction betweenp53  and T-antigene (provided by Clontech. Kit). 
Colonies were found on all the plates where part or all o f TsgalO was present as well as 
the four proteins with which it interacts. This indicates that the yeast cells successfully 
mated to produce progeny cells containing the bait and prey plasmids.
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The results o f the platings onto SD/-Ad/-His/-Leu/-Trp are shown in table 5.2E. This 
illustrates where an interaction has taken place between the bait and prey plasmids.
The untransformed AH 109 and Y187 yeast cells when mated with any other strain 
should have been unable to grow on the ‘-Leu/-Trp/-Ade/-His’ plates as they should 
have had only one o f the LEU2 or TRP1 genes. Yeast cells containing the p53  gene were 
also unable to produce proteins, which could interact with the products o f A '6 , F3, L3 or 
S3. Therefore, no colonies were formed. The protein products o f p53  and the T-antigen 
gene are known to interact strongly yet only a small number o f  colonies were found.
Table 5.2E- Yeast mating of Y187 strains (containing candidate interacting proteins) to AH109 
____________  (containing bait constructs) plus controls (see text)___________________
Y187
AH109
SD/-Ade/-His/-Leu/-Trp
A'6
(CytC l)
F3
(Odf2)
L3
(FLJ32880)
S3
(FLJ32880)
pGADT7-T Y187
TsgalO-N 0 0 100 100 0 0
TsgalO-C 0 0 80 60 0 0
TsgalO 200 100 100 100 0 0
pGBKT7-53 0 0 0 0 50 0
AH 109 0 0 0 0 0 0
As was expected, strong interactions took place between the full TsgalO protein and the 
proteins known to interact with it. Strong interactions between the N-terminal portion o f  
the protein and L3 and S3 (both FLJ32880) also took place, as well as these proteins and 
the C-terminal portion o f TsgalO. These results show that the interaction between 
FLJ32880 and TsgalO takes place in both N-terminal and C-terminal portions o f  TsgalO. 
Although the full TsgalO protein interacted strongly with CYC1 and ODF2, there were
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no interactions between the separate portions o f TsgalO and these proteins. This 
suggests that interactions with these proteins may require the presence o f the whole 
TsgalO protein.
Table 5.2F- Comparison between the results of yeast mating and transformation using TsgalO and
its N, C termini fragments as bait constructs 
__________  Yeast Cotransformation_______    Yeast Mating ________________
L3 S3 A’6 F3 L3 S3 A’6 F3
TsgalO + - + + + + ++ +
N terminus ++ + (few) + (few) + (few) + + - -
C terminus - + (few) - - + + - -
The most conclusive results were obtained from the yeast mating experiment rather than 
the co-transformation (table 5.2F). In this case both the complete TsgalO protein and its 
two proteins interact with L3 and S3, which makes since these clones both contain the 
FLJ32880 gene.
To test any possibility o f TsgalO interaction (the whole gene or the N and/or C-termini) 
with the other major outer dense fiber protein Odfl, its interaction with Odfl protein 
was assayed (by using pGAD424-Odfl plasmid -containing activating domain- which 
was provided by Prof. Frans Van der Hoorn as a gift) both by yeast mating and co­
transformation. However, no significant interaction was found (data not shown).
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This gene is located on human chromosome l l ( l lq l3 .1 )  (accession no. AK057442, 
BAB71488, NP_689975), mouse chromosome 19 (XM_355133) and rat chromosome 1 
(lq43) (NM _001004278, AY690667, XM_341991). There are eight predicted exons in 
the human and mouse FLJ32880 cDNA sequence, and the protein encoded by the gene 
is predicted (by Ensembl) to be a nuclear protein (84% probability). The sequences o f  
mouse and rat (genes that encodes) FLJ32880 hypothetical protein have only 70% 
homology to human sequence (table 6A). This homology was much greater for TsgalO 
(90-94%), and the low homology for FLJ32880 hypothetical protein seems to be due to 
some gaps in the sequences (even between rat and mouse, see table 6.2.3B). Figure 6A 
shows the alignment o f the human, mouse and rat predicted protein sequences. In human 
the gene is expressed just in round spermatids and testis (TESTI2004122 Clone), and 
transcripts are found in the dbEST in NCBI GenBank, which are restricted to the 
embryo, medulla, heart, thymus and pancreas (1810013N20). Searches using 
UniGene have identified two protein similarities for FLJ32880 hypothetical protein: one 
to an “unconventional myosin-15” (A59266) and one to “PRP3-mouse proline-rich 
protein MP-3” (P05143). Also the mouse FLJ32880 hypothetical protein is shown to 
have 29% similarity to human TBP-associated factor 4 (a TATA box binding protein) 
(NP_003176.1).
A number o f F U 32880  neighbouring genes is listed in table 4.5 using MapViewer, 
BLAST (http://www.ncbi.nlm.nih.gov/entrez) which seem to have a role in the cell 
cycle.
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CLUSTAL W (1.82) multiple sequence alignment (FLJ32880 hypothetical protein)
M ouse --------------------MEMAERAVPELAG— TCHFLSTKSRALGDIQKNR------------CLGSGDSLQS 42
R a t  ----------- MLNTDQLLVRAISERPRKSTEPLVPGTPTGLFSLLSNISPEEQGRLGSGDSLQS 54
Human MGQDTDMLNTYQQLVRTPSVRPGQDVRLQAPGTRTGLLKLLSTVSQDKQGCLGSGDGVPN 60
M ouse QSCQLQRSYSAGQTTKKERKARRRNKKGRGSAEAEDLFSPPSRKPSFPFQWAWESFIIDG 102
R a t  QSCQQQRSYSAGQTTKKERKPRRRNKKGRGSAEAEDLFSSP-RKPSFPFQWAWESFIIDG 113
Human QDLQ-QRPQSSRQTAKKDRKPRGQSKKGQGSEESEDHFPLLPRKPSFPFQWAWESIATDV 119
M ouse QALFQSSSSMAMGHRPLLLPPAAPQCKSRHKSVANLSEDLRACHKMEEQSVGRRHHLGGW 162
R a t  QALLQSGSSVAVGHRSLLFPPAAPQCKTRHKSVANLSEDLRACHKSEVQNLGRRYQPGAW 173
Human RAVLQP-SSPTPGHQALPMPSSFSQRQSRRKSTANLPEAHGCCWKTEAQNLKARQQLGAW 17 8
• k • • k k ★ • ★ ★ . ★ • *  • * . . ★ . ★ ★ ★ ★ ★ ★  * *  * * • ★ • ★ ★
M ouse ANFPLPLSKVESQGLDQPS-FWLSGK--GSGSESEDVLEIEGQNSEEAEKSLSSGELPQL 2 1 9
R a t  ANLSLPLGKAESQGLERPT-FWSTGK— GSGSECEDVSEVEGQNADEAEKSLSTGELPQL 2 3 0
Human GGVSIPTGKGE-LGSEPPSGLQLPGRRPGSGSASDKQVQLQSLGAEEAERGLSSGVLPQR 237
• ★  ★ ★  ★  • ★ ★ ★ ★  • • • •
M ouse PGQSLILEEELISEAMEE EHSDPHKGKGSSVNKGGNSGEKGSEEGELQSHNQGSSS 2 75
R a t  PGQGLTLEEELISEVMEE EEHN--RRKGSSVNKGRNSGEKGSEEGELQSHNQGSSS 2 84
Human PRRGSISEEEQFSEATEEAEEGEHRTPCRRRAGCQRKGQISGEEASDEGEVQGQSQGSSP 297
*  ★ * *  ; * * .  * *  * .  ; . * *  * * * ; . ★ . * * * . * ^ ^ * * * * ^
M ouse SFNSLRKPQKGISRAKDLKGPWDLERLHRQLQEELECGPQKQTWKALRAAVQASARNKKT 335
R a t  NSNSLRKSPKGTSGAKEFKGPWDLERLHRQLQEELESGPQKQTWKALRAAVQASARNRKT 344
Human SFNNLRRRQWRKTRAKELQGPWDLEKLHRQLQRDLDCGPQKLPWKTLRAAFQASKRNGKA 357
M ouse PILGDDESFLSANFPNRTFHKRQEATR----------------------------------------------------------------------- 3 62
R a t  PVTGEEESFLTANFPNRTFHKRQEATRTWALRDTYFFPQSLTSGPHAPPCYLGLPRAPDP 404
Human YASGYDETFVSANLPNRTFHKRQEATR----------------------------------------------------------------------- 384
M ouse---------- -------------------NLLRAWEQQQVKERQQAEVRRAREQQVQQQVARCLAAYTSGGNRGTLAPQR 413
R a t  HGHPPFLTRNLLQAWEQQQLKEKQQAEMRRAREQQVQQQVARCLAAYTPGGNRGTLGPQR 464
Human---------- ------------------- SLLQAWERQRQEERQQAELRRARTQHVQRQVAHCLAAYAPRGSRGPGAAQR 435
M ouse KLEELRRKERORFAEYQAELQGIQHRVOARPFLFQQAMQTNARLTANRRFSQVLSALGVD 473
R a t  KLEELRRKERQRFAEYQAELQGIQHRVQARPFLFQQAIRP---------------------------------------------504
Human KLEELRROERORFAEYOAELOGIOHRVQARPFLFOQAMOANARLTVTRRFSQVLSALGLD 495
★ ★★★★★★ • ★★★★★★★★★★★★★★★★★★★★★★★★★★★★★ • •
M ouse EDQLLAEAGNAESTPRKHRSNRSLRAEMEPSSQSPPKTEPTSSQPGRRPSPTLDPDYSPR 543
R a t   MPGSQQTGASPR-CCQHWEWMRNSCWLRQAMQRASPGNTGATGHLE-------------5 49
Human EEQLLSEAGKVDREGTPRKPRSHRSMGVRMEHSPQRPPRTEPTGSQPDRHYNPSLDPECS 555
Figure 6A- Alignment o f the predicted protein sequences encoded by human, mouse and rat 
FLJ32880 gene. Antibodies were raised against the regions marked in red (section 6.2). The underlined 
sequence is a possible PDZ (post-synaptic density) domain. Asterisks indicate exactly identical amino 
acid, while *:* indicates similar amino acids and Shows the ones with less similarity.
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Table 6A- UniGene comparison of the FLJ32880 sequence between human, mouse and rat.
UniGene
H.sapiens Hs.350671 hypothetical protein FLJ32880
M.musculus Mm.329659 RIKEN cDNA 1810013N20 gene
R.norvegicus Rn.56956 Rattus norvegicus similar to hypothetical protein 
FLJ32880 (LOC361707), mRNA
Species Gene aa%ID nt%ID
H .sapiens FLJ32880
vs. M.musculus 1810013N20Rik 57.5 70.4
vs.
R.norvegicus
LOC361707 57.7 70.4
M .m usculus 1810013N20Rik
vs. H.sapiens FLJ32880 57.5 70.4
vs.
R.norvegicus
LOC361707 84.6 90.5
R .norvegicus LOC361707
vs. H.sapiens FLJ32880 57.7 70.4
vs. M.musculus 1810013N20Rik 84.6 90.5
My nucleotide sequence of the rat FLJ32880 protein was longer than the one, which had 
been found in NCBI GenBank, so my sequence was deposited in the NCBI GenBank 
database as accession number AY690667. Also the ‘HUGO Gene Nomenclature 
Committee’ (http://www.gene.ucl.ac.uk/nomenclature) agreed to name it iTSGA10IP’> 
which stands for the gene coding TSGA10 interacting Protein.
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6.1 S tudying the expression  o f  T sgalO ip  gene tran scrip ts (m R N A ) in 
em bryogenesis
Since TsgalO expression is found during developmental stages of embryogenesis as 
well as developmental stages of spermatogenesis, investigation into the expression of 
the gene that encodes Tsga 10-interacting protein (TsgalOip), may be interesting. It may 
indicate a role for TsgalO/TsgalOip in all actively dividing and differentiating cells. For 
RT-PCR using cDNA from various developmental stages of mouse embryos, a pair of 
mouse homologue TsgalOip gene-specific forward (FLJ32880F) and reverse 
(FLJ32880R) primers in different exons were used (9.6-kb genomic and 475-bp cDNA 
size). The result shows the presence of its transcript in embryonic developmental stages 
from 14 dpc onwards (figure 6B). This may indicate a role in embryogenesis.
M E12 E13 E14 E15 E16 E17 E18 -
1636 bp 
1018 bp
517 bp
Figure 6B- Electrophoresis o f  RT-PCR showing TsgalOip gene expression in developmental stages o f  
mouse embryogenesis (E12 -E 1 8 ). PCR products are seen in lanes E14-E18. Bands in lanes E12 and E13 
are probably the result o f non-specific amplification. The control lane (-) has water instead o f  DNA. 
Lane M is 100Kb ladder.
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6.2 Raising antibody against mouse homologue TsgalOip protein, 
and studying its localisation in sperm by immunofluorescence
Bioinformatic analysis of TsgalOip protein to target peptides for raising antibody-
In the case o f the TsgalOip protein, it was hard to find good sequences that were 
homologous in all three species (human, rat and mice). However, the following 
sequences were selected that were completely identical in mouse and rat:
1) Amino acid sequence 56-79 (N-terminus): NH2-RRNKKGRGSAEAEDL- 
COOH- this region is very good in terms o f antigenicity. The hydrophilicity index as is 
the probability o f a surface location.
2) Amino acid sequence 245-260 (Middle): NH2-KGSSVNKGRNSGEKG- 
COOH - is comparable to the first peptide; it also has a good hydrophilicity and 
antigenic index.
3) Amino acid sequence 679-691 (C-terminus): NH2-KLEELRRKERQRFAE- 
COOH- is also a very good choice in terms o f hydrophilicity and surface probability.
The sequences those were high in as many parameters as possible were selected. 
In addition, these sequences were checked for specificity to the TsgalOip protein using 
BLAST sequence homology. No significant homology to other proteins was seen.
6.2.1 Raising polyclonal antibodies against TsgalOip selected 
peptides and evaluation of relative amounts by ELISA
Two immunized rabbits generated antibodies that recognized the TsgalOip protein 
candidate peptides EP040254, EP040255 and EP040256 based on the protocol 
described in materials and methods. Titration o f  these antibodies was determined by
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ELISA assay using the peptide as antigen. As shown in the following graphs (see 
figures 6C (A-B)) the immunization programs were properly done with a good level of 
antibodies consistent with the results from the results obtained subsequently for protein 
assays (immunocytochemistry and immunostaining).
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Figure 6C(A)- ELISA result for TsgalOip protein rabbit antisera against the N-terminus peptide (continuous line) 
and Carrier (discontinuous). PPI= Pre-immune serum, GP 1/2 = final bleeding antibody
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Figure 6C(B)- ELISA result for TsgalOip protein rabbit antisera against the C-terminus peptide; Peptide (continuous 
line) and Carrier (discontinuous). PPI= Pre-immune serum, GP 1/2 = final bleeding antibody
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6.2.2 Studying the location of TsgalOip protein in sperm
The antibodies described above were used to analyse the localisation o f the TsgalOip 
protein pattern in mature sperm by immunofluorescence. Epididymal mouse and bovine 
sperm were prefixed (in 4%  PFA) and smeared on microscope slides. Hybridisation 
with the antibodies against FLJ32880 hypothetical protein demonstrated that the protein 
is localized mainly to the principal piece o f sperm tails (figures 6D and 6E) in a manner 
similar to that o f the N-terminus o f  TsgalO. This result suggested that the TsgalOip 
protein could be a component o f the fibrous sheath (FS).
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TsgalO ip
protein
%
TsgalO ip
p rotein
Figure 6D- Indirect immunofluorescence analyses of TsgalOip in epididymal mouse sperm.
Epididymal spermatozoa were fixed on poly-L-lysine coated glass cover slips and incubated with anti-TsgalOip 
antiserum followed by a secondary antibody conjugated to FITC. The principal piece of sperm tails, which is distal to 
the midpiece, strongly fluoresced (green). Sperm heads show very weak fluorescence. The control (left panel) are 
seen as blue areas due to DAPI staining.
Figure 6E- Indirect immunofluorescence analyses o f TsgalOip in epididymal Bovine sperm.
Epididymal spermatozoa were fixed on poly-L-lysine coated glass slides and incubated with anti-TsgalOip antiserum 
followed by a secondary antibody conjugated to FITC. The principal piece of sperm tails fluoresced more strongly 
than the midpiece, although the midpiece does seem to be fluorescing to some degree. The control (left panel) are 
seen as blue areas due to DAPI staining.
T sgalO ip
p rotein
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6.2.3 D iscussing the function o f  TsgalOip
We found an interaction between TsgalO and TsgalOip proteins by yeast two hybrid 
assays. To show in vitro protein interaction between TsgalOip and TsgalO proteins, 
immunoprecipitation by protein G agarose beads and analysis by SDS-PAGE of the 
precipitants were used several times. However, for unknown reasons it failed and 
remains to be answer in the future. However, in vivo information and TsgalOip 
localization in principal piece of sperm tail led to the renaming of FLJ32880 
hypothetical protein to TsgalO interacting protein (TsgalOip). UniGene is not very 
helpful when it comes to predicting the role of this protein through its similarity to other 
proteins. UniGene predicts human TSGA10IP has 27% similarity to a mouse proline- 
rich protein (PRP3; MP-3, sp: P05143) as well as to a human unconventional myosin 
15. Also mouse TsgalOip is shown to have 29% similarity to human TBP-associated 
factor 4 (a TATA box binding protein) (NP_003176.1). By searching for TsgalOip 
homology by Pfam, VP4 and FliS are come up as candidate proteins, which may have 
similar motif to it (see table 6B). VP4 is a viral protease (Jagadish et al., 1988). The 
large RNA segment of bimaviruses codes for a polyprotein (N-VP2-VP4-VP3-C). FliS 
is a flagellar protein encoded by the FliD operon and is transcribed in conjunction with 
FliD and FliT although no function is known for it.
Table 6B- TsgalOip protein Pfam study 
(http://www.sanger.ac.uk/cgi-bin/Pfam/). fs = fragment domain
Domain Start
B im a V P4
F liS
123
413
137 0.49
426 0.64
fs
fs
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Although it seems that TsgalOip has eight exons in mouse and rat, it is not highly 
conserved (see table 6C). Similarly the TSGA10IP amino acid sequence is not as well 
conserved as TSGA10 in mouse, rat and human.
Table 6 C- TsgalOip exon/intron boundaries using rat genome browser ('http://genome.ucsc.edu)
Rat 
TsgalOip 
NM 001004278. 
AY690667
Mouse
TsgalOip
XM_355133
1 5191551-5191515
2 5191485 -5191356
3 5 1 9 1 304-5191265
4 5190190-5190045
5 5 1 8 9 9 6 2 -5 1 8 9 2 5 9 51 8 9 9 6 2 -5 1 8 9 2 5 9
6 5 1 8 9 0 8 5 -5 1 8 8 9 3 8 51 8 9 0 8 5 -5 1 8 8 9 3 8
7 5 1 8 3 5 9 2 -5 1 8 3 3 0 6
8 5 1 8 3 4 7 6 -5 1 8 3 3 0 6
9 5 1 8 0 0 3 6 -5 1 7 9 0 3 7 51800 3 6 -5 1 7 9 0 3 7
10 51 7 9 7 5 0 -5 1 7 9 6 3 2 51797 5 0 -5 1 7 9 6 3 2
11 5179220-5179070 5179220-5179070
It is likely that TsgalOip also plays a role in the movement o f the sperm tail.
TSGA10 and TsgalOip (FLJ32880 hypothetical) proteins show the following 
similarities:
- Both o f them (or at least a part o f them) are localized in the principal piece 
and head o f sperm (fibrous sheath proteins).
- TsgalO protein has similarities to myosin heavy chain tail and ERM (Ezrin/ 
radixin/merlin that contains a polyproline region between the helical and C-
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terminal domains). Similarly, TsgalOip has a similarity (27% predicted by 
UniGene) to an unconventional myosin 15. This reflects the presence o f a coiled 
coil domain in TsgalOip. Also TsgalOip is similar (27% predicted by UniGene) 
to a mouse proline-rich protein (MP-3 which is aligned with human TSGA10IP). 
A fibrous sheath specific isoform o f glyceraldehyde 3-phosphate dehydrogenase 
(GAPD-S) is reported to have a proline rich amino acid domain as well, which is 
important and critical for sperm motility (Bunch et al., 1998). More interestingly 
and recently, a proline-rich region is detected for ‘enkurin’ protein (a novel 
calmodulin and TRPC - transient receptor potential-canonical- cation channel 
binding protein in sperm) that contains predicted ligand sequences for SH3 
domain proteins, including the SH3 domain o f the p85 regulatory subunit o f 1- 
phosphatidylinositol-3-kinase (PI3-K) (Sutton et al., 2004).
- Both o f these proteins are expressed in glia cell lines derived from 
astrocytoma.
- Both o f these proteins are expressed during embryogenesis and astrocytes (I 
showed by RT-PCR and ICC, see sections 6.1).
The pattern o f co-expression and co-localisation o f these two structural proteins suggest 
that they may share functions other than in the sperm tail. One potential pathway could 
be cell cycle regulation and mitosis (since TsgalO and TsgalOip are expressed in some 
tumours). Another candidate pathway may be cell differentiation (because o f their 
expression during embryogenesis -organogenesis- and development). Expression o f  
TsgalO/TsgalOip in glia cells indicates their role in neurogenesis and synaptogenesis. 
Of course, neurogenesis and neuroproliferation require both cell division and
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differentiation. These proteins are also likely to be present in the structure o f cilia and 
play a dual role (structural and scaffolding) in it.
Structural proteins in sperm (such as odf2) can have some particular functions as well. 
Consistent with this description, we found interactions between TSGA10IP/ODF2 and 
TSGA10, all o f them as structural proteins as well as roles in cell division.
Genes in the vicinity o f  TSGAlO/TsgalO and TSGA10IP/TsgalOip have almost similar 
functions, although in different chromosomes.
The following proteins o f  known function are near to the TsgalOip gene (mapped on 
llq l3 .1  in human and lq43 in rat): mitogen-activated protein kinase kinase kinase 3, 
basophilic leukemia expressed protein BLES03, squamous cell carcinoma antigen, 
cation chanel, kinesin light chain 2 orthologous, breast cancer metastatic suppressor 1, 
Solute carrier nucleotide transport, oral cancer overexpressed protein 2, and a protein 
similar to sperm ion channel are the proteins encoded by genes close to 
TsgalOip/TSGAlOIP on chromosome 11 (table 6D).
TsgalOip/TSGAlOIP is located on or very close to the D11S913 locus o f  human 1 lq l3 
-candidate region for multiple endocrine neoplasia, type I (MEN1)- (Williams et al., 
1997). Also it may be a member o f neighboring cluster genes that bind to TATA-box 
and regulate transcription complex. It may be consistent with the presence o f potential 
transcription factor binding site in 2 Kb upstream o f TSGAlO/TsgalO which does not 
need TATA box for transcription. Transcriptional corepressor DRAP1 (encoded by a 
gene located within 25 Kb o f TsgalOip) has a very specific role in regulation o f nodal 
activity during embryogenesis (Iratni et al., 2002). While TsgalOip is 30% identical to a 
TATA-binding protein, the DRAP1 interacts with DR1 that in turn interacts with
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TATA-binding protein. This could be reinforced by the finding (RT-PCR) (figure 6.1) 
o f TsgalOip expression during mouse embryogenesis.
Table 6D- TSGA10IP (mapped on llq!3 .1  in human and lq43 in rat) and genes within 500 Kb
Name
Location 
Human, 
Rat, Mouse
Distance
Role /  Expression
Squamous cell carcinoma 
Antigen recognized by T- 
cell 1 (SART1)
H llq l3 .1  
R lq43  
M 19qA
2 Kb Squamous cell carcinoma new tumour 
marker (Cromer et al., 2004)
DR1-associated protein 1 
(DRAP1) (Negative 
cofactor 2-alpha)
H l lq l3  
R lq43  
M 19qA
25 kb
Facilitates the maintenance of a 
differentiated state by silencing specific 
genes, a corepressor of the transcription that 
interacts with DR1. DR1 interacts with 
TATA-binding protein
Basophilic leukemia 
(BLES03)
H l lq l3  
R lq43  
M 19qA
30 Kb
Cation channel, sperm 
associated 1
H llq l2 .1  
R lq43  
M 19qA
55 Kb Required for evoked Ca2+ entry and control 
of flagellar function in sperm (Carlson et al., 
2003)
Mitogen-activated protein 
kinase kinase kinase 11
H llq l3 .1 -  
llq l3 .3  
R lq43  
M 19qA
300 Kb
Required for cell proliferation, both mitogen 
and cytokine activation of R-Raf, JNK 
(MAPK8), ERK (MAPK3), and 
p38(MAPK14). Phosphorylate Rbl and 
stimulate kRas2 (Chadee and Kyriakis, 2004)
Kinesin light chain 2 
ortholog
H llq l3 .1  
R lq43  
M 19qA
300 Kb Kinesin structure, target of 14-3-3 (a key 
regulator in cell signaling pathway mediated 
by protein phosphorylation (Ichimura et al., 
2002)
RAB1B H llq l3  
R lq43  
M 19qA
300 Kb Member RAS oncogene family
Breast cancer metastatic 
suppressor 1
H llq l3 -  
llq l3 .2  
R lq43  
M 19qA
400 Kb Human breast carcinoma metastasis 
suppressor gene
Solute carrier nucleotide 
transport H llq !3
400 Kb
Induced by immediate-early response (IER) 
genes following serum or growth factor 
stimulation of cells, within 80 kb of the 
D11S913 locus of human l lq l3  -candidate 
region for multiple endocrine neoplasia, type 
I (MEN1) (Williams et al., 1997)
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What could be the function of TSGA10?
The experimental data presented in the previous results chapters has indicated several 
functions for the TsgalO protein. In this section I will examine further evidence for 
these possible functions.
7.1 The expression pattern of TsgalO
My experiments demonstrated the expression o f the TsgalO gene and its encoded 
protein in the testis where it was localised in the sperm tail. There was also expression 
in developmental stages o f mouse embryos, some cancerous cells and 
A Virtual Northern search among EST data from libraries and SAGE data 
(http://cgap.nci.nih.gov) revealed that the TsgalO gene is predominantly expressed in 
testis but possibly also at very low levels in pancreatic islet, skin, prostate, muscle, lung 
and brain. Microarray expression data deposited in genome browser 
(http://genome.ucsc.edu, GNF Expression Atlas 2 Data from U133A and GNF1H 
Chips) show a very high expression level for TSGA10 in testis, indeed it is one o f the 
most abundant transcripts.
However, UniGene also shows that TsgalO transcripts have been isolated from many 
tissues (including uterus, melanocyte, testis, brain, kidney, liver, spleen, medulla, 
primary Lung Epithelial Cells and placenta as well as some tumours including germ cell 
tumor, leiomyosarcoma, glioblastoma, acute myelogenous leukemia, well-differentiated 
endometrial adenocarcinoma, and poorly differentiated adenocarcinoma with signet ring 
cell features). The pattern o f the gene expression in mouse, (UniGene Cluster Mm 
332756), shows the sources o f cDNAs from some normal tissues including cerebellum,
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bone marrow, thyroid, brain, testis, E9.5 whole embryo, round spermatids, pooled from 
multiple mice, cecum, eyeball, 18-day preleptotene spermatocytes as well as 
hematopoietic Stem Cell (Lin-/c-Kit-/Sca-l) line. In rat, (UniGene Cluster Rn .30052,), 
it is originated from testis. The gene is highly conserved in mammalian species, and a 
search using PBLAST with the TsgalO predicted protein sequence identifies the mud 
gene in Drosophila Melanogaster, which is involved in the control o f neuroblast 
proliferation and encodes a coiled-coil protein with 21% homology to TSGA10.
7.2 Potential transcriptional control regions in TsgalO
Areas o f homology upstream of the first exon may indicate areas that are important 
recognition sites for transcription factors. The Human TSGA10 start position is known 
by 5’ RACE. A Computer search for transcription factor binding sites in TSGA10 (using 
the program TESS at http://searchlauncher.bcm.tmc.edu/seq-search/gene-search.html) 
showed a match with myocyte-specific enhancer factor 2 (MEF2), TTTTAAATAG at 
position -3 2  nucleotide upstream o f human TSGA10. Also the search showed a region 
at -129 to -159  that is present in many sequences and can be a potential promoter site. 
There is neither conventional TATA nor CCAAT box in the expected positions (-30 to 
-70). However, a CAAT/GT box (named epidermal growth factor response element 
‘EGFRE’ in the mouse lactoferrin gene) is placed at -21 . It activates GKLF in human 
endometrial carcinoma (RL95-2) transfected cells. Also, gut-enriched Krueppel-like 
factor (GKLF) (a zinc finger domain transcription factor) binds to CAAT/GT box o f  
mouse lactoferrin gene (Shi et a l., 1999). It shows a series o f temporal changes during 
embryogenesis and binds GC/GT-rich sequences. Potential binding sites within 300 bp
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of the 5’ flanking region o f short TSGA10 transcript found by TESS 
(http://searchlauncher.bcm. tmc.edu/seq-search/gene-search.html) show five binding 
sequences for SRY, PU.I, DEF, STE12 and HiNF-A transcription factors. These 
transcription factors mainly mediate in sex differentiation and spermatogenesis, cell 
cycle, division or immune cell responses. SRY, C/EBPbeta and EBP were shown by 
TESS in 338 bp 5 ’ upstream o f mouse TsgalO (AF530050) transcript as well. A Search 
o f the 2 kb upstream genomic sequence o f  different TsgalO transcripts for transcription 
factor binding sites using TESS and Matinspector V2.2 
(http://www.gsf.de/biodv/matinspector.html) revealed multiple putative transcription 
factor binding sites that were homologous to the known consensus-sequence motifs, 
including more than 20  for octamer-binding factor 1 (which plays an important role in 
germ cell differentiation as well as embryogenesis, embryonic brain development, and 
oncogenesis), 6 for ‘sex hormone receptor’, 6 for neurogenin 1/3 (involved in 
neurogenesis)’, 6 for ‘tumour suppressor p53 and wilm’s’, and 3 for ‘SOX5’ binding 
sites. Putative transcription factor binding sites in the upstream promoter region o f the 
mouse protein kinase C (PKC) gene suggest its involvement in the same processes as 
TSGA10, including spermatogenesis (SRY), embryogenesis (GATA), development 
(MYOD, GATA), brain generation (RORA), oxidative environment (NRF) and 
oncogenesis (p53, AML, NFa:B) (Suh et al., 2003). A similar pattern o f potential 
transcription factor binding sites was found in the 2 kb upstream o f the TSGA10 gene 
including GATA, GAGA, SOX, and p53.
Transcription factor binding sites with high homology are summarized in tables 7.2A 
and 7.2B. The diversity o f the regulatory elements in TsgalO, if  functional, may reflect
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the multitude of pathways to which TsgalO contributes. A description of AP-2, SP1, 
C/EBPbeta, MZF-1 and GKLF transcription factors which are closer and frequent in the 
upstream of both TsgalO transcripts, are discussed below and description of some other 
predicted factors is in the appendix. AP-2 is an activator protein (also known as AP- 
2alpha; activator protein 2; Ker-1; AP-2A; AP2; KER1), which its C-terminal part 
interacts with the bHLH-ZIP (helix-loop-helix-ZIP) domain of c-Myc, but not Mad 
(mitotic arrest deficient). Also it is an activator that controls keratinocyte-specific gene 
expression, and negatively regulates trans-activation exerted by c-Myc with high-level 
expression causes "self-interference" (e. g. in N-ras transformed cells). It appears to be
Table 7.2A- Summarized result o f 2 kb upstream genomic sequence o f short TsgalO (AF530050)
transcript (sites 38180468-38178468 o f  mouse genome) for transcription factor binding sites (using the 
program TESS at http://searchlauncher.bcm.tmc.edu/seq-search/gene-search.html)
F a c to r B e a S n s L en S g f l u e n c e
T01806 d53 -1805 N 10 TGACATGCCT
T01591 P -1755 N 9 ACCAACCAG
T00644 Oct-1A. 1B. 1C. 2.1. 2.3. 2.4 -1737 N, R 10 ATTCAAATGA
T00702 PU.1 -1634 R 10 CAGGAACTGA
T01806 d53 -1519 N 10 AGACTTGCCT
T00395 Hb -1468 R 10 TTTTTTTTTG
T01806 d53 -1124 R, N 10 AGACATGTCT
T00395 Hb -1040 N 10 GAATAAAAAA
T00196 Dl -865 N 11 TGGGAAAAACA
T01427 d300 -709 R 14 GGCAAACTCCCTGA
T02637 RAV1 -647 R 12 GCCTCAGGTGTG
T01481 Pbx-1a -584 R 9 TTGATTGGT
T00196 Dl -573 R 11 TGGTTTTCTGT
00000 VSPADS C -562 N 9 AGTGGTCTC
T00063 Bed -465 N, R 8 GGGATTAT
T00273 Evi-1 -394 N 11 TGAT TAGATAG
T00996 SRY -338 R 12 TCTTTTGTTTTG
T00996 SRY -333 R 12 TGTTTTGTTTTT
T00794 TBP. TFIID -326 R 10 TTTTTAAAGA
T00581 C/EBPbeta -80 N 13 GTTT TCAAAACTT
N: Normal, R: Reverse, Black: highest match, Blue: high match, Red: lowest match
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Table 7.2B- Summarized result of ~2 kb upstream genomic sequence of long TsgalO (AK030254, NM_207228) 
transcripts (sites 38190413-38188413 o f mouse genome) for transcription factor binding sites (using TESS at 
http://searchlauncher.bcm.tmc.edu/seq-search/gene-search.html). [GKLF: gut-enriched Krueppel-like factor]
Factor Beq Sns Len Sequence
T 0 1156 AP-1 -1866 R 11 TGTGAGTCACC
T00321 GCN4 -1864 R 10 TGAGTCACCT
T02450 GKLF -1753 R 14 CCCTTTTCCTTTTT
T02450 GKLF -1752 R 14 CCTTTTCCTTTTTC
T02450 GKLF -1739 R 14 CCTTTCCTTTCCTT
T02450 GKLF -1734 R 14 CCTTTCCTTTCCTT
T02450 GKLF -1729 R 14 CCTTTCCTTTCCTT
T02450 GKLF -1724 R 14 CCTTTCCTTTCCTT
T02450 GKLF -1719 R 14 CCTTTCCTTTCCTT
T02450 GKLF -1714 R 14 CCTTTCCTTCCCTT
T02450 GKLF -1705 R 14 CCCTTCCCTTTCCT
T02450 GKLF -1700 R 14 CCCTTTCCTTTTTC
T02450 GKLF -1671 R 14 CCTCCCTTTCCTTT
T02450 GKLF -1668 R 14 CCCTTTCCTTTTTC
T02450 GKLF -1667 R 14 CCTTTCCTTTTTCC
T00759 S d1 -1467 R 12 AGACCCCTCCCC
T00505 MEF-2 -1452 N 11 TAAAAATGACA
T01614 Skn-1 -1428 R 12 CTAATGATAATG
T00267 GATA-1 -1391 R 10 TTTTATCAGT
T01157 Oct-1 -1342 R 14 GAAATGCAAATTAT
T00644 Oct-1 A. 1B. 1C. 2.1. 2.3, 2.4 -1339 N, R 10 ATGCAAATTA
T01614 Skn-1 -1299 N 12 CATCATCAT GAA
T00120 CF2-II -1016 R 9 TACATATAC
T00107 C /EB Pabha -949 N 9 ATTTGGAAA
T00772 STE12 -826 N 7 ATGAAAC
T00529 MZF-1 -815 N 13 AGGTGAGGGGGAA
T00755 S d 1 -732 R 12 AAGAGGGGGGAT
T02637 RAV1 -701 N 12 AAACAACAGAAA
T00456 Kr -620 N 10 ACAGGGTTAA
T00725 REB1 -193 N 8 TCACCCGG
T01467 deltaEFI -149 N 11 CCCCACCTGAA
T00035 AP-2 -59 N 11 CGCCTGGGGCT
TsgalO (NM_207228)
T00561 NF-muE1 41 R 12 TCGGCCATCTCG
T00755 Sd 1 140 N 12 GAGGCGGGCCGG
T00755 Sd 1 190 R 12 GAGAGGGCGTGT
N: Normal, R: Reverse, Black: highest match, Blue: high match, Red: lowest match
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involved in gene responses to PKA- and PKC-mediated signals (Imagawa et al. 1987). 
Spl has 3 zinc finger motifs and interacts with BPV-1, bovine papilloma virus type 1. It 
has some role in interaction o f nuclear factors with the upstream region o f the alpha- 
subunit gene o f muscle acetylcholine receptor and in muscle differentiation and 
denervation (Piette et al., 1989). Interestingly, Spl activates transcription without 
enhancing DNA-binding activity o f the TATA box factor (Schmidt et. al, 1989). 
C/EBPbeta (also known as IL-6DBP; NF-M; NF-IL6; LAP1; LAP; H-APF-2; CRP2; 
AGP/EBP; ANF-2) has very relaxed DNA-binding specificity, may even bind to AP-1 
sites and may heterodimerize with either c-Fos or c-Jun (Hsu et al., 1994). Its leucine 
zipper motif may also interact with the Rel-domain o f  NF-kappaBl (p50) thus causing 
synergistic effects o f both factors (LeClair et al., 1992; Matsusaka et al., 1993). It is a 
transcriptional activator in vitro and in vivo (Akira et al., 1990) which is involved in 
acute phase reactions, inflammation and haematopoiesis and induced by IL-1, IL-6 and 
LPS (bacterial lypopolysacharides). It is a master regulator o f the acute-phase response 
and regulates constitutive as well as IL-1-induced transcription o f IL-6 at the IL-6 
promoter. It acts antagonistically to the p53 tumor suppressor (Margulies and Seghal, 
1993) and its phosphorylation by p21(ras)-dependent MAP kinases enhances 
transcriptional activation (Nakajima et al., 1993).
MZF-1: it has a glycine-rich structural feature with myeloid cell specificity and a 
negative regulatory effect on CD34 and c-myb (Perrotti et al., 1995). It is possibly 
involved in hematopoietic development (Hromas et al., 1991).
GKLF: gut-enriched Kruppel-like factor (GKLF) amino acid sequence contains three 
tandem zinc fingers that are related to members o f  the Kruppel family o f transcription
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factors. GKLF is localized to the cell nucleus and is found in high levels in growth- 
arrested cells and is nearly undetectable in cells that are in the exponential phase of 
proliferation. In the mouse, GKLF expression is most abundant in the colon, followed 
by the testis, lung, and small intestine. GKLF is enriched in epithelial cells located in 
the middle to upper crypt region o f the colonic mucosa. Taken together, GKLF is 
potentially a negative regulator o f cell growth in tissues such as the gut mucosa and 
testis, where cell proliferation is intimately coupled to growth arrest and differentiation.
The range o f potential transcription factor binding sites in TsgalO indicates sites that 
would be consistent with functions o f the gene in spermatogenesis or cell cycle. For 
example, the SRY/SOX binding sites may be important in male-specific expression and 
C/EBPbeta in expression in the testis during spermatogenesis, and also in mature sperm. 
Sites for GATA, p53, SOX, NFkB and GKLF may be significant in terms o f the 
possible role o f  TsgalO in cell division for example in neural crest (SOX) and 
embryogenesis (GKLF).
The experiment to test which transcription factor-binding sites may actually be used 
would be to locate the promoter o f the gene and assess the effect o f various 
transcription factors on it. For this purpose, a construct o f the promoter with a luciferase 
reporter gene would be transfected into a cell line to achieve a base line expression 
level. Then co-expression with target transcription factors that may regulate the gene 
and its comparison with the base line can indicate which transcription factor up-regulate 
the promoters. Mutagenesis assays o f the promoter by disruption o f transcription factor 
recognition sites can also give good information.
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7.3 Considering the function of TsgalO protein by studying motifs 
in the protein sequence, and homologies to other proteins
The predicted protein sequence o f human TSGA10 protein (Accession number 
AAH28366) consists o f 698 amino acids compared to 689 amino acids in the mouse 
TsgalO protein (Accession number AAN01136). Protein sequences in databases were 
searched using the PBLAST program at NCBI. As I described previously, there are two 
long cDNA sequences in the database for the gene, TsgalO (Accession no. AF530050, 
AK030254) and a predicted sequence similar to mouse cp431 (Accession no. 
XM_136734). Comparison o f these two long 5’UTRs (consisting o f more than 620 
nucleotides) suggests 4 nucleotides less in the 5 ’UTR o f TsgalO (AF530050), which 
results in an ORF o f 202-amino acids more in its predicted protein. A search using 
TsgalO showed 92% identity to TSGA10 and 95% homology to the predicted protein 
translated from the Rattus norvegicus cDNA named cp431. Interestingly, the PBLAST 
search also showed 95% homology o f TsgalO to an unnamed protein product derived 
from Macaca fascicularis testis (Accession no.: BAB84031) but with 237 amino acids 
less due to possible alternative splicing in the protein (aa #267-688). It also gave a 51% 
identity over the whole length o f  a protein derived from Xenopus laevis embryo in stage 
17/19 (Accession no.: AAH48022) and a 40% similarity to a human protein o f unknown 
function (KIAA0635) predicted from a brain cDNA sequence (Accession no. 
AAH62951). In searching the database (using PBLAST) with TsgalO protein sequence, 
putative conserved domains named “Smc (Structural Maintenance Chromosome, 
SMC)” and “MAD (mitotic arrest deficient)” have been detected (figure 7.3A, 7.3B). 
TsgalO and both the Smc and MAD domains can be considered as homologues o f the
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“Myosin class II heavy chain tail” domain (Cytoskeleton). The myosin molecule is a 
multi-subunit complex made up o f two heavy chains and four light chains. It is a 
fundamental contractile protein found in all eukaryote cell types. The members o f the 
myosin protein family consist o f the coiled-coil myosin heavy chain tail region. Many 
coiled-coil proteins showed about 20% homology to TsgalO.
Different parts o f homologous proteins to SMC have conserved similarity in leucin and 
glutamate (E) sites. All SMC proteins have a bipartite ATPase domain (de Jager et al., 
2004). Interestingly TsgalO has a ‘bipartite nuclear localization signal’ motif (table 
7.3A) in amino acids 113-127 (RRXXXXXXXXXXRXK) (Munoz-Fontela et al.,
2003), which is conserved highly in proteins involved in chromosome segregation via 
sister chromatid cohesion mechanism, Jones and Sgouros, 2001).
At least a “Leucine zipper” like domain seems to be conserved in TsgalO protein 
as well as in other proteins. Since the helix-loop-helix (HLH) domain o f myosin tail, is 
the most important part o f myosin to be dimerized and for protein interaction, TsgalO 
protein as a structural protein may interact via it with other proteins. Also, TsgalO 
leucine zipper motif (TsgalO spiral motif in figure 7.3E) may also interact with the 
Odf2 protein by dimerization (making a dimerized HLH) via its leucine zipper motif, 
then resulting in a synergistic effect on spindle formation and centrosome stimulation. 
Interestingly, Ensembl (by Markov CLustering) shows a cluster gene (for TSGA10) 
coding for a centrosomal protein named cepl35. Since leucine zippers act as 
dimerization motifs in the bZIP family o f  transcription factors, as does the myosin tail 
protein it will be interesting to investigate the possibility o f TsgalO self-interaction in 
vivo.
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Figure 7.3A- Putative conserved domains comparison in mouse TsgalO (cp431) by PBLAST 
(http://www.ncbi.nlm.nih.gov/Structure/cdd)
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5 6 0
7 7 0
TsgalO: 
MAD :
1 7 6
1 3 2
EKEMKSLARKAMDTESELGRQKAENNSLRLLYENTEKDLSDTQRHLAKKKYELQL-TQEK
LTDLKQLEESEAKAESEAAEAKERSKQLEQKLDKLSLRTDAQSKKLQKEKEDQQADAKES
2 3 4
1 9 1
TsgalO: 
MAD :
2 3 5
1 9 2
IMCLDEKIDNFTRQNIAQREEISILGATLNDLAKEKECLQACLDKKSENIASLGESLAMK
ISKLKNQLSEMQLRAMNSETELKLLEKELEDLKEQLEELQKELAEAEQKLQSLKASQAER
2 9 4
2 5 1
TsgalO: 
MAD :
2 9 5
2 5 2
EKTISGMKNIIAEMEQASRQSTEALIMCEQ----- DISRMRRQLDETNDELGQIARERDI
ADNEQLIKHLEEELKLYEQDAEWKSMKEQLQRLPELERELEQLREENKKLKSSHENNEL
3 4 9
3 1 1
TsgalO: 
MAD :
3 5 0
3 1 2
LAHENDNLQ----------- EQFAKVKQENQALSKKLN--------------------DTHNEL
LKEELEDLQRKLERAEKMRSKLADLELENEKLEAELKSWENLLQNIGLNLRTPEDISRRI
3 8 2
3 7 1
TsgalO: 
MAD :
3 8 3
3 7 2
SDIKQKVQDTNLEVNKLKNILKSEESENRQIMEQLRKANEDAENWENKARQTEAENNTLK 
VELQKEELILTEKNGSLT SDAKNLKTANQQLQLERQQALAEILELKKKLETLKRLNRRLQ
4 4 2
4 3 1
TsgalO: 
MAD :
4 4 3
4 3 2
LELITAEAEGNRLKEKVDALNREVEQHLNAERSYKSQIATLHKSLVKMEEELQKVQFEKV
RQLSLLTKERDLLRAILDSYDSE-NTETEASNQLTRRLEEAEDMVQLVDSYKAKMEAQLK
5 0 2
4 9 0
TsgalO: 
MAD :
5 0 3
4 9 1
SALADLSSTRELCIKLDSSKELLNRQLVAKDQE---------IEMMENELDSARSEIELLR
ELEDELGGQKQRAETLEKELKLLKEQLSSNEREALNALRLKNESLERERDRLRSEKALLE
5 5 4
5 5 0
T s g a l O :  5 5 5  SQM 5 5 7
MAD : 5 5 1  MKL 5 5 3
Figure 7.3B- Top: alignment o f  TsgalO sequence to its homologue domain Smc (consensus) 
sequence, possible leucine zipper domain (in red) and hypothetical motif (-X-Ser/Thr-X-Val/Leu-COOH 
which) may be involved in TsgalO cleavage. Bottom: alignment o f TsgalO sequence to its
homologue domain MAD (consensus) sequence.
The coiled-coil domain and some other known motifs among the TsgalO protein 
sequence are listed in table 7.3A. The coiled-coil is composed of the tail from two 
molecules of myosin. These can then assemble into the macromolecular thick filament
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and provide the structural backbone o f it. Figure 7.3C shows a possible 3-dimensional 
structure o f  the TSGA10 protein, predicted by the genome browser database (at 
http://genome.ucsc.edu/), based on the significant homology o f TSGA10 to myosin II 
heavy chain (fused to alpha-actinin 3). TsgalO self-interaction (such as myosin tail 
dimerisation), can also be tested via making TsgalO bait and prey constructs in a yeast 
two hybrid assay.
TsgalO protein shows (see figure 7.3D) a region with low compositional complexity 
(RKMMRNRSKSPRRPSPTSRAAN) and another region o f scattered coiled-coils along 
all the rest o f the amino acid sequence. Coiled-coil sequences are often involved in 
protein-protein interactions (Beck and Brodsky 1998; Lupas 1997).
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m ‘ m .
Figure 7.3C- Predicted Comparative 3D Structure of TSGA10 by ModBase (http://genome.ucsc.edu 
/cgi-bin/hgGene?org=Human&hgg_gene=BC028366&hgg_chrom=none&hgsid=37747339&db=hgl7). 
A) Front view B) Top view C) Side view
Region with low complexity
(with similarity to some domains
Coiled-coil sequence regions
(with similarity to some domains 
listed in tables 7-3B  ^7-3C
Figure 7.3D- shows Domain within TsgalO (cp431) amino acid sequence. Different regions (in
different colors) show different domains.
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Table 7.3A- Occurrence and position of known conserved motifs and domains in mouse TsgalO protein
M otif / domain Description # Amino acid
Coiled-coil
Coiled-coil myosin heavy chain tail is composed of 
the tail from two molecules of myosin which can then 
assemble into the macromolecular thick filament. 
Coiled-coil domain often involved in protein-protein 
interactions
26-88, 112-164, 
172-199, 228-248, 
263-283, 319-500, 
522-570, 613-633
Keratin-I
Found in the manchette, the insertion site of the 
microtubular mantle. The manchette is a highly 
dynamic structure providing microtubular tracks to 
structural proteins participating in the sperm tail 
development (Kierszenbaum et al., 2002)
322-345
476-502
Rabaptin
A coiled-coil protein that interacts with the GTP form of the 
small GTPase Rab5, a potent regulator of endocytic 
transport (Stenmark et al., 1995). Mainly cytosolic, but a 
fraction co-localises with Rab5 to early endosomes. 
Demonstrating functional similarities with other members 
of the Ras superfamily. Rabaptin-5 is a Rab effector 
required for membrane docking and fusion
33-51
324-344
476-498
PKD-2 Play a role in ion channel and in ciliary beating 65-84, 384-401, 
535-553
Helix-Loop-Helix Most important part of myosin to be dimerized and 
for protein interaction
PDZ
(-X-Ser/Thr-X-V al/Leu- 
COOH)
Bind to a C-terminal motif with the sequence -X- 
Ser/Thr-X-Val/Leu-COOH, where X represents any 
residue. The presence of a PDZ domain suggested 
that rhophilin (a highly expressed sperm flagellar 
protein in Rho kinase pathway) works as an adaptor 
molecule
62-66, 108-112, 
171-175, 189-193, 
255-259, 390-394, 
484-488, 501-505, 
619-623
LXXLL
Mediate in interactions of CBP [cAMP-response 
element-binding protein (CREB)-binding protein = a 
general co-integrator of various signalling pathways 
and interacts with lots of transcription factors] with 
ligand-binding domains of nuclear receptors (Klein et 
al., 2004)
567-571
LSK RII binding domain of AKAPs 371-373
Conventional R/KVXF
Type I phosphatase interacts through it, a 
recognizable characteristic of many phosphatase PP1- 
targeting subunit in AKAP350 (a centrosomal 
anchoring protein)
496-499
ESEIQLLK MAPKKK highly conserved motif in several embryo 
and non embryo ESTs
589-596
Bipartite nuclear 
localization signal
(RRXXXXXXXXXXRXK)
Necessary and sufficient for nuclear import of the 
proteins; All SMC proteins are predicted to have a 
bipartite ATPase domain (de Jager et al., 2004)
113-127
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From table 7.3A it can be seen that there are a large number of coiled coil and PDZ 
domains in the TsgalO sequence. These are seen significant and consistent in terms of 
the function of the TsgalO protein. Many different genes and molecules are related to 
myosin tail (e.g. giantin in Golgi) and probably all of them conserved a helix-loop-helix 
domain. TsgalO protein, as well as other proteins, might have evolved from myosin 
heavy chain tail (figure 7.3E). In TsgalO, it is likely that these coiled coil domains allow 
TsgalO to interact with other proteins, and in self-dimerisation. The PDZ domains 
(highly expressed in a sperm flagellar protein) act as an adaptor molecule. In TsgalO 
they may mediate in Rho kinase pathway.
Other domains are also found:
The PKD2 gene is highly expressed in ovary, foetal and adult kidney, testis, and small 
intestine. Polycystin-1 requires this protein for its proper function via its C-terminus, 
and all mutations between exons 1 and 11 result in nonfunctional polycystin-2 because
T s g a l O : 2 6  jLKSTARDREELKCMX.EKYERHLAEIQGNVKVLTSERDKTFLLYEQAQEEIARLRREMMKSCKSPKSTTAHAl|RRV  
C p 4 3 1 : 3 1 7  LKSTARDREELBCMLEKYERHLAEIjGNVKVLTSERDKTFLLYEQAQEEIARLRREMMKSCKSPKSTTAHAILRRV
SMC: 2 6 2  |E E A E K E IE E L |S E L E E L R E E L E E l | e ELLELKEEIEELEG EISLLRERI,EEI.ENELEELEERLEELKE— KIEAL
T s g a l O :  
C p 4 3 1 :  3 9 3  
MHT1 : 4 0 2  
SMC : 3 3 6  
SMC : 6 7 0  
HEC1 : 2 6 0  
S b c C  : 1 9 7  
MAD : 1 3 2  
O d f2  : 1 0 5
e t e r | v | f t d l | r m t | e r d s l r e r l k i a q e t a f n e k a h i ,e q r i e e i ,e c t v h n l d d e r m e q m a n m t l m k e t i t t v e k
e t e r 1 v | f t d l | r m t | e r d s l r e ^ B i a q e t a f n e k a h l e q r i e e l e c t v | n l d | e r m e q m s | m t l m k e t i t t v e k
E K E L |t | q REa | n L s | e L  F B B N E L E E L K D Q V E A 3£,R R E N K N JiQ D E l|D L T |Q L G E G G R |vH E L E K A R R R L E A
KEELEERETLLEELEQLLAEt,EEAKEELEEKLSALLEEI,EELFEALREELAELEAELAEIRNELEE$KREIESLEE
k e l e e e l a e l e a q l e k l e e e l k s l k n e l r s l e d l l e e L r r q l e e i ,e r
FV H IIN T D iA N L K |Q N D N |Y E K IQ E A M K ------------------ fSQKIKTLREKWRALKSDSNKYENYVNAMKQKSQEWPG
LLEDIEDLLEA
LT
DK
T s g a l O :  EMKSLARKAMDTESELGRQKAENNSLRLLYENTEKDLSDTQRHLAKKKYELQLT---------- Q E K |mc| d E K |dNFTRQN
C p 4 3 i : 4 6 2  e m k s l a r k | m d t e s e l g r q k a e n n s l r l l y e n t e k d l s d t q r h l a k k | y e l q l | ----------q e | i m c l d e k | d n f t r q n
m h t i  : e k d e | — q | a l e e a e a a l e l e e s k v l r a q v e l s q i r - s e i e r r l a e k | e e f e n | r k n h q r a i e s l q a t l e a e a k g k
SMC : 3 9 6 ----RLER|SERLEDLKEELKELEAELEELQTELEELNEELEELEEQLEELRDRLKEL-------ERELAELQEELQRLEKEL
SMC : 7 1 5 ----QLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEEL|EELESL-------EEALAKLKEEIEELEEKR
HEC1 : KLEK l|KSEIELKEEE!lKALQSNIDEIiHKQLRKQGISTEQFELM NQER| K L |-------R ELD K -IN IQ SD K LTK SV
S b c C  : LEEElK ELK K LEEIQ EEQ EEEELEQ EIE A LEER LA Et,EEEK ER LEEL|A R LLEI-------ESLELEALKIREEELREL
MAD : 1 3 4  DLKQLEESEAKAESELAEAKERSKQLEQKLDKLSLRTDAQSKKLQKElEDQQ--------ADAKESISKLKNQIiSEMQLRA
O d f2  : 1 0 7  KIDS^MNAVGCLKSEVKMQKGERQMAKRFLEERKEELEEVAHELAETEHENTVt-------R H N IE R IK E E K D -FT --------
MBMP : 4 1  K Q IQ K E |A A L E K K lR E (J|D Q R A K i-------EKQ^Ks S e T e I a SLEAQL
SMC' : 1 8 4  TEEN
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T s g a l O :  IAQREEI-SILGATLNDLAKEKECLQACL-DKKSENIASLGESLAM KEKTISGM KNIIAEM EQASRQSTEALIM CE
C p 4 3 1 : IA Q R EEI-SILG A TLND iLA K EK ECI,Q TCti-D K K SENIA S|G ESLA M K EK TlBM K NIIAEM EQ A SR Q STEA liIM C E
MHT1 : AEASRLK -K K LEG D INEL----------------- EIA1-DHANKANAEAQKNVKKYQQQVKELQTQVEEEQRAREDAREQLAVAE
SMC : SSLEARL-DRLEAEQRASQGVRAVLEALE-SGLPGVYGPVAELIKVKEKYENRLQAVW ENEEVAKKAIEFLKENK
SMC : QALQEEL-EELEEELEEAERRLDALEREL-ESLEQRRERtiEQEIEELEEEIEELEEKLDELEEELEELEKELEELK
HEC1 : K SR K L E A -Q G IFK StE K T L R Q Y D SL IQ N I-T R SR SQ IG H N V N D SSL K F PK G H IlN E SIK K SIL E L N D E IQ E R IK T E
S b c C  : ER L L E E L -E E K IE R L E E L E R E IE E L E E E L -E G L R A L L E E Je ELLEKLKSLEERLEKLEEKLEKLESELEELAEEKN
m ad  : m n s e t e l - k l l e k e l e d l k e q l e e l q k e l - a e a e q k l q s l k a s q a e r a d n e q l i k h l e e e l k l y e q d a e v v k s m k e
O d f2  : MLQKKH-------------------------LQQEKECLMSKLVEAEMDGAAAAKQVMALKD-TIGKLK----------------------------- TEKQMTCT
MBMP : IETADDL-KKLRKQIADLNARLNALEVQE-REQRRRLAEQ----------------------------------------- LAALQRSGRNPPPALLVSP
R a b a p t i n :  KA IATVSLETLGEAADW K -SK KREEVAKV— Q A IEQ EEV A |LESSLK D SLESEEA Q IA A Y R E ESE
HAP1 ; KVLQERNEFlEEQi-GKARDEIVQjjRHELNKKDELLRVYSHADDDGEDESQCSTPLQHNES
SMC' : LERLEDLLEELEKQLEKLERQAEKAERYQ-ELKAE-------------------------LR ELELA LLLAK LKELRKELEELEEELSR--
T s g a l O : 
C p 4 3 1 : 
MHTl 
SMC 
SMC 
HEC1 
S b c C  
MAD:
O d f2  : 
MBMP : 
R a b a p t i n :  
HAP1 : 
SMC' :
- d i s r m r r q l d e t n d e l g 1 i a | e r d i l a h q n t n l q -
- d i s r m r r q l d e t n d e l g I i a I e r d i l a h e n d n l q -
- r a t a l e a e l e e l r s a l e | a e | a r k q a e t e l a e a s -
-GLDRIK PLRSLK SDAAPGFLGLASDLIDFDPKYE-
- EQFAKVKQENQALS KKLN- 
-EQFAKVKQENQALSKKLN- 
-ERVNELTAQNSSLIAQKR- 
-PA V R FV LG -D TLW D D LE-
Q---------
Q---------
R--------
A --------
E -----------------EjjEELEAEKEELEDELKE----------------------------------£,E-----------------------EEKEELEEELRELESELA-----------
EN K SITLEEDIN ELTQ ILEK LELELSEA N SK FELSK EEN EREL-----------------------VAQ R IEIEK fcEK ELN -----------
E----------------- LAKLLEERLKELEERLEELEKELEKALERLKQLE------------------------EAIQELKEELAELSAALE-----------
QLQRLP ELERELEQLREENKKLKSSHENNELLKEELEDLQRKLERAEKMRSKLADLELENEKLEAELKSWENL
-------------------- DlNTLTRQFEETNRTLRDgLREQ-------------------HCK-----------------------EDSERLMEQQGTLLKRLA-----------
E -----------------DAQRSVR L A l  Y YGAI,N PARAERIDALKATL------------------------KQL AAVRAEIAAE QAELT-----------
R-----------------EIADLRKKVRELGNKJjGQEAETRDQRAQEEDQIiE------------------------KEMKKAQE DEEKLREVVL-----------
Y -----------------STLQRSNQLEALQEKLKSLEEENERLRSEASHLK------------------------TETITYEEKEQQ p-----------------------
-------------------- ELEELQ EELEEAEKEIEELKSELEELREELEELQ-----------------------E E L L E tK E E IE E L E G E jS ------------
T s g a l O :   SDTHNELSDIKQKVQDTNLEVNKLKNILKSEESENRQIMEQLRKANEDAENWENKARQTEAENNT|K
C p 4 3 1 :  SDTHNELSDIKQKVQDTNLE^NKtKNItKSEESENRQIMEQLRKANEDAENWENKARQLEAENNTLK
MHTl :  KLEGEpLAALQSDLDEAVNELKAAEERAKKAQADAARLAEELRQEQEHSQHLERLRKQLESQVKELQ
SMC :  QARRLARKIiRIKYRIVTLDVEPSGSITGGSRNKRSSLAQKRELKELEEELAELEAQ-LEKLEEELK
SMC :  ELKEEIEKLRERLEELEAKLERLEVELPELEEELEEEYEDTLE------------T E L E R E IE R IE E E IE a I g
HEC1 : -----------------------DSKTSILDAEQLVQSTEIKLDEtKVDIiNRKRYK
S b c C  :  e i q e e | , e e I e k e l e e l e r e l e e l e e e i ;k k l e e q i n q l e s k e l m i a e l a g a g e k c p v c g q e l p e e h e
MAD: LLQNIRkTPEDISRRJVELQKEELILTEKNGSLTSDAKNLKTANQQLQLERQQALAEILELKKKLETiKRLNRR^Q
O d f2  :  EADSEKARLLLLLQDKDKEVEELLQEIQCEKAQAKTASELSKSMESMRGHLQAQLRCKEAENSRiC
MBMP :  TLLSEQRAQQAKLAQ]iLEERKKTLAQLNSELSADQKKLEE|RA-------NESRLKNEIASAEAAAAKAR
R a b a p t i n :  -----------------------PMEKEjlEALK
HAP1 : LDCVLREANDQMASi,SEEI,EQKTEELNRQQEE|TKLLAEIADLQKKLKM|SMEKEEiiG
SMC' :  LLRERLEELENELEELEERLEELKEKIEALKEELEERETLLEELEQLLAELEEAKEELEEKLSALL
FERM : QMEEDMRRAQKELEEYERTALELEEKLKQEE
TsgalO: LELIT-AEA-----EGNRLKEKVDALNREVEQHLNAERSYKSQ|ATLHKSiVKMEEE|Q— KVQFEKVSALAD|iSST
C p 4 3 1 : L E ij lT -A E A --------- EGNRLKEKVDALNREVEQHtNAERSYKSQIATLHKSLVKMEEELQ— KVQFEKVSALADliSST
MHTl : VRLDE-AEAAALKGGKKMIQKLEARVRELEAEfiDGE QRRHAETQKNliRKMERRVK— ELQFQVEEDKKNLERL
SMC : L K N E L -R SL ---------- EDLLLERQLEELKRELAALEEELEQLQSRLEELEEELEELEEELE— ELQERLEELEEEJ,ESL
SMC : PVNLR-AIE EYEEHEERYEE|KSQREDLEEAKEKLLEVIEELDKEKRERFKE 1 0 1 3
SbcC : KEfiLELYEL ELEELEEEL— LEEELIELLELEEALKEELEEKLEKLENLLEELEEEKLQLQQLKEELRQLED
MAD: R Q ^ SL -L T K ---------- ERDL^RAILDSYDSE-NTETEASNQLTRR£EEAEDM ^QLVDSYKA--KM EAQLKELEDE|GGQ
O d f2  : M Q IK N-LER  SGNQHKAEVEAI---------------------------------------------------------MEQLKELKQ— KGDRDKETLKKa | rAQ
MBMP : EA AA A -AEA  AAARARAAEAKRTGETYKPTAPEKMLIS 2 8 7
HAP1 : QHllA-MKDAQRQLTAEiiKEMQDRYAECMAMLHEAQEELKKLRS 3 1 0
s m c ' : e e l  e e ---------- l f e a l r e e l a e l e a e l a e i r n e l e e l k r e i e s l e e r | e r l s e r | e — d l k e e l k e l e a e E e e l
FERM : EAAQL-LEK KASELEEENRRLEEEAMASEEERERLEAEVDEATAE^AKLEEERE— RREEETRQLQTE|REA
TsgalO: RELCIKLDSSKELLNRQ&VAKDQEIEMMENELDSARSEJELLRSQMTNERISMQNLEALLVANRD
C p 4 3 1 : RELCIKtDSSKELlNRQLVAK-QEIEMMENELDSARSEIELLRTELKSPRSRIPRVLTKVHAAN 8 5 0
m h t i  : q d l v d k l q a k i k t y k r q l e e a e r e l e d a e e r a d t a e r s l n k l r a k s r r
SMC : EEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELE
S b c C  : RLQELKELLEELRLLRTRKEELEELRERLKELKKLRSEKALLEMKLKLKELEERLSQLEE 6 1 4
MAD: KQRAETlEKELKLLKEOLSSNEREALNALRLKNESLERERDR
O d f 2 : KER A EKSEEYAEQ LHVQLADK DLY^AEALSTlESW RSRYNQ fVK DK GDLELE|lV|NDR|TDLVNQ QQSlEEK M R
SMC' : QTELEELNEELEELEEQtEELRDRlK ELERELAELQ E---------------------------------E ^ Q R tE K E lsS L E A R L  4 9 0
Figure 7.3E- TsgalO protein homology to myosin heavy chain tail and other proteins which may have 
evolved from myosin. As it is shown, possible leucine zipper domain (marked in gray) may be involved
in protein function and interaction
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lack o f a calcium-binding, which is required for the interaction o f polycystin-2 with 
polycystin-1 (Veldhuisen et al., 1997). The PKD2 gene is shown to be responsible for 
autosomal dominant polycystic kidney disease (Mochizuki et al., 1996).
Rabaptin is a coiled-coil protein that interacts with the GTP form o f the small GTPase 
Rab5, a potent regulator o f endocytic transport (Stenmark et al., 1995). Rabaptin-5 with 
its GTP-dependent manner, demonstrates functional similarities with other members o f  
the Ras superfamily. Rabaptin-5 is shown to be a Rab effector required for membrane 
docking and fusion. It seems that this protein may regulate regeneration o f injured 
axons at neuromuscular junctions as a neurite outgrowth. Neurocrescin (rabaptin) is 
shown to be secreted in active dividing processes such as growth or proliferation 
(Nishimune et al., 1997).
Type I keratins are differentiation markers which are known as a group o f acidic 
intermediate filament proteins and associated with a number o f inherited developmental 
disorders including baldness, beading o f hair, and skin blistering. Also it has been 
recently shown that by PKCalpha overexpression, expressions o f differentiation 
markers such as keratin 1 (MK1) and keratin 10 (MK10) were increased, and ERK1/2 
phosphorylation is concurrently induced without change o f  other MAPK such as p38 
MAPK and JNK1/2 (Seo et al., 2004). In Pfam (http://www.sanger.ac.uk/cgi- 
bin/Pfam/pfamblast_server) and NCBI database search o f TsgalO amino acid sequence, 
similar matches to other proteins are found using other database searches. These are 
summarised in tables 7.3B and 7.3C. A description o f each protein with similarity to 
TsgalO and its alignment is written in the Appendix 8.2.2. Below are brief descriptions 
o f two proteins with high homology to TsgalO protein, and to myosin heavy chain).
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T a b le  7 .3 B - C o n serv ed  d o m a in s o f  rod en t T sg a lO  (cp 4 3 1 ) p rote in  (892  aa in m ouse)
Sim ilar Fam ily Proteins Start End H om ology %
Chromosome segregation ATPase -160 178 29.1
Chromosome segregation ATPase 25 612 49.3
Myosin tail, Myosin class II heavy chain 23 554 60.2
Membrane-bound metallopeptidase 208 477 58.8
HEC1, involved in chromosome segregation 98 498 45.2
Mitotic checkpoint protein 175 556 57.1
ERM (Ezrin/radixin/moesin) 278 517 27.9
SbcC (ATPase involved in DNA repair) 25 534 46
Hook protein 105 578 44.5
Intermediate filament protein 301 576 49.3
H om ologous proteins to TsgalO (TsgalO starts at aa # 203) by NCBI GenBank 
(http://www.ncbi.nlm.nih.gov/entrez/viewer) and Ensembl (www.ensem bl.org) databases. Each 
hom ologous protein was aligned with TsgalO by usin ‘Genebee’ (http://www.genebee.msu.su/).
T a b le  7 .3 C - P o ten tia l m a tch es fo r  T sgalO  892 a m in o  a c id s res id u es u sin g  P fam .
'}.......................’ " I ................ ’ " '1 ..................  T ~ ............. ..................  "T
■ = r m
:! ; 
M y o s in t a i l l -177 563 0.00054 PF01576 Is
EB1 -66 -27 0.27 PF03271 Is
E-M AP-115 13 186 0.37 PF05672 Is
M AD 106 688 0.078 PF05557 Is
ERM 223 502 0.47 PF00769 Is
i. . . . . —
Prefoldin 238 346 0.39 PF02996 Is
Rabaptin 259 386 0.27 PF03528 Is
Filament 345 628 0.035 PF00038 Is
I .........
Tropomyosin 355 385 0.032 PF00261 fs
Known domains w ith E-values below  the cut o ff  (Evalue <  0.5) are considered.
Is =  complete domain, fs =  fragment domain (http://www.sanger.ac.uk/cgi-bin/Pfam/)
Mitotic checkpoint protein family- consists of several eukaryotic MAD (mitotic arrest 
deficient) proteins. The mitotic spindle checkpoint monitors proper attachment of the 
bipolar spindle to the kinetochores of aligned sister chromatids and causes cell cycle 
arrest in prometaphase when failures occur. Several mitotic spindle checkpoint 
components including Mad 1-dependent complex (Mad2, Mad3, Bub3 and Cdc20) have 
been identified.
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Membrane bound metallopeptidase domain- there is a rat protein with 22.8% (not 
very high but considerable) similarity to TsgalO, encoded by the gene in rat 
chromosome 9q21 and human chromosome 2 (synteny to the same place o f TsgalO) 
named “E cell” (endothelin converting enzyme-like 1) that plays a role (Kato et al.,
2002) in damage-induced neuronal metallo-endopeptidase and is involved in 
neuroprotection. Interestingly it is a membrane-bound metallopeptidase with molecular 
function o f hydrolase activity. It may mediate neuropeptide processing and enhances the 
expression and the activity o f antioxidant enzymes such as Cu/Zn-superoxide dismutase 
(SOD), Mn-SOD, and glutathione peroxidase under oxidative stress. Its expression is in 
neurons o f the central nervous system (CNS) and peripheral nervous system. Its 
transcription is increased by nerve growth factor (NGF) deprivation and by leukemia 
inhibitory factor (LIF) but not by other growth factors and cytokines; mRNA is 
increased in the dorsal root ganglion (DRG) neurons by sciatic nerve injury. 
Intracellular signalling cascade, neuropeptide signalling pathway, proteolysis and 
peptidolysis are some o f its biological functions. More interestingly it is a cellular 
component integrating into membrane and plasma membrane and plays a role in 
pathogenesis o f respiratory insufficiency (Schweizer et al., 1999).
Bioinformatic analysis o f the 84-kD protein also revealed the presence o f a 
region with significant similarity to the ERM (Ezrin/radixin/moesin) domain (aa # 223- 
502). The similarity o f domains to ERM (as a key membrane-cytoskeleton linker) may 
indicate a role for TsgalO in the formation o f the fibrous sheath (FS) during 
spermiogenesis. A CD44-ERM attachment complex is involved in migration o f  
embryonic fibroblasts, activated macrophages, and metastatic cells. It has been
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demonstrated that the function o f the NF2/ERM/4.1 superfamily is to maintain cell 
integrity, motility and differentiation. Some o f these proteins are involved in human 
diseases (Surace et al., 2004), and suppression o f the expression o f all ERM proteins 
with antisense oligonucleotides in cultured fibroblasts/epithelial cells blocked 
membrane ruffling and motility (Bomhauser et al., 2003). It has been speculated that 
ERM proteins regulate cell motility by linking cortical F-actin to the plasma membrane 
in different cell types (Olsson et al., 2000) and may have an identical function in tumor­
cell invasion (Kosako et al., 2000): EhM2, which contains the ERM domain, is 
expressed in high-metastatic but not in low-metastatic K-1735 murine melanoma cells 
and regulate the metastatic potential o f melanoma cells by affecting cytoskeletal- 
membrane interactions (Shimizu et al., 2000). It is also expressed in the liver, lung, 
kidney, and testis and in 7 to 17 day mouse embryos. TsgalO, which may have 
functional myosin/ERM sequences, is also expressed in foetal tissues and several cancer 
cells including cancers originating from bone marrow, thyroid, germ cell, stomach and 
uterus. It has been shown that ezrin protein suppression results in reduction o f activation 
of Rho kinase, CD44 and MAPK phosphorylation.
Since TsgalO has similarity to a membrane-bound metallopeptidase and an 
ezrin/radixin/moesin (ERM) protein domain, it may have some contribution in cell 
trafficking via the ‘nexin’ protein family. These proteins have an endocytic pathway 
function to internalise extracellular components and participate in diverse signal- 
transduction pathways. SNX9 one member o f the nexin family binds preferentially to 
the precursor, but not the processed forms, o f the metalloproteases through the 
interaction o f its SH3 domain with Pro-rich sequences that are present in the
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cytoplasmic tails o f the metalloproteases. SNX17 has an ezrin/radixin/moesin (ERM) 
protein domain 4.1: four-point-one, ezrin/radixin/moesin, FERM and is also associated 
with the cytoskeleton (Worby et al., 2002). It is indicated that FERM domains o f ERM 
proteins evolved in response to multi-cellularity, rather than as cytoskeletal proteins 
while ERM proteins are involved in microfilament-membrane attachment and Rho- 
signal-transduction pathways. The FERM domain also binds to Rho pathway signalling 
molecules while an F-actin binding site is present in the carboxy terminus o f ERM 
proteins (Bretscher et al., 2002). Since the connection between the cell membrane and 
actin cytoskeleton is required for metastatic cells to engage their microenvironment, and 
for axonal transport, TSGA10 may be an indicator o f  metastasis (marker) in addition to 
being a tumour marker (recently proposed as a tumour marker by Tanaka et al., 2004). 
The location o f the ERM domain in the TsgalO protein is downstream o f the proposed 
TsgalO-N-terminus 27-KD cleavage site. ERM members are phosphorylated at a C- 
terminal threonine through kinases such as Rho kinase/PKC, and at N-terminal 
tyrosines through receptor tyrosine kinases such as growth factors (probably GDNF 
which is shown to be expressed during spermatogenesis), cytokines and c-MET (Krieg 
et al., 1992; Crepaldi et al., 1997). It is shown that IL-1 P activates ERM family 
members (e.g. TsgalO) by inducing phosphorylation, allowing them to form a bridge 
between F-actin and integral membrane proteins at the plamalemma (Mangeat et al., 
1999). Then activated ERM family members associate with integral membrane proteins 
directly (e.g. the sodium-hydrogen exchanger isoform 1, CD44, membrane-bound 
TsgalO) and indirectly via the scaffolding proteins (e.g. ODF2) (John et al., 2004).
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ERM proteins are identified as targets o f a single regulatory mechanism, a signalling 
pathway mediated by GTPases o f  the Rho family (Amano et al., 2000).
PBLAST at NCBI GenBank (table 7.3B) showed homology between TsgalO and 
chromosome segregation ATPase, myosin heavy chain, membrane-bound 
metallopeptidase, hook protein and polyamine modulated factor 1 binding protein 1 
which is expressed in sperm tail (Ohuchi et al., 2001). In the Gene Ontology database 
(www.ensembl.org/) several functions for the TSGAlO/TsgalO protein are given: 
G0:0005741: Mitochondrial outer membrane G0:0007283: Spermatogenesis 
G0:0015288: Porin activity G0:0016021: Integral to membrane
TSGA10 protein in other species- Other proteins with homology to TSGA10 are 
found in species in addition to mouse and rat, these are summarized in table 7.3D. Some 
proteins with high similarity to TsgalO have known functions. These include “Rab6- 
interacting protein 2” that regulates intracellular transport at the level o f the Golgi 
complex, “Restin’’ (Reed-Steinberg cell-expressed intermediate filament) and “CLIPs” 
(cytoplasmic linker proteins). These proteins are involved in the local regulation o f  
microtubule dynamics in response to positional cues.
Rab6 protein is a member o f ‘Ras-like GTPase’ family and 4 Rab 6-interacting protein 2 ’ 
(Rab6IP2) is involved in endosome-to-TG [trans-Golgi] network and participates in 
assembly o f a multiprotein complex including PI3-kinase (Monier et al., 2002). GTP- 
Ras proteins bind to and activate a number o f effector molecules including protein 
kinase B (PKB), protein kinase C (PKC) and lipid kinase PI3-K (Vojtek and Der, 1998). 
Rab6IP2 is expressed mostly in brain cytosol and is recruited on to Golgi membranes in
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Table 7.3D- UniGene study shows TsgalO sequence homology to some known functional genes and 
__________proteins http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?ORG=Mm&CID=332756
Mus musculus ref:NP 444434.1 - Rab6-interactina protein 2 20 .58% /710  aa
R.non/egicus: ref.NP 113933.1 -restin 20.41 % / 702 aa
A.thaliana: ref:NP 176681.1 - hvoothetical Drotein 22.37 % / 707 aa
C.elegans: ref:NP 505094.1 - mvosin 20.44 % / 709 aa
D. melanogaster. Dir:T13030 - T13030 microtubule bindina 
protein D-CLIP-190
19.78% /730  aa
S. cerevisiae: sd:P25386 - US01 YEAST Intracellular 
protein transport protein US01
21 .07% /714  aa
a Rab6 :GTP-dependent manner. Apart from Rab6 , a melanosomal membrane protein - 
Rab27- is another Rab protein, which is expressed particularly in testis and recruits 
myosin Va to the melanosome surface or links to myosin through a synaptotagmin-like 
protein (Slac2). Also TsgalOip neighbouring gene encodes synaptotagmin protein. 
Slac2 also displays an actin-binding site and is highly expressed in brain, lung, and 
testis itself (Fukuda and Kuroda, 2002). Null expression o f myosin Va, Rab27 and 
Slac2 results in a failure o f melonosome transfer to keratinocytes and partial albinism o f  
hair and skin (Seabra et al., 2002; Wu et al., 2002). Proteins in non-mammals, which are 
conserved with 20 percent homology, may be more important as evolutionarily related 
proteins. This includes a “Myosin heavy chain family member” which has ATP binding 
and nuclear localization domains, motor activities and localises in membrane. Another 
protein is “Microtubule binding protein D-CLIP-190” in Drosophila melanogaster. 
Myosin is associated with it in neurons and at the posterior pole o f Drosophila embryos. 
“Intracellular transport protein U SO l” in yeast is the other similar protein to TsgalO 
which plays a role as a cytoskeletal component in the protein transport from the ER to 
the later secretory compartments (Golgi complex).
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7.4 W h a t does localisation o f the  p ro te in  tell us abou t function?
7.4.1 TsgalO in the fibrous sheath and its role in male fertility
After completing a range o f immunohistochemistry and immunofluorescent (IF) 
experiments it was clear that TSGA10 is expressed in testis (throughout sperm 
maturation), and is localized in the sperm tail. This was consistent with the gene 
expression data (obtained by RT-PCR and Northern Blot analysis) that TSGA10 was 
found throughout sperm development. TsgalO mRNA is detectable from the pachytene 
stage o f meiosis but protein expression is not seen until the elongating spermatid stage. 
So a delay between TsgalO transcription and its encoded protein expression is 
predicted. TsgalO whole protein was localised in seminiferous tubules and a 27-KD 
product was detected in the fibrous sheath component o f sperm tails. Therefore post- 
translational processing o f the protein happens during spermiogenesis. The 27 KD form 
o f TsgalO associated with the fibrous sheath o f the sperm tail, is likely to play a role in 
sperm motility.
It is not clear whether myosin is present within the sperm tail. However, there is 
some evidence for the possibility o f myosin involvement in sperm function (Ashizawa 
et al., 1995; Kierszenbaum et al., 2003; Weil et al., 1995). A number o f  unconventional 
myosins, including myosin-X, contain the Myosin Tail Homology 4 and ERM domains 
(Berg et al., 2000). Interestingly TsgalO subcellular localization and its pattern within 
the cell showed filament formation which is consistent with the above description and it 
may suggest the presence o f a putative functional myosin/ERM domain in elongating 
spermatids.
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Recent models suggest that FS proteins can also serve as scaffolds for protein 
complexes involved in regulating signal transduction processes (Miki et al., 2002; Eddy 
et al., 2003). It was suggested that components o f the Rho signaling pathway associated 
with the FS might be involved in regulating flagellar function. These include the Rho- 
binding protein rhophilin (Nakamura et al., 1999) and ropporin, a spermatogenic cell- 
specific protein that binds to rhophilin and to the FS (Fujita et al., 2000). Rhophilin is 
highly expressed in testis and is localized specifically in sperm flagella. The presence o f  
a PDZ domain suggested that rhophilin works as an adaptor molecule (Peck et al.,
2002). PDZ domains bind to a C-terminal motif with the sequence -X-Ser/Thr-X- 
Val/Leu-COOH (figure 7.3A), where X represents any residue. This motif (PDZ) is 
present nine times among TsgalO amino acid sequence (aa numbers 62-66, 108-112, 
171-175, 189-193, 255-259, 390-394, 484-488, 501-505, and 619-623), while its 
presence in the region between aa numbers 255 and 259 may be involved in cleavage o f  
TsgalO (see section 4.2). It is therefore possible that the cleavage site o f TsgalO is 
between aa 259 and 260. Further investigation will confirm whether TsgalO is involved 
in regulating signal transduction and/or can bind rhophilin via measurement o f  that in 
the environment containing TsgalO FS protein. This pathway is known as a main 
regulator o f cell shape, migration, and motility (Schmitz et al., 2000; Riento and Ridley,
2003). TsgalO has an apparent ERM domain and I have shown it to be expressed in 
astrocytes. ERM family proteins deactivate GTPase-Rho kinase (ROCK) pathway in the 
presence o f IL-1 P. It has been shown that the deactivation o f the Rho GTPase-Rho 
kinase (ROCK) pathway by IL-lP regulates the phenotype o f astrocytes (John et al.,
2004). Deactivation o f this pathway affects cellular morphology and migration via
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effects on F-actin and its interactions with focal adhesions, nonmuscle myosin, and 
microvillar adapter proteins o f the ezrin-radixin-moesin (ERM) family. Hypothetically, 
TsgalO is most likely phosphorylated in Rho-ROCK axis in parallel with the proposed 
role o f ROCK in ERM phosphorylation (Matsui et al., 1998). If we can consider sperm 
maturation and migration in testis as an active natural model o f metastasis, then there 
might be a common Rho-GTPase-Tsga 10 pathway in cancer metastasis and sperm 
motility.
Again considering the possible biological activity o f TSGA10 (bearing in mind its 
interaction with Cyt C l, which is one o f the major proteins involved in ATP synthesis 
in sperm mitochondria), TsgalO could be a protein that plays an important role in the 
mechanism by which ATP (as sperm motility energy supplement) can be shuttled from 
the mitochondrial sheath (MS) to the rest o f the flagellum.
During spermiogenesis, microtubules are twisted round the axoneme in the sperm tail. 
This process localises mitochondria to the tail so that large amounts o f ATP can be 
synthesised in order for the tail to move. The fibrous sheath extends from the 
mitochondria, gathered around the axoneme, to the end o f the sperm tail, which is 
further evidence for a connection between TsgalO and Cyt C l. The fibrous sheath 
surrounds the outer dense fibres, which in turn surround the axoneme in the midpiece o f  
the sperm tail. These fibres, o f  which one type is encoded by outer dense fibre 2 
(ODF2), are also involved in sperm motility.
A function o f the fibrous sheath (FS) is to protect sperm from oxidative stress that could 
interfere with sperm motility and DNA damage has been proposed (Fulcher et al, 1995). 
In the case o f any defect in mitochondrial oxidative phosphorylation, sperm still
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produce ATP (in lower amounts) and sperm motility is still present (although reduced) 
(Narisawa et al, 2002). This is achieved via a glycolysis reaction compartmentalized 
within the FS/principal piece (Turner 2003). TsgalO protein also interacts with HIFla 
(Dr. D.M. Katschinski, Martin-Luther-Universitat Halle, personal communication). 
H IF lo r , Cyt Cl, and TSGA10 may play a role in glycolysis in the principal piece to 
supply the fuel for the tail while oxidative stress via its interaction with HIFla and Cyt 
C l. HIF1 a is a transcription factor that enables tumors to adapt to hypoxic 
environments by activating survival genes. Interestingly, the H IFla protein is among 
the list o f known flagellar proteins. The HIF la  gene is frequently overexpressed in 
colon tumors (Zhong et al, 1999), and regulation often occurs at the level o f protein 
degradation; however, studies also document the regulation o f HIF la-mRNA levels 
(Lukahev et al, 2001, Caniggia et al, 2002).
It is shown that in absence o f an A-kinase anchor protein -AKAP4- (the major mouse 
sperm fibrous sheath protein), a major reduction or loss o f other FS proteins occurs 
resulting in severely reduced sperm motility (Carrera et al, 1994 and Miki et al, 2002). 
A possible case o f this effect is thought to be an alteration in protein kinase A (PKA) 
distribution resulting in either significant structural changes or complete disruption of 
other FS proteins (Miki et al., 2002). It is shown that AKAPs tether protein kinase A 
(PK-A) to the FS. The presence o f at least two identified FS components as members of 
the A-kinase anchoring protein (AKAP) family (AKAP3, AKAP4), implies that 
“TSGA10 & TSGA10IP” proteins may also be members o f the AKAP family. 
Considering TsgalO similarity to ERM and consistent with it, there is some evidence 
that ‘Ezrin’ protein is an AKAP as well (Dransfield et al., 1997). Interestingly human
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and mouse pro-AKAP82 proteins are proteolytically processed in a similar manner to 
TsgalO. The C-terminal part o f  pro-AKAP82 remains in the fibrous sheath. Most of 
known FS proteins (AKAP4 which is isolated as more than half o f FS proteins, AKAP3 
and TAKAP-80) have anchoring sites for cAMP-dependent protein kinase (Eddy et al.,
2003). PK-A activates a downstream tyrosine kinase(s) whose targets are primarily 
located in the flagellum (Leclerc et al, 1996; Si and Olds-Clarke, 2000). To date, just a 
few number known target proteins for PK-A phosphorylation have been identified in 
sperm (Tash and Bracho, 1998) including axonemal dynein (Tash 1989). TSGA10 
protein with a high number o f  phosphorylation sites (nine PK-A among forty six in 
total) could be one o f  the protein targets for PK-A phosphorylation. AKAP4 recruits 
PKA to the fibrous sheath to facilitate neighbouring proteins that regulate flagellar 
function to be phosphorylated (Miki et al., 2002). In that case, TSGA10 could be 
considered as another member o f the AKAP fibrous sheath proteins. In this case, 
possible roles for TSGA10 are broadened to include serving as scaffolds for protein 
complexes involved in regulating signal transduction processes (Edwards and Scott, 
2000; Colledge and Scott, 2000; Colledge et al., 2000; Dodge and Scott, 2000). 
Interestingly in agreement o f  our hypotheses o f TSGA10 as an AKAP as well as its role 
in Rho signalling pathway and to link both o f them together, it was recently suggested 
that Rho signalling pathway components associated with the fibrous sheath via AKAP 
to regulate flagellar function (Carr et al., 2001); including Rho-binding protein 
rhophilin (Nakamura et al., 1999) and ropporin that binds to rhophilin and fibrous 
sheath (Fujita et al., 2000). Also AKAP-associated sperm protein and ropporin have
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similar regions to the AKAP-binding domain o f PKA and bind to the PKA-anchoring 
domain o f  AKAP3 (Carr et al., 2001).
All o f the above findings suggest that the TSGA10 protein has both functional and 
structural roles in the fibrous sheath.
Finally, a defect in TSGA10 may be one o f the causes o f a known sperm motility 
disease, dysplasia o f the fibrous sheath (DFS). To date all studies have failed to identify 
problems with any FS known genes or proteins (e.g. AKAP4) in this disease. Common 
characteristics o f this disease include marked disorganization o f the FS as well as 
distortion o f the microtubule doublet and axonemal (Chemes et al., 1987).
It is thought that, complete formation o f the fibrous sheath occurs near the end o f  
spermiogenesis in mouse (Sakai et al., 1986) and rat (Irons and Clermont, 1982), and it 
is after the appearance o f the axonemal ribs and concurrent with the AKAP4 
incorporation into the FS (Miki et al., 2002). DFS might be caused by a mutation in a 
gene affecting FS formation rather than in the AKAP4 gene, in DFS there are 
disorganised, thickened FS; (Turner et al., 2001). Therefore, because o f the gene 
expression pattern and localisation o f the protein, mutations in the TSGA10 could result 
in DFS aethiology.
Usher syndrome, is an autosomally inherited subtype o f ‘retinitis pigmentosa’ and is 
characterised by infertility, retinal degeneration and congenital deafness. It is possible 
that mutations o f the TSGA10 gene might cause a form of Usher syndrome (type IB) 
since defects in a myosin molecule (Vila) are known to cause this disease (Gibson et al, 
1995; Hasson et al, 1995; Weil et al, 1995).
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7.4.2 O ther functions of TsgalO in the sperm tail
Apart from the localisation o f the TsgalO protein in the fibrous sheath, it is possible that 
TsgalO may play a role in mitosis. This function has been proposed for Odf2 protein 
(Nakagawa et. al, 2001) as well. It seems the pathway by intracellular cAMP that 
activates PKA may play a fundamental role here via AKAP family members in sperm; 
Odf2 is co-localized with P-tubulin (Nakagawa et al, 2001): tubulin is identified as a 
binding partner o f  an AKAP (AKAP84/AKAP121), that binds and target protein kinase 
A (PKA) to the outer mitochondrial membrane. It concentrates on mitochondria in 
interphase and on mitotic spindles during M phase (Cardone et al, 2002). S- 
AKAP84/AKAP121 complexes localize signalling enzymes to mitochondrial and 
cytoskletal components in sperm (Cardone et al, 2002). So, the FS complex o f  
TSGA10/Odf2/Tsgal0ip may play a similar role in sperm mitochondria outer 
membranes via the mitochondrial Cyt Cl protein: TSGA10 has predicted porin activity 
(Gene Ontology, Ensembl) in mitochondrial outer membrane and I have shown that it 
interacts with Cyt C l. A proteolytic activity in the TsgalO complex might possibly 
mediate assembly and degradation processes o f membrane protein complexes and 
thereby exert a key function in the maintenance o f mitochondrial membrane integrity 
such as other mitochondrial members o f ATP dependent metallopeptidases (AAA) 
family (Arlt et al., 1996). Similarly a membrane-embedded metallopeptidase, Omal, as 
a quality control system component (including a proteolytic ATP-dependent AAA 
protease) is known to maintain the inner membrane o f mitochondria by removal o f  
misfolded membrane proteins (Kaser et al., 2003).
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Protein kinase C (PKC) and an inositol dephosphorylation enzyme (Inositol 
polyphosphate-4-phosphatase type I, that participates in cell growth downstream of  
transcription factor GATA-1 and catalyzes the hydrolysis o f the 4-position phosphate o f 
phosphatidylinositol 3 -PI3-) are encoded by genes which lay within 300-400 kb o f 
TsgalO. It has been shown that PKC is upregulated specifically during the spermatid 
stage o f  spermatogenesis (Um et al., 1995). It has been recently shown that inhibition o f  
PKC signal transduction results in an activation o f  matrix metallopeptidase (Woo et al.,
2004). So TSGA10 protein (which has similarity to membrane-bound 
metallopeptidases), may be a candidate for playing a role in the PKC pathway during 
spermatogenesis. PKC and phosphatidylinositol 3-kinase (PI3-kinase) are associated 
with development and hyperactivation o f  sperm motility (via Ras). After thrombin 
activation, the 4-phosphatase is translocated to the actin cytoskeleton along with PI 3- 
kinase, which requires both integrin engagement and aggregation (Munday et al., 1999). 
Meanwhile a considerable fraction o f PKC is associated with PI3-kinase and Ras in 
cauda sperm plasma membrane. Also, activation o f PI3-kinase by GTP-Ras can activate 
PKC as a potential signal transduction pathway in spermatozoa (NagDas et al., 2002); 
then PKC phosphorylate flagellar proteins (such as TsgalO with its high number o f  
phosphorylation sites) on serine and threonine residues or activate other signalling 
elements to function in the regulation o f sperm motility.
TsgalO has about fifty potential phosphorylation kinase sites including nineteen for 
PKC, and nine for PKB, which is also most widely associated with the PI3K signalling 
pathway (Vanhaesebroeck and Alessi 2000). The TsgalO protein may play a role in 
polarising the sperm tail in a pathway via PI3-K (Haugh et al., 2000). TsgalO has a
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similarity to microtubule binding protein D-CLIP-190 (cytoplasmic linker protein 190 
and/or its mouse homologue [CLIP-170]). The distribution o f CZ/P-associated proteins 
(CLASPs) is mediated by PI3-kinase. CLIP-170 and CLIP-115 contain two 
microtubule-binding domains. Microtubules are essential for chromosome segregation 
in mitosis and for organelle movement and positioning in interphase cells (Akhmanova 
et al., 2001). Hereby, TsgalO similarities to mitotic checkpoint protein and to 
chromosome segregation domain are interesting. Most o f the CLASPs are involved in 
the regulation o f microtubule dynamics, represented by the hippocampus cDNA clones 
(in consistent with our immunostaining results) and mainly detected in the region o f the 
Golgi complex. All o f these findings suggest TsgalO protein as a candidate member o f  
trans-Golgi CLASPs.
Coordination o f sperm motility requires the interaction o f the cytoskeletal filament 
systems in the sperm tail. In addition, these systems are involved in the transport o f 
cellular components in the cell. Interestingly, a molecule that mediates coordination 
between the actin and microtubule cytoskeletons is a homologue o f cytoplasmic linker 
protein (CLIP)-170 that interacts with a class VI unconventional (95F) myosin. 
Consistent with our findings, it is shown that this unconventional myosin and D-CLIP- 
190 are coexpressed in a number o f tissues during embryogenesis and axonal process of 
neurons in Drosophila (Lantz and Miller, 1998). TsgalO is similar to both myosin and a 
homologue o f  microtubule-binding protein, and these two proteins are associated with 
the nervous system and the posterior pole o f Drosophila embryo, where both 
microtubule and actin dependent processes are known to be important. TSGA10 may 
link the actin and microtubule cytoskeletons (dynein in sperm). This hypothesis is
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reinforced in sperm by the evidence that CLIP-170 is a member o f a protein family that 
includes DP-150Glued, which is known to be a part o f a large complex, dynactin. The 
dynactin complex stimulates dynein-mediated motility o f vesicles in vitro (Schroer, 
1996). An interaction is reported (by Ensembl) between Cep 135 (a coiled-coiled 
centrosome protein which shows 45% homology to TSGA10) and dynein/dynactin 
complex. While centrosomes ensure fidelity o f chromosome segregation during mitosis 
by guiding microtubule nucleation towards the formation o f a bipolar spindle, this 
Cepl35/dynein complex is shown to be necessary in assembly and maintenance o f both 
microtubule and centrosome functionalities (Uetake et al., 2004) where TsgalO may 
play a role. Also similar to TsgalO overexpression in the cell, a pattern o f filamentous 
polymers induced by Cep 135 overexpression is seen (Ryu et al., 2000).
Spag4 is another ODF-interacting spermatid-specific protein localized to two 
microtubule-containing spermatid structures; to the manchette and to the axoneme in 
elongating spermatids and epididymal sperm (Shao et al., 1999). Like TSGA10, SPAG4 
is expressed in testis and pancreas as well as being upregulated in a wide range o f  
neoplastic tissues (Kennedy et al., 2003). The similarity between the localisation o f  
TsgalO and Spag4, and the interaction o f both with ‘outer dense fibres’ (Odf) proteins 
proteins suggest that TSGA10 may be another component o f the manchette.
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7.4.3 Further evidence for role in m icrotubules
By consideration of dimerized HLH domain o f TsgalO protein, its possible role in 
microtubule movement regulation in sperm tail while interacting with Odf2 (which is 
colocalized with P-tubulin), TsgalO dimer walking along microtubule filaments such as 
kinesin (Hoenger et al., 2000) can be proposed. That is why similarly, kinesin is shown 
with two motor domains and the alpha-helical neck forming a coiled-coil (Sack et al., 
1997; Kozielski et al., 1997) to walk on the tubulin protofilament towards the plus-end 
of microtubules (right side o f figure 7.4.1).
Figure 7.4.1- Kinesin; A candidate model for TsgalO protein function. The motor domains attach to 
successive beta-tubulin subunits and the two heads move in a non-equivalent fashion in order to avoid 
twisting the stalk. alpha-Tubulin is pale blue, beta-Tubulin is pale green. The upper (C-terminal) part of 
the coiled-coil neck is shown to be permanently connected since it has a high coiled-coil potential, similar 
to a leucine zipper. The lower part o f  the neck is shown to open and close reversibly in order to allow the 
heads to detach, move, and reattach. This is coupled to a reorientation o f the linker region (yellow) 
between the neck helix and the motor domain. The picture is from the web site: http://www.mpasmb- 
hamburg.mpg.de/ktdock.
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Finally a dual microtubule-based and actin-based motor protein has already been 
suggested to mobilize vesicle cargos by intramanchette transport in developing 
spermatids (Kierszenbaum et al., 2003). TsgalO protein may give a good description for 
the reason o f these two transport systems or a link between them.
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7.5 TsgalO protein expression in tissues other than sperm
From the IHC studies I have shown that TsgalO is expressed in a range of tissues in the 
embryo. It is possible that the gene is involved in patterning morphogenetic change in 
the vertebrate embryo. Its role could be in events occurring at the embryonic cell 
surface that involve cell migration, signaling and probably adhesion. There is some 
variance in the expression o f the two forms o f  TSGA10 (namely the N Terminus and 
the C-Terminus), whereby in some cases it appeared that both the N  terminus and the C- 
terminus were being expressed which suggests that the protein is present in its whole 
form and has not been post-translationally modified. In other instances only one 
terminus was being expressed, the differential expression o f the termini is nicely 
illustrated in figure 4.3C o f mature rat testis where the N-terminus is clearly only being 
expressed in the sperm midpiece, whereas the C-terminus is being expressed in all germ 
line cells. In these cases the protein has been post translationally modified into a 
smaller 27kDa protein. It is likely that the different forms o f the protein have specific 
roles with the roles linked to dividing or differentiating cells.
TsgalO protein expression in the primordia o f vibrissae follicles is reminiscent o f a 
similar pattern o f expression o f some proteins in testis and the olfactory system. For 
example, such ‘pheromone receptors’ are expressed in the accessory olfactory organs as 
well as spermatids and have an important role in sperm maturation and/or migration 
(Tatsura et al., 2001). In both cases this may reflect a connection with the presence o f  
cilia.
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7.6 The role of the TsgalO protein in neurogenesis, cell cycle 
regulation and cancer
Neurogenesis: the mammalian hippocampus is a highly plastic brain structure in which 
new neurons are generated throughout adulthood (Jessberger and Kempermann, 2003). 
The mechanical problem o f accommodating the dividing neurons has been overcome by 
the discovery that neural stem cells exist throughout life in the adult brain and can 
renew and give rise to new neurons, astrocytes, and oligodendrocytes, just as in the 
developing brain. This was first shown from the subventricular zone (Reynolds and 
Weiss, 1992; Richards et al., 1992) and then in the dentate gyrus o f the hippocampus 
(Gage et al., 1995; Palmer et al., 1997), and in most structures o f the brain examined 
(Palmer et al., 1995; Shihabuddin et al., 2000), even where no neurons existed (Palmer 
et al., 1999; Kondo and Raff, 2000).
TsgalO protein is localized in some part o f embryonic and mature brain where it may 
be involved either in the process o f axonal transport (synaptogenesis) during 
embryogenesis or glia cells (active neurogenesis). Interestingly the cilium is seen within 
the astrocytes as well as in the brain (named as ependymal dynein). Actin 
rearrangement is crucial in axonal transport and synaptogenesis via PKC pathway while 
PKC expression level in brain newborn mice is elevated (Peters et al., 1999) indicating 
its role in brain development. Also, protein kinase C (PKC) plays an important role in 
neurogenesis and synaptogenesis in particular in some parts that need axonal transport 
while PKC activation is triggered by contact o f astrocytes via actin rearrangement 
(Hama et al., 2004). It is shown that D-AKAP1 colocalizes with a PKA subunit at the 
postsynaptic membrane o f the vertebrate neuromuscular junction (but not in the
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presynaptic region) (Perkins et al., 2001). Astrocytes participate actively in 
synaptogenesis, and adult neurogenesis occurs in two regions o f the adult brain: 
subventricular zone (SVZ) and the hippocampus subgranular zone (Hama et al., 2004) 
(exactly where we got the signals o f TsgalO expression). In parallel, it is well shown 
that myosin regulatory interacting protein (MIR, a member o f ERM protein family) is 
localized specifically to neurons in cerebellum and hippocampus (Olsson et al., 2000). 
Mature hippocampus astrocytes regulate neurogenesis by instructing stem cells to adopt 
a neural fate. TsgalO may play a role in this common pathway (because o f its similarity 
to myosin domain) based on its expression in the part o f brain with active 
synaptogenesis and neurogenesis.
Other areas o f current project consist o f the mechanisms o f neural crest cell migration 
because o f TsgalO expression in some components o f it including melanocyte, 
pancreatic islet cell, intestinal mucosa, primordial vibrassea follicles (Nosrat et al.,
2004) and brain (cranial neural crest cells). TsgalO expression in intestinal mucosa from 
E l5 to newborn is compatible with the time when submucosal ganglia are first detected 
around E l5.5 (Jiang et al., 2003).
The expression o f  a gene that is expressed predominantly in the testis and in the mature 
rat brain is at first thought puzzling, as it was previously thought that cell division is 
very rare in the adult brain. However, recent research supports the idea o f select pockets 
o f continually dividing cells in the adult brain (A. Alvarez-Buylla et al 2001). This 
would explain the correlation as to why so many testis specific genes are also expressed 
in the brain. (I.A. Muslimov et al 2002, S. Suzu et al 2002, J.Dalmau et al 1999). The 
cell types that are widely accepted as continually dividing in the adult brain are granular
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cells (found in the cerebellum and hippocampus) and glial cells (found throughout the 
central nervous system especially in the cortex). Our results showed that TSGA10 is 
being expressed strongly in certain areas o f the cerebellum and hippocampus as well as 
being weaklier expressed in the cortex. The signals in the cortex have a striated pattern, 
which reflects the morphology o f glial cells (G.W. Kreutzberg 1996). Only the N- 
terminus is expressed in the cortex and hippocampus whereas the N- and C-terminus 
were both expressed in the cerebellum. It is possible that this differential pattern o f  
TSGA10 expression in the cerebellum could be due to a different morphology o f the 
cell types expressing the protein, thus they could be using TSGA10 for alternative 
purposes. Only certain layers o f the cerebellum expressed TSGA10, namely the 
granular layer and the white matter both o f which contain continually dividing cells. In 
the hippocampus there were certain distinct areas that did not express TSGA10. The 
areas where there was no staining in the hippocampus correlated with the areas where 
pyramidal neurons were found. Pyramidal neurons were also found in the areas in the 
cerebellum where TSGA10 was not being expressed.
There was staining in the cortex, which was apparent throughout the white matter and 
was most likely also from glial cells. Glial cells divide throughout adulthood and are 
first present in the foetal cortex towards the end o f development. The presence o f 
staining in the foetal cortex o f E l5.5 embryos is further evidence that support the 
hypothesis that it is glial cells that are expressing TSGA10 in the adult cortex. There 
was a striking difference in the staining between certain areas. For example the corpus 
collosum (the neural tract which joins the left and right cortical hemispheres) and 
fimbria are clearly unstained in contrast to the other areas o f cortex. Consistent with this
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finding, the presence o f  TsgalO N-terminus within the glia nuclei, and TsgalO-C- 
terminus in perinuclear region, may mean the whole TsgalO protein (without any 
cleavage) is localized in a structure adjacent to nuclear membrane but after processing, 
its N-terminus enters the astrocytes nuclei. Considering the perinuclear localization (by 
IF and subcellular localization using GFP construct) o f the TsgalO protein, and its 
homology to a centrosomal protein 4cep 135’, TsgalO is most likely a protein which is 
associated with the centrosome as a microtubule organizing structure in flagellae or 
related to Golgi apparatus.
As described earlier, Gene Ontology predicts that TsgalO may be a 4porin\ Evidence in 
appoint o f  this hypothesis might be found from the fact that TsgalO binds to 4Cyt C l’, 
and that TsgalO is a component o f 4voltage-dependent anion-selective channel’ proteins 
(VDACs). Interestingly, VDACs form pores in the outer mitochondrial membrane of 
eukaryotes as well as in brain postsynaptic membranes (Al-jamal 2004) and 
Cytochrome C is a component o f the isolated VDAC complex (Vyssokikh et al, 2004). 
Recently, a correlation between overexpression o f 4 Glial cell line-derived neurotrophic 
factor’ (GDNF), RET (GDNF receptor) and testicular seminoma is confirmed. Also, 
GDNF expression is increased during testis development and peaks on postnatal day 7 
in rat testis (Devouassoux-Shisheboran et al., 2003) as well as it is identified as a 
candidate regulator o f  germinal stem cell (GSC) proliferation and differentiation 
(Ymogida et al., 2003; Tadokoro et al., 2002). GDNF signal transducing receptor 
complex is composed o f  RET (Rearranged during Transfection) receptor tyrosine kinase 
and a glycosylphosphatidylinositol-linked co-receptor, GFR <* 1 (Saarma & Sariola 
1999). GDNF is expressed in Sertoli cells while its receptors (RET and GFRal) in
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spermatogonia (Meng et al., 2000). We show TSGA10 protein expression specifically 
in glial cells o f brain and in neural crest originated cells o f embryos.
Cell cycle regulation and cancer- Additionally, GDNF and its receptors (RET, GFRa 
1) are expressed in sperm as well as primordial o f vibrassea follicles (Nosrat et al., 
2004) while RET proto-oncogene is known as a neural crest marker (Tanaka et al., 
2004). Alternatively, TsgalO expression in vibrassea follicles may be described by the 
fact that hair follicles have been recently shown to be local reservoirs o f skin mast cell 
precursors (Kumamoto et al., 2003). There are evidences for RET and c-kit proto­
oncogenes collaboration in the tumours with neural crest origin (Kato et al., 2004). The 
c-kit receptor tyrosine kinase belongs to PDGF/CSF-l/c-kit receptor subfamily. The 
proto-oncogene C-KIT encodes a tyrosine kinase receptor for SCF (Stem Cell Factor) 
and expressed in PGC (Primordial Germ Cells) (Devouassoux-Shisheboran et al., 
2003). The coincidence o f sites o f expressions o f TSGA10 and o f GDNF and its 
receptors suggests that TSGA10 could be a component in an unclear pathway 
(involving GDNF, RET/GFRal and C-KIT), which spermatogonia enter for maturation 
and differentiation. Interestingly, in the context o f TsgalO expression in the tissues with 
neural crest origin, apart from some ESTs from pancreatic islet cells in BLAST for 
TsgalO, F U 32880  is shown to be expressed in pancreas as well as spermatid cells. 
Modarressi (and co-aouthors 2001; 2004) have shown expression o f TSGA10 in tumour 
cells. This is confirmed and extended in this thesis (chapters 3 section 3.6 and chapter 4 
section 4.3.3) where I have shown TsgalO expression in premyeloid leukemia and the 
protein expression in human germ cell tumour. In addition Tanaka (et al., 2004)
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detected TsgalO protein as a testis-cancer tumour marker in some cancers including 
hepatocellular carcinoma and melanoma. However, it is not clear why TSGA10 is 
expressed in these tumours.
Hypothetically, all the cells that express TSGA10 (astrocytoma, acute myeloid 
leukemia, germ cell tumour, primordia o f vibrassea follicles, malignant melanoma and 
others) originate from a common tissue they are either among totipotential germ cell or 
pluripotential stem cells or neural crest origin. Interestingly, TsgalO protein expression 
is shown in primary cultures o f neural crest cells (NCC) o f 8-day mouse embryos by 
IHC (personal communication with Aldamaria Puliti, Universita di Pisa, Italy).
TsgalO expression in the embryonic brain and its localization in the perinuclear 
membrane, bearing in mind the similarity o f TsgalO to membrane-bound 
metallopeptidase while being expressed in some cancers may raise the possibility o f a 
role for TsgalO in number o f processes such as axonal transport during brain 
development via Rho-ROCK-ERM axis (described in section 7.4.1), as well as a 
function in the cell membrane to afford spatial regulation o f Rho family GTPase 
signaling through ERM proteins during metastasis as has been recently shown for the 
LyGDI protein (Ota et al., 2004). The possibility o f a role for TsgalO in metastasis is 
reinforced by its similarity to ERM (and PKC-matrix metalloproteinase interaction 
described formerly), as it is shown that degradation o f extracellular matrix mediated by 
matrix metalloproteinases (MMPs) is necessary during tumor invasion and metastasis 
(Stetler-Stevenson 2001). ADAMs (A Disintegrin And Metalloprotease) -  a newly 
described family o f proteins- have important roles in adhesion and migration o f cranial 
neural crest cells, the latter o f  which give rise to a number o f  important structures in the
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head (Alfandari et al., 2001). Similarly, ‘integrins’ are a large family o f transmembrane 
receptors that bind to components o f the extracellular matrix (ECM) and to other cell 
surface receptors. One o f  the most significant features o f integrins is that they serve as 
transmembrane links between ECM molecules and the actin cytoskeleton. Integrins 
have been shown to participate in both outside-in and inside-out signaling events that 
influence cell adhesion, cytoskeletal organization, and gene expression (Marsden et al., 
2003; Davidson et al., 2002; Smith et al., 2002).
There is some other evidence for a parallel expression o f TSGA10 and c-kit proto­
oncogene as well. In melanogenesis, c-kit is expressed in melanoblasts from the time 
they leave the neural crest and expression continues during embryonic development and 
in the melanocytes o f postnatal animals (Besmer et al., 1993). The kit-ligand, KL, also 
called steel factor, is synthesised from two alternatively spliced mRNAs as 
transmembrane proteins that can either be proteolytically cleaved to produce soluble 
forms o f KL or function as cell-associated molecules. SCF/c-kit is involved in different 
functions in the testis, including cell adhesion, cellular proliferation, PGC migration and 
anti-apoptotic actions. Studies in white spotting and steel mice have shown that 
functional SCF and c-kit are critical in the survival and development o f stem cells 
involved in hematopoiesis, pigmentation and reproduction (review, Linnekin, 1999). 
Downstream o f c-kit, multiple signal transduction components are activated, such as the 
Ras-Raf-MAP kinase cascade, which is one o f the important signalling cascades in 
tumourigenesis and cell division. There is some circumstantial evidence supporting the 
TSGA10 link to c-kit:
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a) Similarity o f  the site for phosphorylation by the tyrosine kinase in c-kit to 
one o f TSGA10 predicted protein sites (ENST00000288135).
TSGA10 phosphorylation predicted sites:
Name Pos Context Score Pred
Sequence 43 MLEKYERHL 0.711 *Y*
Sequence 653 RRQNYSSNA 0.655 *Y*
Sequence 658 SSNAYHMSS 0.701 *Y*
Sequence 695 ENLCYRDF- 0.487 . 
c-kit phosphorylation predicted sites:
2 EVTNYSLKG
3 VKRAYHRLC
b) TSGA10 is expressed in melanocytes (EST accession no. N33757).
c) Expression o f both proto-oncogene c-kit in a broad spectrum o f human 
cancers (Matsuda et a l., 1993) and TSGA10 in at least six different tumours (three from 
EST database and others by using RT-PCR and immunohistochemistry).
d) Both are expressed in spermatocytes (although c-kit expressed elsewhere
too).
TsgalO is introduced as a mitotic spindle checkpoint protein in yeast and higher 
eukaryotic probably via Madl, Mad2, Mad3, Bub3 and Cdc20 complex by gene 
ontology survey in BLAST
(http://www.ensembl.org/Homo_sapiens/geneview?gene=ENSG00000135951). In 
agreement to it, MAPK member proteins family encoded by the genes in neighbouring 
of both TsgalO and Tsgaip (F U 32880) genes have been found; ‘mitogen-activated
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protein kinase kinase kinase kinase 4’ in neighbouring TsgalO and ‘mitogen-activated 
protein kinase kinase kinase 3’ just downstream to TsgalOip (Ilq l3 .1-q l3 .3). Again 
bioinformatically, an-eight aminoacid identity to mitogen activating protein kinase 
(MAP kinase kinase kinase (kinase3) sequence (ESEIQLLK) in TsgalO C-terminus is 
found, which is highly conserved in ESTs originating from tissues including: whole eye 
embryo, four-cell-Embryo, normal thyroid, male adrenal gland, newborn kidney, 
blastocyst, 7.5-dpc whole embryo, tumors and infiltrating ductal carcinoma. 
Considering above facts and TsgalO (and TsgalOip) protein expression in hipoccampal 
neurons and our hypothesis o f TsgalO role in Rho-ROCK-ERM axis (described 
previously), TsgalO/TSGAlO is more likely to be a member o f MAPK family (most 
probably JNK subgroup among its four known -ERK, p38, JNK, ERK5- subfamily) that 
regulates the signaling via scaffolding mechanism (Tanoue and Nishida, 2002, 2003). 
That’s why, it is shown that JNK-interacting protein family members (JIP1, JIP2 and 
JIP3) are well-known scaffold proteins which are required for stress-induced activation 
o f JNK in hippocampal neurons via interaction with the kinesin light chain that has a 
role in axonal cargoes (Whitmarsh et al., 2001; Verhey et al., 2001). Also they are 
reported to associate with RhoGEF (Meyer et al., 1999; Stockinger et al., 2000). Also, it 
is shown that ‘tumour suppressor RASSF1A’ plays a critical role in mitotic progression 
and tumor suppression by controlling APC-Cdc20 activity.
TsgalO may play an active role in the cell cycle via Raf kinases. It is shown that Raf 
kinase inhibitory protein inhibits beta-cell proliferation (Zhang et al., 2004) while 
TsgalO is expressed strongly in pancreatic islet cells. Generally, tubulin (which is 
colocalized with Odf2) glutamylation is shown to be an important posttranslational
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modification in microtubule interaction with structural and motor microtubule- 
associated proteins (MAPs) in brain and axonemes. More specifically it is shown that 
tubulin glutamylation can be involved in the regulation o f the intracellular traffic 
including chromosomes and in the regulation o f ciliary and flagellar motility (Kann et 
al., 2003).
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7.7 TsgalO and cilia
Different types o f  cilia including ‘ependymal’ cilia in the brain, ‘respiratory’ cilia in 
lung epithelium, ‘nodal’ cilia in testis (sperm tail) and embryo, ‘renal’ cilia and 
‘connecting cilia’ are known. The results o f the experiments in this project point to the 
presence o f  TsgalO protein wherever there is a flagellum or a cilium. TsgalO is 
expressed in sperm tail, olfactory and lung epithelium (which have cilia), some parts of 
brain (most likely these containing glia cells), astrocytes (which have cilia), and 
embryo. Afzelius proposed the presence o f ciliary beating in the embryo in 1974 for the 
first time. It has been recently shown that localized dynein in E7.5 node (in the pole of 
embryo) is the source o f  nodal flow which in turn is necessary for left/right asymmetry 
during embryogenesis (Ibanez-Tallon et al., 2003, 2004). The nodal flow is leftward, 
situs solitus and if  rightward situs inversus. Also it is shown that the ventral cells o f the 
embryo node are a monociliated nonproliferative layer that can induce the second axis 
o f nodal flow which is necessary for left/right assembly. They then make the embryonal 
groove o f  neural crest with contribution o f dorsal ectodermal proliferative cells 
(Schneider and Brueckner 2000). The pattern o f TsgalO protein expression and 
localization during embryogenesis (in the parts which originated from neural crest) as 
well as in neural crest derived cells reinforce the hypothesis o f  TsgalO role in (embryo) 
nodal cilia. PKD-2 (as a motif o f TsgalO) which is a cation channel required for normal 
left/right development, localizes to this embryo monocilia node (Barr et al., 2001), is 
colocalized with a-tubulin (Portmann and Emmons 2004), and plays a role in flow- 
induced Ca2+ signalling (Kaletta et al., 2003). In this project TsgalO expression is 
shown in olfactory epithelium which contains cilia microtubule organization and any
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disruption in this structure results in anosmia (Kulaga et al., 2004). Also the time of 
TsgalO expression in early development (sometime between 4.5 and 7.5 dpc) is 
comparable to Dnah5, which its role in left/right assembly and its specific time o f  
expression (E7.5) is confirmed (Olbrich et al., 2002). Mutations in mouse Dnah5fDnah5 
cause primary ciliary dyskinesia. This gene is expressed in ependymal cells from which 
the ependymal flow originates. Ependymal flow is necessary for the aqueduct not to be 
closed; its closure results in hydrocephalus. Nephronophthisis proteins (NPHP1, 
NPHP2, NPHP3, NPHP4 and NPHP5) are members o f a protein family o f cilia in which 
‘nodal’ expression during embryogenesis has been shown (Olbrich et al., 2003). NPHP1 
is mapped in 2ql3 in the region o f TSGA10- and is necessary for cerebella development 
(TsgalO is also expressed in cerebellum) (Parisi et al., 2004) and is colocalized with 
kinesin (personal communication). Problems in cilia structure may result in some 
diseases including primary ciliary dyskinesia. Clinical manifestations o f  this disease are 
hydrocephalus, retinitis pigmentosa, infertility and respiratory infection. The pattern o f  
TsgalO expression is consistent with all o f the tissues involved in this disease.
It would be interesting to examine patients with this disease for aberrant expression o f  
TSGA10. Also it would be interesting to study the roles o f cilia in sperm, both in normal 
conditions and the pathological consequences caused by their dysfunction. Sperm cilia 
can be considered as required components for assembly, ion transport, providing energy 
source and motility. It will be interesting to study whether sperm cilia are the sites o f  
the initial events o f sperm signal transduction, and to study the activity o f ciliary 
adenylate cyclases (ACs) (in particular the effects o f calcium concentration). Also it is 
interesting to find the proteins, which may have a role for directional movement inside
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the female reproductive tract and are part o f a complex or a signalling pathway involved 
in directional cues necessary for recognition and entry into the female storage organs.
To check TsgalO and other sperm tail (fibrous sheath) proteins for phosphorylation by 
activated PKA via intracellular cAMP (and being a member o f AKAPs family) as well 
as their possible porin activity will be interesting. Also possible subcellular 
colocalization o f centrosome (less likely Golgi) and micrortubule-associated TsgalO, 
TsgalOip (and AKAPs) as well as their specificity for anchoring protein containing 
tethering domains for RI & RJI-alpha could be nice to understand other proteins' 
possible role in the PKA phosphorylation pathway (also by kinase A activity o f  
transfected cells and/or an assay for cations/anions o f cells environment or western 
blot). TsgalO (with its KVXF motif through which type I phosphatase interacts) could 
be recognized by PP1-targeting subunits such as AKAP350. It is also interesting to note 
the homology o f TsgalO to microtubule interacting protein in Drosophila and the 
neighbouring MAP2. Also, it is logical to study flagellar function by finding out which 
components o f  the Rho signaling pathway (rhophilin and ropporin) are associated with 
the fibrous sheath (and AKAPs) as scaffolds for signal transduction proteins. For 
example both TsgalO and TsgalOip as FS proteins (and possible AKAPs) have PDZ 
domains (rhophilin is an adaptor for it) in the site o f its possible cleavage. I am 
interested to find out more sperm tail proteins which play a role in Ras(/Raf) GTPase 
Rho kinase pathway. Better understanding this pathway in sperm flagellar, can lead us 
to understand better the biological process(es) o f cancer metastasis since sperm could be 
the most motile (metastatic! because it is close to undifferentiated germ line as well) 
normal cell in the body.
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Conclusion
In conclusion, there is strong evidence that TsgalO has a significant role in the 
development and function o f the sperm tail. This role may be both as a structural 
component o f the flagellum, and perhaps also in terms o f protein trafficking and energy 
production. We know that the transcript is absent in two patients with non-obstructive 
infertility, and it would be logical to think that TsgalO may be mutated or deleted in 
case o f infertility involving lack o f sperm motility such as dysplasia o f fibrous sheath.
There seem to be consistent findings o f TsgalO expression in dividing cells, 
both in embryogenesis, and in adult dividing cells such as astrocytes. In these cases the 
Tsgalo protein may be functioning as a component o f microtubules and/or manchette 
assembly.
Over-expression o f  TsgalO in cancer cells mimics the expression pattern o f a 
number o f  other genes (e.g. AKAPs) that are expressed in sperm and are over-expressed 
in some tumours. These so-called cancer-testis antigens can be indicators o f the 
prognosis o f these tumours, and may be useful target antigens for immunotherapy.
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Appendix A: Sequences, alignments and sequences analysis
The sequences of the inserts that encodes activating protein via AD with TsgalO 
bait construct in yeast two hybrid assay
A1
CGTGGGCGGGGGGAATTGTGGACACAAAGAGAGTACGCATTAACCGCGGGGATAGCGCTTG
CTAGTCCGCCAGAGCATACATGAATACGTAGATAACTGCAAAAACACACACGCCAAGTAAA
AAAGCCTACTTCTTTATTAAGCAAAGTGTGTAAAGGTTGCCATAAAGGACAAACAAGTGAA
GTATTTTATCCATTACAGTGGCTGGAATAAAAATTGGGATGAATGGGTGCCAGAAAGCAGA
GTGCTCAAATACGTGGACGCCAATTTGCAGAAACAGCGGGAACTTCAAAAGGCCAACCAGG
AACAATATGCAGAGGGCAAGATGAGAGGGGCTGCTCCAGGGAAGAAGACATCCGGTCTGC
AACAGAAAAATGTTGAAGTGAAAACAAAAAAGAACAAACAGAAAACACCTGGAAACGGAG
ATGGTGGCAGTACCAGTGAGACCCCTCAGCCTCCTAGGAAGAAGCGAGCCCGGGTAGATCC
AACCGTTGAAAATGAAGAAACATTCATGAACAGAGTTGAAGTTAAAGTGAAGATTCCTGAG
GAGCTGAAACCATGGCTTGTAGATGACTGGGACTTGATCACCAGACAAAAGCAGCTTTTTTA
TCTACCTGCCAAGAAGAATGTGGATTCCATATTGGAGGATTATGCAAACTATAAGAAGTCTC
GAGGAAATACAGATAATAAGGAGTATGCTGTTAATGAGGTTGTGGCAGGGATAAAGGAGTA
CTTCAATGTAATGTCGGGGCACTCAGCTACTCTACAAAATATGAGAGACCACAGNATGCTGA
AATTTCTGGCCGATCACCCGGGATGCACCCCATGTTCCCAGGGTGTATTGGAAGCGCCCACA
CTTAACCTGAGAAATTGTTTTG
A ’6
GGGAGGGGTTGACAAAAGAGATCGAATTACCCGGGGATCCGTCGATCCTGCAGAGATCTAT
GAATCGTAGATACTGAAAAACCCCGCCAAGTAACACAAGCGTGGAGGTCCAGGATGGCCCT
AATGAGGATGGGAATATGTTCATGCGGCCAGGGAAGCTGTCTGACTATTTTCCAAAACCATA
CCCCAACCCTGAGGCTGCAAGAGCTGCTAACAATGGAGCTTTACCCCCTGACCTCAGCTACA
TCGTTCGAGCAAGGCACGGTGGTGAGGACTATGTGTTTTCCTTGCTCACTGGCTACTGTGAA
CCTCCCACTGGGGTGTCATTGCGAGAAGGCCTCTATTTCAACCCTTACTTTCCTGGCCAGGCC
ATTGGCATGGACTCCTCCCATCTACACAGAAGTCTTGGAGTATGACGATGGTACCCCAGCTA
CCATGTCACAAGTAGCCAAGGATGTTGCCACCTTCCTTCGCTGGGCATCAGAGCCAGAGCAT
GACCATCGAAAACGCATGGGACTCAAGATGTAGTTGATGATGGGCTTGCTGCTGCCCCTGAC
CTATGCCATGAAGCGGCATAAGTGGTCAGTCCTGAAGAGTCGAAAGCTGGCTTATCGGCCA
CCCAAGTGACCCTGTTCAGTATCTGCTTGTCATCTTGCCTGAACAAGCTCTCAGCAGACCAG
GAACAGTCCGAGGGCCTTTCAGGCCTGGCCCCCTTTTCATCAGATACCAGGGGCCAGGGAG
ACCAGACTCTGGCCTTCTGATCCTCCCTTAGCCCTTCATTGTGGAATTAANTAGGTTCTCAAA
CAAAAAAAAAAAAGTCACCGCGAATTTTGATTGTTATCGGAACCCAAGTAAAAAAAAA
304
Appendices
F2
AGGNTTACAAAAAGAGATCGAATACCAGTGTGACGAATTCACCGGTGAATTCGTCACCTGG
GCTGGAGAAAAACCTGGCGACGGCGGCACGGAACCTGGAGGCCCTGGAGGACGACCTGGA
CTTCCTGCGGGACCAGTTCACCACCACGGAAGTCAACATGGCGCGCGTTTACAACTGGGACG
TGAAGCGCAGGAACCGGGACGATGGCGGCGCCGCCAAGAGCAAAGCGTGAGGGCGCCGAC
CACTGCGCTCGCCCGCCCGATGTCCGTCTCACGCCTGAACATTAATGTATAGCTCACCGGTTT
AATGTATATCACACCCGATTTGrmTCCCTCCCTCCCCTCCCAACCCCACCTTTTTTCTTTAC
AACTGGAGAAATGATTGTTTTCTTTCAAGAAAAACCACAGTGGATTCATCTACATTAAAAAG
TACTCTGAATAAATCACCTATACCTAGAGTGACAATTGCCAACCAAATGCCTAATAAAATAT
ATNCTTGAGCCC
F3
GTTNAACAAAAGAGATCGAATTACCAGTGTGACGAATTCACCAAGACAGCGTCTGAGCTCT
CCAAGTCCATGGAGTCCATGCGGGGGCATTTGCAGGCACAGCTTCGCTGCAAAGAGGCTGA
GAACAGCCGCCTGTGCATGCAGATCAAGAATTTAGAGCGCAGTGGGAACCAGCACAAGGCG
GAAGTAGAGGCCATCATGGAGCAGCTAAAGGAACTGAAGCAAAAGGGAGACCGAGACAAA
GAGACCCTGAAGAAGGCCATCCGAGCCCAGAAGGAGCGAGCTGAGAAGAGTGAGGAGTAT
GCCGAGCAGCTACATGTGCAGCTGGCCGACAAGGACCTTTATGTTGCTGAAGCTTTATCTAC
TCTGGAGTCATGGAGGAGCCGTTACAACCAAGTTGTGAAAGACAAAGGAGACCTTGAGTTG
GAGATCATTGTCCTAAATGACCGGGTGACAGATCTTGTAAACCAACAACAGAGCTTGGAGG
AGAAGATGCGGGAAGACCGGGACAGCTTGGTAGAGAGACTGCACCGGCAAACTGCTGAGT
ATTCTGCCTTCAAGCTAGAGAACGAGAGGCTCAAGGCTAGCTTTGCCCCTATGGAGGACAA
GCTCATTCAAGCTCCCTTGGAGGTCCAGCACTGAAAGCTTCATGANAACTACAAGGGATATC
CACACCTCAACCAGTATAACAATTGAGCGACAATTTGTTTTTCATAACCCCACNAAACAATC
F5
AAATTGCCAGTGTGACGAATTGCACCCCCAGAGGTGAAATGCAGGAGAAGAAGCAGTAGAG
GACTGTACTCCATCGAAGTGTCTGGAACTTTTCTGACAGCCAGAGACAGTCTTACTGGCTGT
CCTAGAACTGGATATATAGACCAAGCTGGCCTCAAACTCACAGAGATCCAACCCAGAGCAC
TGCGATTAAAGGTGTGGCCACCACACCTGGCTTAATGGATTTTTTTATATGAATGTACCTGTT
CATCCAGGGGAGAAAGTATTGTTTGTATCCATCTCAGTGTCCAGAGAGGAGTGTGAGTACTC
TGCACCATCACATACCACCATTCCTCAGTGCTACGGGTTCCACAGACATCACTTCTGGGTTG
CAGACATCACTGGAAGAATGTTACAAACCTTTTAAACATGGAATTGAGTTGATTTTAAGTAA
ACTTATTTGTGTACTGAAAAAAACCTGCAGAGATCTATGAATCGTAGATACTGAAAAACCCC
GCAAGTAAACAAAAA
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LI
AANAAATGCAAAAAGAGATCGAATGCCAGATGTGACGAATTCTCCGGTGAATCGTCACACT
GGAATTCCCGGGGATCCGTCGACCTGCAGAGATCTATGAATCGTAGATACTGAAAAACCCC
GCAAGTACACAACA
L3
GGGGTTACAAAAAGAGATCGAATACCAGGACGAATTCACTCGAGCTGGCAGGTAGGGGTGG
GAGAGGACAACATGCCAATATGCTGAACACTGACCAACTGTTGGTTAGGGCCATATCGGAG
AGACCAAGGAAGAGCACAGAGCCCTTGGTTCCAGGGACACCTACAGGACTGTTCAGCCTTC
TATCAAACATCTCTCCGGAGGAGCAGGGCCGCCTTGGGAGCGGAGACAGTCTCCAGAGTCA
GAGCTGCCAGCAGCAAAGGTCTTACAGCGCAGGGCAGACAACAAAGAAAGAACGAAAACC
CCGGAGGCGCAACAAGAAAGGACGTGGCTCAGCTGAGGCAGAGGATCTCTTCAGTTCACCT
CGGAAGCCTTCCTTCCCTTTCCAGTGGGCCTGGGAGAGCTTCATCATAGATGGCCAGGCTCT
GCTTCAGTCAGGCTCCTCTGTGGCCGTGGGCCATCGATCCTTGCTCTTCCCTTCAGCAGCCCC
CCAGTGCAAGACCAGGCACAAGTCAGTAGCCAACCTCTCAGAAGACCTTCGAGCCTGCCAC
AAGTCGGAAGTGCAAAACCTGGGAAGGAGATATCAGCCTGGGGCCTGGGCCAACCTTTCCC
TGCCTCTGGGCAAGGCTGAGAGCTATTGGCTATATCGACCCACCTTCTGGGTCAACAGGGAA
TTGGTCATTGGTCTTAGTGTGATGATGTCTCAGAGGTAGAAGGCCAGAATGCTGACCAGGCT
AATATATGTCTCAGCACTGGGGAACTGACCAGCTCCGAGGGCTAGGGTTGATCTTGGATGAT
GATTTGATCTCCAAGGTTATTGAGGAGGATGAACCCTTCCCGACAAAGGGCCATTTGTGTNC
TTGGTATGAmTGTAAAAACGCCCAAATATTGTGTACCTTCCACTCCTTTGTGGAGGGGCTC
CCCCCCTTCTCNAATTTAAGG
S3
ACTNACAAAAAGAGATCGAAtTACCAGGACGAATTCACCTAGCTGGCAGGTAGGGGTGGGA
GAGGACAACATGCCAATATGCTGAACACTGACCAACTGTTGGTTAGGGCCATATCGGAGAG
ACCAAGGAAGAGCACAGAGCCCTTGGTTCCAGGGACACCTACAGGACTGTTCAGCCTTCTAT
CAAACATCTCTCCGGAGGAGCAGGGCCGCCTTGGGAGCGGAGACAGTCTCCAGAGTCAGAG
CTGCCAGCAGCAAAGGTCTTACAGCGCAGGGCAGACAACAAAGAAAGAACGAAAACCCCG
GAGGCGCAACAAGAAAGGACGTGGCTCAGCTGAGGCAGAGGATCTCTTCAGTTCACCTCGG
AAGCCTTCCTTCCCTTTCCAGTGGGCCTGGGAGAGCTTCATCATAGATGGCCAGGCTCTGCTT
CAGTCAGGCTCCTCTGTGGCCGTGGGCCATCGATCCTTGCTCTTCCCTTCAGCAGCCCCCCAG
TGCAAGACCAGGCACAAGTCAGTAGCCAACCTCTCAGAAGACCTTCGAGCCTGCCACAAGT
CGGAAGTGCAAAACCTGGGAAGGAGATATCAGCCTGGGGCCTGGGCCAACCTTTCCCTGCC
TCTGGGCAAGGCTGAGAGCCAAGGGCTAGAGCGACCCACCTTCTGGTCAACAGGGAAAGGG
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TCAGGGTCAGAGTGTGAGGATGTCTCAGAGGTAGAAGGCCAGAATGCTGACGAGGCTgAGG
AAAAGTCTCACCACTGGGGAACTGcCCCAGCTCCCAGGGCAGGGTTGACCTGGAGGAGAGT
GATCTCGAGGTATGAGAGAGACCAACGGAAAAGCACTTTTCCCAGGAGGATTTGAAAAGGC
AAAAA
U14
GGGGGTGTGAAACAAAAGGAGGATGCAATACCGCGGGGATCGATTGTACCGCCAGAGGAT
ACTGATGAATCGTCAGATACTGAAAAACACCCGGCGACGCTAAAGAAGCGGGAAGATGGG
GAACCACAGACCAAGCAGCTCAGAGAAGAGGAAGAGGAAGTTGGGAAGCACAGGGGCCTC
AGGCTTCGGAACTATGTCCCAGAGGATGAAGACCTGAAGAGGAGGCGGGTTCCCCAGGCCA
AACCAGTTGCAGTGGAAGAGAAGGTGAAGGAGCAGCTGGAGGCTGCCAAGCCAGAGCCTG
TCATAGAGGAAGTGGACCTGGCCAACCTGGCACCCCGGAAACCCGATTGGGATCTCAAGAG
AGATGTGGCTAAGATTTCTAGAGAAGTTAGAAAAGCGGACCCAGAGAGCCATTGCAGAGCT
GATCCGTGAACGGCTAAAAGGGCAGGAAGACAACCTGGCCTCTGCAGTGGACGCCACCACC
GGACAAGAGGCTTGTGACTCTGACTGAGATGTCTTCTGAGTCCCACCTGTTCAGAACACTCA
TCCTGGGGGAGGATAGTCTCAGCAGGGATGGGGTTAGACTGGCTAGCACTTCTGGGTCTTGA
GAACCGAGCCAACCCACTGAGTCTCAGCTTCTGTGGGCTGTGACCAGTTCATCTCCCAAGGG
TGCCCACCCCCTGAGTGGGTCGAAGCTGAGATCTGTACATATGTATGTTAACGGAGCCTTTT
AACCTTT AGAAATAACCTCC ATTTAGT AGAGAAAAAAAAAAAAAAAAAGGTGGACCTGGCG
GAGATCTTTGGANTCTGTAATTCCTGGAAAACCCCCGCAGTACCCAAAGAAA
Y1
TGACAAAAAGAGATCGAATTGCCAGTGTGACGAATTCTACCCCAGGGCTGGCGCGCGGATG
AAAAATGGCGAAATGGTGGGTAGCCGGTGGGAAACCTGACGGGATGGGGCGCGGAGGTGG
CACTGTCGTGGGAGCCTGCTGAGGTGAGCGCAGCTGACCTGGCGACCTCGGGCCGGCGCCT
GACAGCAGACACGGACTCCGAGGGTCGCCGAGGGCCCCGCCGAGAGCCGGAGGCAATGGA
TGAGCAGAGTGTGGAGAGCATTGCTGAGGTTTTCCGATGCTTCATTTGTATGGAGAAATTGC
GGGATGCCCGACTGTGTCCTCACTGCTCCAAGCTCTGTTGTTTCAGCTGTATTAGGCGCTGGC
TGACAGAGCAGAGAGCTCAGTGTCCTCATTGTCGTGCTCCACTCCAGCTACGGGAACTTGTA
AATTGTCGCTGGGCGGAAGAGGTGACACAGCAGCTGGATACTCTCCAGCTGTGTAGTCTCAC
CAAACATGAAGAAAATGAGACAGACAAATGTGAGAATCACCATGAAGAACTTAGTGTGTGT
TGCTGGACTTGTAAGACGTGTATCTGCCATCAGTGTGCACTTTGGGGAGGAATGCATGGTGG
ACACACGTTTAAACCTTTGGCAGAAATCTATGAACAGCATGTCACTAAAGTGAACGAAGAG
GTAGCTAAACTTCGTCGACCTGCAGAGATCTATGATTCGTAGATACTGAATACCCGATTACC
ACAAAGAAAAAA
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TsgalO amino acid sequence showing exons/introns boundaries, the exon 16 
(underlined) and two halves of TsgalO (N,C-termini) which were used in Yeast two 
hybrid. An 18-aa is common in both halves (labeled in green).
MM RNRSKSPRRPSPTSRAANCDVELLKSTARDREELKCMLEKYERHLAEIQGNVKVLTSE
RDKTFLLYEQAQEEIARLRREMMKSCKSPKSTTAHAILRRVETERDVAFTDLRRMTTERD
SLRERLKIAQETAFNEKAHLEQRIEELECTVHNLDDERMEQMANMTLMKETITTVEKEMK
SLARKAMDTESELGRQKAENNSLRLLYENTEKDLSDTQRHLAKKKYELQLTQEKIMCLDE
KIDNFTRQ NIAQ REEISILG ATLNDLAK EK ECLQ ACLDK K SENIASLG ESLAM K EK TISG
M K NIIAEM EQASRQSTEALIM CEQDISRM R
R Q LD ETND ELG Q IARERD
ILAHENDNLQEQFAKVKQENQALSKKLNDTHNELSDIKQKVQDTNLEVNKLKNILKSEESE
NRQIMEQLRKANEDAENWENKARQTEAENNTLKLELITAEAEGNRLKEKVDALNREVEQHL
NAERSYKSQIATLHKSLVKM EEELQKVQFEKVSALADLSSTRELCIKLDSSKELLNRQLVA
KDQEIEM M ENELDSARSEIELLRSQM TNERISM QNLEALLVANRDKEYQSQIALQEKESEI
QLLKEHLCLAENKMAIQSRDVAQFRNW TQLEADLDITKRQLGTERFERERAVQELRRQNY
SSNAYNLGPM KPNTKCHSPERAHHRSPDRGLDRSLEENLCYRDF
N ucleotide an d  deduced  am ino  acid sequences o f m ouse TsgalO. Number of 
nucleotide and amino acid are shown on each line. The complete (and alternative 
splicing isoforms) sequences of TsgalO has been deposited in GenBank under 
Accession No. A F530050. Exon 16 is completely spliced out and underlined (Acc. No. 
A Y 618264). TsgalO contains EZR/myosin, ATPase dependent seggeregation and 
metallopeptidase domains (Shaded). Myosin Class II/ERM (Ezrin/Radixin/Moesin) domain 
(aa # 34-648) ‘ESEIQLLKE’ is a MapKKK m otif A T P a se  d ep en d en t c h ro m o so m e  segreg a tio n  
d o m a in  (aa  # 131-493) Membrane bound metallopeptidase domain (aa # 318-578)
a n a g a c a g a a a t t a t t a t a a a a c t a a a a c t c a a a a t t t a a q a a a a a tq a tq a q a a a ta g a
A D R D Y Y K T E A Q N L R K M M R N R
t c t a a g a g t c c g a g a c g c c c a t c g c c a a c t t c c c g g g c t g c a a a c t g tg a tg t a g a g c t t
S K S P R R P S P T S R A A N C D V E L
t t g a a g t c a a c t g c a a g a g a c c g t g a a g a g c t a a a g t g t a t g c t g g a a a a a t a t g a a c g t  
L K S T A R D R E E L K C M L E K Y E R  
c a t t t g g c a g a a a t c c a g g g c a a c g t c a a g g t t c t c a c a t c t g a g a g a g a c a a g a c c t t c  
H L A E I  Q G  N V K V L T S E R D K T F  
c t c c t t t a t g a g c a g g c a c a g g a a g a a a t t g c t c g a c t t c g a c g a g a a a t g a t g a a a a g c  
L L Y E Q A Q E E I A R L R R E M M K S  
t g t a a g t c t c c t a a g t c a a c c a c a g c a c a t g c t a t t c t t c g t c g g g t a g a g a c g g a g a g a  
C K S  P K S T T A H A I L R R V E T E R  
g a t g t a g c c t t c a c t g a c c t a c g a a g a a t g a c c a c a g a g c g a g a c a g t c t g a g a g a a a g g  
D V A F T  D L R R M T T E R D S L R E R  
c t c a a g a t t g c t c a a g a g a c a g c g t t c a a c g a g a a g g c t c a c t t g g a a c a g c g g a t a g a g  
L K I A Q E T A F N E K A H L E Q R I E
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g a g c t g g a g t g c a c a g t t c a c a a c c t t g a t g a t g a g c g c a t g g a a c a g a t g g c a a a c a t g  
E L E C T V H N L D D E R M E Q M A N M  
a c t t t g a t g a a g g a a a c c a t a a c c a c t g t g g a a a a a g a a a t g a a a t c a t t a g c a a g a a a g  
T L M K E T I T T V E K E M K S L A R K  
g c a a t g g a c a c c g a g a g t g a g c t t g g c a g a c a a a a a g c a g a g a a t a a t t c t t t g a g a c t t  
A M D T E S E L G R Q K A E N N S L R L  
t t a t a t g a a a a c a c a g a a a a a g a t c t c t c t g a t a c t c a g c g a c a t c t t g c t a a g a a a a a a  
L Y E N T E K D L S  D T Q R H L A K K K  
t a t g a g c t a c a g c t t a c t c a g g a g a a a a t t a t g t g c t t g g a t g a a a a a a t t g a t a a t t t c  
Y E L Q L T Q E K I M C L D E K I D N F  
a c g a g g c a a a a t a t t g c a c a g c g a g a a g a a a t c a g c a t t c t t g g t g c a a c c c t c a a t g a c  
T R Q N I A Q R E E I S I L G A T L N D  
c t g g c t a a a g a a a a g g a a t g c c t g c a a g c g t g t c t g g a t a a a a a g t c t g a g a a c a t t g c a  
L A K E K E C L Q A C L D K K S E N I A  
t c c c t t g g c g a g a g c t t g g c a a t g a a a g a a a a a a c c a t t t c a g g c a t g a a g a a t a t c a t t  
S L G E S L A M K E K T I S G M K N I  I  
g c t g a g a t g g a a c a g g c a t c a a g a c a g t c t a c t g a a g c c c t c a t t a t g t g c g a a c a a g a t  
A E M E Q A S R Q S T E A L I M C E Q D  
a t t t c c a g g a t g c g c c g g c a g t t g g a c g a g a c a a a t g a t g a g c t g g g t c a g a t t g c c a g g  
I  S R M R R Q L D E T N D E L G Q I A R  
g a g a g a g a t a t c t t g g c t c a t g a g a a t g a c a a t c t t c a a g a a c a g t t t g c c a a a g t c a a a  
E R D  I  L A H E N  D N L Q E Q F A K V K  
c a a g a a a a c c a g g c a c t g t c c a a a a a a c t g a a t g a t a c t c a t a a c g a a c t c a g t g a c a t a  
Q E N Q A L S K K L N D T H N E L S D I  
a a g c a g a a g g t c c a g g a c a c g a a t c t g g a g g t t a a c a a g t t g a a g a a c a t a t t a a a g t c t  
K Q K V Q D T N L E V N K L K N I L K S  
g a g g a a t c t g a g a a c c g g c a a a t a a t g g a a c a a c t c c g a a a a g c c a a t g a a g a t g c t g a a  
E E S E N R Q I M E Q L R K A N E D A E  
a a c t g g g a a a a t a a g g c c c g c c a g a c a g a g g c a g a a a a c a a c a c c c t c a a a c t g g a a c t t  
N W E N K A R Q T E A E N N T L K L E L  
a t c a c t g c t g a a g c a g a g g g c a a c a g a t t a a a g g a a a a a g t t g a t g c c c t t a a c a g a g a g  
I T A E A E G N R L K E K V D A L N R E  
g t t g a q c a a c a c c t a a a c g c a g a g c g c t c t t a c a a a t c c c a q a t t g c a a c t t t a c a c a a g  
V E Q H L N A E R S Y K S Q I A T L H K  
t c t c t t q t q a a q a t q q a q q a q q a q c t t c a q a a q q t t c a q t t t q a q a a q q t q t c t q c t c t c  
S L  V K M E E E L Q K V Q F E K V S A L  
q c a q a t t t q t c t t c c a c a a q q q a a c t c t q c a t a a a a c t c q a c t c a a q c a a a q a a c t t c t t  
A D L S S T R E L C I K L D S S K E L L  
a a t c q a c a q c t q q t t q c c a a a q a t c a q q a a a t a q a a a t q a t q q a q a a t q a q c t q q a c t c a  
N R Q L V A K D Q E I E M M E N E L D S  
g c g c g c t c t g a a a t t g a a c t g c t c c g g a g t c a g a t g a c a a a c g a g a g g a t c t c c a t g c a g  
A R S E I E L L R S Q M T N E R I S M Q  
a a t c t c g a g g c t c t g c t g g t g g c c a a c c g g g a c a a a g a g t a c c a g t c t c a g a t a g c a c t g  
N L E A L L V A N R D K E Y Q S Q I A L  
c a q q a a a a q q a q t c t q a q a t c c a q t t q c t q a a q q a q c a c c t c t q c c t q q c t q a q a a c a a a  
Q E K E  S E  I  Q L L K E H L C L A E N K  
a t g g c c a t c c a g a g c a g a g a c g t g g c a c a g t t c a g a a a t g t t g t a a c g c a g t t a g a a g c a  
M A I Q S R D V A Q F R N V V T Q L E A  
g a t t t g g a c a t t a c c a a a a g g c a a c t c g g g a c a g a a c g t t t t g a a a g g g a a a g g g c t g t c  
D L D I  T K R Q L G T E R F E R E R A V  
c a a g a a c t t c g c c g c c a g a a t t a c t c a a g c a a t g c c t a t a a t t t g g g t c c a a t g a a g c c a  
Q E L R R Q N Y S S N A Y N L G P M K P  
a a t a c a a a a t g c c a c t c a c c a g a g c g t g c t c a c c a t c g a t c t c c t g a c c g a g g c c t c g a c  
N T K C H S P E R A H H R S P D R G L D  
c g a t c a t t g g a a g a g a a t c t t t g c t a t a g a g a t t t c t g a c a t g t g a a a a g a t t c t c c a c a  
R S L E E N L C Y R D F -
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Alignment of mouse TsealO nucleotide sequence
NM_2 0 7 2 2 8  ( 1 )------------------------- GCGCCGGACGGAAGTGGAGCGTAGGCGCCGGGGAGGTGGAAGAAGAGCCC
B C 0 6 6 7 8 2  ( 1 )------------------------- GCGCCGGACGGAAGTGGAGCGTAGGCGCCGGGGAGGTGGAAGAAGAGCCC
A F 5 3 0 0 5 0  ( 1 )-------------------------------------------------------------------------------------------------------------------------------------------------
A K 0 3 0 2 5 4  ( 1 2 8 )  t c g c t a c g t g c t c g c t c g g g t g c g c g c g c a c g a t c c g t a g t c t c c g c g a g a g g g c g t g t c
NM _2 0 7 2 2 8  ( 5 1 )  CGCTCAGGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTTTCTGAAGCTGG
B C 0 6 6 7 8 2  ( 5 1 )  CGCTCAGGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTTTCTGAAGCTGG
A F 5 3 0 0 5 0  ( 1 )----------------GGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTTTCTGAAGCTGG
A K 0 3 0 2 5 4  ( 1 8 8 )  gagaCAGGTTAACACCAAAGAACATCAGTTTGGTCTTGGGGCTCCAGTTTCTGAAGCTGG
NM_2 0 7 2 2 8  ( 1 1 1 )  AAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGATAGATTCATCTC
B C 0 6 6 7 8 2  ( 1 1 1 )  AAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGATAGATTCATCTC
A F 5 3 0 0 5 0  ( 5 5 )  AAGAAACCAGAATACTTTCCAACTAGAACAAGAAGTGAGAACCCAAGATAGATTCATCTC
A K 0 3 0 2 5 4  ( 2 4 8 )  AAGAAAC C AG AAT AC T T T C C AAC T AG AAC AAG AAGT G AGAAC C C AAG AT AG ATT C AT C T C
+ + + + + + + + + +  + + + + + + + + + + + + + + + + + + . + +  + + + + + + + + + + + + + + + + + + + + + + +
N M _ 2 0 7 2 2 8  ( 1 7 1 )  TACACTGAAA-TTACAGATTGAAGATCTCAAACAGACAAATCATGACTTGGAAGAATATG
B C 0 6 6 7 8 2  ( 1 7 1 )  TACACTGAAA-TTACAGATTGAAGATCTCAAACAGACAAATCATGACTTGGAAGAATATG
A F 5 3 0 0 5 0  ( 1 1 5 )  TACACTGAAAtTTACAGATTGAAGATCTCAAACAGACAAATCATGACTTGGAAGAATATG
A K 0 3 0 2 5 4  ( 3 0 8 )  TACACTGAAA-TTACAGATTGAAGATCTC-AAACAGAAAATCATGACTTGGAAGAATATG
NM_2 0 7 2 2 8  ( 2 3 0 )  TTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGACTTAGCCAACC
B C 0 6 6 7 8 2  ( 2 3 0 )  TTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGACTTAGCCAACC
A F 5 3 0 0 5 0  ( 1 7 5 )  TTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGACTTAGCCAACC
A K 0 3 0 2 5 4  ( 3 6 6 )  TTAGGAAACTCTTGGATAGTAAAGAGGCGGTAAGCACTCAAGTAGATGACTTAGCCAACC
N M _ 2 0 7 2 2 8  ( 2 9 0 )  ACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACTAGCAGAGAAATTACAAA
B C 0 6 6 7 8 2  ( 2  9 0 )  ACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACTAGCAGAGAAATTACAAA
A F 5 3 0 0 5 0  ( 2 3 5 )  ACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACATGCAGAGAAATTACAAA
A K 0 3 0 2 5 4  ( 4 2  6 )  ACAATGAGCACCTTTGTAAAGAGTTGATTAAACTTGACCAACTAGCAGAGAAATTACAAA
N M _ 2 0 7 2 2 8  ( 3 5 0 )  AAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGCAAAGATTGAAC
B C 0 6 6 7 8 2  ( 3 5 0 )  AAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGCAAAGATTGAAC
A F 5 3 0 0 5 0  ( 2  9 5 )  AAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGCAAAGATTGAAC
A K 0 3 0 2 5 4  ( 4 8 6 )  AAGAAAAAAATTTTGTGGTGGACACTGCCGACAAGGAACTTGAAGAAGCAAAGATTGAAC
N M _ 2 0 7 2 2 8  ( 4 1 0 )  TCATTTGCCAGCAAAATAATATAACAGTATTAGAAGATACAATCCAAAGGCTTAAGTCCA
B C 0 6 6 7 8 2  ( 4 1 0 )  TCATTTGCCAGCAAAATAATATAACAGTATTAGAAGATACAATCCAAAGGCTTAAGTCCA
A F 5 3 0 0 5 0  ( 3 5 5 )  TCATTTGCCAGCAAAATAATATAACAGTATTAGAAGATACAATCCAAAGGCTTAAGTCTA
A K 0 3 0 2 5 4  ( 5 4 6 )  TCATTTGCCAGCAAAATAATATAACAGTATTAGAAGATACAATCCAAAGGCTTAAGTCCA
NM_2 0 7 2 2 8  ( 4 7 0 )  TAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGATTCCTTTGTCA
B C 0 6 6 7 8 2  ( 4 7 0 )  TAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGATTCCTTTGTCA
A F 5 3 0 0 5 0  ( 4 1 5 )  TAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGATTCCTTTGTCA
A K 0 3 0 2 5 4  ( 6 0 6 )  TAATTTTAGAGACTGAAAAGGCACAAAATACATCTCCTTCTAGACTGGATTCCTTTGTCA
N M _ 2 0 7 2 2 8  ( 5 3 0 )  AGACTTTAGAAGCAGACAGAGATTATTATAAGACTGAAGCTCAG  AATTTAAGAAAAA
B C 0 6 6 7 8 2  ( 5 3 0 )  AGACTTTAGAAGCAGACAGAGATTATTATAAGACTGAAGCTCAG AATTTAAGAAAAA
A F 5 3 0 0 5 0  ( 4 7 5 )  A G A C T T T A G A A G C A G A C A G A G A T T A g tta ta a g a a c tg a a g ctca g a A T T T A A G A A A A A A
A K 0 3 0 2 5 4  ( 6 6 6 )  AGACTTTAGAAGCAGACAGAGATTATTATAAGACTGAAGCTCAG AATTTAAGAAAAA
N M _ 2 0 7 2 2 8  ( 5 8 7 )  TGATGAGAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCGGGCTGCAAACT
B C 0 6 6 7 8 2  ( 5 8 7 )  TGATGAGAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCGGGCTGCAAACT
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A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
5 3 5 )  TGATGAGAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCGGGCTGCAAACT 
7 2 3 )  TGATGAGAAATAGATCTAAGAGTCCGAGACGCCCATCGCCAACTTCCCGGGCTGCAAACT
N M _ 2 0 7 2 2 8  ( 6 4 7 )  GTGATGTAGAGCTTTTGAAGTCAACTGCAAGAGACCGTGAAGAGCTAAAGTGTATGCTGG
B C 0 6 6 7 8 2  ( 6 4 7 )  GTGATGTAGAGCTTTTGAAGTCAACTGCAAGAGACCGTGAAGAGCTAAAGTGTATGCTGG
A F 5 3 0 0 5 0  ( 5 9 5 )  GTGATGTAGAGCTTTTGAAGTCAACTGCAAGAGACCGTGAAGAGCTAAAGTGTATGCTGG
A K 0 3 0 2 5 4  ( 7 8 3 )  GTGATGTAGAGCTTTTGAAGTCAACTGCAAGAGACCGTGAAGAGCTAAAGTGTATGCTGG
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
7 0 7 )  AAAAATATGAACGTCATTTGGCAGAAATCCAGGGCAACGTCAAGGTTCTCACATCTGAGA 
7 0 7 )  AAAAATATGAACGTCATTTGGCAGAAATCCAGGGCAACGTCAAGGTTCTCACATCTGAGA 
6 5 5 )  AAAAATATGAACGTCATTTGGCAGAAATCCAGGGCAACGTCAAGGTTCTCACATCTGAGA 
8 4 3 )  AAAAATATGAACGTCATTTGGCAGAAATCCAGGGCAACGTCAAGGTTCTCACATCTGAGA
N M _ 2 0 7 2 2 8  ( 7 6 7 )  GAGACAAGACCTTCCTCCTTTATGAGCAGGCACAGGAAGAAATTGCTCGACTTCGACGAG
B C 0 6 6 7 8 2  ( 7 6 7 )  GAGACAAGACCTTCCTCCTTTATGAGCAGGCACAGGAAGAAATTGCTCGACTTCGACGAG
A F 5 3 0 0 5 0  ( 7 1 5 )  GAGACAAGACCTTCCTCCTTTATGAGCAGGCACAGGAAGAAATTGCTCGACTTCGACGAG
A K 0 3 0 2 5 4  ( 9 0 3 )  GAGACAAGACCTTCCTCCTTTATGAGCAGGCACAGGAAGAAATTGCTCGACTTCGACGAG
N M _ 2 0 7 2 2 8  ( 8 2 7 )  AAATGATGAAAAGCTGTAAGTCTCCTAAGTCAACCACAGCACATGCTATTCTTCGTCGGG
B C 0 6 6 7 8 2  ( 8 2 7 )  AAATGATGAAAAGCTGTAAGTCTCCTAAGTCAACCACAGCACATGCTATTCTTCGTCGGG
A F 5 3 0 0 5 0  ( 7 7 5 )  AAATGATGAAAAGCTGTAAGTCTCCTAAGTCAACCACAGCACATGCTATTCTTCGTCGGG
A K 0 3 0 2 5 4  ( 9 6 3 )  AAATGATGAAAAGCTGTAAGTCTCCTAAGTCAACCACAGCACATGCTATTCTTCGTCGGG
N M _ 2 0 7 2 2 8  ( 8 8 7 )  TAGAGACGGAGAGAGATGTAGCCTTCACTGACCTACGAAGAATGACCACAGAGCGAGACA
B C 0 6 6 7 8 2  ( 8 8 7 )  TAGAGACGGAGAGAGATGTAGCCTTCACTGACCTACGAAGAATGACCACAGAGCGAGACA
A F 5 3 0 0 5 0  ( 8 3 5 )  TAGAGACGGAGAGAGATGTAGCCTTCACTGACCTACGAAGAATGACCACAGAGCGAGACA
A K 0 3 0 2 5 4  ( 1 0 2 3 )  TAGAGACGGAGAGAGATGTAGCCTTCACTGACCTACGAAGAATGACCACAGAGCGAGACA
N M _ 2 0 7 2 2 8  ( 9 4 7 )  GTCTGAGAGAAAGGCTCAAGATTGCTCAAGAGACAGCGTTCAACGAGAAGGCTCACTTGG
B C 0 6 6 7 8 2  ( 9 4 7 )  GTCTGAGAGAAAGGCTCAAGATTGCTCAAGAGACAGCGTTCAACGAGAAGGCTCACTTGG
A F 5 3 0 0 5 0  ( 8 9 5 )  GTCTGAGAGAAAGGCTCAAGATTGCTCAAGAGACAGCGTTCAACGAGAAGGCTCACTTGG
A K 0 3 0 2 5 4  ( 1 0 8 3 )  GTCTGAGAGAAAGGCTCAAGATTGCTCAAGAGACAGCGTTCAACGAGAAGGCTCACTTGG
NM_2 0 7 2 2 8  ( 1 0 0 7 )  AACAGCGGATAGAGGAGCTGGAGTGCACAGTTCACAACCTTGATGATGAGCGCATGGAAC
B C 0 6 6 7 8 2  ( 1 0 0 7 )  AACAGCGGATAGAGGAGCTGGAGTGCACAGTTCACAACCTTGATGATGAGCGCATGGAAC
A F 5 3 0 0 5 0  ( 9 5 5 )  AACAGCGGATAGAGGAGCTGGAGTGCACAGTTCACAACCTTGATGATGAGCGCATGGAAC
A K 0 3 0 2 5 4  ( 1 1 4 3 )  AACAGC GGATAGAGGAGCT GGAGT GCACAGTT CACAACCTT GAT GAT GAGCGCAT GGAAC
N M _ 2 0 7 2 2 8  ( 1 0 6 7 )  AGATGGCAAACATGACTTTGATGAAGGAAACCATAACCACTGTGGAAAAAGAAATGAAAT
B C 0 6 6 7 8 2  ( 1 0 6 7 )  AGATGGCAAACATGACTTTGATGAAGGAAACCATAACCACTGTGGAAAAAGAAATGAAAT
A F 5 3 0 0 5 0  ( 1 0 1 5 )  AGATGGCAAACATGACTTTGATGAAGGAAACCATAACCACTGTGGAAAAAGAAATGAAAT
A K 0 3 0 2 5 4  ( 1 2 0 3 )  A GAT GGC AAAC AT GACT TT GATGAAGGAAACC AT AACC ACT GT GGAAAAAGAAAT GAAAT
N M _ 2 0 7 2 2 8  ( 1 1 2 7 )  C ATT AGCAAGAAAGGCAAT GGACAC C GAGAGT GAGCTT GGCAGACAAAAAGCAGAGAATA
B C 0 6 6 7 8 2  ( 1 1 2 7 )  CATTAGCAAGAAAGGCAATGGACACCGAGAGTGAGCTTGGCAGACAAAAAGCAGAGAATA
A F 5 3 0 0 5 0  ( 1 0 7 5 )  CATTAGCAAGAAAGGCAATGGACACCGAGAGTGAGCTTGGCAGACAAAAAGCAGAGAATA
A K 0 3 0 2 5 4  ( 1 2 6 3 )  CATTAGCAAGAAAGGCAATGGACACCGAGAGTGAGCTTGGCAGACGAAAAGCAGAGAATA
N M _ 2 0 7 2 2 8  ( 1 1 8 7 )  ATTCTTTGAGACTTTTATATGAAAACACAGAAAAAGATCTCTCTGATACTCAGCGACATC
B C 0 6 6 7 8 2  ( 1 1 8 7 )  ATTCTTTGAGACTTTTATATGAAAACACAGAAAAAGATCTCTCTGATACTCAGCGACATC
A F 5 3 0 0 5 0  ( 1 1 3 5 )  ATTCTTTGAGACTTTTATATGAAAACACAGAAAAAGATCTTTCTGATACTCAGCGACATC
A K 0 3 0 2 5 4  ( 1 3 2 3 )  ATTCTTTGAGACTTTTATATGAAAACACAGAAAAAGATCTCTCTGATACTCAGCGACATC
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
1 2 4 7 )  TTGCTAAGAAAAAATATGAGCTACAGCTTACTCAGGAGAAAATTATGTGCTTGGATGAAA 
1 2 4 7 )  TTGCTAAGAAAAAATATGAGCTACAGCTTACTCAGGAGAAAATTATGTGCTTGGATGAAA
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A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
( 1 1 9 5 )  TTGCTAAGAAAAAATATGAGCTACAGCTTACTCAGGAGAAAATTATGTGCTTGGATGAAA
( 1 3 8 3 )  TTGCTAAGAAAAAATATGAGCTACAGCTTACTCAGGAGAAAATTATGTGCTTGGATGAAA
NM _2 0 7 2 2 8  ( 1 3 0 7 )  AAATTGATAATTTCACGAGGCAAAATATTGCACAGCGAGAAGAAATCAGCATTCTTGGTG
B C 0 6 6 7 8 2  ( 1 3 0 7 )  AAATTGATAATTTCACGAGGCAAAATATTGCACAGCGAGAAGAAATCAGCATTCTTGGTG
A F 5 3 0 0 5 0  ( 1 2 5 5 )  AAATTGATAATTTCACGAGGCAAAATATTGCACAGCGAGAAGAAATCAGCATTCTTGGTG
A K 0 3 0 2 5 4  ( 1 4 4 3 )  AAATTGATAATTTCACGAGGCAAAATATTGCACAGCGAGAAGAAATCAGCATTCTTGGTG
NM_2 0 7 2 2 8  ( 1 3 6 7 )  CAACCCTCAATGACCTGGCTAAAGAAAAGGAATGCCTGCAAGCGTGTCTGGATAAAAAGT
B C 0 6 6 7 8 2  ( 1 3 6 7 )  CAACCCTCAATGACCTGGCTAAAGAAAAGGAATGCCTGCAAGCGTGTCTGGATAAAAAGT
A F 5 3 0 0 5 0  ( 1 3 1 5 )  CAACCCTCAATGACCTGGCTAAAGAAAAGGAATGCCTGCAAGCGTGTCTGGATAAAAAGT
A K 0 3 0 2 5 4  ( 1 5 0 3 )  CAACCCTCAATGACCTGGCTAAAGAAAAGGAATGCCTGCAAGCGTGTCTGGATAAAAAGT
NM _2 0 7 2 2 8  ( 1 4 2 7 )  CTGAGAACATTGCATCCCTTGGCGAGAGCTTGGCAATGAAAGAAAAAACCATTTCAGGCA
B C 0 6 6 7 8 2  ( 1 4 2 7 )  CTGAGAACATTGCATCCCTTGGCGAGAGCTTGGCAATGAAAGAAAAAACCATTTCAGGCA
A F 5 3 0 0 5 0  ( 1 3 7  5 )  CTGAGAACATTGCATCCCTTGGCGAGAGCTTGGCAATGAAAGAAAAAACCATTTCAGGCA
A K 0 3 0 2 5 4  ( 1 5 6 3 )  CTGAGAACATTGCATCCCTTGGCGAGAGCTTGGCAATGAAAGAAAAAACCATTTCAGGCA
,++++++++++
N M _ 2 0 7 2 2 8  ( 1 4 8 7 )  TGAAGAATATCATTGCTGAGATGGAACAGGCATCAAGACAGTCTACTGAAGCCCTCATTA
B C 0 6 6 7 8 2  ( 1 4 8 7 )  TGAAGAATATCATTGCTGAGATGGAACAGGCATCAAGACAGTCTACTGAAGCCCTCATTA
A F 5 3 0 0 5 0  ( 1 4 3 5 )  TGAAGAATATCATTGCTGAGATGGAACAGGCATCAAGACAGTCTACTGAAGCCCTCATTA
A K 0 3 0 2 5 4  ( 1 6 2 3 )  TGAAGAATATCATTGCTGAGATGGAACAGGCATCAAGACAGTCTACTGAGGCCCTCATTA
NM_2 0 7 2 2 8  ( 1 5 4 7 )  TGTGCGAACAAGATATTTCCAGGATGCGCCGGCAGTTGGACGAGACAAATGATGAGCTGG
B C 0 6 6 7 8 2  ( 1 5 4 7 )  TGTGCGAACAAGATATTTCCAGGATGCGCCGGCAGTTGGACGAGACAAATGATGAGCTGG
A F 5 3 0 0 5 0  ( 1 4  9 5 )  TGTGCGAACAAGATATTTCCAGGATGCGCCGGCAGTTGGACGAGACAAATGATGAGCTGG
A K 0 3 0 2 5 4  ( 1 6 8 3 )  TGTGCGAACAAGATATTTCCAGGATGCGCCGGCAGTTGGACGAGACAAATGATGAGCTGG
NM_2 0 7 2 2 8  ( 1 6 0 7 )  GT CAGATT GC CAGGGAGAGAGATAT CTTGGCTCAT GAGAAT GACAAT CTT CAAGAACAGT
B C 0 6 6 7 8 2  ( 1 6 0 7 )  GTCAGATTGCCAGGGAGAGAGATATCTTGGCTCATGAGAATGACAATCTTCAAGAACAGT
A F 5 3 0 0 5 0  ( 1 5 5 5 )  GTCAGATTGCCAGGGAGAGAGATATCTTGGCTCATCAGAATACCAATCTTCAAGAACAGT
A K 0 3 0 2 5 4  ( 1 7 4 3 )  GTCAGATTGCCAGGGAGAGAGATATCTTGGCTCATGAGAATGACAATCTTCAAGAACAGT
NM _2 0 7 2 2 8  ( 1 6 6 7 )  TTGCCAAAGTCAAACAAGAAAACCAGGCACTGTCCAAAAAACTGAATGATACTCATAACG
B C 0 6 6 7 8 2  ( 1 6 6 7 )  TTGCCAAAGTCAAACAAGAAAACCAGGCACTGTCCAAAAAACTGAATGATACTCATAACG
A F 5 3 0 0 5 0  ( 1 6 1 5 )  TTGCCAAAGTCAAACAAGAAAACCAGGCACTGTCCAAAAAACTGAATGATACTCATAACG
A K 0 3 0 2 5 4  ( 1 8 0 3 )  TTGCCAAAGTCAAACAAGAAAACCAGGCACTGTCCAAAAAACTGAATGATACTCATAACG
NM _2 0 7 2 2 8  ( 1 7 2 7 )  AACTCAGTGACATAAAGCAGAAGGTCCAGGACACGAATCTGGAGGTTAACAAGTTGAAGA
B C 0 6 6 7 8 2  ( 1 7 2 7 )  AACT CAGT GACATAAAGCAGAAGGT C CAGGACAC GAAT C T GGAGGTTAACAAGT TGAAGA
A F 5 3 0 0 5 0  ( 1 6 7 5 )  AACT CAGT GACATAAAGCAGAAGGT C CAGGACACGAAT CT GGAGGT TAACAAGTT GAAGA
A K 0 3 0 2 5 4  ( 1 8 6 3 )  AACTCAGTGACATAAAGCAGAAGGTCCAGGACACGAATCTGGAGGTTAACAAGTTGAAGA
N M _ 2 0 7 2 2 8  ( 1 7 8 7 )  ACATATTAAAGTCTGAGGAATCTGAGAACCGGCAAATAATGGAACAACTCCGAAAAGCCA
B C 0 6 6 7 8 2  ( 1 7 8 7 )  ACATATTAAAGTCTGAGGAATCTGAGAACCGGCAAATAATGGAACAACTCCGAAAAGCCA
A F 5 3 0 0 5 0  { 1 7 3 5 )  ACATATTAAAGTCTGAGGAATCTGAGAACCGGCAAATAATGGAACAACTCCGAAAAGCCA
A K 0 3 0 2 5 4  ( 1 9 2 3 )  ACATAT TAAAGT CT GAGGAAT CT GAGAAC C GGCAAATAAT GGAACAACTCC GAAAAGC CA
NM_2 0 7 2 2 8  ( 1 8 4 7 )  ATGAAGATGCTGAAAACTGGGAAAATAAGGCCCGCCAGACAGAGGCAGAAAACAACACCC
B C 0 6 6 7 8 2  ( 1 8 4 7 )  ATGAAGATGCTGAAAACTGGGAAAATAAGGCCCGCCAGACAGAGGCAGAAAACAACACCC
A F 5 3 0 0 5 0  ( 1 7 9 5 )  ATGAAGATGCTGAAAACTGGGAAAATAAGGCCCGCCAGACAGAGGCAGAAAACAACACCC
A K 0 3 0 2 5 4  ( 1 9 8 3 )  ATGAAGATGCTGAAAACTGGGAAAATAAGGCCCGCCAGACAGAGGCAGAAAACAACACCC
NM_2 0 7 2 2 8  ( 1 9 0 7 )  TCAAACTGGAACTTATCACTGCTGAAGCAGAGGGCAACAGATTAAAGGAAAAAGTTGATG
BC 0 6 6 7 8 2  ( 1 9 0 7 )  TCAAACTGGAACTTATCACTGCTGAAGCAGAGGGCAACAGATTAAAGGAAAAAGTTGATG
A F 5 3 0 0 5 0  ( 1 8 5 5 )  TCAAACTGGAACTTATCACTGCTGAAGCAGAGGGCAACAGATTAAAGGAAAAAGTTGATG
A K 0 3 0 2 5 4  ( 2 0 4 3 )  TCAAACTGGAACTTATCACTGCTGAAGCAGAGGGCAACAGATTAAAGGAAAAAGTTGATG
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NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
NM_2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
NM_2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
1 9 6 7
1 9 6 7
1 9 1 5
2 1 0 3
2 0 2 7
2 0 2 7
1 9 7 5
2 1 2 6
2 0 8 7
2 0 8 7
2 0 3 5
2 1 2 6
2 1 4 7
2 1 4 7
2 0 9 5
2 1 2 6
CCCTTAACAGAGAGGTTGAGCAACACCTAAACGCAGAGCGCTCTTACAAATCCCAGATTG 
CCCTTAACAGAGAGGTTGAGCAACACCTAAACGCAGAGCGCTCTTACAAATCCCAGATTG 
CCCTTAACAGAGAGGTTGAGCAACACCTAAACGCAGAGCGCTCTTACAAATCCCAGATTG 
CCCTTAACAGAGAGGTTGAGCAA----------------------------------------------------------------------------------------
CAACTTTACACAAGTCTCTTGTGAAGATGGAGGAGGAGCTTCAGAAGGTTCAGTTTGAGA
CAACTTTACACAAGTCTCTTGTGAAGATGGAGGAGGAGCTTCAGAAGGTTCAGTTTGAGA
CAACTTTACACAAGTCTCTTGTGAAGATGGAGGAGGAGCTTCAGAAGGTTCAGTTTGAGA
AGGTGTCTGCTCTCGCAGATTTGTCTTCCACAAGGGAACTCTGCATAAAACTCGACTCAA
AGGTGTCTGCTCTCGCAGATTTGTCTTCCACAAGGGAACTCTGCATAAAACTCGACTCAA
AGGTGTCTGCTCTCGCAGATTTGTCTTCCACAAGGGAACTCTGCATAAAACTCGACTCAA
 +++++++
GCAAAGAACTTCTTAATCGACAGCTGGTTGCCAAAGATCAGGAAATAGAAATGATGGAGA 
GCAAAGAACTTCTTAATCGACAGCTGGTTGCCAAAGATCAGGAAATAGAAATGATGGAGA 
GCAAAGAACTTCTTAATCGACAGCTGGTTGCCAAAGATCAGGAAATAGAAATGATGGAGA 
-------------------------------------------------------------------------------------------------------------------------------- aTGGAGA
2 2 0 7 )  ATGAGCTGGACTCAGCGCGCTCTGAAATTGAACTGCTCCGGAGTCAGATGACAAACGAGA 
2 2 0 7 )  ATGAGCTGGACTCAGCGCGCTCTGAAATTGAACTGCTCCGGAGTCAGATGACAAACGAGA 
2 1 5 5 )  ATGAGCTGGACTCAGCGCGCTCTGAAATTGAACTGCTCCGGAGTCAGATGACAAACGAGA 
2 1 3 3 )  ATGAGCTGGACTCAGCGCGCTCTGAAATTGAACTGCTCCGGAGTCAGATGACAAACGAGA
2 2 6 7 )  GGATCTCCATGCAGAATCTCGAGGCTCTGCTGGTGGCCAACCGGGACAAAGAGTACCAGT 
2 2 6 7 )  GGATCTCCATGCAGAATCTCGAGGCTCTGCTGGTGGCCAACCGGGACAAAGAGTACCAGT 
2 2 1 5 )  GGATCTCCATGCAGAATCTCGAGGCTCTGCTGGTGGCCAACCGGGACAAAGAGTACCAGT 
2 1 9 3 )  GGATCTCCATGCAGAATCTCGAGGCTCTGCTGGTGGCCAACCGGGACAAAGAGTACCAGT
2 3 2 7 )  CTCAGATAGCACTGCAGGAAAAGGAGTCTGAGATCCAGTTGCTGAAGGAGCACCTCTGCC 
2 3 2 7 )  CTCAGATAGCACTGCAGGAAAAGGAGTCTGAGATCCAGTTGCTGAAGGAGCACCTCTGCC 
2 2 7 5 )  CTCAGATAGCACTGCAGGAAAAGGAGTCTGAGATCCAGTTGCTGAAGGAGCACCTCTGCC 
2 2 5 3 )  CTCAGATAGCACTGCAGGAAAAGGAGTCTGAGATCCAGTTGCTGAAGGAGCACCTCTGCC
2 3 8 7 )  TGGCTGAGAACAAAATGGCCATCCAGAGCAGAGACGTGGCACAGTTCAGAAATGTTGTAA 
2 3 8 7 )  TGGCTGAGAACAAAATGGCCATCCAGAGCAGAGACGTGGCACAGTTCAGAAATGTTGTAA 
2 3 3 5 )  TGGCTGAGAACAAAATGGCCATCCAGAGCAGAGACGTGGCACAGTTCAGAAATGTTGTAA 
2 3 1 3 )  T GGCT GAGAACAAAAT GGC CAT C CAGAGCAGAGACGT GGCACAGTT CAGAAAT GT T GT AA
2 4  4 7 )  CGCAGTTAGAAGCAGATTTGGACATTACCAAAAGGCAACTCGGGACAGAACGTTTTGAAA 
2 4 4 7 )  CGCAGTTAGAAGCAGATTTGGACATTACCAAAAGGCAACTCGGGACAGAACGTTTTGAAA 
2 3 9 5 )  CGCAGTTAGAAGCAGATTTGGACATTACCAAAAGGCAACTCGGGACAGAACGTTTTGAAA 
2 3 7 3 )  CGCAGTTAGAAGCAGATTTGGACATTACCAAAAGGCAACTCGGGACAGAACGTTTTGAAA
2 5 0 7 )  GGGAAAGGGCTGTCCAAGAACTTCGCCGCCAGAATTACTCAAGCAATGCCTATAATTTGG 
2 5 0 7 )  GGGAAAGGGCTGTCCAAGAACTTCGCCGCCAGAATTACTCAAGCAATGCCTATAATTTGG
2 4  5 5 )  GGGAAAGGGCTGTCCAA CTTCGCCGCCAGAATTATTCAAGCAATGCTTATAATTTCG
2 4  3 3 )  GGGAAAGGGCTGTCCAAGAACTTCGCCGCCAGAATTACTCAAGCAATGCCTATAATTTGG
2 5 6 7 )  GTCCAATGAAGCCAAATACAAAATGCCACTCACCAGAGCGTGCTCACCATCGATCTCCTG 
2 5 6 7 )  GTCCAATGAAGCCAAATACAAAATGCCACTCACCAGAGCGTGCTCACCATCGATCTCCTG 
2 5 1 2 )  GTCCAATGAAGCCAAATACAAAATGCCACTCACCAGAGCGTGCTCACCATCGATCTCCTG 
2 4  9 3 )  GTCCAATGAAGCCAAATACAAAATGCCACTCACCAGAGCGTGCTCACCATCGATCTCCTG
. . + . + + + .  +  + ...........
2 6 2 7 )  ACCGAGGCCTCGACCGATCATTGGAAGAGAATCTTTGCTATAGAGATTTCTGACATGTGA 
2 6 2 7 )  ACCGAGGCCTCGACCGATCATTGGAAGAGAATCTTTGCTATAGAGATTTCTGACATGTGA 
2 5 7 2 )  ACCGAGGCCTCGACCGATCATTGGAAGAGTAAGTGTGCACAGGACCTGGAGTGTAGCCAT 
2 5 5 3 )  ACCGAGGCCTCGACCGATCATTGGAAGAGTAAGTGTGCACAGGACCTGGAGTGTAGCCAT
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NM _2 0 7 2 2  8 
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
NM _2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
N M _ 2 0 7 2 2 8
B C 0 6 6 7 8 2
A F 5 3 0 0 5 0
A K 0 3 0 2 5 4
NM_2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
NM_2 0 7 2 2 8  
B C 0 6 6 7 8 2  
A F 5 3 0 0 5 0  
A K 0 3 0 2 5 4
+  + + + . . .  + . + ........................................................
2 6 8 7 )  AAAGATTCTCCACAGCCTTGGAAAGGTCAAAGATACAAATGGATTTTTTTTTTTTTTTTT 
2 6 8 7 )  AAAGATTCTCCACAGCCTTGGAAAGGTCAAAGATACAAATGGATTTTTTTTTTTTTTTTT
2 6 3 2 )  GTTCACAGTGAGATTTGAGGAAGCGAGGAAACTGATA------------------------------------------------------
2 6 1 3 )  GTTCACAGTGAGATTTGAGGAAGCGAGGAAACTGATA------------------------------------------------------
2 7 4 7
2 7 4 7
2 6 6 9
2 6 5 0
TTTTGCTATGTGATTGCATTTATCTTTTGAATGCTTGACAGGGTTAAATGTATTTATTAA
TTTTGCTATGTGATTGCATTTATCTTTTGAATGCTTGACAGGGTTAAATGTATTTATTAA
 +++ + . + . + . + . +
2 8 0 7 )  CTTTGTGCCTCTGAGTCTGTTCTCGAGTGCCCTAACACAGCTATCTGGGATGATTGATGT 
2 8 0 7 )  CTTTGTGCCTCTGAGTCTGTTCTCGAGTGCCCTAACACAGCTATCTGGGATGATTGATGT
2 6 6 9 )  ----------------------------------------------------------------------------------------------- CT AAACCTGGTT AAT AAGAC
2 6 5 0 )  ----------------------------------------------------------------------------------------------- CTAAACCTGGTTAATAAGAC
+ + + . . . + + + . . . + + + . . . + + + + . . + .....................................................
2 8 6 7 )  ATGCAAACAAAATGCATATGGCTCTTTCCACACAGTAATAGTGAGTGTGAAATCTGCTTA  
2 8 6 7 )  ATGCAAACAAAATGCATATGGCTCTTTCCACACAGTAATAGTGAGTGTGAAATCTGCTTA  
2 6 8 9 )  A T G A T G A C A C C A A A A A T A A A G G G T T T T C A T C T ataaaaaaaaaa--------------------------------------
2 6 7 0 )  AT GAT GACAC CAAAAATAAAGGGTTT T CAT C T-------------------------------------------------------------------
2 9 2 7
2 9 2 7
2 7 3 3
2 7 0 2
CATCACTATTGAGCACTGGTTTGTTAACTACCCGGAGTAAATAAAGAAGCTTGAAAAAGA
CATCACTATTGAGCACTGGTTTGTTAACTACCCGGAGTAAATAAAGAAGCTTGAAAAAGA
2 9 8 7
2 9 8 7
2 7 3 3
2 7 0 2
GGGAAAAGTGTTTTTACAAAACTGATTTCCTTTCCTTTCTTGCTATCTCAAATGACTGGT
GGGAAAAGTGTTTTTACAAAACTGATTTCCTTTCCTTTCTTGCTATCTCAAATGACTGGT
3 0 4 7
3 0 4 7
2 7 3 3
2 7 0 2
TGGTTAGATTTTTTTTTCTTTGTGATTTATATTCTCATGGCTGGAGAAGCTGGGCCAAGA
TGGTTAGATTTTTTTTTCTTTGTGATTTATATTCTCATGGCTGGAGAAGCTGGGCCAAGA
3 1 0 7
3 1 0 7
2 7 3 3
2 7 0 2
TGGGCACAGCCTAGCAGCACTGGCCTGGGAGCCAGTATCACATTTTGGAACCAACCTGAC
TGGGCACAGCCTAGCAGCACTGGCCTGGGAGCCAGTATCACATTTTGGAACCAACCTGAC
3 1 6 7
3 1 6 7
2 7 3 3
2 7 0 2
ATAACTTCCATGCCACAGTCTACCTTCAAAGTAGGAGTAGGCCAGGGCTCTCGGGGCACA
ATAACTTCCATGCCACAGTCTACCTTCAAAGTAGGAGTAGGCCAGGGCTCTCGGGGCACA
3 2 2 7
3 2 2 7
2 7 3 3
2 7 0 2
CTGTTGCAGTGTTCAGCCCAGGCACCATGCGTTTTTACAGTTGTGTTTGCTCTTACTGTT
CTGTTGCAGTGTTCAGCCCAGGCACCATGCGTTTTTACAGTTGTGTTTGCTCTTACTGTT
3 2 8 7
3 2 8 7
2 7 3 3
2 7 0 2
GTGAGAAAGGTAGGTGATGATCTATCTATCCACATGTAAGATTTTTTTAAAATATGTACT
GTGAGAAAGGTAGGTGATGATCTATCTATCCACATGTAAGATTTTTTTAAAATATGTACT
3 3 4 7
3 3 4 7
2 7 3 3
2 7 0 2
CTTAATAAGTTTTCTTCAAAACATTAAAGTACCGCAATGAGCTTACTTGCCATTTAAAAA
CTTAATAAGTTTTCTTCAAAACATTAAAGTACCGCAATGAGCTTACTTGCCATTTAAAAA
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NM_2 0 7 2 2 8  ( 3 4 0 7 )  AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
B C 0 6 6 7 8 2  ( 3 4 0 7 )  AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A F 5 3 0 0 5 0  ( 2 7 3 3 ) ------------------------------------------------------------------------------------------------------------------------------------------------
A K 0 3 0 2 5 4  ( 2 7 0 2 )  -----------------------------------------------------------------------------------------------------------------------------------------------
N M _ 2 0 7 2 2 8  ( 3 4 6 7 )  AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
B C 0 6 6 7 8 2  ( 3 4 6 7 )  AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
A F 5 3 0 0 5 0  ( 2 7 3 3 ) --------------------------------------------------------------------------------
A K 0 3 0 2 5 4  ( 2 7 0 2 ) --------------------------------------------------------------------------------
Alignment of Hum an and mouse TSGA10 amino acid sequences (Exon sixteen which spliced 
out completely is marked in blue, (aa # 176-557: mitotic checkpoint domain, aa # 469-538: Exon 16)
Human
M ice
MMRSRSKSPRRPSPTARGANCDVELLKTTTRDREELKCMLEKYERHLAEIQGNVKVLKSE 60 
MMRNRSKSPRRPSPTSRAANCDVELLKSTARDREELKCMLEKYERHLAEIQGNVKVLTSE 60 
* * *  * * * * * * * * * * * * *  * * * * * * * * * . * . * * * * * * * * * * * * * * * * * * * * * * * * * * *  * *
Human
M ice
RDKIFLLYEQAQEEITRLRREMMKSCKSPKSTTAHAILRRVETERDVAFTDLRRMTTERD 120 
RDKTFLLYEQAQEEIARLRREMMKSCKSPKSTTAHAILRRVETERDVAFTDLRRMTTERD 120 
* * *  * * * * * * * * * * * . * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Human
M ice
SLRERLKIAQETAFNEKAHLEQRIEELECTVHNLDDERMEQMSNMTLMKETISTVEKEMK 180 
SLRERLKIAQETAFNEKAHLEQRIEELECTVHNLDDERMEQMANMTLMKETITTVEKEMK 180 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * . * * * * * * * * * . * * * * * * *
Human
M ice
SLARKAMDTESELGRQKAENNSLRLLYENTEKDLSDTQRHLAKKKYELQLTQEKIMCLDE 240 
SLARKAMDTESELGRQKAENNSLRLLYENTEKDLSDTQRHLAKKKYELQLTQEKIMCLDE 240 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Human
M ice
KIDNFTRQNIAQREEISILGGTLNDLAKEKECMQACLDKKSENIASLGESLAMKEKTISG 300 
KIDNFTRQNIAQREEISILGATLNDLAKEKECLQACLDKKSENIASLGESLAMKEKTISG 300 
★ ★★★■*•★★★★★★★★★★★★★★★ ★★★★★★★★★★★ • ★★★★★★★★★★★★★★★★★★★★★★★★★★★
Human
M ice
Human
M ice
Human
M ice
Human
M ice
Human
M ice
Human
M ice
MKNIIAEMEQASRQCTEALIVCEQDVSRMRRQLDETNDELAQIARERDILAHDNDNLQEQ 360 
MKNIIAEMEQASRQSTEALIMCEQDISRMRRQLDETNDELGQIARERDILAHQNTNLQEQ 360
' k ' k - k ' k - k ' k ' k ' k ' k " k ' k ' k ' k ' k  ^ k  ★ ★ ★ ★ ★
FAKAKQENQALSKKLNDTHNELNDIKQKVQDTNLEVNKLKNILKSEESENRQMMEQLRKA 420 
FAKVKQENQALSKKLNDTHNELSDIKQKVQDTNLEVNKLKNILKSEESENRQIMEQLRKA 420 
*** * * * * * * * * * * * * * * * * * *  _ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * •* * * * * * *
NEDAENWENKARQSEADNNTLKLELITAEAEGNRLKEKVDSLNREVEQHLNAERSYKSQI 480 
NEDAENWENKARQTEAENNTLKLELITAEAEGNRLKEKVDALNREVEQHLNAERSYKSQI 480
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★  • ★ ★  •  •  ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k i e ' k i r - k ' k ' k - k i e
STLHKSVVKMEEELQKVQFEKVSALADLSSTRELCIKLDSSKELLNRQLVAKDQEIEMRE 54 0 
ATLHKSLVKMEEELQKVQFEKVSALADLSSTRELCIKLDSSKELLNRQLVAKDQEIEMME 540
★ ★ *  *  ★  ★  • - k ' k ' k l c ' k - k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k i e ' k ' k ' k ' k ' k ' k ' k - k ' k ^ c ' k ' k ' k J e ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k  ★
NELDSAHSEIELLRSQMANERISMQNLEALLVANRDKEYQSQIALQEKESEIQLLKEHLC 600 
NELDSARSEIELLRSQMTNERISMQNLEALLVANRDKEYQSQIALQEKESEIQLLKEHLC 600
★  ★ ★ ★ ★ ★  • ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ •  • k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k - k
LAENKMAIQSRDVAQFRNWTQLEADLDITKRQLGTERFERERAVQELRRQNYSSNAYHM 660 
LAENKMAIQSRDVAQFRNWTQLEADLDITKRQLGTERFERERAVQ-LRRQNYSSNAYNF 659
Human
M ice
SSTMKPNTKCHSPERAHHRSPDRGLDRSLEENLCYRDF 698
G - PMKPNTKCHS PERAHHRS PDRGLDRSLEE----------------689
* * * * * * * * * * * * * * * * * * * * * * * * * * * *
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Alignment of TsgalO (AF530050) and cp431 (XM 136734) aminoacids sequences
+  ★ ★★ ★ ★ ★ -j_ -j.
530050  ( 1) L------------------------------TPKNISL-------VLGLQF-LKLEETRILSNZN-------------KKZEP
136734 ( 1) MgpekassrsperraggGPRRYVLarvnTKEHQFgLGAPVSEAGRNQNtfqleqeVRTQD
530050  ( 33) K ID SSL hN L Q IE D L K Q T N H D L E E Y V R K L L D SK E A V ST Q V D D L A N H N E H L C K E L IK L D Q H A
136734 ( 61) R FIST L -K L Q IE D L K Q T N H D L E E Y V R K L L D S K E A V ST Q V D D L A N H N E H L C K E L IK L D Q L A
530050 ( 93) EKLQKEKNFWDTADKELEEAKIELICQQNNITVLEDTIQRLKSIILETEKAQNTSPSRL
136734 ( 120) EKLQKEKNFWDTADKELEEAKIELICQQNNITVLEDTIQRLKSIILETEKAQNTSPSRL
★ ' k ' k ' k i r i r i t ' k i r - k i r ' i r i c ' k - k ' k ' k i e - k ' k - k ' k ' k ' k ' k ' k ' k ' k ' k ' i r ' k - k ' k j r ' k ' k ' k ' k
530050 ( 153) DSFVKTLEADRDZ1ZELKLRIZEKMMRNRSKSPRRPSPTSRAANCDVELLKSTARDREEL
1367 34 ( 18 0) DSFVKTLEADRDY-YKTEAQNLRKMMRNRSKSPRRPSPTSRAANCDVELLKSTARDREEL
i c - k i c ' k i e ' k ' k - k - k - k i r ' k i r j e - k - k i r - k ' k i ' - k ' k j c i e ' k ' k ' k ' k ' k ' k i e ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k l c j c i r ' k ' k - k l e l t ' k i t l r ' k - k ' k ' k ' k i e ' k ' k
530050 ( 213) KCMLEKYERHLAEIQGNVKVLTSERDKTFLLYEQAQEEIARLRREMMKSCKSPKSTTAHA
136734 ( 239) KCMLEKYERHLAEIQGNVKVLTSERDKTFLLYEQAQEEIARLRREMMKSCKSPKSTTAHA
• k i c ' k i e i r l e ' k ' k i c - k i c ' k - k i f k ' k l c - k - k i f ' k ' k ' k ' k i e ' k ' k ' k i e ' k - k - k ' k ' k ' k ' k J c i c ' k ' k - k ' k ' k ' k j c ' k ' k ' k l e ' k ' k - i e ' k J c - k ' k ' k - k - k l e
530050 ( 273) ILRRVETERDVAFTDLRRMTTERDSLRERLKIAQETAFNEKAHLEQRIEELECTVHNLDD
136734 ( 299) ILRRVETERDVAFTDLRRMTTERDSLRERLKIAQETAFNEKAHLEQRIEELECTVHNLDD
530050 ( 333) ERM EQM ANM TLM K ETITTVEK EM K SLA RK AM DTESELG RQ K A ENN SLRLLYEN TEK D LSD
136734 ( 359) ERM EQM ANM TLM K ETITTVEK EM K SLA RK AM DTESELG RQ K A ENN SLRLLYEN TEK D LSD
530050 ( 393) T Q R H L A K K K Y E L Q L T Q E K IM C L D E K ID N F T R Q N IA Q R E E ISIL G A T L N D L A K E K E C L Q A C
136734 ( 419) T Q R H L A K K K Y E L Q L T Q E K IM C L D E K ID N F T R Q N IA Q R E E ISIL G A T L N D L A K E K E C L Q A C
J c i c i e i c ' k ' k - k ' k ' k ' k ' k ' k 1 c 1 e ' k 1 r j c ' k 1 t i c - k ' k ' k i c ' k ' k ' k ' k ' k ' k ' k ' k 1 r ' k ' k - k 1 r - i c ' k j c - k i e ' k ' k - k ' k - k 1 r - k j e ‘k ' k - k ' k J r mk ' k ' k i r ' i c
530050 ( 453) L D K K S E N IA S L G E S L A M K E K T IS G M K N IIA E M E Q A S R Q S T E A L IM C E Q D IS R M R R Q L D E T
136734 ( 479) L D K K S E N IA S L G E S L A M K E K T IS G M K N IIA E M E Q A S R Q S T E A L IM C E Q D IS R M R R Q L D E T
• k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k l c - k j c ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k i r ' k ' k ' k ' k ' k ' k ' k ' k ' k
530050 ( 513) N D E L G Q IA R E R D IL A H Q N T N L Q E Q FA K V K Q E N Q A L SK K L N D T H N E L SD IK Q K V Q D T N L E V
136734 ( 539) N D E L G Q IA R E R D IL A H E N D N L Q E Q FA K V K Q E N Q A L SK K L N D T H N E L SD IK Q K V Q D T N L E V
i e ' k ' k ' k ' k i r ' k - k ' i e - k - k - k ' k ' k - k ' k ' k - k ' k ' k ' k i e ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k - k ' k ' k i r ' k ' k ' k ' k ' k ' k ' k ' k ' k i r i c ' k ' k - k ' k ' k ' k i f ' k
530050 ( 573) N K LK N IL K SE E SE N R Q IM E Q L R K A N E D A E N W E N K A R Q T E A E N N T L K L E L IT A E A E G N R L K
13 6734 ( 599) N K LK N IL K SE E SE N R Q IM E Q L R K A N E D A E N W E N K A R Q T E A E N N T L K L E L IT A E A E G N R L K
530050 ( 633) EKVDALNREVEQHLNAERSYKSQIATLHKSLVKMEEELQKVQFEKVSALADLSSTRELCI
136734 ( 65 9) EKVDALNREVEQHLNAERSYKSQIATLHKSLVKMEEELQKVQFEKVSALADLSSTRELCI
• k ' k ' k - k - k - k - k - k  +  ' k - k - k - k - k - k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k ' k l t ' k ' k ' k ' k ' k ' k ' k i t ' k ' k ' k ' k ' k - k ' k J t l c ' k - k ' k
530050 ( 693) K L D SSK E L L N R Q L V A K D Q E IE M M E N E L D SA R SE IE L L R SQ M T N E R ISM Q N L E A L L V A N R D
136734 ( 719) K L D SSK E L L N R Q L V A K D Q E IE M M E N E L D SA R SE IE L L R SQ M T N E R ISM Q N L E A L L V A N R D
530050 ( 753) KEYQSQIALQEKESEIQLLKEHLCLAENKMAIQSRDVAQFRNWTQLEADLDITKRQLGT
136734 ( 77 9) KEYQSQIALQEKESEIQLLKEHLCLAENKMAIQSRDVAQFRNWTQLEADLDITKRQLGT
530050 ( 813) E R FE R E R A V Q -L R R Q N Y SSN A Y N F G P M K P N T K C H SP E R A H H R SP D R G L D R SL E E
136734 ( 839) ER FE R E R A V Q eL R R Q N Y SSN A Y N L G PM K PN T K C H SPE R A H H R SPD R G L D R SL E E
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S3
L3
Alignment of S3 and L3 inserts with candidate activating domain 
-FLJ32880 hypothetical protein-
(1) -ACTNACAAAAAGAGATCGAAtTACCAGGACGAATTCAC-CTAGCTGGCAGGTAGGGGT 
(1) ggGGTTACAAAAAGAGATCGAA-TACCAGGACGAATTCACtCGAGCTGGCAGGTAGGGGT
S3 (58) GGGAGAGGACAACATGCCAATATGCTGAACACTGACCAACTGTTGGTTAGGGCCATATCG
L3 ( 60) GGGAGAGGACAACATGCCAATATGCTGAACACTGACCAACTGTTGGTTAGGGCCATATCG
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
S3
L3
(118
(120
(178
(180
(238
(240
(298
(300
(358
(360
[418
[420
[478
1480
(538
(540
(598
(600
(658
(660
(716
(720
(776
(778
(823
(838
(864
(898
GAGAGACCAAGGAAGAGCACAGAGCCCTTGGTTCCAGGGACACCTACAGGACTGTTCAGC
GAGAGACCAAGGAAGAGCACAGAGCCCTTGGTTCCAGGGACACCTACAGGACTGTTCAGC
CTTCTATCAAACATCTCTCCGGAGGAGCAGGGCCGCCTTGGGAGCGGAGACAGTCTCCAG
CTTCTATCAAACATCTCTCCGGAGGAGCAGGGCCGCCTTGGGAGCGGAGACAGTCTCCAG
AGTCAGAGCTGCCAGCAGCAAAGGTCTTACAGCGCAGGGCAGACAACAAAGAAAGAACGA 
AG T C AGAG C T G C CAGC AGC AAAGG T C T T AC AGCGC AGG GC AGAC AACAAAGAAAG AACG A
AAACCCCGGAGGCGCAACAAGAAAGGACGTGGCTCAGCTGAGGCAGAGGATCTCTTCAGT
AAACCCCGGAGGCGCAACAAGAAAGGACGTGGCTCAGCTGAGGCAGAGGATCTCTTCAGT
TCACCTCGGAAGCCTTCCTTCCCTTTCCAGTGGGCCTGGGAGAGCTTCATCATAGATGGC
TCACCTCGGAAGCCTTCCTTCCCTTTCCAGTGGGCCTGGGAGAGCTTCATCATAGATGGC
CAGGCTCTGCTTCAGTCAGGCTCCTCTGTGGCCGTGGGCCATCGATCCTTGCTCTTCCCT
CAGGCTCTGCTTCAGTCAGGCTCCTCTGTGGCCGTGGGCCATCGATCCTTGCTCTTCCCT
TCAGCAGCCCCCCAGTGCAAGACCAGGCACAAGTCAGTAGCCAACCTCTCAGAAGACCTT
TCAGCAGCCCCCCAGTGCAAGACCAGGCACAAGTCAGTAGCCAACCTCTCAGAAGACCTT
CGAGCCTGCCACAAGTCGGAAGTGCAAAACCTGGGAAGGAGATATCAGCCTGGGGCCTGG
CGAGCCTGCCACAAGTCGGAAGTGCAAAACCTGGGAAGGAGATATCAGCCTGGGGCCTGG
GCCAACCTTTCCCTGCCTCTGGGCAAGGCTGAGAGCCAAGGGCTAGAGCGACCCACCTTC
GCCAACCTTTCCCTGCCTCTGGGCAAGGCTGAGAGCTATTGGCTATATCGACCCACCTTC
+ + + + + + + + + + + + + +  + ++++  ++++ + + ++ ++ + + + + + + + ++ + + + ++ + + + ++ + + + +  
T-GGTCAACAGGGAAAGGGTCA-GGGTCAGAGTGTGAGGATGTCTCAGAGGTAGAAGGCC 
TgGGTCAACAGGGAATTGGTCAtTGGTCTTAGTGTGATGATGTCTCAGAGGTAGAAGGCC
+ + + + + + + + + + +  + ++++  + + + + +++++  + + + + + + + ++ + + + +  + +++++++ ++++  
AGAATGCTGACGAGGCTgAGGAAAAGTCTCACCACTGGGGAACTGcCCCAGCTCCCAGGG 
AGAATGCTGACCAGGCT-AATATATGTCTCAGCACTGGGGAACTG-ACCAGCTCCGAGGG
+ + + + + + + + +  + + +++  ++ ++ + +++++  + +++ ++ ++++ ++ ++
C -A G G G T T G A -C C T G G A G G A -G A -G T G A T C T -C G A G G -T A -T G A G A G A G A C C A A --------------
C tA G G G T T G A tC T T G G A T G A tG A tT T G A T C T cC A A G G tT A tT G A G G A G G A T G A A cc c ttc
++ + + + + + + +  + + + + ++ ++++ ++++ ++ +++
- C G — G A A A A G -C A C T T -------- T T C C C A G G A G G A -T T T G --A A A A G G C A A A A A ---------------------
c C G a c A A A G G G c C A T T T g tg T N C T T G G T A T G A tT T T G ta A A A A C G C C C A A A ta t tg tg ta
c c t t c c a c t c c t t t g t g g a g g g g c t c c c c c c c t t c t c n a a t t t a a g g
317
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Mice FLJ32880m cDNA Sequence
ATGGAGATGG CAGAGAGGGC AGTTCCAGAG CTGGCAGGAA CTTGTCACTT 50
CCTCAGCACT AAGTCCAGAG CCCTGGGTGA CATCCAGAAA AATAGGTGCC 1 0 0
TTGGGAGTGG TGACAGTCTC CAGAGTCAGA GCTGCCAGCT ACAAAGATCT 1 5 0
TACAGCGCAG GGCAGACAAC AAAGAAAGAG CGAAAGGCCC GGAGGCGGAA 2 0 0
CAAGAAAGGC CGTGGCTCAG CTGAGGCAGA GGATCTCTTC AGTCCACCTT 2 5 0
CTCGAAAGCC TTCCTTCCCT TTCCAGTGGG CCTGGGAGAG CTTCATCATA 3 0 0
GATGGCCAGG CTCTGTTTCA GTCAAGTTCC TCTATGGCCA TGGGCCATCG 3 5 0
ACCCCTGCTC CTCCCTCCAG CAGCCCCCCA GTGCAAGTCC AGGCACAAGT 4 0 0
CAGTAGCCAA CCTCTCAGAA GACCTTCGAG CCTGCCACAA GATGGAAGAG 4 5 0
CAAAGCGTGG GGAGGAGACA TCACCTAGGG GGCTGGGCCA ACTTTCCCCT 5 0 0
GCCTCTGAGC AAAGTGGAGA GTCAAGGGCT AGATCAACCT AGCTTCTGGT 5 5 0
TATCAGGGAA AGGGTCAGGA TCAGAGTCTG AGGATGTCTT AGAGATAGAA 6 0 0
GGCCAGAATT CTGAAGAGGC TGAGAAAAGT CTCAGCTCTG GGGAACTGCC 6 5 0
TCAGCTCCCA GGGCAGAGCT TGATCTTGGA GGAGGAATTG ATATCAGAGG 7 0 0
CGATGGAGGA GGAACACAGC GACCCCCACA AGGGAAAGGG CAGTTCTGTC 7 5 0
AATAAGGGGG GGAATTCTGG AGAGAAGGGC TCAGAAGAGG GGGAGCTGCA 8 0 0
GAGCCACAAC CAGGGAAGCA GCTCTAGCTT CAACAGTCTC CGAAAGCCAC 8 5 0
AGAAGGGGAT CTCAAGGGCC AAGGACCTGA AGGGGCCCTG GGACCTGGAG 9 0 0
CGGCTACACA GGCAGTTACA GGAAGAACTG GAATGTGGTC CCCAGAAGCA 9 5 0
GACCTGGAAG GCGCTGCGGG CAGCTGTCCA GGCCTCTGCC AGGAACAAGA 1 0 0 0
AGACCCCCAT CTTGGGAGAT GATGAAAGTT TCTTGTCTGC CAACTTCCCT 1 0 5 0
AATCGTACTT TCCATAAACG ACAGGAAGCC ACCAGGAACC TGCTCCGGGC 1 1 0 0
CTGGGAACAG CAGCAGGTGA AGGAGAGGCA GCAGGCCGAG GTGCGCAGAG 1 1 5 0
CCCGGGAGCA GCAGGTGCAG CAGCAGGTGG CTCGCTGCCT GGCAGCCTAC 1 2 0 0
ACATCCGGAG GGAACAGAGG GACCCTGGCA CCTCAGCGCA AACTAGAGGA 1 2 5 0
GCTAAGGCGC AAGGAGCGAC AGCGTTTTGC TGAGTACCAA GCAGAGCTCC 1 3 0 0
AAGGTATCCA GCATAGGGTG CAGGCCCGGC CCTTCCTGTT CCAGCAGGCC 1 3 5 0
ATCAGACCAA CGCCAGACTC ACTGCAAATC GGCGCTTCTC CCAGGTGCTG 1 4 0 0
TCAGCACTGG GGGTAGACGA GGACCAGCTG CTGGCCGAGG CAGGCAATGC 1 4 5 0
TGAGAGCACC CCCCGGAAGC ACAGGAGCAA CCGATCACTT AGAGCAGAAA 1 5 0 0
TGGAGCCCTC TTCTCAGAGC CCCCCCAAAA CAGAGCCAAC CAGCAGCCAG 1 5 5 0
CCTGGAAGAC GCCCCTCCCC AACCCTGGAC CCAGACTACA GTCCCCGAGA 1 6 0 0
GAAAAATTAA ACGCTTTATG GCC
Length: 5 5 6  aa, m olecular w eight: 6 2 3 9 1  Da, CRC64 checksum: 
9F 524 11E B C 14 88D 4
MGQDTDMLNT YQQLVRTPSV RPGQDVRLQA PGTRTGLLKL LSTVSQDKQG CLGSGDGVPN 60
QDLQQRPQSS RQTAKKDRKP RGQSKKGQGS EESEDHFPLL PRKPSFPFQW AWESIATDVR 120
AVLQPSSPTP GHQALPMPSS FSQRQSRRKS TANLPEAHGC CWKTEAQNLK ARQQLGAWGG 180
VSIPTGKGEL GSEPPSGLQL PGRRPGSGSA SDKQVQLQSL GAEEAERGLS SGVLPQRPRR 240
GSISEEEQFS EATEEAEEGE HRTPCRRRAG CQRKGQISGE EASDEGEVQG QSQGSSPSFN 300
NLRRRQWRKT RAKELQGPWD LEKLHRQLQR DLDCGPQKLP WKTLRAAFQA SKRNGKAYAS 360
GYDETFVSAN LPNRTFHKRQ EATRSLLQAW ERQRQEERQQ AELRRARTQH VQRQVAHCLA 420
AYAPRGSRGP GAAQRKLEEL RRQERQRFAE YQAELQGIQH RVQARPFLFQ QAMQANARLT 480
VTRRFSQVLS ALGLDEEQLL SEAGKVDREG TPRKPRSHRS MGVRMEHSPQ RPPRTEPTGS 540
QPDRHYNPSL DPECSP
(82.6 %: nuclear 13.0 %: cytoskeletal 4.3 %: vesicles o f  secretory system) Similar to hypothetical 
protein FLJ32880 [Homo sapi] -> P05143 Proline-rich protein MP-3 (Mus musculus Chromosome 19 );
27%
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H um an ( 1) a g t t c t a c g g t g c g g a tg g g g g a t g g g g c a g g a tg g g g c a g g a c a c c g a t A T G C T A A A T A
M ic e  ( 1) ------
R a t  ( 1)---------------------------------------------------------------------------------------------------------- ATGCTGAACA
 + . + .....................+ . + . . + . + . . . + . + + . + +  + + ..................+
H um an ( 6 1 ) CCTACCAACAGTTGGTTAGGACCCCGTCGGTGCGACCAGGGCAGGAC-GTGCGGCTCCAG
M ic e  ( 1) ----------------------------------- ATGG— AGATGGCAGAG AGGGCAGTTC-CAGAGCTGGCAG
R a t  ( 1 1 ) CTGACCAACTGTTGGTTAGGGCCATATCGGAGAGACCAAGGAAGAGCaCAGAGCC-CTTG
+ . + . ++ . . + . + . . + +  + . . + + .  . .  + + .+  + + . . + +  . +
H um an ( 1 2 0 )  GCTCCAGGAACCAGAACGGGGCT— GCTCAAGCTGCTGTCGACCGTCTCTCAGGACAAGC
M ic e  ( 3 8 )  GAACTTGTCACTTCCTCAGCACTaaGTCCAGAGCCCTGGGTGACA TCCAGAAAAAT
R a t  ( 7 0 )  GTTCCAGGGACACCTACAGGACT— GTTCAGCCTTCTATCAAACATCTCTCCGGAGGAGC
. + + + + . + + + + + . + + . + + . . + + . + . + . . + . + + + . + + . . . + + . + + . . + + . + + . . + + .  
H um an ( 17 8) AGGGCTGCCTGGGGAGTGGTGATGGTGTGCCAAATCA-AG— ACCTGCAGCAGAGGCCTC
M ic e  ( 9 4 ) A— GGTGCCTTGGGAGTGGTGACAGTCTCCAGAGTCAGAGCTGCCAGCTACAAAGATCTT
R a t  ( 1 2 8 )  AGGGCCGCCTTGGGAGCGGAGACAGTCTCCAGAGTCAGAGCTGCCAGCAGCAAAGGTCTT
+ . + + + . + + . + + + + + + + + . + + + + + + + . + +  + + . + + . . + + . + + . + . + . . + . + + + + + + + + + . +  
H um an ( 2 3 5 )  AGAGCTCAAGGCAGACAGCAAAGAAGGACCGCAAGCCCAGGGGCCAGAGCAAGAAAGGAC
M ic e  ( 1 5 2 )  ACAGCGCAGGGCAGACAACAAAGAAAGAGCGAAAGGCCCGGAGGCGGAACAAGAAAGGCC
R a t  ( 18 8) ACAGCGCAGGGCAGACAACAAAGAAAGAACGAAAACCCCGGAGGCGCAACAAGAAAGGAC
 + . + + + + . + + . + + . + + + + + + + + . +
H um an ( 2 9 5 ) AGGGCTCTGAAGAGTCTGAAGATCACTTCCCGCTTCTTCCTCGGAAACCCTCCTTCCCCT
M ic e  ( 2 1 2 )  GTGGCTCAGCTGAGGCAGAGGATCTCTTCAGTCCACCTTCTCGAAAGCCTTCCTTCCCTT
R a t  ( 2 4 8 )  GTGGCTCAGCTGAGGCAGAGGATCTCTTCAGTTCAC CTCGGAAGCCTTCCTTCCCTT
+ + + + + + + + + + + + + + + + + + + + .+ + . .+ + .+ + + + + .+ + .+ + + + .+ + .+ + + + + .+ + .+ .+ + + .  
H um an ( 3 5 5 )  TCCAGTGGGCCTGGGAGAGCATCGCCACAGATGTCCGGGCTGTGCTTCAGCCAAGCTCC-
M ic e  ( 2 7 2 )  TCCAGTGGGCCTGGGAGAGCTTCATCATAGATGGCCAGGCTCTGTTTCAGTCAAGTTCCT
R a t  ( 3 0 5 )  TCCAGTGGGCCTGGGAGAGCTTCATCATAGATGGCCAGGCTCTGCTTCAGTCAGGCTCCT
+  ++ . . + + + + + . + . +  + + . + + + . +  +
Hum an ( 4 1 4 )  CCA--ACCCCTGGCCACCAAGCCCTGCCCATgCCCTCC-TCGTTCTCCCAGCGTCAGTCC
M ic e  ( 3 3 2 )  CTATGGCCATGGGCCATCGACCCCTGCTCCT-CCCTCCAGCAGCCCCCCAGTGCAAGTCC
R a t  ( 3 6 5 )  CTGTGGCCGTGGGCCATCGATCCTTGCTCTT-CCCTCCAGCAGCCCCCCAGTGCAAGACC
+ + + + . + + + + + + . . . . + + + + + + + + + . + + + + . + . + + . + . + . . . + + + + . . . + + + . . . + + . +
+
H um an ( 4 7 1 )  AGGCGCAAGTCCACGGCCAACCTCCCAGAGGCCCATGGCTGCTGCTGGAAGACAGAGGCG
M ic e  ( 3 9 1 )  AGGCACAAGTCAGTAGCCAACCTCTCAGAAGACCTTCGAGCCTGCCACAAGATGGAAGAG
R a t  ( 4 2 4 )  AGGCACAAGTCAGTAGCCAACCTCTCAGAAGACCTTCGAGCCTGCCACAAGTCGGAAGTG
+ + + + . + . + +  + + + + . + . + + . + .  + + . + . + + + + + . + . . .  + . . + + . + . + + +  +++ +
H um an ( 5 3 1 )  CAAAACCTGAAGGCGAGACAGCAGCTGGGAGCCTGGGGCGGTGTCTCCATCCCTaCTG-G
M ic e  ( 4 5 1 )  CAAAGCGTGGGGAGGAGACATCACCTAGGGGGCTGGGCCAACTTTCCCCTGCCT-CTGAG
R a t  ( 4 8 4 )  CAAAACCTGGGAAGGAGATATCAGCCTGGGGCCTGGGCCAACCTTTCCCTGCCT-CTGGG
+++.+ +.+++ +.+++. . .+++.+ .++.+ . + . . +++............ +++
H uman ( 5 9 0 )  CAAAG--GGGAG-CTAGGATCAGAGCCCCCCAgtggtctCCAGCTGCCTGGGAGGagGCC
M ic e  ( 5 1 0 )  CAAAGTGGAGAGTCAAGGGCTAGATCAACCTA---------------GCTTCTGGTTATCAGG— GAA
R a t  ( 5 4 3 )  CAAGGCTGAGAGCCAAGGGCTAGAGCGACCCA---------------CCTTCTGGTCAACAGG— GAA
+ + + . + + + + + . + + . + . + + . . +  + + . + . + + + .  . . + +  + . . + + . + + + . + . . + . + + + +  ++
Human ( 6 4 7 ) AGGATCAGGATCGGCGTCCGacaAGCAGGTC CAGCTGCAAAGCCTGGGTGCTGAGGA
M ic e  ( 5 6 1 )  AGGGTCAGGATCAGAGTCTG AGGATGTCTTAGAGATAGAAGGCCAGAATTCTGAAGA
R a t  ( 5 9 4 )  AGGGTCAGGGTCAGAGTGTG AGGATGTCTCAGAGGTAGAAGGCCAGAATGCTGACGA
319
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Hum an
M ic e
R a t
Hum an
M ic e
R a t
Hum an
M ic e
R a t
Hum an
M ic e
R a t
Human
M ic e
R a t
Human
M ic e
R a t
Human
M ic e
R a t
H uman
M ic e
R a t
H uman
M ic e
R a t
Human
M ic e
R a t
Human
M ic e
R a t
Human
M ic e
+ + + . + + + + . . . + + + + . + + . . + + + + + + . . + + + + + . + + + + . + + + . . + + . . . . +  + . + + . + + .  
7 0 4 )  GGCCGAGAGGGGTCTGAGTTCTGGGGTGCTGCCCCAGCGCCCCAGGAGGGGGTCGATCTC 
6 1 8 )  GGCTGAGAAAAGTCTCAGCTCTGGGGAACTGCCTCAGCTCCCAGGGCAGAGCTTGATCTT 
6 5 1 )  GGCTGAGAAAAGTCTCAGCACTGGGGAACTGCCCCAGCTCCCAGGGCAAGGTTTGACCTT
.++++++++ + +++ ++++. .+ . .+++++++ . ++ +  +++. + .
7 6 4 )  AGAGGAGGAGCAATTTTCAGAGGCCACAGAGGAGGCTGAgGAG-GGAGAGCACAGGActC
67 8 )  GGAGGAGGAATTGATATCAGAGGCGATGGAGGAGGAACA-CAGcGACCCCCACAAG--------
7 1 1 )  GGAGGAGGAGTTGATCTCAGAGGTGATGGAGGAGG-------------AG-GAACACAACAGGA------
+ + +  + + + + + . + . + . + + + +  + .  + + + + + +  . + + . + + + + + + + + + + . + . + . + + + .  
8 2 3 )  cctgcAGAAggAGGGCTGGT-TGTCagAGAAAGGGGCAGATTTCTGGAGAGGAAGCCTCC
7 3 3  ) -----------GGAA— AGGGCAGTTCTGTC— AATAAGGGGGGGAATTCTGGAGAGAAGGGCTCA
7 6 1 )  ------------- GAA--AGGGCAGTTCTGTC— AACAAGGGGAGGAATTCTGGAGAGAAGGGCTCA
+ + . + + . + + . + + . . + + + + + +  
8 8 2 ) GATGAGGGAGAAGTGCAGGGCCAGAGCCAGGGGAGCAGCCCCAGCTTCAACAACCTCCGA 
7 8 4 )  GAAGAGGGGGAGCTGCAGAGCCACAACCAGGGAAGCAGCTCTAGCTTCAACAGTCTCCGA 
8 1 1 )  GAAGAAGGGGAGCTGCAGAGCCACAACCAGGGAAGCAGCTCTAACTCCAACAGCCTCCGA
. . + + . + + + + + + + + + +  . + . . + + + + + + + . + + + + + + + + + + + + . . +  
9 4 2 )  AGGCGACAATGGAGGAAGACAAGGGCCAAGGAGCTGCAGGGGCCATGGGACCTGGAGAAG 
8 4 4 )  AAGCCACAGAAGGGGATCTCAAGGGCCAAGGACCTGAAGGGGCCCTGGGACCTGGAGCGG 
8 7 1 )  AAGTCACCAAAGGGGACCTCAGGGGCCAAGGAATTCAAGGGGCCCTGGGACCTGGAGCGG
++ + + + + + + + + + .+ + + + + . . .+ + . .+ + + + . .+ + + + .+ + + + + .+ + + + .+ .+ + + + + + + + .+ .  
1 0 0 2 )  CTGCACAGGCAGCTACAGAGAGACCTGGACTGTGGCCCCCAAAAGCTGCCCTGGAAGACT 
9 0 4 )  CTACACAGGCAGTTACAGGAAGAACTGGAATGTGGTCCCCAGAAGCAGACCTGGAAGGCG 
9 3 1 )  CTCCACAGGCAGTTACAGGAGGAATTGGAAAGTGGTCCCCAGAAGCAGACCTGGAAGGCG
. +  + . + + + + . . + + + + + + + + + +  + + + . + +  + . . + + + + . +  ++.
1 0 6 2 )  TTGAGGGCTGCCTTCCAGGCCTCCAAGCGGAATGGAAAGGCCTATGCCTCGGGATACGAT 
9 6 4 )  CTGCGGGCAGCTGTCCAGGCCTCTGCCAGGAACAAGAAGACCCCCATCTTGGGAGATGAT 
9 9 1 )  TTGCGGGCAGCTGTCCAGGCCTCTGCCAGAAACAGGAAGACCCCCGTCACGGGAGAAGAG
+ + + + .+ + + + .+ + .+ + + + + + + + .+ + + + + + + + + + .+ + .+ + + + + .+ + + + + + + + + + + .+ + + + + +  
1 1 2 2 )  GAAACTTTCGTGTCTGCCAACCTCCCTAATCGCACCTTCCACAAACGACAGGAAGCCACC 
1 0 2 4 )  GAAAGTTTCTTGTCTGCCAACTTCCCTAATCGTACTTTCCATAAACGACAGGAAGCCACC 
1 0 5 1 )  GAAAGTTTCTTGACTGCCAACTTCCCTAATCGTACCTTCCATAAACGACAGGAGGCCACC
+++
1 1 8 2 )  AGG------------------------------------------------------------------------------------------------------------------------
1 0 8 4 )  AGG------------------------------------------------------------------------------------------------------------------------
1 1 1 1 )  A G G a c t t g g g c t c t t a g a g a c a c g t a c t t c t t c c c a c a g t c c c t c a c c t c t g g a c c a c a t
1 1 8 5  
1 0 8 7 ;
1 1 7 1 )  g c t c c t c c a t g c t a c c t t g g c c t t c c t c g a g c t c c t g a t c c c c a t g g a c a t c c c c c c t t t
+ . + + + + + + . + . + + + + + + + + + . + . + + + + + . + . . + . + + + + + . . + + + + + + + + + .
1 1 8 5 )  -------------------AGCCTGCTGCAGGCCTGGGAGCGGCAGCGGCAGGAGGAGCGGCAGCAGGCC
1 0 8 7 )  -------------------AACCTGCTCCGGGCCTGGGAACAGCAGCAGGTGAAGGAGAGGCAGCAGGCC
1 2 3 1 )  ctcaccagaAACCTGCTGCAGGCCTGGGAACAGCAGCAGCTGAAGGAGAAGCAGCAGGCG
+++ + + + + . . + . + + . + + + . . . + + + + +  + + . + + + + . + + + + + + + + + . + . . + + . + + + + + . + + +  
1 2 3 6 )  GAGCTGCGGCGGGCCCGGACACAGCATGTACAGCGGCAGGTGGCCCACTGCCTGGCAGCC 
1 1 3 8 ) GAGGTGCGCAGAGCCCGGGAGCAGCAGGTGCAGCAGCAGGTGGCTCGCTGCCTGGCAGCC
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R a t
Hum an
M ic e
R a t
Hum an
M ic e
R a t
H um an
M ic e
R a t
Hum an
M ic e
R a t
Human
M ic e
R a t
Hum an
M ic e
R a t
Human
M ic e
R a t
Human
M ic e
R a t
; 1 2 9 1 )  GAGATGCGCAGGGCTCGGGAGCAGCAAGTGCAGCAGCAGGTGGCCCGGTGTCTGGCGGCC
+ + . + + + + + + + + . + + . + + + + + + + + . +  
12  9 6 ) TACGCACCCAGAGGGAGC— CGGGGCCCTGGGGCggCCCAGCGCAAGCTGGAGGAGCTGA 
1 1 9 8 )  TACACATCCGGAGGGAACAGAGGGACCCTGGCAC— CTCAGCGCAAACTAGAGGAGCTAA 
1 3 5 1 )  TACACGCCAGGAGGGAACAGAGGGACCCTGGGTC— CTCAGCGCAAACTAGAGGAGCTGA
+ + + + + .+ + + + + + + + + + + + + .+ + + + + .+ + + + + + + + .+ + .+ + + + + .+ + .+ + .+ + + + + + + +  . + 
1 3 5 4 )  GGCGCCAGGAGCGACAGCGCTTTGCTGAGTACCAGGCGGAGCTGCAAGGCATCCAGCACA 
1 2 5 6 )  GGCGCAAGGAGCGACAGCGTTTTGCTGAGTACCAAGCAGAGCTCCAAGGTATCCAGCATA 
14 0 9 )  GGCGCAAGGAGCGACAGCGTTTTGCCGAGTACCAAGCAGAGCTCCAGGGCATCCAGCATA
1 4 1 4 )  GGGTGCAGGCCCGGCCCTTCCTGTTCCAGCAGGCTATgCAGGCCAATGCCCGGCTCACCG 
1 3 1 6 )  GGGTGCAGGCCCGGCCCTTCCTGTTCCAGCAGGCCAT-CAGACCAACGCCAGACTCACTG 
14 6 9 ) GAGTGCAGGCCCGGCCCTTCCTGTTCCAGCAGGCCAT-CAGACCAATGCCAGGCTCACAG
. . + . . + + + + + + + + + + + + + + + + + + + + + + + + + + + . + + + + . . + . + + . + + + + +  +++++++++ .  
1 4 7 4 )  TCACTCGGCGCTTCTCCCAGGTGCTGTCAGCACTGGGGCTGGATGAGGAGCAGCTGCTGT 
1 3 7 5 )  CAAATCGGCGCTTCTCCCAGGTGCTGTCAGCACTGGGGGTAGACGAGGACCAGCTGCTGG 
1 5 2 8 )  CAAACCGGCGCTTCTCCCAGGTGCTGTCAGCATTGGGAGTGGATGAGGAACAGCTGCTGG
+ . + + + + + + + + . + +  . . . . + + + . + + + . + + + + . + + + + . + . + + + + + + +  + + . + . + + +  
1 5 3 4 )  CTGAGGCAGGAAAggtggaCAGAGAGGGCACCCCCAGGAAACCCAGGAGCCACAGGTCAA
1 4 3 5  ) CCGAGGCAGGCAA------------ TGCTGAGAGCACCCCCCGGAAGCACAGGAGCAACCGATCAC
1 5 8 8 )  CTGAGGCAGGCAA------------ TGCAGAGGGCATCCCCCGGAAACACAGGAGCTACCGGTCAT
+ . . . . + + + + + + + . . + + + + . + + + + + + +  + + + + + .+ . .+ + + + + .+ + .+ + + .+ + + + + +  
1 5 9 4 )  TGGGGGTGAGAATGGAGCACTCTCCTCAGAGGCCCCCAAGGACAGAACCCACCGGCAGCC 
14 8 9) TTAGAGCAGAAATGGAGCCCTCTTCTCAGAGCCCCCCCAAAACAGAGCCAACCAGCAGCC 
1 6 4 2 )  TTGGAGTAGAAATGGAGTCCTCTCCTCAGAGTCCCCCAAAGACAGAGCCAACCAGCAGCC
++++++ . . + + .  + . + ...........+++ . + . +++++....................................... + . ++++ . . ++++++
1 6 5 4 )  AGCCTGACAGGCACTACAACCCCAGCCTGGACCCGGAGTGCAGTCCCTGAGA-TAAAATT 
1 5 4  9) AGCCTGGAAGACGCCCCTCCCCAACCCTGGACCCAGACTACAGTCCCCGAGAGAAAAATT 
17 02 ) AGCCTGGAAGACACCCTTCCCCAACCCTGG------------------------------- ACTGAGAGAAAAATT
1 7 1 3 )  AAAGGCTTTATGGC- 
1 6 0 9 )  AAACGCTTTATGGCC 
1 7 4 7 )  AAATGCTTTATGGCC
321
Appendices
BAB71488.1 (Human TSGA10IP)
MGQDTDMLNTY QQL VRTPS VRPGQD VRLQ APGTRTGLLKLLSTVSQDKQGCLGSGDG VPNQD
LQQRPQSSRQTAKKDRKPRGQSKKGQGSEESEDHFPLLPRKPSFPFQWAWESIATDVRAVLQPSS
PTPGHQALPMPSSFSQRQSRRKSTANLPEAHGCCWKTEAQNLKARQQLGAWGGVSIPTGKGEL
GSEPPSGLQLPGRRPGSGSASDKQVQLQSLGAEEAERGLSSGVLPQRPRRGSISEEEQFSEATEEA
EEGEHRTPCRRRAGCQRKGQISGEEASDEGEVQGQSQGSSPSFNNLRRRQWRKTRAKELQGPW
DLEKLHRQLQRDLDCGPQKLPWKTLRAAFQASKRNGKAYASGYDETFVSANLPNRTFHKRQEA
TRSLLQAWERQRQEERQQAELRRARTQHVQRQVAHCLAAYAPRGSRGPGAAQRKLEELRRQE
RQRFAEY QAELQGIQHRV QARPFLFQQ AMQANARLTVTRRFSQVLS ALGLDEEQLLSEAGKVD
REGTPRKPRSHRSMGVRMEHSPQRPPRTEPTGSQPDRHYNPSLDPECSP
XM 355133. (Mus musculus TsealOiv)
MEMAERAVPELAGTCHFLSTKSRALGDIQKNRCLGSGDSLQSQSCQLQRSYSAGQTTKKERKAR
RRNKKGRGSAEAEDLFSPPSRKPSFPFQWAWESFIIDGQALFQSSSSMAMGHRPLLLPPAAPQCK
SRHKSVANLSEDLRACHKMEEQSVGRRHHLGGWANFPLPLSKVESQGLDQPSFWLSGKGSGSE
SEDVLEIEGQNSEEAEKSLSSGELPQLPGQSLILEEELISEAMEEEHSDPHKGKGSSVNKGGNSGE
KGSEEGELQSHNQGSSSSFNSLRKPQKGISRAKDLKGPWDLERLHRQLQEELECGPQKQTWKAL
RAAVQASARNKKTPILGDDESFLSANFPNRTFHKRQEATRNLLRAWEQQQVKERQQAEVRRAR
EQQ V QQQV ARCL AAYTSGGNRGTL APQRKLEELRRKERQRF AEY QAELQGIQHRV Q ARPFLFQ
QAIRPTPDSLQIGASPRCCQHWG
XM 341991. (Rattus norvesicus TsealOip)
MLNTDQLLVRAISERPRKSTEPLVPGTPTGLFSLLSNISPEEQGRLGSGDSLQSQSCQQQRSYSAG
QTTKKERKPRRRNKKGRGSAEAEDLFSSPRKPSFPFQWAWESFIIDGQALLQSGSSVAVGHRSLL
FPPAAPQCKTRHKSVANLSEDLRACHKSEVQNLGRRYQPGAWANLSLPLGKAESQGLERPTFW
STGKGSGSECEDVSEVEGQNADEAEKSLSTGELPQLPGQGLTLEEELISEVMEEEEHNRRKGSSV
NKGRN SGEKGSEEGELQSHNQGSS SN SNSLRKSPKGTSG AKEFKGPWDLERLHRQLQEELESGP
QKQTWKALRAAVQASARNRKTPVTGEEESFLTANFPNRTFHKRQEATRTWALRDTYFFPQSLTS
GPHAPPCYLGLPRAPDPHGHPPFLTRNLLQAWEQQQLKEKQQAEMRRAREQQVQQQVARCLA
AYTPGGNRGTLGPQRKLEELRRKERQRFAEYQAELQGIQHRVQARPFLFQQAIRPMPGSQQTGA
SPRCCQHWEWMRNSCWLRQAMQRASPGNTGATGHLE
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Appendix B: TsgalO protein analysis
SMART TsgalO study
Defensins, also known as alpha-defensins, are a family o f  structurally related cysteine- 
rich peptides active against many Gram-negative and Gram-positive bacteria, fungi, and 
enveloped viruses. Defensins kill cells by forming voltage-regulated multimeric 
channels in the susceptible cell’s membrane. They play a significant role in innate 
immunity to infection and neoplasia (nucleotide # 10-39)
Methyl-accepting chemotaxis-like domains- chemotaxis sensory transducer 
(nucleotide # 244-449).
Anaphylatoxin homologous domain: C3a, C4a and C5a anaphylatoxins are protein 
fragments generated enzymatically in serum during activation o f complement molecules 
C3, C4, and C5. They induce smooth muscle contraction (nucleotide #332-363).
Saposin (B) Domains: Present in multiple copies in prosaposin and in pulmonary 
surfactant-associated protein B (nucleotide #361-436).
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Description and alignments of TsgalO residues with potential matches
M yosin  ta il-  described in result. 
Alignment of Mvosin tail 1 vs Tsga 10/25-765
* - > d l e r q k r e l e e q l k r k e s e l s q l s l k l E d E q a l v a q L q k k i k e l e a R  
+ + +  + e  + 1 s e +  + +  E q + + +  q  i +  1 +
T S G A 1 0  2 5  -ARVNTKEHQFGLGAPVSEAGRNQNTFQLEQEVRTQDR-FISTLKLQ 6 9
I e E L e E e L E a E R a A R a K a E k q R a D L s r E L E e L s E R L e E a g G a T a a Q i E l n
I e + L  + + L E e +  +L + +  a  + Q++
T S G A 1 0  7 0 I E D L ---------------------------------------------KQTNHDLEEYVRKLLDSKEAVSTQVD—  9 9
k K R E a E L a K L R r d L E E a n l q h E e a l a t L R K K H q d a i n E l s d Q i e q L q K q K  
+ +E +L K q  a  e  LqK K
T S G A 1 0  1 0 0 ------------------------------------ DLANHNEHLCKELIKLDQLA-------------------EKLQKEK 1 2 6
a k a E K e K s q l q a E v d d l l a q l d q i a K a K l n a E K k a k q l E s Q l s E l q v K l d  
+ + + d  + 1 +  + +  + + + +  + 1 E + + + + + 1 + +  +
T S G A 1 0  1 2 7 ------------------- N F W D T A D K --E L E E A K IE L I C Q Q N N IT V L E D T I Q R L K S IIL  1 6 6
E l q R q l n D l t s q K s R L q s E N s d L t r q l e E a E a q v s q l s k l K s q l e s Q L E e
E + + + +  + + + +  sR L  s  + L + + + +  + + + 1  k  + +
T S G A 1 0  1 6 7  ETEKA QNTSPSRLDSFVKTLEADRDYYKTEAQNLRKMMRNRSKS 2 1 0
A k R s l E E E s R e R a n L q a q l r n l e h D l D s l r E q l E E E s E A K a e l e R q L s K a  
R+ s R +  + 1 + +  ++ D  + 1 +  I E  + + e R  L + +
T S G A 1 0  2 1 1  -PRRPSPTSRAANCDVELLKSTARDREELKCM LE----------------- KYERHLAEI 2 5 2
n a e i q q w  r s K f E s E g a l r a E E l E E l K k K l n q k i s E l E e a a E a a n a
+ + + + + + + + + +  + E a +  EE 1 + +  + + +  + + + a +
T S G A 1 0  2 5 3  Q G N V K V L tserd K T F L L Y E Q A Q — EEIARLRREMMKSCKSPKSTTAHAIL 3 0 0
K c s s L E K t K s R L q s E l E D l q i e v E r a n a a a s e L E K K q k n F D K i l a E w K k k  
+ + +  E + + + +  + +  r  + +  +L + k  + + +  +K+
T S G A 1 0  3 0 1  RRVETER------------------------ DVAFTDLRRMTTERDSLRERLKIAQETAFNEKAH 3 4 1
v d e l q a E l e t A q r e a R n l s t E l f r l K n e l e E l k D q v E a L r R E N K n L q d E i  
+ + +  + E l e  n l  E + + k + + +  + + + + E  K+L+
T S G A 1 0  3 4 2  L E Q R IE E L E C  TVHNLDDERMEQMANMTLMKETITTVEKEMKSLA 3 8 5
k D L t d q L g E g G R n v H E L E K a r R r L E a E k d E L q a A L e E A E a A L e q e E s K v l  
+ + d +  +E GR aE  + L + e  E +L ++
T S G A 1 0  3 8  6 RKAMDTESELGRQ-----------------------------KAENNSLRLLYENTEKDLSDTQRHLA 4 2 4
R a q v E l s q i R s E i E R R L a E K E E E f E n . t R K n h q r . . a i e s L q a s L a E a E a  
E l  q +  +E + +  +E + + n  t R  n  + + + + i  L a + L  a
T SG A 10  4 2 5  K KK YEL-Q LTQ E--------- K IM C L D E K ID N fT R Q N IA Q re E IS IL G A T L -N D L A  4 6 9
K g K a E a l R . l K K K L E g d l n E L E i a L D h a N k a n a e a q K n v K k y q q q v k e L Q  
K K  + + 1 K K E  I + L  + + L  + k +  + +K n+
T SG A 10  4 7  0 K E K E C L Q A cL D K K SE -N IA SL G E SL A M K E K T -ISG M K N I------------------------------5 0 6
t q v E e e Q R a r e d a r e q l a v a E R R a t a L q a E l E E L r v a L e q a e R a R K q A E t  
+ E + e Q +  r +  + + +  + + E + + 1 + E  L q  R R
T SG A 10  5 0 7  -IA EM EQ ASRQ STEALI-M CEQ DISRM RRQ LDETNDELG Q IARERDILAH  5 5 4
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E l a E a s e r v n e L t a q n s s L i a q K R K L E g e l a a l q s D L D E a v n E l k a A e E R  
E + + + © +  + + n  + L +  + + © 1 + + +  + + + +  E
T S G A 1 0  5 5 5  ENDNLQEQFAKVKQENQALSKKLNDTHNELSDIKQKVQDTNLEVNKLKNI 6 0 4
a k k a q a D a a r L a e E L r q E Q e h s q k l E r l R K q L E s q v K e L q v R L . . d E a E a  
k + +  + e + L r +  6  + E+ q  E + +  L+ L + + E a E
T S G A 1 0  6 0 5  LKSEESENRQIMEQLRKANEDAENWENKARQTEAENNTLKLELitAEAEG 6 5 4
T S G A 1 0
a A l k g G K k v I q K L E a R V R e L E a E L d g E q R R h a e t q K n l R K a e R r v K E L q f  
+ l k +  K a  R e + E +  L +E R + +  + + + + 1  K+ + +  E +
6 5 5  NRLKE KVDALNREVEQHLNAE-RSYKSQIATLHKSLVKMEEELQ 6 9 7
Q v E E D k K n l e  r l Q D L v D K L q a K i K t y K R Q I E E a E E i a q i n l s K y R k
v  + k  + + + + + + + L  KL + + +  RQ1 + +
T S G A 1 0  6 9 8  K V Q F E K V S A L a d lsS T R E L C IK L D S S K E L L N R Q L ---------------VAKD---------------7 3 5
a Q r e L E d A E E R A D q A E s s l n k l R q r e a K s R r s O *
+ e + E  +E D A  s + +  + 1 R  + R s
T S G A 1 0  7 3 6  — QEIEM M ENELDSARSEIELLRSQ M TNERIS 7 6 5
EB1 (microtubule binding) - The human EB1 protein was originally discovered as a 
protein interacting with the C-terminus o f the APC protein. This interaction is often 
disrupted in colon cancer, due to deletions affecting the APC C-terminus. Several EB1 
orthologues are also included in this family. The interaction between EB1 and APC has 
been shown to have a potent synergistic effect on microtubule polymerization. Neither 
o f EB1 or APC alone has this effect. It is thought that EB1 targets APC to the + ends o f  
microtubules, where APC promotes microtubule polymerization. This process is 
regulated by APC phosphorylation by Cdc2, which disrupts APC-EB1 binding. Human 
EB1 protein can functionally substitute for the yeast EB1 homologue Mal3. In addition, 
Mal3 can substitute for human EB1 in promoting microtubule polymerization with 
APC.
Alignment of EB1 vs TsgalO/136-175
* - > g L E k E R D F Y F s K L R d I E i L C Q e T h e t e n s s l v d v k L e L v k r i q a I L Y  
+ L E + + +  IE + + C Q +  n +  + v  + + + r + + + I +
T s g a l O  1 3 6  E LEEA K ---------------------IE L I C Q Q  N N I T V L E - - D T I Q R L K S I I L  1 6 6
A T e e g f e h p O *
+ T e
T s g a l O  1 6 7  ETEKAQNTS 1 7 5
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M AP (E-MAP-115): The organisation o f microtubules is controlled by tissue-specific 
microtubule-associated proteins (MAPs). This protein is a microtubule-stabilising 
protein predominantly expressed in cell lines o f epithelial origin. It plays a role in 
epithelial polarization and differentiation during embryogenesis.
Alignment of E-MAP-115 vs TsgalO/215-388
* - > A P . g k a e n s . a A l s K p t A G T T D a e E A t r L L A E K . . R R qA R eQ rE kE E  
+ P + +  a + n  + +  1 K t A  D + eE  +L EK +R +A Q 
T s g a l O  2 1 5  S P tS R A A N C d V E L L K S T A — RDREELKCM L-EKyeRHLAEIQGNV—  2 5 6
q E R r e q e E r d r r k R E E l k r r a a E e R t l r r E e E A R r r E e e r a R e k e e k K K q  
+ +  E r d +  1 a  E e  + r +  E + + + +
T s g a l O  2 5 7  — K VLTSERDKTFL— LYEQAQEEI-ARLRREMMKSCKSPKSTTAHAILR 3 0 1  
E G E E K R K .A G E E lk R k A E E e L L L K e k r E q E e q E r A m iq k Q K E e A E a r a R E  
E R A  + 1 + R  E +  + r E +  + E + E
T s g a l O  3 0 2 -RVETERDvAFTDLRRMTTER DSLRERL KIAQ -------------------------ETAFNE 3 3 8
e A . . E r v R l E R E k h f q q e E Q E R l E R k K R L e E I M K R T R k s e v s e k V K k e D s  
A + E+ E E  ER+E + MK T + e  k+
T s g a l O  3 3 9  KAhlEQRIEELECTVHNLDDERMEQMANMT-LMKETITTVEKEM— KSLA 3 8 5
k e G < - *
+
T s g a l O  3 8 6  RKA 3 8 8
MAD- described in result.
Alignment of MAD vs Tsga 10/308-898
* - > D d l e s n t t v m a d s s n d r s i l r S a l n k f I s a r L e g s f s e L g v s t s c t y  
D+ + + t + +  + +  + r +  1 +  r L +
T S G A 1 0  3 0 8  DV A F T D L  RRMTTERD SLRERLK 3 2  9
r c R e m v k i e l k d a l s s l e k q v q e s m a l l q d l e s t n s k s r a e l i r l k f k L i  
a  + +  + + e  + 1 + q  + + 1 +  +
T SG A 1 0  3 3 0  -------------------------- IA Q E T A -------FNEKAHLEQ RIEELECTVH 3 5 4
T SG A 10
q l e n E l a q k e l e h k r a q l e L e k k a s t l a e r Y e r e i d k n q e L l t d l K q L e e  
+ 1 E + + + a  L k+  + + K L
3 5 5  NLDDE RMEQMANMTLMKE------------------------------ TITTVEKEMKSLAR 3 8 6
s e a k a e s e l a e a k E r l k q l e q k l d k L s e e l r k d a e s K k L ........................ qk E
+ e s e l  + + k + + + + + l + +  + + K + L + + + + + +  + k +
T SG A 10 3 8 7  KAMDTESELGRQKAENNSLRLLY E N T E K D L s d t q r h la K K K  4 2 7
k e d q q e d a k e s i s k l k n q l s e m q l r A q n a e t e l k l l e k e l e d l k e q l e e l  
e + q +  + + k  i  + 1  + + +  + + + + + e +  1 1 + 1
T SG A 10 4 2 8  YELQLTQEK— IM C L D E K ID N FT -----------------RQ NIAQ RE E ISIL G AT L N DL  4 68
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T S G A 1 0
T SG AIO
T SG AIO
TSG AIO
TSGAIO
TSG AIO
TSG AIO
TSGAIO
TSGAIO
TSG AIO
TSGAIO
TSGAIO
TSGAIO
q k e l S G F E q L R a E a e q k L q s l k a s q a e r a d n D D e q l i k h L e e e l k e y e q e  
k e +  E L a  + + k  + + +  + +  a  6 +  i +  + e  e q
4 6 9  AKEK-------ECLQACLDKKSENIASLGESLAMK— EKTISGMKNIIAEMEQA 5 1 3
v e v v K s m k e q l l r l . p e L E r e l e q l r e E n k k L k s s k e n n e L L k E e l e d l q  
+ e 1 + + r  q l e n L +  + + L e + l q
5 1 4  S  RQSTEALIMCeQDISRMRRQLDETNDELGQIARERDILAHENDNLQ 5 6 0
s k L e R a E k m r s k l a d L e l e n e k L e a e L k s W e i Y N D S D D D D D N N V N N N D N N  
+ + + a  e n +  L + + L +
5 6 1 ----------------------- EQFAKVKQENQALSKKLNDTH------------------------------------------------5 8 1
N N N K N D N N N D N N N D T S N N N n L l q n i g L k N n l r N t P e d i s r k i v e L Q k e e l
n  + 1 +  d i  + k +  + +  e +
5 8 2  ------------------------------------------------------- N ---------- E L S -----------DIKQKVQDTNLEVN 5 9 9
i l t e k n s s l t s d l k n L k t a n q q L q l e r q q a l a e i t e l k k k l e e l k a l n r R  
+ 1 + +  s  + s  + + +  + + + + + a +  + + +  + + k +  + a + n
6 0 0  K L K N IL K SE E SE N R Q ---------------- IMEQLRKANEDAENWENKARQTEAENNT 6 4 2
L q r r l s L v t k E r D l L R a i l d s L Y S A q N N A L y d s e n t e t e a S n q l v r r L e e  
L + 1 + + +  E + L + +  + d  N + n + e  + + +  q  +
6 4  3 LKLELITAEAEGNRLKEKVDA LNREVEQHLNAERSYKSQIA 6 8 3
Gm Hn. . i s a E d m v Q k v d s y k a k m E a l t v q L d v k e l e d e l g g q K d r a e t l e  
+H + + E + Q k v +  E +  + + +  + 1 + +  + + + +  1
6 8 4  TLHKslVKM EEELQKVQF EK------- V  SA L A DLSSTR ELCIK LD 7 2 1
k E l k l l k e q l s s n e r s l s f v k E a l n a e d f L r l k i e s L E r e r d r L r s e i a l  
+ 1 1 +  q l +  + +  + i e  E e + d  + r s e i + l
7 2 2  SSKELLNRQLVAKDQ---------------------------------------- EIEM M ENELDSARSEIEL 7 5 4
L E m k L e h l c L q G D Y s a s s t k V L h m s n n P a v k a e q i k k n t l e a L Q a . .  . E l  
L + + +  + s  L + + v  + +  + a L Q + + + + E +
7 5 5  LRSQMTN---------------- ERISM QNL-------- E A L L V A N R D K E Y Q SQ IA L Q E kesE I 7 94
e k L k e r L k a l E e g n e q a L v d l e p i v d s k i a e k E l a q L k k q v e s a E .............
+ L k e  L + + s  + + i  + +  + a q + + +  v  +E + +
7 9 5  QLLKEHL CLAENK---------------------M A IQ S R D V A Q F R N W T Q L E a d ld i  8 3 1
......................k r n q R L K e V F q t K i l E F R k A C y s L f G Y k l d R i d d q Q r s N G t p e
+ + + +  + +  r + + R  + + V  +E R+ y s  Y + + p +
8 3 2  t k r q l g t E R F E R E R A V -----------QELRRQNYSSNAYNLGPM------------------- KPN 8 68
s r y r l t S . . . m Y A e s d d d k L i f d l e s s s t s k c w l k L l e t a s s e t f e d l l d  
+ + + S + + +  + s + d  L+ + l e + +  +
8 6 9  T — K C H SperAH H R SPDRG L DR SL E E N L CY-------------------------------------------------- 8 9 6
l w l r k r n s i P A F l A a L T L E L F n k r t < - *
r +
8 9 7  --------------------------------------------------------RD 8 9 8
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The E R M  family consists o f three closely-related proteins, ezrin, radixin and moesin. 
Ezrin is known as a constituent o f microvilli PUBMED:6885906, radixin as a barbed, 
end-capping actin-modulating protein PUBMED:2500445, and moesin as a heparin 
binding protein PUBMED:3046603. A tumour suppressor molecule responsible for 
neurofibromatosis type 2 (NF2) which is named as merlin (moesin-ezrin-radixin-like 
protein) is highly similar to ERM proteins. ERM molecules contain 3 domains, a 
charged C-terminal domain PUBMED:9048483; an N-terminal globular domain; and an 
extended a-helical domain. Ezrin, radixin and merlin also contain a polyproline region 
between the helical and C-terminal domains. The N-terminal domain is highly 
conserved, and is also found in merlin, band 4.1 proteins and members o f the band 4.1 
superfamily. ERM proteins crosslink actin filaments with plasma membranes. They co- 
localise with CD44 at actin filament-plasma membrane interaction sites, associating 
with CD44 via their N-terminal domains and with actin filaments via their C-terminal 
domains PUBMED:9048483. Interestingly, myosin regulatory light chain interacting 
protein (MIR) belongs to ERM family (Bomhauser et al., 2003) while is localized 
specially to neurons in cerebellum and hippocampus. The presence o f it in brain 
neurons during development together with its known effects on neurite outgrowth is 
suggestive an important function o f it in nerve cell motility and cytoskeletal interaction 
regulation (Olsson et al., 2000).
Alignment of ERM vs Tsga 10/425-704
* -> N K K G T d L W L G V D A L G L N IY ek d D rL T P K IG F P W S E IR N IS F n D K K F v  
KK+ +L  +LT +K
TSG AIO  4 2 5  -K K K Y E L--------------------------------------- QLT------------------------------------QEK-----4 3 6
I K P i D K K A p d F v . . F Y a p r l R I N K R I L  aLCmGNHELYMRRRKPDT
I  +D K + + + F + + +  a + r  1 +  I L +  + ++L  
TSGAIO 4 3 7  IM C L D E K I D N F T r q N I A Q R E E I S — I L g a t l n D L ---------------------------------------- 4 68
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T SG AIO
I E V Q Q M K a Q A r E E K a l K q a E R e k L e r E k k a R E i a e k e k E e a E r e q q . . E l  
+K+ E + k k  i a  + a + + e +  + +
4 6 9   AKEKECLQACLDKKSENIASLGESLAMKEKTisGM 5 0 3
TSG AIO
e e r l k q m e E d m r r a q k e L e e s e e k a l e L e e k l k q e q e a a q k L e k k q k e l e  
+ + m e  + r  + + + L  e +  + + + 1  + +  + + + + + +  1 +
5 0 4  KNIIAEM EQASRQSTEALIMCEQDISRMRRQLDETNDELGQIARERDILA 5 5 3
TSG AIO
e e n r r L e e e a a a s e e E r e r L e a e v d e a t a e v a k l e e e r e k k e e E t e q l q a  
e n +  L + 6 +  a +  + E + L + + + +  + 6  + + +  + +  E+ + 1 +
5 5 4  HENDNLQEQFAKVKQENQALSKKLNDTHNELSDIKQKVQDTNLEVNKLKN 6 0 3
TSG AIO
e l r e a q e k e e e a k e e l l e v l a a p t a p p m h h v s a p e a E L t t d n g e q l e q d d  
1 + +  + + + e  1 + + + + +
6 0 4  IL K S E E SE N R Q IM E Q L --------------------------------------------------------- RKANEDAENW 6 2 9
TSG AIO
n g e e a s a d l e P k E F i L t d e d m k d r s n E i E e e R v t e a e k n e r l q t q L k a L k  
+ +  + + ©  + n  + + e  + t + +  r l + + +  + a L
6 3 0  ENKARQTEAE-----------------------------------NNTLKLELITAEAEGNRLKEKVDALN 6 6 5
T SGAIO
s E L a a v r d e s K . . e t a n D i l H e E N s v R a G r D K Y k T L R q I R k G N T K q R V D q  
+E + + +  + + + +  + + + +  1H v +  + L + q
6 6 6  REV E Q H L NA E RsyK SQ IAT L H K SL -VK M E E E  LQKV----------------------- Q 7 0 0
TSG AIO
F E s M O *
FE
7 0 1  FEKV 7 0 4
Prefoldin: This family comprises o f  several prefoldin subunits. The biogenesis o f the 
cytoskeletal proteins actin and tubulin involves interaction o f nascent chains o f each o f  
the two proteins with the oligomeric protein prefoldin (PFD) and their subsequent 
transfer to the cytosolic chaperonin CCT (chaperonin containing TCP-1).
Alignment of Prefoldin vs Tsga 10/440-548
* - > l k e e i e s L q a e l a r L q e a i e e l e k s l e t l k t l k k k e e d e g k e v l v p l  
l + e + i + + + + + +  + +  e e +  + + t l + + l  k + k e  1
TSGAIO 4 4 0  L D E K ID N F T R Q N I A Q R E E ISIL G A T  LN DLAK-------------EKECLQ—  4 7 6
g a g l f v k a e v i d t d k v l V d l G a g y y v E k s l e e A i e i L d k r i e e l e k q l e k  
a + + + + + + +  + + 1 G + +  + + + +  + +  + + e + + + + q +  +
TSGAIO 4 7 7   ACLDKKSENIASLGESLAMKEKTISGMKNIIAEMEQASRQSTE 5 1 9
. . . . l e e e l e k L r d q i t t l e a n l q q v q q k o *
+ e + + + +  r + q + + + +  + + 1  q + +  +
TSGAIO 5 2 0  a l im C E Q D ISR M R R Q L D E T N D E L G Q IA R E  5 4 8
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Rabaptin (growth factor activity)- Regeneration o f injured axons at neuromuscular 
junctions has been assumedto be regulated by extra-cellular factors that promote neurite 
outgrowth. A novel neurite outgrowth factor from chick denervated skeletal muscle has 
been cloned and characterised. The protein, termed neurocrescin (rabaptin), has been 
shown to be secreted in an activity-dependent fashion PUBMED:9427343.
Alignment of Rabaptin vs TsgalO/461-588
* - > k a i a t v s l e t l q e a a d v v k s k k r E e v a k v . . q a i e q E e v a s l e s s l k  
+ + 1  + e  + k k  E + a + + + +  ++ E  + s  +
TSG AIO  4 6 1  LGATLNDLAKEKECLQACLDKKSENIASLgeSLAM KEKTISGMKNII 5 0 7
d s l e s e e a q i a a y r e e s e r e i a d L r k k v r e l G N K L G R R C D m C S N Y E K q L q  
+ e + +  q  + e + + i  + r + + +  e  LG
TSG AIO  5 0 8  AEMEQASRQSTEALIMCEQDISRMRRQLDETNDELG------------------------------------5 4 3
G i q i q E A E t R D q v k K l l L s r a q e e d q L E k e M k k a q E d e e k L R e v v l p m e k  
q  A RD + a  e + d + L  + k  + L +
TSGAIO 5 4 4   Q I A R E R D I---------------- LAHENDNLQEQFAKVKQENQALSKKLNDTHN 5 8 2
e I e a L k < - *  
e  + k
TSG AIO  5 8 3  E L S D IK  5 8 8
Intermediate filaments (IF) PUBMED:8771189, PUBMED:3052284,
PUBMED:2183847 are proteins which are primordial components o f the cytoskeleton 
and the nuclear envelope. They generally form filamentous structures 8 to 14 nm wide.
Alignment of Filament vs Tsga10/547-830
* - > n E K e q m Q n L N D R L A s Y I d K V R f L E q q N k e L e v k i e e l r q k q s r g g p a  
E + + +  + ND L KV q+N +L k + + +  ++
TSGAIO 5 4 7  RERDILAHENDNLQEQFAKVK QENQALSKKLNDTHNEL---------------- 5 8 4
TSGAIO
s v s r l y s l Y e t . . . e i e e L R r q i d q l t n e r a r l q l E i d n l r e a l e d f r k K  
s  + + + +  + + +  e  + L + +  + + + + e +  ++  + +  + +  e + + e  ++K
5 8 5  — SDIKQKVQDtnlEVNKLKNILKSEESENRQIMEQLRKANEDAENW ENK 6 3 2
TSGAIO
y e d K e D L a a Q n q l k d l E i a l n t k e a e L a T a L . e R q e a E n d l v g L R a Q i A k  
+ E + + + n t +  e L  T a +  e  + + + + + L
6 3 3  ARQ------------------------------ TEAENNTLKLELITAEaEGNRLKEKVDAL--------------- 6 6 4
330
Appendices
TSG AIO
l E s l a a R k d l D e a T L a r v D L E n . . . . k v E s L q E E l a F L K k n H e E E v k e L q  
+ + + +  + + +  + E + +  + + + +  +L  1 + e E E +  + q
6 6 5  ------------- NREVE--------- QHLNAERsyksQIATLH KSLVK M ---------EEELQKVQ 7 0 0
T SG AIO
a q i q d t g q v n V E m D a a r q q E w k l D L t k a L r E i R a Q Y E e i A e k n r q e a E e w  
+ +  + +  + r  E + + L + +  + e
7 0 1  FE K V SA--------L A D L SST R — E L C IK L D S -------------------------------------------- SKEL 7 2 6
T SG AIO
Y k s K l e e L q t a a a r n g e a l r s a K e E i t E l R R q i Q s L e i E L q s l k s q n a s L  
+ + + 1  + + + + +  + 1  s a + + E i  1R q +  + i  q + 1  + + L
7 2 7  LNRQLVAKDQEIEMMENELDSARSEIELLRSQMTNERISMQNL EAL 7 7 2
TSG AIO
E r q l a E l E e r y e a e l a q y q a l i s q l E e e L q q l r e E M a r q L r E Y Q e L L d V K  
+ + +  E + +  + + 1 + +  + +  i +  1 e  L + + Ma q  r +  + +V  
7 7 3  LVANRDKEYQSQIALQEKESEIQLLKEHLCLAENKMAIQSRDVAQFRNW 8 2 2
TSG AIO
l a L D i E I A T Y R K L L E G E E s R O *  
+ L + +  +
8 2 3  TQLEA-----------------------------DLD 8 3 0
Tropomyosin- is a family o f closely related proteins present in muscle and non-muscle 
cells. In striated muscle, tropomyosin mediates the interactions between the troponin 
complex and actin so as to regulate muscle contraction. The role o f tropomyosin in 
smooth muscle and non-muscle tissues is not clear. Tropomyosin is an a-helical protein 
that forms a coiled-coil structure o f 2 parallel helices containing 2 sets o f 7 alternating 
actin binding sites PUBMED:6993480. There are multiple cell-specific isoforms, 
created by differential splicing o f the messenger RNA from one gene, but the 
proportions o f  the isoforms vary between different cell types.
Alignment of Tropomyosin vs Tsga 10/557-587
* - > D r L E D e L v a e K e k Y k a i s d e L D q t l n e L t g i < - *
D L + +  + +  K + +  a + s  L t  n e L +  i  
T s g a l O  5 5 7  DNLQEQFAKVKQENQALSKKLNDTHNELSDI 5 8 7
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Appendix C: Potential phosphorylation, glycolyzation and 
myrtolyzation sites of TsgalO (689 aa 
residues)
N-glycosylation site: PA N-{P>-[ST]-{P}
NRSK 4 - 7  NMTL 1 6 4 - 1 6 7  NNSL 2 0 0 - 2 0 3  NFTR 2 4 4 - 2 4 7
NDTH 3 7 6 - 3 7 9  NNTL 4 3 8 - 4 4 1  NYSS 6 5 2 - 6 5 5
1 1 0  2 0  3 0  4 0
m m r N R S K s p r r p s p t s r a a n c d v e l l k s t a r d r e e l k c m l e k y e r h l a e i  5 0  
q g n v k v l t s e r d k t f  l l y e q a q e e i a r l r r e i r i m k s c k s p k s t t a h a i l r r  1 0 0  
v e t e r d v a f t d l r r m t t e r d s l r e r l k i a q e t a f n e k a h l e q r i e e l e c t  1 5 0  
v h n l d d e r m e q m a N M T L m k e t i t t v e k e m k s l a r k a m d t e s e l g r q k a e N  2 0 0  
N S L r l l y e n t e k d l s d t q r h l a k k k y e l q l t q e k i m c l d e k i d N F T R q n i  2 5 0  
a q r e e i s i l g a t l n d l a k e k e c l q a c l d k k s e n i a s l g e s l a m k e k t i s g  3 0 0  
m k n i i a e m e q a s r q s t e a l i m c e q d i s r m r r q l d e t n d e l g q i a r e r d i l  3 5 0  
a h e n d n l q e q f a k v k q e n q a l s k k l N D T H n e l s d i k q k v q d t n l e v n k l k  4 0 0  
n i l k s e e s e n r q i m e q l r k a n e d a e n w e n k a r q t e a e N N T L k l e l i t a e a  4 5 0  
e g n r l k e k v d a l n r e v e q h l n a e r s y k s q i a t l h k s l v k m e e e l q k v q f e  5 0 0  
k v s a l a d l s s t r e l c i k l d s s k e l l n r q l v a k d q e i e m m e n e l d s a r s e i  5 5 0  
e l l r s q m t n e r i s m q n l e a l l v a n r d k e y q s q i a l q e k e s e i q l l k e h l c  6 0 0  
l a e n k m a i q s r d v a q f r n v v t q l e a d l d i t k r q l g t e r f e r e r a v q e l r r  6 5 0  
q N Y S S n a y n l g p m k p n t k c h s p e r a h h r s p d r g l d r s l e e n l c y r d f  6 9 7
cAMP- and cGMP-dependent protein kinase phosphorylation site: 
PA [RK](2)-x-[ST]
RRPS 1 0 - 1 3  RRMT 1 1 3 - 1 1 6
1 1 0  2 0  3 0  4 0
m m r n r s k s p R R P S p t s r a a n c d v e l l k s t a r d r e e l k c m l e k y e r h l a e i  5 0  
q g n v k v l t s e r d k t f l l y e q a q e e i a r l r r e i n m k s c k s p k s t t a h a i l r r  1 0 0  
v e t e r d v a f t d l R R M T t e r d s l r e r l k i a q e t a f n e k a h l e q r i e e l e c t  1 5 0  
v h n l d d e r m e q m a n m t l m k e t i t t v e k e m k s l a r k a m d t e s e l g r q k a e n  2 0 0  
n s l r l l y e n t e k d l s d t q r h l a k k k y e l q l t q e k i m c l d e k i d n f t r q n i  2 5 0  
a q r e e i s i l g a t l n d l a k e k e c l q a c l d k k s e n i a s l g e s l a m k e k t i s g  3 0 0  
m k n i i a e m e q a s r q s t e a l i m c e q d i s r m r r q l d e t n d e l g q i a r e r d i l  3 5 0  
a h e n d n l q e q f a k v k q e n q a l s k k l n d t h n e l s d i k q k v q d t n l e v n k l k  4 0 0  
n i l k s e e s e n r q i m e q l r k a n e d a e n w e n k a r q t e a e n n t l k l e l i t a e a  4 5 0  
e g n r l k e k v d a l n r e v e q h l n a e r s y k s q i a t l h k s l v k m e e e l q k v q f e  5 0 0  
k v s a l a d l s s t r e l c i k l d s s k e l l n r q l v a k d q e i e m m e n e l d s a r s e i  5 5 0  
e l l r s q m t n e r i s m q n l e a l l v a n r d k e y q s q i a l q e k e s e i q l l k e h l c  6 0 0  
l a e n k m a i q s r d v a q f r n v v t q l e a d l d i t k r q l g t e r f e r e r a v q e l r r  6 5 0  
q n y s s n a y n l g p m k p n t k c h s p e r a h h r s p d r g l d r s l e e n l c y r d f  6 9 7
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Protein kinase C phosphorylation site :
SPR 8 - 1 0  
SCK 8 5 - 8 7  
SLR 1 2 1 - 1 2 3  
SKK 3 7 2 - 3 7 4  
SS K  5 2 0 - 5 2 2
TSR 1 5 - 1 7  
SPK 8 8 - 9 0  
SLR 2 0 2 - 2 0 4  
TLK 4 4 0 - 4 4 2  
SAR 5 4 5 - 5 4 7
TAR 2 9 - 3 1  
TER 1 0 3 - 1 0 5  
TEK 2 1 0 - 2 1 2  
SYK 4 7 5 - 4 7 7  
TKR 6 3 0 - 6 3 2
PA [ST]-x-[RK]
SER 5 9 - 6 1  
TER 1 1 7 - 1 1 9  
TQR 2 1 7 - 2 1 9  
STR 5 1 0 - 5 1 2  
TER 6 3 6 - 6 3 8
1 1 0  2 0  3 0  4 0
m m r n r s k S P R r p s p T S R a a n c d v e l l k s T A R d r e e l k c m l e k y e r h l a e i  5 0  
q g n v k v l t S E R d k t f l l y e q a q e e i a r l r r e m m k S C K S P K s t t a h a i l r r  1 0 0  
v e T E R d v a f t d l r r m t T E R d S L R e r l k i a q e t a f n e k a h l e q r i e e l e c t  1 5 0  
v h n l d d e r m e q m a n m t l m k e t i t t v e k e m k s l a r k a m d t e s e l g r q k a e n  2 0 0  
n S L R l l y e n T E K d l s d T Q R h l a k k k y e l q l t q e k i m c l d e k i d n f t r q n i  2 5 0  
a q r e e i s i l g a t l n d l a k e k e c l q a c l d k k s e n i a s l g e s l a m k e k t i s g  3 0 0  
m k n i i a e m e q a s r q s t e a l i m c e q d i s r m r r q l d e t n d e l g q i a r e r d i l  3 5 0  
a h e n d n l q e q f a k v k q e n q a l S K K l n d t h n e l s d i k q k v q d t n l e v n k l k  4 0 0  
n i l k s e e s e n r q i m e q l r k a n e d a e n w e n k a r q t e a e n n T L K l e l i t a e a  4 5 0  
e g n r l k e k v d a l n r e v e q h l n a e r S Y K s q i a t l h k s l v k m e e e l q k v q f e  5 0 0  
k v s a l a d l s S T R e l c i k l d S S K e l l n r q l v a k d q e i e m m e n e l d S A R s e i  5 5 0  
e l l r s q m t n e r i s m q n l e a l l v a n r d k e y q s q i a l q e k e s e i q l l k e h l c  6 0 0  
l a e n k m a i q s r d v a q f r n v v t q l e a d l d i T K R q l g T E R f e r e r a v q e l r r  6 5 0  
q n y s s n a y n l g p m k p n t k c h s p e r a h h r s p d r g l d r s l e e n l c y r d f  6 9 7
Casein kinase II phosphorylation site: PA [ST]-x(2)-[DE]
TARD 2 9 - 3 2 SERD 5 9 - 6 2 TERD 1 0 3 - 1 0 6 TERD 1 1 7 - 1 2 0
SLRE 1 2 1 - 1 2 4 TTVE 1 7 3 - 1 7 6 TESE 1 8 9 - 1 9 2 TEKD 2 1 0 - 2 1 3
TLND 2 6 2 - 2 6 5 SLGE 2 8 6 - 2 8 9 TNDE 3 3 6 - 3 3 9 THNE 3 7 8 - 3 8 1
TNLE 3 9 2 - 3 9 5 TEAE 4 3 4 - 4 3 7 STRE 5 1 0 - 5 1 3 SSKE 5 2 0 - 5 2 3
S E I E 5 4 8 - 5 5 1 TQLE 6 2 1 - 6 2 4 SLEE 6 8 7 - 6 9 0
1 1 0 2 0 3 0 4 0
m m r n r s k s p r r p s p t s r a a n c d v e l l k s T A R D r e e l k c m l e k y e r h l a e i  5 0  
q g n v k v l t S E R D k t f l l y e q a q e e i a r l r r e m m k s c k s p k s t t a h a i l r r  1 0 0  
v e T E R D v a f t d l r r m t T E R D S L R E r l k i a q e t a f n e k a h l e q r i e e l e c t  1 5 0  
v h n l d d e r m e q m a n m t l m k e t i T T V E k e m k s l a r k a m d T E S E l g r q k a e n  2 0 0  
n s l r l l y e n T E K D l s d t q r h l a k k k y e l q l t q e k i m c l d e k i d n f t r q n i  2 5 0  
a q r e e i s i l g a T L N D l a k e k e c l q a c l d k k s e n i a S L G E s l a m k e k t i s g  3 0 0  
m k n i i a e m e q a s r q s t e a l i m c e q d i s r m r r q l d e T N D E l g q i a r e r d i l  3 5 0  
a h e n d n l q e q f a k v k q e n q a l s k k l n d T H N E l s d i k q k v q d T N L E v n k l k  4 0 0  
n i l k s e e s e n r q i m e q l r k a n e d a e n w e n k a r q T E A E n n t l k l e l i t a e a  4 5 0  
e g n r l k e k v d a l n r e v e q h l n a e r s y k s q i a t l h k s l v k m e e e l q k v q f e  5 0 0  
k v s a l a d l s S T R E l c i k l d S S K E l l n r q l v a k d q e i e m m e n e l d s a r S E I  5 5 0  
E l l r s q m t n e r i s m q n l e a l l v a n r d k e y q s q i a l q e k e s e i q l l k e h l c  6 0 0  
l a e n k m a i q s r d v a q f r n v v T Q L E a d l d i t k r q l g t e r f e r e r a v q e l r r  6 5 0  
q n y s s n a y n l g p m k p n t k c h s p e r a h h r s p d r g l d r S L E E n l c y r d f  6 9 7
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Tyrosine kinase phosphorylation site: PA [RK] -x(2 ,3) - [DE] -x(2 ,3) -Y
RSLEENLCY 6 8 6 - 6 9 4
1 1 0  2 0  3 0  4 0
m m r n r s k s p r r p s p t s r a a n c d v e l l k s t a r d r e e l k c m l e k y e r h l a e i  5 0  
q g n v k v l t s e r d k t f  l l y e q a q e e i a r l r r e m m k s c k s p k s t t a h a i l r r  1 0 0  
v e t e r d v a f t d l r r m t t e r d s l r e r l k i a q e t a f n e k a h l e q r i e e l e c t  1 5 0  
v h n l d d e r m e q m a n m t l m k e t i t t v e k e m k s l a r k a m d t e s e l g r q k a e n  2 0 0  
n s l r l l y e n t e k d l s d t q r h l a k k k y e l q l t q e k i m c l d e k i d n f t r q n i  2 5 0  
a q r e e i s i l g a t l n d l a k e k e c l q a c l d k k s e n i a s l g e s l a m k e k t i s g  3 0 0  
m k n i i a e m e q a s r q s t e a l i m c e q d i s r m r r q l d e t n d e l g q i a r e r d i l  3 5 0  
a h e n d n l q e q f a k v k q e n q a l s k k l n d t h n e l s d i k q k v q d t n l e v n k l k  4 0 0  
n i l k s e e s e n r q i m e q l r k a n e d a e n w e n k a r q t e a e n n t l k l e l i t a e a  4 5 0  
e g n r l k e k v d a l n r e v e q h l n a e r s y k s q i a t l h k s l v k m e e e l q k v q f e  5 0 0  
k v s a l a d l s s t r e l c i k l d s s k e l l n r q l v a k d q e i e m m e n e l d s a r s e i  5 5 0  
e l l r s q m t n e r i s m q n l e a l l v a n r d k e y q s q i a l q e k e s e i q l l k e h l c  6 0 0  
l a e n k m a i q s r d v a q f r n v v t q l e a d l d i t k r q l g t e r f e r e r a v q e l r r  6 5 0  
q n y s s n a y n l g p m k p n t k c h s p e r a h h r s p d r g l d R S L E E N L C Y r d f  6 9 7  
N-myristoylation site: PA G-{EDRKHPFYW}-x(2)-[STAGCN]-{P}
GATLND 2 6 0 - 2 6 5  GLDRSL 6 8 3 - 6 8 8
1 1 0  2 0  3 0  4 0
m m r n r s k s p r r p s p t s r a a n c d v e l l k s t a r d r e e l k c m l e k y e r h l a e i  5 0  
q g n v k v l t s e r d k t f l l y e q a q e e i a r l r r e m m k s c k s p k s t t a h a i l r r  1 0 0  
v e t e r d v a f t d l r r m t t e r d s l r e r l k i a q e t a f n e k a h l e q r i e e l e c t  1 5 0  
v h n l d d e r m e q m a n m t l m k e t i t t v e k e m k s l a r k a m d t e s e l g r q k a e n  2 0 0  
n s l r l l y e n t e k d l s d t q r h l a k k k y e l q l t q e k i m c l d e k i d n f t r q n i  2 5 0  
a q r e e i s i l G A T L N D l a k e k e c l q a c l d k k s e n i a s l g e s l a m k e k t i s g  3 0 0  
m k n i i a e m e q a s r q s t e a l i m c e q d i s r m r r q l d e t n d e l g q i a r e r d i l  3 5 0  
a h e n d n l q e q f a k v k q e n q a l s k k l n d t h n e l s d i k q k v q d t n l e v n k l k  4 0 0  
n i l k s e e s e n r q i m e q l r k a n e d a e n w e n k a r q t e a e n n t l k l e l i t a e a  4 5 0  
e g n r l k e k v d a l n r e v e q h l n a e r s y k s q i a t l h k s l v k m e e e l q k v q f e  5 0 0  
k v s a l a d l s s t r e l c i k l d s s k e l l n r q l v a k d q e i e m m e n e l d s a r s e i  5 5 0  
e l l r s q m t n e r i s m q n l e a l l v a n r d k e y q s q i a l q e k e s e i q l l k e h l c  6 0 0  
l a e n k m a i q s r d v a q f r n v v t q l e a d l d i t k r q l g t e r f e r e r a v q e l r r  6 5 0  
q n y s s n a y n l g p m k p n t k c h s p e r a h h r s p d r G L D R S L e e n l c y r d f  6 9 7
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Potential phosphorylation sites for protein kinase GSK3 (C-terminal +4 S must be 
prephosphorylated):
•  T - 1 1 7  RMTTERDS
•  S - 2 8 6  N IA SL G E S
•  T - 4  8 2  QIATLHKS
•  T - 6 6 6  KPNTKCHS
No phosphorylation sites for protein kinase MLCK found.
Potential phosphorylation sites for protein kinase p34cdc2:
•  S - 8  RSKSPRR
•  S - 6 7 0  KCHSPER
•  S - 6 7 8  HHRSPDR
Potential phosphorylation sites for protein kinase p70s6k:
•  S - 8  RNRSKSPRR
Potential phosphorylation sites for protein kinase PKA:
•  S - 6  RNRSKSP
•  S - 1 3  R R PSPT S
•  T - 6 4  RDKTFLL
•  T - 1 0 3  RVETERD
•  T - 1 1 6  RRMTTER
•  S - 1 2 1  RDSLRE
•  T - 3 1 6  RQSTEAL
•  T - 4 3 4  RQTEAE
•  S - 5 6 3  RISMQN
Potential phosphorylation sites for protein kinase PKG:
•  S - 1 3  R R P S P T S
•  T - 1 1 6  RRMTTER
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O-glycosylation potential
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Appendices
Appendix D: The composition of buffers, solutions and media
Buffers, solutions, and media were prepared using glass-distilled deionised 
water. Solutions were autoclaved or filtered to sterilise where appropriate.
LB (Lauria-Bertani) medium, per litre
B actotryp ton e  
Y e a st extract 
N a C l
10g
5g
10g
soc
2 0  g /L  B actotryp ton e
5 g /L  Y e a st extract
lO m l/L  1 M  N a C l 
2 .5  m l/L  1 M  KC1 
10 m l/L  1 M  M g C l2 • 6  H 20  
10 m l/L  1 M  M g S 0 4 • 7  H 20  
2 0  m l/L  1 M  g lu c o se  
9 6 0  m l/L  d e io n ise d  H 20
TAE buffer (50X), per litre
T ris b ase  2 4 2 g
G lacia l a ce tic  a c id  57 .1  m l
E D T A  0 .5 M , p H 8 .0  100 m l
A d just to  p H 7 .2  and bring th e  fina l v o lu m e  to  1 litre w ith  d istilled  w ater
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SSC buffer(20X)- 500ml
NaCl 87.7
Na-citrate 44. lg
TE buffer (IX), per litre
Tris base
EDTA, sodium salt
Solutions for R N A  ISH
Hybridisation Buffer
Substance 1 ml 10 mis Final
Cone.
10 x Salts 100 pi 1 ml lx
formamide 500 pi 5 mis 50%
50% Dextran Sulphate 200pl 2 mis 10%
tRNA (10 mg/ml) 100 pi 1 ml 1 mg/ml
50 x Denhardts 5 pi 50 pi 1 x
ddwater 90 pi 900 pi
1.21g
0.372g
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lOx Salts
Substance Amount
NaCl 114 g
Tris HCL pH7.5 14.04 g
Tris Base 1.34 g
NaH2P 0 4-2H20 7.8 g
Na2H P04 7-1 g
0.5 M EDTA 100 mis
water to 1000 mis
Washing Solution
lx  SSC, 50% formamide, 0.1% Tween-20.
MABT
100 mM Maleic acid, 150 mM NaCl, 0.1% Tween-20
For 5x stock: the maleic acid dissolved, titrated with NaOH and the rest was added.
(e.g. for 1 litre: 58 g maleic acid, titrate, 43.8 g NaCl, 5 mis Tween-20)
(a 5X stock o f MAB was made and then added the tween as needed as it goes off)
M-Block
MABT + 2% Blocking Reagent1 + 20% heat-inactivated serum.
('Blocking Reagent is Boehringer’s own made up in maleic acid at 10% stocks, autoclaved and frozen in 
aliquots)
500ul stocks of M block made and by using 5XMAB, 0.5% tween, 10% blocking reagent; stored at -  
20C. To make working solution o f  M block, 500ul frozen M block was used, then 500ul lamb serum  
and 1.5ml water were added, and flnaly heated at 70C for 30min then cooled.
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Staining B uffer
For 25 mis:
Substance Amount Final Cone.
5 M NaCl 0.5 mis 100 mM
1 M MgCl 1.25 mis 50 mM
1 M Tris pH9.5 2.5 mis 100 mM
Tween-20 25 |il 0.1%
To 25 mis with water
Dissolving Buffer
50% Glycerol 2.5ml
dH20 6.55ml
0.5M Tris-HCl pH6.8 0.8ml
10% SDS 2.5ml
2-Mercaptoethanol 0.6ml
Bromophenol Blue small end o f spatula
2X Treatm ent Buffer
0.125 M Tris, pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, and 0.05% 
bromphenol blue
0.5 M Tris, pH 6.8 25%
DTT 0.031 gr/ml
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Sample Buffer (for veast protein extraction) 
pH=6.8
Tris-HCl 0.5 M,
NaV (sodium orthovanadate, inhibitor o f phosphatase)
SDS-PAGE Running Buffer 
pH8.3 - for 4.51itres
0.025M Tris 13.6g
0.192M Glycine 64.8g
0.1% SDS 45ml
TGM Transfer Buffer pH 8.3 - 5 Litres
25mMTris 15.15g
192mM Glycine 72.0g
20% Methanol 1 litre
Dissolve Tris and Glycine in 4 litres dH2 0  then add Methanol. (pH shouldn’t need 
adjusting but check.)
Western Blot Blocking Buffer
5% Fat-free dried milk in PBS
342
Appendices
Yeast
SD - synthetic dropout
6.7g Yeast nitrogen base without amino acids 
850ml H20
100ml appropriate sterile lOxdropout solution *
For plates, 20g agar was added to the above. Nutrients omitted according to the selection required, see 
below.
10 x dropout solution
200 mg/L L-Adenine hemisulfate salt
200 mg/L L-Arganine HC1
200 mg/L L-Histidine HC1 monohydrate
300 mg/L L-Isoleucine
1000 mg/L L-Leucine
300 mg/L L-Lysine HC1
200 mg/L L-Methionine
500 mg/L L-Phenylalanine
2000 mg/L L-Threonine
200 mg/L L-Tryptophan
300 mg/L L-Tyrosine
200 mg/L L-Uracil
1500 mg/L L-Valine
YPD
20g/L Difco peptone 
1 Og/L Yeast extract
For plates, 20g/L agar was added to the above. For Kanamycin-containing medium, add 10-15 mg/L 
Kanamycin.
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PEG/LiAc solution - Polyethylene glvcol/Lithium acetate
For 100ml o f  solution:
80 ml 50% PEG 4000
10 ml l O x T E
10 ml lO x L iA c
Herring testes carrier DNA - Supplied by Clontech lOpg/pl 
DMSO - Dimethyl sulphoxide 100%
PBS 67mM potassium phosphate pH 7.5
Lyticase - Supplied by Clontech
Phenol:chloroform:isoamyl alcohol- (25:24:1)
Ammonium acetate - 10 M
Solution PI - E. coli mini-prep resuspension buffer (pH = 8)
50 mM Glu
25mM Tris HC1
lOmM EDTA
Solution P2 - E. coli mini-prep lvsis solution
0.2 M NaOH
1% SDS
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Solution P3 -_____ E. coli mini-prep precipitation solution
For 200 |il o f  solution:
120 (0.1 5M Potassium acetate
23 |xl 37% acetic acid
47 pi dd H20
EtBr - Ethidium bromide
DNA taq pol - T. aquatieus thermostable DNA polymerase
Supplied by Advanced Biotechnologies
10 x buffer IV - Supplied by Advanced Biotechnologies
Contents o f  vial:
1.25 ml of: 200 mM (NH4)2S 0 4
750 mM Tris-HCl, pH 8.8 at 25°C 
0.1% (v/v) Tween® 20
15 mM MgCl
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Appendix E Vectors maps and information
£co01091
CGfP m IMS
Ase\ SnaB I
£co47 III
HSVTK
BsrG I
4.7 kb
IXD
Stu I
•m m 13 so -I39D 1«0
IAC AAG TCCGGCCGG ACT CAG ATC TCG A6CTCA AGC TTC GAATTC TGC AGTCGACGG TAC CGCGGG CCC GGG ATCCAC CGG ATCTAGATA ACTJAJ CA
Eag\ fig/II Xio\ | K/id III kd  I hiT f c / l  Kfi\ " ^  \litni I
[cf\3 6 II A cc l A*p71ll \ « m 12B I * w I  
t ac  II Sou I
Xbl'
pEGFP-C2 (BD) vectors map and its MCS
Hind II!
Ofi y AOHJ
GAL 4 
DNA-BO
MCS
pGBKT7
7.3 kb
Vind
pUC
o ri
ofi
a  c-M yc ep ito p e  tag
pGBKT7 (BD) vectors maps
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MCS 
Nile I 
Nco I 5*1 fee* I 
S/rwl
Xntal 
BfirwH I Sfl/I,F«I
Murine pS3 insert
I’ ii t» l
PGBKT7 
•  3 M>
A m c-Myc epitope tag
Figure 3. Map of pGBKT7-53 DNA-BD C ontrol Vector. pGBKT7-53 encodes a  fusion of the 
murine p53 protein (a.a. 72-390) and the GAL-4 DMA-BO (a a. 1-147). The murine p53 cDNA 
(GenBank A ccession 4K01700> w as cloned mtopGBKT7 a t the EcoR t and AarnH I sites. The p53 
insert w as derived from the plasmid described in iwabocN era/. (1993>: plasmid modification was 
performed at CLONTECH. pGBKT7-53 h a s  not b een  sequenced.
MCS Bp/tl Ndel 
5*1 
f c o f i l  
Sin* I
Xma I 
CUl 
BnmM I Seel 
Xhel -
h«HLt 
0«.4 Alp G A 0 T 7
8*  kb
SV40 large T-antigen
itv :
HA epitope tug
F igure 4. Map of pGADT7-T AO C ontro l Vector. pGADT7-T encodes a  lesion of the SV40 large 
T-antigen <a a  eft-708) and  the GAL4 AD <a.a. 768-8*1). The SV40 large T DNA (G enB ar* Locus 
SV4CG) w n i derived from a  plasmid referenced in Li & Fields (1903) and w as cloned Into pGADT7 
using the EcoR I and Xho  I sites. pGADT7-T h as not been sequenced.
M C S  
fcofll 
Sma I 
BapiH I 
San 
Pst\ 
Bgl II
Sph\ Wind III Kpn I 
Mfu ISnaB I
A 0H 1
GA14,
AO
A E H I
Amp'
Pvu I
Bgl I
C/a I
Pvu 11
pGAD424 plasmid map (BD Clontech) and its MCS
347
